
<html lang="en"     class="pb-page"  data-request-id="3fc711a9-4363-467d-a3cf-d6cb15166bf5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00662;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-14;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1" /></meta><meta name="dc.Creator" content="Sanjeev  Kumar" /></meta><meta name="dc.Creator" content="Jesse P.  Waldo" /></meta><meta name="dc.Creator" content="Firoz A.  Jaipuri" /></meta><meta name="dc.Creator" content="Agnieszka  Marcinowicz" /></meta><meta name="dc.Creator" content="Clarissa  Van Allen" /></meta><meta name="dc.Creator" content="James  Adams" /></meta><meta name="dc.Creator" content="Tanay  Kesharwani" /></meta><meta name="dc.Creator" content="Xiaoxia  Zhang" /></meta><meta name="dc.Creator" content="Richard  Metz" /></meta><meta name="dc.Creator" content="Angela J.  Oh" /></meta><meta name="dc.Creator" content="Seth F.  Harris" /></meta><meta name="dc.Creator" content="Mario R.  Mautino" /></meta><meta name="dc.Description" content="A novel class of 5-substituted 5H-imidazo[5,1-a]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate t..." /></meta><meta name="Description" content="A novel class of 5-substituted 5H-imidazo[5,1-a]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 18, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00662" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00662" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00662" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00662" /></link>
        
    
    

<title>Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00662" /></meta><meta property="og:title" content="Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0042.jpeg" /></meta><meta property="og:description" content="A novel class of 5-substituted 5H-imidazo[5,1-a]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate the 5H-imidazo[5,1-a]isoindole core and to improve potency and pharmacological properties. Suitably placed hydrophobic and polar functional groups in the lead molecule allowed improvement of IDO1 inhibitory activity while minimizing off-target liabilities. Structure–activity relationship studies focused on optimizing IDO1 inhibition potency and a pharmacokinetic profile amenable to oral dosing while controlling CYP450 and hERG inhibitory properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00662"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00662">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00662&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00662&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00662&amp;href=/doi/10.1021/acs.jmedchem.9b00662" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6705-6733</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00672" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00706" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Clinical Candidate (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sanjeev Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sanjeev Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sanjeev++Kumar">Sanjeev Kumar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jesse P. Waldo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jesse P. Waldo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jesse+P.++Waldo">Jesse P. Waldo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Firoz A. Jaipuri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Firoz A. Jaipuri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Firoz+A.++Jaipuri">Firoz A. Jaipuri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Agnieszka Marcinowicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agnieszka Marcinowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agnieszka++Marcinowicz">Agnieszka Marcinowicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clarissa Van Allen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clarissa Van Allen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clarissa++Van+Allen">Clarissa Van Allen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Adams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Adams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Adams">James Adams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tanay Kesharwani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tanay Kesharwani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tanay++Kesharwani">Tanay Kesharwani</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8193-0004" title="Orcid link">http://orcid.org/0000-0001-8193-0004</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoxia Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoxia Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxia++Zhang">Xiaoxia Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Metz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Metz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Metz">Richard Metz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela J. Oh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela J. Oh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela+J.++Oh">Angela J. Oh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Seth F. Harris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seth F. Harris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seth+F.++Harris">Seth F. Harris</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mario R. Mautino</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mario R. Mautino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NewLink Genetics Corporation, Ames, Iowa 50010, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1d70707c68697473725d717473766d337e7270"><span class="__cf_email__" data-cfemail="4a27272b3f3e2324250a262324213a64292527">[email protected]</span></a>. Phone: 515-598-2927. Fax: 515-296-3520.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mario+R.++Mautino">Mario R. Mautino</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2729-4996" title="Orcid link">http://orcid.org/0000-0003-2729-4996</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00662&amp;href=/doi/10.1021%2Facs.jmedchem.9b00662" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6705–6733</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 April 2019</li><li><span class="item_label"><b>Published</b> online</span>18 June 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00662" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00662</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6705%26pageCount%3D29%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSanjeev%2BKumar%252C%2BJesse%2BP.%2BWaldo%252C%2BFiroz%2BA.%2BJaipuri%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D14%26contentID%3Dacs.jmedchem.9b00662%26title%3DDiscovery%2Bof%2BClinical%2BCandidate%2B%25281R%252C4r%2529-4-%2528%2528R%2529-2-%2528%2528S%2529-6-Fluoro-5H-imidazo%255B5%252C1-a%255Disoindol-5-yl%2529-1-hydroxyethyl%2529cyclohexan-1-ol%2B%2528Navoximod%2529%252C%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BIndoleamine%2B2%252C3-Dioxygenase%2B1%26numPages%3D29%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6733%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00662"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2354</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00662" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sanjeev&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Jesse&quot;,&quot;last_name&quot;:&quot;P. Waldo&quot;},{&quot;first_name&quot;:&quot;Firoz&quot;,&quot;last_name&quot;:&quot;A. Jaipuri&quot;},{&quot;first_name&quot;:&quot;Agnieszka&quot;,&quot;last_name&quot;:&quot;Marcinowicz&quot;},{&quot;first_name&quot;:&quot;Clarissa&quot;,&quot;last_name&quot;:&quot;Van Allen&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Adams&quot;},{&quot;first_name&quot;:&quot;Tanay&quot;,&quot;last_name&quot;:&quot;Kesharwani&quot;},{&quot;first_name&quot;:&quot;Xiaoxia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Metz&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;J. Oh&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;F. Harris&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;R. Mautino&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6705-6733&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00662&quot;},&quot;abstract&quot;:&quot;A novel class of 5-substituted 5H-imidazo[5,1-a]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate the 5H-imidazo[5,1-a]isoindole core and to improve potency and pharmacological properties. Suitably placed hydrophobic and polar functional groups in the lead molecule allowed improvement of IDO1 inhibitory activity while minimizing off-target liabilities. Structure–activity relationship studies focused on optimizing IDO1 inhibition potency and a pharmacokinetic profile amenable to oral dosing while controlling CYP450 and hERG inhibitory properties.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00662&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00662" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00662&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00662" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00662&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00662" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00662&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00662&amp;href=/doi/10.1021/acs.jmedchem.9b00662" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00662" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00662" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00662%26sid%3Dliteratum%253Aachs%26pmid%3D31264862%26genre%3Darticle%26aulast%3DKumar%26date%3D2019%26atitle%3DDiscovery%2Bof%2BClinical%2BCandidate%2B%25281R%252C4r%2529-4-%2528%2528R%2529-2-%2528%2528S%2529-6-Fluoro-5H-imidazo%255B5%252C1-a%255Disoindol-5-yl%2529-1-hydroxyethyl%2529cyclohexan-1-ol%2B%2528Navoximod%2529%252C%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BIndoleamine%2B2%252C3-Dioxygenase%2B1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D14%26spage%3D6705%26epage%3D6733%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (6)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292460" title="Bioinorganic chemistry">Bioinorganic chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/jmcmar.2019.62.issue-14/20190725/jmcmar.2019.62.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0042.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel class of 5-substituted 5<i>H</i>-imidazo[5,1-<i>a</i>]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate the 5<i>H</i>-imidazo[5,1-<i>a</i>]isoindole core and to improve potency and pharmacological properties. Suitably placed hydrophobic and polar functional groups in the lead molecule allowed improvement of IDO1 inhibitory activity while minimizing off-target liabilities. Structure–activity relationship studies focused on optimizing IDO1 inhibition potency and a pharmacokinetic profile amenable to oral dosing while controlling CYP450 and hERG inhibitory properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Indoleamine 2,3-dioxygenase 1 (IDO1) is a 45 kDa cytosolic monomeric heme-dioxygenase that catalyzes the initial and rate-limiting oxidative cleavage of the 2,3-indole position of <span class="smallcaps smallerCapital">l</span>-tryptophan (<span class="smallcaps smallerCapital">l</span>-Trp) and incorporates both atoms of molecular oxygen (O<sub>2</sub>), resulting in the production of <i>N</i>-formyl kynurenine. The main function of IDO1 is the regulation of acquired local and peripheral immune tolerance in normal and pathological scenarios. IDO1-expressing cells are found constitutively in many normal tissues where IDO1 regulates local inflammation and moderates responses against pathogens as well as to foreign or uncommon nonpathological antigens. Constitutive IDO1 activity is also found at the maternal–fetal interface, where IDO1 plays a critical role in the induction of maternal immune tolerance to the father-derived allogeneic antigens expressed by the fetus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> IDO1 expression can also be induced in antigen-presenting cells of the immune system in response to inflammation signals and is subject to complex regulation by an array of immunological signals. In response to inflammatory signals, IDO1 exerts its immunosuppressive effects by both local depletion of tryptophan (Trp) and by the generation of kynurenine (Kyn). Degradation of Trp deprives cells of an essential nutrient, triggering changes in metabolism and protein synthesis that can result in changes of cellular function. Cells have sensing mechanisms to detect deficiency in any amino acid, thus allowing them to transiently stop noncritical protein synthesis and coordinate a survival response. One such amino-acid deficiency-sensing mechanism is the stress kinase GCN2, which contains a regulatory domain that binds uncharged amino acid free-tRNA. When GCN2 binds uncharged tRNA, this activates its kinase domain, which phosphorylates the ribosomal initiation factor eIF2α.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In its phosphorylated configuration, p-eIF2α prevents the translation of most mRNA species, except those involved in compensation responses to starvation stress.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> In addition to depleting Trp, IDO1 generates a series of bioactive downstream metabolites along the Kyn pathway. Kyn and other Trp metabolites are immunologically active ligands for the aryl hydrocarbon receptor (AhR).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The AhR is a ligand-activated transcription factor, which regulates transcription of genes that include IDO1<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and FoxP3, a key transcription factor that controls differentiation of Foxp3<sup>+</sup> regulatory T cells (Tregs),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> which are a population of cells that play a key role in the regulation of immune responses.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The activation of both the GCN2 and AhR pathways leads to differentiation and activation of Tregs, the induction of anergy of effector T cells, and modulation of the function and phenotype in antigen-presenting cells. Together, these IDO1-driven changes mediate local and systemic immunosuppressive effects that block immune response.</div><div class="NLM_p">Given the important role of IDO1 in control of acquired immune tolerance, it is not surprising that the IDO1 pathway is induced in tumor cells and in host immune cells and contributes to acquired immunologic tolerance toward those tumors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> IDO1 expression and activity is observed in many types of tumors, including melanoma, leukemia, pancreatic, ovarian, colorectal, endometrial, and prostate cancers, and its expression is associated with significantly worse clinical outcomes.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> IDO1 can also be expressed by cells of the host immune system that are associated with tumors, where it contributes to acquired immunologic tolerance of tumors.</div><div class="NLM_p last">Consequently, inhibition of IDO1 activity to restore immune response against tumors is an area of active interest, triggering the development of numerous classes of IDO1 inhibitory compounds in the last decade.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Here, we describe our structure–activity relationship (SAR) strategy and efforts that resulted in the selection of the clinical development candidate navoximod (<b>NLG-919</b>), starting from the available crystal structure of IDO1 complexed with the inhibitory compound 4-phenyl imidazole (<b>1</b>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Substitution of the Phenyl Ring of <b>1</b></h3><div class="NLM_p">Our present work in this area stems from the published X-ray crystal data of IDO1 complexed with <b>1</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and the preliminary studies by Kumar et al. on these structures.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In 5-(2-hydroxyphenyl)imidazole (<b>3</b>), the increase of 10-fold in potency with respect to <b>1</b> (hIDO1 IC<sub>50</sub> = 28 μM) was attributed to the hydrogen bonding interactions of hydroxyl with Ser167 in the IDO1 active site. Docking studies with <b>3</b> showed that small substituents might be accommodated at 3′, 5′, and 6′-positions of the phenyl ring. By diligently selecting a combination of small hydrophilic and hydrophobic moieties, we were able to increase the potency to about 5-fold over <b>3</b> to generate <b>11</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The compounds that showed submicromolar activity are <b>4–6</b>, <b>8</b>, and <b>11</b>, indicating that the IDO1 active site has a small pocket that could accommodate a hydrophobic group para to 2′-OH (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Switching the Cl and F positions in <b>11</b> resulted in substantial loss of activity (<b>14</b>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Predicted binding mode for <b>11</b> (magenta) minimized in the IDO1 pocket using the crystal IDO1 structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a> (hydrogen bonding and heme interaction with <b>11</b> shown with the red dotted line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Substitution on the Phenyl Ring of <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0032.gif" alt="" id="GRAPHIC-d7e421-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">3′</th><th class="colsep0 rowsep0" align="center">5′</th><th class="colsep0 rowsep0" align="center">6′</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">LE<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.7 (4.8)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">–Cl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">–Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">–Br</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.76</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.96</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">–OH</td><td class="colsep0 rowsep0" align="left">4.7<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left">–Cl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">–Cl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">–Cl</td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Biochemical LE.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Value determined previously.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div></div></div><div class="NLM_p">The most potent compound of this series was <b>11</b> and it showed very good biochemical ligand efficiency; however, it showed a significant 6-fold shift in cellular potency and had a very short half-life in vivo (<i>t</i><sub>1/2</sub> < 1 h). The short half-life was attributed to high clearance (CL) because of the phase 2 metabolization of phenol (data not reported). Several prodrugs of phenol were synthesized to overcome the metabolic liability, but in vivo PK could not be improved (data not reported). We decided to remove the phenolic hydroxyl group and attempted substitutions on <i>N</i>-1 nitrogen to achieve favorable interactions within the active site. In an attempt to gain hydrogen bond interactions between hydrogen bond donors and the heme propionate, compounds with different linker lengths such as primary alcohol <b>15</b>, amides <b>18</b> and <b>23–24</b> were prepared. However, these attempts led to compounds with only marginal inhibitory activity (<b>23</b>) or inactive compounds (<b>15</b>, <b>18</b>, and <b>24</b>). Hydrophobic side chains such as 2,2-dimethylbutyl <b>21</b> and cyclohexyl <b>22</b> were explored in an attempt to gain favorable van der Waals interactions with Phe226. However, these approaches did not afford any improvement in the activity compared with parent compounds <b>3</b> and <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Nonetheless, they indicated that substitutions on <i>N</i>-1 imidazole could be tolerated, confirming that <i>N</i>-1 of the imidazole ring points toward the open region of the active site.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Substitution on the <i>N</i>-1 of <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0033.gif" alt="" id="GRAPHIC-d7e811-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">2′</th><th class="colsep0 rowsep0" align="center">5′</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CONHMe</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">187</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>CONHMe</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">Next, we turned our attention to the hydrophobic pocket formed by Phe163 and Phe226, independent of the interactions between 2-OH and Ser167. In order to access the hydrophobic pocket, ether analogues of <b>3</b> were synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The active site seems to be able to accommodate a wide range of hydrophobic groups and linker lengths while showing improvement in enzymatic inhibition with respect to the parent compound <b>1</b>. Comparison between benzyl, phenethyl, and phenpropyl ethers showed that the ethylene linker was more favorable than methylene and propylene linkers (<b>26–28</b>). <i>t</i>-Butyl <b>29</b> and <i>i</i>-propyl <b>30</b> were well tolerated with acceptable biochemical ligand efficiencies. Cycloalkyl compounds with 3-, 5-, and 6-membered rings (<b>31–33</b>) connected to an <i>O</i>-ethylene linker were nearly equipotent in biochemical assays and also had good biochemical ligand efficiencies. Notably, an <i>O</i>-ethylene linker terminating with a cyclohexyl group (<b>33</b>) was nearly equipotent with phenol (<b>3</b>) in biochemical assay. Side chains terminating with polar heterocycles such as pyrimidine <b>34</b> or pyrazole <b>35</b> resulted in the loss of biochemical IDO1 inhibition and decreased ligand efficiencies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of the Linker Length and Distal Hydrophobic Group on 2′-Phenylethers</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0034.gif" alt="" id="GRAPHIC-d7e1040-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0035.gif" alt="" id="gr33" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Biochemical LE. -: not determined.</p></div></div><div></div></div><div class="NLM_p">With these data in hand, we investigated whether a hybrid molecule of <b>3</b> and <b>33</b> would provide a synergistic effect on improving potency (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). A combination of the 2′-OH and 6′-ethylcyclohexyl ether side chain resulted in slight improvement in biochemical activity (<b>36</b>) as compared to parent <b>33</b>, but was equipotent with <b>3</b>. This data suggest that only one component, 2′-hydroxyl or 6′-ethylcyclohexyl ether, is contributing to the binding energy of <b>36</b> and that the optimal conformation adopted within the active site for each group is not compatible with the preferred binding mode provided by the combined substituents. The molecular conformation of <b>36</b> shows that because of increased torsional strain between the phenyl and imidazole rings, the phenyl and imidazole rings are at a dihedral angle of 45°.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Compound <b>36</b> was not considered for further optimization as it exhibited a large shift in cellular activity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of Combination on IDO1 Inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effect of Molecular Rigidification on IDO1 Activity</h3><div class="NLM_p">One established strategy to increase membrane permeability and cellular potency of small molecule inhibitors is to reduce the number of rotatable bonds.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In order to reduce the number of rotatable bonds, we envisioned restricting the rotation of the carbon–carbon single bond of phenyl imidazole by synthesizing fused rigid derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). A methylene linker fusing the <i>N</i>-1 and 2′-position of the phenyl ring (<b>37</b>) improved biochemical IDO1 inhibition 4-fold over <b>1</b> with improved ligand efficiency. Two carbon linker-containing compounds, oxazepine derivative <b>44</b> and imidazo[5,1-<i>a</i>]isoquinoline <b>45</b>, resulted in the loss of IDO1 inhibition. In order to exploit interactions of the imidazoisoindole ring with Ser167, we explored whether the addition of a 9-OH group would substantially improve binding affinity (<b>41</b>). However, <b>41</b> was found to be biochemically equipotent with <b>37</b>, suggesting that the phenolic OH group on <b>41</b> does not interact with Ser167 in a similar orientation as the 2′-OH group of phenylimidazole series. Energy minimization of <b>37</b> in the IDO1 active site revealed that the methylene carbon vector toward the opening of the pocket could potentially accommodate various substituents (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). This presented an excellent opportunity for further modifications to explore 5<i>H</i>-substituted imidazoisoindole analogues. Given the comparable biochemical potency of the imidazoisoindoles, <b>37</b> and <b>41</b>, and the potential metabolic sensitivity of phenolic compounds to glucuronidation,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> we chose to explore substituents on <b>37</b> instead of <b>41</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>37</b> (magenta) minimized in the IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) pocket (receptor surface shown in gray, heme, and ligand interaction shown by red dashes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of Rigidification on Phenylimidazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0036.gif" alt="" id="gr34" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Biochemical LE. -: not determined.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Substitution at the C5-Position of the Imidazo[5,1-<i>a</i>]isoindole Core and Lead Identification</h3><div class="NLM_p">Aiming to engage favorable interactions within the IDO1 active site, our focus turned toward synthesizing imidazo[5,1-<i>a</i>]isoindole analogues containing functional groups that might form favorable interactions with the heme propionate side chain or residues Phe226, Ser263, Ser235, or Arg231. We extended <b>37</b> by substituting the 5-methylene carbon of 5<i>H</i>-imidazo[5,1-<i>a</i>]isoindole. Because phenylimidazole <b>33</b> containing an ethylcyclohexyl ether side chain had good biochemical IDO1 inhibition when compared to <b>1</b>, we synthesized fused analogue <b>46</b> by incorporating an ethylcyclohexyl side chain onto the 5-position of the imidazoisoindole core. Racemic imidazoisoindole <b>46</b> exhibited superior biochemical (IC<sub>50</sub> = 0.135 μM) and cellular inhibition of IDO1 (EC<sub>50</sub> = 1.1 μM) when compared to <b>33</b> and to <b>37</b>, representing a >20-fold improvement in cellular potency, suggesting that molecular rigidification improved biochemical and cellular potency. Docking studies suggested that the <i>S</i>-enantiomer of <b>46</b> would be best accommodated, establishing hydrophobic interactions with Phe226, while the <i>R</i>-enantiomer of <b>46</b> would likely make an unfavorable clash with Ser263 and Ala264 residues (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>S</i>-Isomer of racemate <b>46</b> (magenta) minimized in IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) and cyan dashes show distance (4.2 Å) between the heme propionate side chain and methylene carbon linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Targeting Interactions with Heme Propionate</h3><div class="NLM_p">In the minimized structure of <i>S</i>-<b>46</b>, the linker methylene adjacent to the cyclohexyl ring is within close proximity (4.2 Å) of the heme propionate side chain (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). We envisioned that a suitably placed hydrogen bond donor or basic amine could form a hydrogen bond or have ionic interaction, respectively, with the heme propionate side chain, while at the same time reduce its clogP to improve solubility and cellular potency. Hydroxyl and amino groups were introduced into <b>46</b> giving rise to <b>52</b> and <b>54</b>. Amine analogue <b>54</b> was not tolerated in the side chain. Interestingly, diastereomeric mixture <b>52</b> bearing a hydroxyl group on the side chain was 13-fold more potent (EC<sub>50</sub> = 83 nM) in cellular IDO1 inhibition assay when compared to parent imidazo[5,1-<i>a</i>]isoindole <b>46</b>. An analogous noncyclized derivative <b>48</b> was found to be >100-fold less active than <b>52</b>, highlighting the importance of restricting conformational freedom and orienting the hydroxyl group vector toward the heme propionate to form a hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of C11 substitution to target heme propionate interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of Various Substituents at C5 of the Imidazo[5,1-<i>a</i>]isoindole Core on IDO1 Inhibition</h3><div class="NLM_p">We evaluated different substituents at the C5 position that could afford favorable interactions with the IDO1 enzyme (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Owing to the difficulty in separating and isolating individual diastereomers for each compound, initial efforts were focused on the evaluation of IDO1 inhibition for the mixture of diastereomers of each compound. Compounds lacking a cycloalkyl group such as <b>57</b> and <b>58</b> were 100-fold less potent than <b>52</b>, suggesting that a combination of van der Waals interactions arising from the cyclohexyl moiety and hydrogen bonding by the hydroxyl group is required for potent IDO1 inhibition. Cyclopentyl derivative <b>61</b> resulted in a 2.5 fold decrease in biochemical IDO1 inhibition compared to that of <b>52</b>. Increasing the linker length by one carbon between the hydroxyl and cyclohexyl of <b>52</b> resulted in significant loss in potency (<b>63</b>). A ketone functional group (<b>64</b>) was not tolerated in the side chain. Presumably, electron pair repulsion between the carbonyl oxygen’s lone pair and the heme propionate side chain decreases the binding efficiency of <b>64</b>, resulting in a loss of potency. In case of pyridine analogues <b>67</b>, <b>69</b>, and <b>71</b>, 4-pyridyl derivative <b>71</b> was equipotent with the corresponding phenyl analogue <b>65</b>, indicating that binding to IDO1 was highly dependent upon the position of the heteroatom in the aromatic ring side chain; presumably, the heteroatom in the 4-pyridyl analogue occupies the solvent-exposed region. Polar functional groups were not tolerated near hydrophobic residue Phe226 within the IDO1 pocket. Pyran analogue <b>73</b> resulted in a 10-fold decrease in IDO1 potency. A similar trend was observed with 5-membered azoles such as thiazole <b>75</b>, <i>N</i>-methyl-imidazole <b>77</b>, and <i>N</i>-methyl-pyrazole <b>79</b> or with basic secondary amines such as piperidine <b>84</b> and azetidine <b>85</b>. However, the carbamate derivatives of azetidine or piperidine (<b>81</b> and <b>83</b>) were found to be >25-fold more active as compared to the corresponding free amines. Six-membered ring carbamate <b>83</b> was preferred over the corresponding azetidine <b>81</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cyclic Side Chain Modification of 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0037.gif" alt="" id="gr35" /></img><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Optimization of Piperidine Analogues of 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindoles</h3><div class="NLM_p">The nitrogen atom in piperidine analogue <b>84</b> offered a convenient handle for derivatization to possibly improve potency and drug-like properties.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A library of piperidine amide and urea analogues was prepared and representative examples are shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Acyclic and cyclic aliphatic or aromatic R-groups <b>87–89</b> resulted in a decrease in potency compared to <b>83</b>. A methylene linker between the phenyl ring and amide bond was required to maintain potent IDO1 inhibition as evidenced by a 60-fold improvement in IDO1 inhibition from <b>89</b> to <b>90</b> and <b>91</b>. The urea derivate <b>94</b> also exhibited a similar profile. Unfortunately, these compounds showed potent CYP3A4 inhibition. Lowering clogP by introducing heteroatoms in the phenyl ring (<b>92–93</b>) improved the CYP3A4 profile at the expense of decrease in IDO1 potency. In general, structural modifications that were incorporated to mitigate CYP liabilities resulted in loss of IDO1 potency. Because of their propensity to be potent inhibitors of multiple CYP isoforms, piperidine derivatives were no longer considered for further development as potent IDO1 inhibitors.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Analogues of <i>N</i>-Piperidine Amides of 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindoles<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0038.gif" alt="" id="gr36" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">-: not determined.</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Lead Optimization of <b>52</b></h3><div class="NLM_p">Because optimization of the piperidine series based on <b>84</b> did not yield good lead candidates, we focused lead optimization efforts on cyclohexyl derivative <b>52</b>. Because of difficulty in developing methods to synthesize and separate pure stereoisomers for each compound, the initial lead optimization efforts were carried out on mixtures of diastereomers. Compound <b>52</b> exhibited high in vitro CL (HLM Clint = 18.03 mL/min/kg) and potent CYP3A4 inhibition (0.17 μM). Therefore, we focused our efforts on mitigating CYP3A4 inhibition and improving the metabolic stability of <b>52</b> while maintaining potency. First, the effect of small halogen substitutions on the phenyl ring of the imidazo[5,1-<i>a</i>]isoindole core was investigated (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Substitutions with fluoro or chloro at the 7 or 8-position resulted in a loss of potency. Specifically, substitution at the 8-position by fluoro or chloro (<b>100</b> and <b>106</b>) resulted in a >60-fold decrease in biochemical inhibition, suggesting tight fitting of the imidazo[5,1-<i>a</i>]isoindole core in the IDO1 pocket ceiling and in a different position compared to what was inferred for the mode of binding of phenylimidazole <b>11</b>. However, a fluoro group placed at the 6-position in <b>96</b> maintained potent IDO1 inhibition and improved the CYP3A4 profile about 10-fold.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effect of Substituents on the Phenyl Ring of the 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindole Pharmacophore<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0039.gif" alt="" id="gr37" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">-: not determined.</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Mitigating CYP450 and Human Liver Microsomal CL</h3><div class="NLM_p">We then focused our efforts on improving the hepatic CL of lead molecule <b>96</b> (18.91 mL/min/kg). We hypothesized that the high CL of <b>96</b> could be due to poor metabolic stability of the cyclohexyl group. First pass metabolism of cycloalkyl groups is a well-documented pathway.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We presumed C15 of the cyclohexyl side chain to be the hot spot for metabolization, and several strategies were explored to circumvent high CL in human liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Blocking the C15-position by a geminal-difluoro group offered modest improvement in CL as observed in compounds <b>108</b> and <b>110</b>. Other C15-cyclohexyl modifications such as methylcarboxylate <b>112</b> and ketone <b>114</b> resulted in decreased IDO1 inhibition. Benzamides <b>116</b> and <b>118</b> derived from 4-<i>trans</i> and 4-<i>cis</i> cyclohexyl amines, respectively, exhibited promising activity against IDO1, but these compounds exhibited poor aqueous solubility near neutral pH and suffered from moderate CYP3A4 and CYP2D6 inhibition.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effect of Substituents on the Distal Cyclohexyl Ring<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0040.gif" alt="" id="gr38" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">* solubility data in μM: <b>120</b> (pH 1 = 353; pH 6.5 = 329; pH 7.4 = 316); <b>118</b> (pH 1 = 400; pH 6.5 = 65; pH 7.4 = 56); <b>116</b> (pH 1 = 363; pH 6.5 = 22; pH 7.4 = 25).</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">−: not determined.</p></div></div><div></div></div><div class="NLM_p last">Modeling of the (C5 <i>S</i>, C11 <i>R</i>) stereoisomer of <b>52</b> within the IDO1 active site revealed that the C15-position of the cyclohexyl ring is within close proximity to Ser235 and Arg231 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). We hypothesized that a polar group at the C15-position could improve IDO1 activity by interacting with Ser235 or Arg231. Furthermore, introduction of a polar group would lower clogP, which could improve the CYP3A4 inhibition profile. Several case studies have established that compounds with lower clogP tend to decrease the risk of potent CYP3A4 inhibition and drug–drug interactions,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> while also leading to improvement in metabolic stability.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Substitution at the C15-position by a hydroxyl group resulted in significant improvement in human microsomal CL (4.06 mL/min/kg) and improved CYP profile (<b>120</b>) while maintaining IDO1 potency. By decreasing the clogP of lead candidate <b>96</b> (clogP = 3.64), CYP inhibition and high CL were greatly improved. Overall, <b>120</b> (clogP = 1.55) had the best balance of potency, metabolic stability, off-target liabilities, and physiochemical properties (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Stereochemistry and IDO1 Activity Relationship</h3><div class="NLM_p">Because <b>120</b> is a mixture of eight stereoisomers, we first determined the effect of C5 and C11 stereochemistry on isomers isolated from the active analogue <b>52</b>, which only contains two chiral centers. For this purpose, diastereomers of compound <b>52</b> were isolated by chiral SFC, giving rise to stereoisomers <b>121–124</b>. The absolute stereochemistry of each stereoisomer was determined by X-ray crystallography and <sup>1</sup>H NMR. These <i>syn</i> and <i>anti</i> enantiomer pairs showed a typical splitting pattern by <sup>1</sup>H NMR for C5–H, with a triplet δ 5.39 (<i>J</i> = 6.3 Hz, 1H) or a doublet of doublet δ 5.48 (<i>J</i> = 10.6, 3.2 Hz, 1H), respectively. Stereochemistry at the C5 ring junction plays an important role in the binding of imidazo[5,1-<i>a</i>]isoindole derivatives within the IDO1 active site. C5 <i>S</i>-substituted imidazoisoindole compounds were drastically more potent than the corresponding C5 <i>R</i>-stereoisomers, just as it had been predicted by in silico modeling. Stereoisomers <b>124</b> and <b>123</b> were 100-fold to 1000-fold more active than their corresponding C5 <i>R</i>-stereoisomers <b>121</b> and <b>122</b> in biochemical IDO1 assay. C11 <i>S</i>-hydroxy stereoisomer <b>123</b> was over 5-fold more potent than C11 <i>R</i>-hydroxy stereoisomer <b>124</b> in an IDO1 biochemical inhibition assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Evaluation of <b>52</b> isomers toward IDO1 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We hypothesized that the cyclohexyl moiety occupies the hydrophobic region near Phe226 and the hydroxyl group forms hydrogen bond interaction with the heme propionate side chain (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Our modeling hypothesis was later confirmed by the recently published X-ray cocrystal structure of various 5-<i>H</i>-substituted imidazoisoindole analogues bound to IDO1.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>124</b> minimized in the IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) pocket; ligand–receptor interactions including hydrogen bond shown by red dashes. The cyan dashes shows the distance between C15 of cyclohexyl and Ser235 oxygen (4.4 Å) and Arg231 nitrogen (4.4 Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Effect of Stereochemistry in <b>120</b> and Selection of NLG-919</h3><div class="NLM_p">Encouraged by the overall profile of <b>120</b>, we synthesized both <i>cis</i> (<b>126</b>) and <i>trans</i>-cyclohexanol (<b>127</b>) derivatives. <i>cis</i> and <i>trans</i>-cyclohexanol derivatives <b>126</b> and <b>127</b>, respectively, were equipotent in biochemical assays as mixtures of diastereomers (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). Diastereomeric mixtures <b>126</b> and <b>127</b> were separated by chiral SFC. As observed with the stereoisomers of compound <b>52</b>, the predominant effect on IDO1 activity was determined by the stereochemistry of C5.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Effect of Stereochemistry on C5 and C11<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0041.gif" alt="" id="gr39" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">−: not determined.</p></div></div><div></div></div><div class="NLM_p"><i>trans</i>-Cyclohexanol C5-<i>S</i> isomers <b>NLG-919</b> and <b>132</b> were 100-fold and 70-fold more potent than their corresponding C5-<i>R</i> isomers <b>133</b> and <b>134</b>, respectively. Similarly, <i>cis</i>-cyclohexanol isomers <b>130</b> and <b>128</b> were 35-fold and 3-fold more potent than their C5 <i>R</i>-isomers <b>129</b> and <b>131</b>, respectively. The stereochemistry of the C11–OH group also played an important secondary role in IDO1 inhibition, with the <i>R</i>-isomer being 2-fold to 5-fold more active than the corresponding <i>S</i>-isomer. Similarly, the stereo configuration of the cyclohexanol group played an important role, with the trans configuration being 3-fold to 10-fold more potent than the <i>cis</i> form. <b>NLG-919</b> exhibited superior biochemical and cellular potency, an acceptable CYP450 profile, low hERG inhibition (71 μM), low protein binding (<i>f</i><sub>u</sub> 52%), low CL in human liver microsomes (8.52 mL/min/kg), and excellent solubility at a wide pH range (>200 μM at pH 1–7.4).</div><div class="NLM_p">The biochemical potency of <b>NLG-919</b> (IC<sub>50</sub> 28 nM) was close to the concentration of the enzyme being used in the enzymatic potency assay, indicating that <b>NLG-919</b> is a tight binding inhibitor of IDO1. Determination of <i>K</i><sub><i>i</i></sub> was performed by measuring <i>v</i><sub><i>i</i></sub>/<i>v</i><sub>0</sub> at IDO1 enzyme concentrations of 63–1080 nM in the presence of varying concentrations of <b>NLG-919</b> (0–8100 nM) followed by nonlinear fitting of the data to the Morrison equation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This analysis indicated that <b>NLG-919</b> has a <i>K</i><sub><i>i</i></sub> of 5.8 nM. An analysis of the mode of inhibition by determination of IC<sub>50</sub> at different concentrations of <span class="smallcaps smallerCapital">l</span>-Trp (10–400 μM) indicated that <b>NLG-919</b> inhibits IDO1 activity in an uncompetitive or a noncompetitive mode with respect to the <span class="smallcaps smallerCapital">l</span>-Trp substrate with α < 1. The noncompetitive or uncompetitive mode of inhibition with respect to <span class="smallcaps smallerCapital">l</span>-Trp was determined under conditions of pseudo-first order, assuming a nonlimiting concentration of O<sub>2</sub>, the second substrate of the reaction, and is in agreement with the proposed mode of binding of <b>NLG-919</b> directly coordinated to heme Fe<sup>2+</sup>.</div><div class="NLM_p">The binding mode was corroborated by determination of the crystal structure of <b>NLG-919</b> bound to hIDO1. The core imidazoisoindole maintains its anticipated iron-coordinated position with the upper tricyclic scaffold, forming tight van der Waals contacts in the hydrophobic cavity created by IDO1 residues Val130, Phe163, Phe164, and Leu234. This positioning accounts for the dramatic negative impact of halogens at C-7 and C-8 in compounds <b>98</b> and <b>100</b>, while the design of the C-6 fluoro-substituent is well-braced to C-α of Gly262, providing positive contribution to potency. The stereochemistry of the linker positions its hydroxyl group to achieve the designed hydrogen bond with the heme propionate, while the cyclohexanol moiety continues outward toward the solvent-accessible opening of the heme-proximal cavity, its saturated bulk affording contacts in the widening channel. Additionally, the terminal hydroxyl is able to form hydrogen bond interaction with Ser235, giving a specific orientation to the distal end of the ligand. Combined, the interplay of stereochemistry and the observed interactions provides a consistent account for the potency and selectivity of <b>NLG-919</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>NLG-919</b> bound to human IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3I">6O3I</a>). The protein is colored ivory. The heme molecule is displayed in light blue ball-and-stick, highlighting protein/heme interactions at the propionate (yellow dashes) and the iron atom (grey dashes). Hydrogen bonds from <b>NLG-919</b> to the protein are indicated in red dashes, and select residues in the immediate vicinity of the binding site are shown in stick and labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Pharmacological Properties of <b>NLG-919</b></h3><div class="NLM_p"><b>NLG-919</b> showed favorable pharmacological properties that prompted us to select it as a clinical development candidate. First, <b>NLG-919</b> was not extensively metabolized by human or rat microsomes, with >85% remaining after 90 min incubation in the presence of Phase I + II cofactors. Second, <b>NLG-919</b> showed no CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP2C19 (IC<sub>50</sub> > 100 μM) inhibition; a weak inhibitory effect for CYP2D6 (IC<sub>50</sub> 86 μM) and moderate inhibitory effect on CYP3A4 with IC<sub>50</sub> values of 5.7 μM (midazolam) or 15 μM (testosterone). In Caco-2 assay, <b>NLG-919</b> was highly permeable (22.7 × 10<sup>–6</sup> cm/s from A to B, 35.0 × 10<sup>–6</sup> cm/s from B to A) and demonstrated an efflux ratio <2 in the presence of verapamil at 100 μM, indicating that <b>NLG-919</b> is not a potential substrate for P-glycoprotein (P-gp). <b>NLG-919</b> did not activate the arylhydrocarbon receptor (AhR) at 10 μM and it exhibited low transactivation of PXR at 300 μM, suggesting low probability of CYP450 induction.</div><div class="NLM_p">The pharmacokinetics of <b>NLG-919</b> was studied in rats, mice, and dogs. Following single intravenous doses at 10–50 mg/kg in SD rats, <b>NLG-919</b> exhibited a half-life (<i>t</i><sub>1/2</sub>) of 1 h, and the CL was about 23–39.1 mL/min/kg. CL decreased with the increased dose level, indicating inverse dose-dependent CL and saturation of elimination pathways. In C57Bl6 mice, the CL was found to be ∼26 mL/min/kg with a <i>t</i><sub>1/2</sub> of 3–4 h. Following a single IV dose administration to dogs, <b>NLG-919</b> exhibited variable <i>t</i><sub>1/2</sub>, ranging from 1.6 to 6.9 h. <b>NLG-919</b> was rapidly eliminated in rats with a plasma CL value ranging from 41.4 to 59.3 mL/min/kg. A similar trend of decreasing CL with increased dose was observed in dogs, though to a lesser extent than in rats. The systemic exposure increased proportionally as the dose was increased from 1 to 25 mg/kg. Following single oral doses at 10, 25, and 50 mg/kg in SD rats, <b>NLG-919</b> was rapidly absorbed (<i>T</i><sub>max</sub> = 0.5 h) and exhibited moderate oral bioavailability of 41–60% with a <i>t</i><sub>1/2</sub> of about 1 h. In C57Bl6 mice, <b>NLG-919</b> exhibited high oral bioavailability of 69 and 87% for the dose levels of 10 and 100 mg/kg, respectively, and a <i>t</i><sub>1/2</sub> of ∼1 h for lower doses and 3 h for the higher dose. In dogs, oral bioavailability increased from 14% at 5 mg/kg to 72% at 150 mg/kg, suggesting saturation of metabolic CL at higher doses (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Single Dose Pharmacokinetic Profile of <b>NLG-919</b> in Different Species after IV and Oral Dosing<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" align="center" char=".">CL (mL/min/kg)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">AUC<sub>0–inf</sub> (ng·h/mL)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="rowsep1 colsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">IV</th><th class="colsep0 rowsep0" align="center" char=".">IV</th><th class="colsep0 rowsep0" align="center" char=".">PO</th><th class="colsep0 rowsep0" align="center" char=".">IV</th><th class="colsep0 rowsep0" align="center" char=".">PO</th><th class="colsep0 rowsep0" align="center" char=".">PO</th><th class="colsep0 rowsep0" align="center" char=".">% F</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">44.6</td><td class="colsep0 rowsep0" align="char" char=".">3930</td><td class="colsep0 rowsep0" align="char" char=".">1630</td><td class="colsep0 rowsep0" align="char" char=".">1.44</td><td class="colsep0 rowsep0" align="char" char=".">1.05</td><td class="colsep0 rowsep0" align="char" char=".">1560</td><td class="colsep0 rowsep0" align="char" char=".">41.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">32.0</td><td class="colsep0 rowsep0" align="char" char=".">13 400</td><td class="colsep0 rowsep0" align="char" char=".">7975</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">1.15</td><td class="colsep0 rowsep0" align="char" char=".">6420</td><td class="colsep0 rowsep0" align="char" char=".">60.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">23.2</td><td class="colsep0 rowsep0" align="char" char=".">34 950</td><td class="colsep0 rowsep0" align="char" char=".">15 400</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char=".">10 050</td><td class="colsep0 rowsep0" align="char" char=".">44.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">27.5</td><td class="colsep0 rowsep0" align="char" char=".">6132</td><td class="colsep0 rowsep0" align="char" char=".">3777</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2257</td><td class="colsep0 rowsep0" align="char" char=".">69.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">25.0</td><td class="colsep0 rowsep0" align="char" char=".">34 633</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">60 195</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">14 165</td><td class="colsep0 rowsep0" align="char" char=".">87.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">59.3</td><td class="colsep0 rowsep0" align="char" char=".">282</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">56.1</td><td class="colsep0 rowsep0" align="char" char=".">901</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">207</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">132</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">53.7</td><td class="colsep0 rowsep0" align="char" char=".">3127</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">1045</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">1400</td><td class="colsep0 rowsep0" align="char" char=".">22.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">41.4</td><td class="colsep0 rowsep0" align="char" char=".">10 050</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">8645</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">7855</td><td class="colsep0 rowsep0" align="char" char=".">43.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">57 750</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">40 450</td><td class="colsep0 rowsep0" align="char" char=".">71.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">−: not determined.</p></div></div></div><div class="NLM_p"><b>NLG-919</b> was found to be moderately bound to plasma proteins (43–49% in SD rats, 48–52.0% in cynomolgus monkey, and 52–55% in human plasma at 0.2, 2, and 20 μM concentration). After a single oral dose of 50 mg/kg administered to C57Bl/6 mouse, <b>NLG-919</b> was found to be present at higher concentration in plasma than in other organs, the maximum exposure occurred at 1 h post-dose.</div><div class="NLM_p">The pharmacodynamic effect of <b>NLG-919</b> in vivo was measured in a mouse model where IDO1 activity is induced in the lungs by intranasal instillation of bacterial lipopolysaccharides.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In this mouse model, plasma Kyn was reduced by 50% and lung Kyn was reduced by 60%, 6 h after oral dosing of <b>NLG-919</b> at 50 mg/kg. Given that approximately 50% of systemic Kyn levels in plasma is contributed by IDO1 and the rest is contributed by the liver enzyme Trp 2,3-dioxygenase (TDO2),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the results suggest that an oral dose of 50 mg/kg produces almost complete inhibition of IDO1 activity in this model.</div><div class="NLM_p">The antitumor activity of <b>NLG-919</b> was determined in the Pan02 tumor model in C57Bl/6 mice, where it demonstrated to reduce tumor growth and enhance survival as a single agent (<i>p</i> = 0.0005; <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A) as well as to enhance the antitumor effect of cyclophosphamide in a combination chemotherapy regimen (<i>p</i> = 0.0083; <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor activity of <b>NLG-919</b> in the Pan02 tumor model. (A) 5 × 10<sup>6</sup> Pan02 cells were implanted s.c. into the flank of C57Bl/6 mice (<i>n</i> = 7/group). <b>NLG-919</b> was dosed at 500 mg/kg/day, from days 7–32. (B) Survival of C57Bl/6 mice bearing Pan02 tumors (<i>n</i> = 12/group), where mice were dosed with <b>NLG-919</b> at 400 mg/kg/day from days 7– 25 post-tumor inoculation, with or without three doses of cyclophosphamide 100 mg/kg i.p. on days 8, 13, and 15.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Toxicology studies were conducted in rats and dogs in 28-day repeat dose studies with 2-week recovery. It was determined that the no-observed-adverse-event level was 250 mg/kg/dose BID for rats (AUC<sub>0–inf</sub> = 22 500 h·ng/mL) and 200 mg/kg/dose BID for dogs (AUC<sub>0–12h</sub> of 22 550 h·ng/mL).</div><div class="NLM_p last">In summary, <b>NLG-919</b> had a favorable drug-like profile and was selected as a clinical candidate for further evaluation in Phase 1 clinical trials. Furthermore, this study describes for the first time, the use of imidazo[5,1-<i>a</i>]isoindoles as a new class of heme-binding chemical pharmacophore, which could become a structural scaffold for other heme-containing pharmacologic targets. In fact, further SAR studies focusing on different C5 side chain substituents have afforded potent specific inhibitors of the related enzyme TDO2 and dual inhibitors of both IDO1 and TDO2 enzymes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p">The synthesis of 4-phenylimidazole derivatives <b>4–8</b> was achieved by the reaction of α-bromoketone derivatives with formamide (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compounds <b>3</b> and <b>9</b> were synthesized according to the literature.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Substituted 5-(Phenyl)-1<i>H</i>-imidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) CuBr<sub>2</sub>, CHCl<sub>3</sub>, 60 °C; (ii) H<sub>2</sub>NCHO, 170–180 °C, 33–61%.</p></p></figure><div class="NLM_p">Compound <b>11</b> was prepared by palladium-catalyzed Negishi cross-coupling<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of 4-iodo-1-trityl-1<i>H</i>-imidazole with 4-chloro-2-fluoro-6-iodophenol<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> followed by deprotection of the trityl group with acetic acid in methanol (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0023.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) EtMgBr, THF, rt, 1.5 h; (ii) ZnCl<sub>2</sub>, 1.5 h; (b) 4-chloro-2-fluoro-6-iodophenol, 10% Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, 70 °C, 12 h; (c) AcOH, MeOH, 80 °C, 37%.</p></p></figure><div class="NLM_p">Compounds <b>13–20</b> and <b>36</b> were obtained via <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><i>N</i>-1 substituted arylimidazole derivatives were synthesized by the Van Leusen imidazole synthesis. TosMIC was allowed to react with the requisite benzaldehydes, followed by a dehydration and cyclization sequence (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The intermediate aldehyde (<b>12c</b>) for <b>36</b> was synthesized from 5-hydroxy-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> via <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0025.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>13–20</b> and <b>36</b> by Van Leusen Imidazole Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: conditions A: (a) (i) R<sup>4</sup>NH<sub>2</sub>, MeOH, 15–20 h; (ii) TosMIC, piperidine, 36 h, 46–65%. Conditions B: (a) TosMIC, NaO<i>t</i>-Bu, THF, −40 °C, 50 min, (b) Et<sub>3</sub>N, POCl<sub>3</sub>, −10 °C, 45 min, (c) R<sup>4</sup>NH<sub>2</sub>, MeOH, 25 °C, 12 h, 26–95%.</p></p></figure><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0026.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-(2-Cyclohexylethoxy)-6-hydroxybenzaldehyde (<b>12c</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-cyclohexylethan-1-ol, DEAD, PPh<sub>3</sub>, THF, overnight, 69%; (b) DIBAL-H, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 1.5 h, 35%.</p></p></figure><div class="NLM_p">Compound <b>21</b> was prepared by demethylation of <b>19</b> in refluxing aqueous HBr. The benzyl group of <b>20</b> was removed by hydrogenation in the presence of Pd/C to afford <b>22</b>. Esters <b>16</b> and <b>17</b> were converted to <i>N</i>-methylamides <b>23</b> and <b>24</b>, respectively, by allowing them to react in the presence of methylamine.</div><div class="NLM_p">The <i>O</i>-alkyl derivatives (<b>26–35</b>) were prepared by SN2 displacement reactions of 2-(1-trityl-1<i>H</i>-imidazol-4-yl)phenol (<b>25</b>) with their appropriate halide or tosylate followed by deprotection of the trityl group (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0027.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>26–35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 1 h; (ii) R–X, 0 °C to rt, 10–15 h; (b) AcOH, MeOH, 80 °C, 2 h, 15–73%.</p></p></figure><div class="NLM_p">Compound <b>41</b> was synthesized from 1-(2-iodo-3-methoxybenzyl)-1<i>H</i>-imidazole (<b>39</b>), by an intramolecular palladium-catalyzed Heck cross-coupling reaction followed by demethylation of <b>40</b>. 1-(2-Iodo-3-methoxybenzyl)-1<i>H</i>-imidazole (<b>39</b>) was prepared by a Mitsunobu reaction with (2-iodo-3-methoxyphenyl)methanol (<b>38</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and imidazole (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0028.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) imidazole, DEAD, PPh<sub>3</sub>, THF, 0–60 °C, 14 h, 43%; (b) Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 36 h, 37%; (c) HBr (aq, 48%), 100 °C, 14 h, 68%.</p></p></figure><div class="NLM_p">Intramolecular Mitsunobu reaction of <b>43</b> afforded <b>44</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>) and <b>45</b> was synthesized from isoquinoline.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Alkylation of <b>37</b> with (2-iodoethyl)cyclohexane afforded <b>46</b> in 80% yield (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>).</div><figure id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0029.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-amino-1-ethanol, MeOH, 40 °C, 1 h; (b) TosMIC, DME/MeOH, rt, 72 h, 46%; (c) PPh<sub>3</sub>, DEAD, THF, 0 °C to rt, 16 h, 84%.</p></p></figure><figure id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0030.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −40 °C, 1 h; (ii) (2-iodoethyl)cyclohexane, −40 °C to rt, 14 h, 80%.</p></p></figure><div class="NLM_p">Compound <b>48</b> was prepared by an SN2 reaction of <b>25</b> with 2-bromo-1-cyclohexylethanone followed by deprotection of the trityl group with acetic acid and ketone reduction with NaBH<sub>4</sub> (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>).</div><figure id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0031.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 1 h; (ii) 2-bromo-1-cyclohexylethan-1-one, 0 °C to rt, 14 h; (b) AcOH, MeOH, 80 °C, 2 h, 62%; (c) NaBH<sub>4</sub>, MeOH, 0 °C to rt 1 h, 90%.</p></p></figure><div class="NLM_p">Imidazoisoindole <b>52</b>, <b>63</b>, <b>67</b>, <b>69</b>, <b>75</b>, <b>77</b>, <b>79</b>, <b>81</b>, <b>83</b>, <b>87</b>, <b>98</b>, <b>108</b>, <b>110</b>, <b>112</b>, <b>116</b>, and <b>118</b> were synthesized by Horner–Wadsworth–Emmons reaction of dimethyl (2-oxo)phosphonates with substituted aldehydes followed by an acid-catalyzed in situ ring closure via vinylogous intramolecular Michael addition and ketone reduction with sodium borohydride (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>).</div><figure id="sch10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0013.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Horner–Wadsworth–Emmons Reaction of Dimethyl (2-Oxo)phosphonates with Substituted Aldehydes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 40 min; (ii) <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0010.eps.gif" alt="" /></img></span> 0 °C to rt, 16 h; (b) AcOH, MeOH, 90 °C, 2 h, 24–96%; (c), NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 43–95%.</p></p></figure><div class="NLM_p">The dimethyl (2-oxo)phosphonate derivatives <b>49(a-p)</b> were synthesized according to <a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>, the ester intermediates <b>49(n-o)-SM</b> were synthesized by benzoylation of the corresponding methyl 4-aminocyclohexane carboxylates, and <b>49p-SM</b> was synthesized according to the literature.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="sch11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0014.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Dimethyl (2-Oxo)phosphonates <b>49(a-p)</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −78 °C, 0.5 h; (ii) R<sup>1</sup>CO<sub>2</sub>R<sup>2</sup> [<b>49(a-p)-SM]</b>, −78 to 0 °C, 1.5 h. [R<sup>2</sup> = Me for <b>49(a-o)-SM</b>; R<sup>2</sup> = Et for <b>49p-SM</b>].</p></p></figure><div class="NLM_p">2-(1-Trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde derivatives <b>50(a-f)</b> were synthesized by Suzuki cross-coupling of 4-iodo-1-trityl-1<i>H</i>-imidazole with the corresponding phenyl boronic acids (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>).</div><figure id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0015.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of <b>50(a-f)</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF/H<sub>2</sub>O, 90 °C, 16 h, 46–87%.</p></p></figure><div class="NLM_p">Amine <b>54</b> was synthesized by converting <b>52</b> to phthalimide derivative <b>53</b>, followed by deprotection by using hydrazine hydrate (<a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>).</div><figure id="sch13" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0016.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthesis of <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PPh<sub>3</sub>, DEAD, phthalimide, THF, 0 °C to rt, 16 h; (b) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, 6 h, rt, 20%.</p></p></figure><div class="NLM_p">Imidazoisoindoles <b>57</b> and <b>102</b> were synthesized in three steps from <b>10</b>, by Negishi cross-coupling with <b>55a</b> or <b>55b</b>, respectively, followed by an intramolecular aza-Michael cyclization assisted by acetic acid. Finally, reduction of ketone with sodium borohydride afforded <b>57</b> and <b>102</b>. Compound <b>58</b> was synthesized by Grignard addition of methylmagnesium bromide to ester <b>56</b> (<a class="ref internalNav" href="#sch14" aria-label="Scheme 14">Scheme 14</a>).</div><figure id="sch14" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0017.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Imidazoisoindoles <b>57</b>, <b>58</b>, and <b>102</b> Synthesis by Negishi Cross-Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) EtMgBr, THF, rt, 1.5 h; (ii) ZnCl<sub>2</sub>, <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0011.eps.gif" alt="" /></img></span>, Pd(PPh<sub>3</sub>)<sub>4</sub>, rt to 70 °C, 12.5 h; (iii) AcOH, MeOH, 80 °C, 3 h, 23–25%; (b) NaBH<sub>4</sub>, LiCl, THF, EtOH, rt, 16 h, 91%; (c) NaBH<sub>4</sub>, MeOH, 0 °C, 1 h, 98%; (d) MeMgBr, THF, 0 °C to rt, 2 h, 52%.</p></p></figure><div class="NLM_p">Imidazoisoindoles <b>61</b>, <b>65</b>, <b>71</b>, <b>73</b>, <b>96</b>, <b>100</b>, <b>104</b>, and <b>106</b> were synthesized by aldol condensation of substituted arylcarboxaldehydes with corresponding ketones followed by intramolecular aza-Michael cyclization and ketone reduction with NaBH<sub>4</sub> (<a class="ref internalNav" href="#sch15" aria-label="Scheme 15">Scheme 15</a>).</div><figure id="sch15" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0018.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Aldol Condensation of 2-(1-Trityl-1<i>H</i>-imidazol-4-yl)benzaldehydes with Methyl Ketones Followed by Intramolecular Aza-Michael Cyclization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaOMe, THF/MeOH, rt, 3 h; (ii) AcOH, MeOH, 80 °C, 3–10 h, 11–61%; (b) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 15–98%.</p></p></figure><div class="NLM_p"><b>84</b> and <b>85</b> were synthesized by deprotecting <b>83</b> and <b>81</b>, respectively. Piperidine amides (<b>88-93</b>) were synthesized by HATU coupling of <b>84</b> with substituted acids (<a class="ref internalNav" href="#sch16" aria-label="Scheme 16">Scheme 16</a>).</div><figure id="sch16" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0019.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Amide Synthesis by HATU Coupling of <b>84</b> with Substituted Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, HCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt, 18 h, 29–76%.</p></p></figure><div class="NLM_p">Piperidinyl urea <b>94</b> was obtained by the reaction of <b>84</b> with phenyl isocyanate (<a class="ref internalNav" href="#sch17" aria-label="Scheme 17">Scheme 17</a>).</div><figure id="sch17" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0020.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of <b>94</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhNCO, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 0.5 h, 62%.</p></p></figure><div class="NLM_p">Compound <b>120</b> was prepared in two steps from <b>113</b>, involving ketal deprotection and ketone reduction (<a class="ref internalNav" href="#sch18" aria-label="Scheme 18">Scheme 18</a>).</div><figure id="sch18" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0021.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of <b>120</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCl, MeOH, 0–50 °C, 2.5 h, 99%; (b) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 78%.</p></p></figure><div class="NLM_p">The diastereomeric mixture of <b>52</b> was separated by chiral SFC to provide isolated stereoisomers <b>121–124</b>. The absolute stereochemistry of <b>123</b> was assigned based on the single-crystal X-ray data of the hydrobromide salt. Based on <sup>1</sup>H NMR resonance, compound <b>121</b> was found to be the enantiomer of <b>123</b>. In both <b>121</b> and <b>123</b>, the C5 proton exhibits a doublet of doublet δ 5.48 (dd, <i>J</i> = 10.6, 3.2 Hz, 1H). The stereochemistry of <b>122</b> and <b>124</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">Supporting Information</a> for X-ray structure determination) was also assigned based on the X-ray crystallographic data of the hydrochloride and hydrobromide salts, respectively. Both <b>122</b> and <b>124</b> enantiomers exhibit a triplet δ 5.38 (t, <i>J</i> = 6.3 Hz, 1H) in the proton NMR for the C5 proton (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><div class="NLM_p">Sodium borohydride reduction of <b>125</b> and subsequent TBS deprotection yielded diastereomeric mixture <b>127</b>, which was separated by chiral SFC into 4-stereoisomers <b>132</b>, <b>133</b>, <b>134</b>, and <b>NLG-919</b>. The absolute stereochemistry of <b>NLG-919</b> was determined based on the single crystal X-ray data. The C5 proton appears as a triplet in the case of <b>NLG-919</b> and <b>133</b>, δ 5.57 (t, <i>J</i> = 5.1 Hz, 1H) both having a relative 1,3-<i>syn</i> conformation between the C5–H and C11–H. Single enantiomers <b>132</b> and <b>134</b> exhibit a doublet of doublet splitting pattern at C5–H by <sup>1</sup>H NMR, δ 5.64 (dd, <i>J</i> = 10.8, 2.8 Hz, 1H). Based on the <sup>1</sup>H NMR spectroscopic data and single-crystal small molecule X-ray crystal data, <b>132</b> was assigned as C5 <i>S</i>-stereochemistry and <b>134</b> as C5 <i>R</i>-stereochemistry. <b>NLG-919</b> and <b>133</b> represent a pair of pseudoenantiomers, while <b>132</b> and <b>134</b> represent another pair (<a class="ref internalNav" href="#sch19" aria-label="Scheme 19">Scheme 19</a>).</div><figure id="sch19" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0022.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 19. Synthesis and Chiral Separation of <b>127</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 2 h; (ii) 6 N HCl, 50 °C, 45 min; (iii) NaHCO<sub>3</sub>, 92%; (b) chiral SFC.</p></p></figure><div class="NLM_p">Compound <b>126</b> was synthesized by sodium borohydride reduction of C11 ketone <b>113</b> followed by deprotection of the C15 ketal to afford ketoalcohol <b>114</b>. Cyclohexanone <b>114</b> was subjected to LS-selectride reduction to afford <i>cis</i>-cyclohexanol <b>126</b> (<a class="ref internalNav" href="#sch20" aria-label="Scheme 20">Scheme 20</a>). The diastereomeric mixture <b>126</b> was separated by chiral SFC to yield <b>128–131</b>. The stereochemistry of separated isomers of <b>126</b> was assigned based on their IDO1 inhibition activity and their <sup>1</sup>H NMR resonances. Compounds <b>130</b> and <b>131</b> make a pair of pseudoenantiomers, and <b>128</b> and <b>129</b> make the other pair.</div><figure id="sch20" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0024.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 20. Synthesis and Chiral SFC Separation of <b>126</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, HCl, MeOH, 0–50 °C, 2.5 h, 99%; (b) LS-selectride, THF, −78 °C, 3 h, 86%; (c) chiral SFC.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The structure-based drug design approach was used to develop 5-phenyl-1<i>H</i>-imidazole into a novel class of heme-coordinating imidazo[5,1-<i>a</i>]isoindole-based IDO1 inhibitors. Physicochemical properties were used as a guiding tool to optimize the lead molecule’s ADME profile while minimizing CYP inhibition. Because IDO1 and CYP3A4 are heme-containing enzymes, subtle balance was required to optimize IDO1 potency while keeping CYP3A4 inhibition in check. Lowering clogP and placing a fluoro group at the 6-position of the imidazo[5,1-<i>a</i>]isoindole core improved CYP3A4 inhibition, metabolic CL, while maintaining IDO1 potency by maximizing H-bond interactions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and solvents were purchased from commercial sources. All commercial reagents and solvents were used as received without further purification. The reactions were monitored using analytical thin layer chromatography (TLC) with 0.25 mm EM Science silica gel plates (60F-254). The developed TLC plates were visualized by short-wave UV light (254 nm) or immersion in potassium permanganate solution followed by heating on a hot plate. Flash chromatography was performed with Selecto Scientific silica gel, 32–63 μm particle sizes. All reactions were performed in flame or oven-dried glassware under a nitrogen atmosphere. All reactions were stirred magnetically at ambient temperature unless otherwise indicated. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained with a Bruker DRX400, Varian VXR400, or VXR300. <sup>1</sup>H NMR spectra were reported in parts per million (δ) relative to TMS (0.0), DMSO-<i>d</i><sub>6</sub> (2.50), or CD<sub>3</sub>OD (4.80) as an internal reference. All <sup>1</sup>H NMR spectra were taken in CDCl<sub>3</sub> unless otherwise indicated. MS was conducted on the Waters ACQUITY UPLC system with a QDa detector. High-resolution mass spectrometry (HRMS) spectra for <b>NLG-919</b> were obtained using an Agilent G6224A ESI-TOF mass spectrometer. The purity of isolated stereoisomer compounds was determined on a Waters e2695 high-performance liquid chromatography (HPLC) using XBridge 3.5 μM, 4.6 × 150 mm column (conditions are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">Supporting Information</a>). Purity of all final target compounds was 95% or higher.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> General Procedure for the Synthesis of <b>4–8</b> from the Requisite Acetophenone Derivatives</h3><div class="NLM_p last">A solution of the acetophenone derivative (6.03 mmol) in CHCl<sub>3</sub> (10 mL) was added to a refluxing suspension (2.69 g, 12.06 mmol) of CuBr<sub>2</sub> in ethyl acetate (8 mL), and the reaction was refluxed for 2 h. After cooling to rt, the mixture was filtered through the Celite bed and the solvent was removed under reduced pressure. The residue was diluted with ethyl acetate (70 mL) and the organic layer was washed with 50% aq NaHCO<sub>3</sub> (2 × 25 mL). The organic layer was washed with brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated in vacuo. The crude residue was passed through a short column and used as such for the next step. A solution of the α-bromophenone derivative (1.34 mmol) was heated (170–180 °C) in formamide (10 mL) for 5–10 h. The solution was allowed to cool to rt, the mixture was diluted with saturated NaHCO<sub>3</sub> (20 mL), and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with water and brine, dried using Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to afford the crude residue which was purified by flash column chromatography on silica gel to yield <b>4–8</b>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure for TosMIC Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Conditions A</h4><div class="NLM_p last">A solution of substituted benzaldehyde (3.19 mmol) in THF (3 mL) and ammonia solution (19.16 mmol, 2.0 M solution in EtOH) was stirred overnight at room temperature followed by the addition of TosMIC (3.19 mmol) and piperazine (4.79 mmol). After stirring for 36 h, the solvent was evaporated and replaced with THF (10 mL) and continued to be stirred for another 24 h. The solvent was evaporated under reduced pressure and the crude was purified by column chromatography to afford <b>13</b>, <b>14</b>, or <b>36</b>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Conditions B</h4><div class="NLM_p">To a stirred solution of NaO<i>t</i>-Bu (124.0 mg, 1.3 mmol) in THF (12 mL) at −40 °C was added a solution of 1-((isocyanomethyl)sulfonyl)-4-methylbenzene (390.0 mg, 2.0 mmol) in THF (6.0 mL). The solution was allowed to stir at −40 °C for 20 min and a solution of the substituted aldehyde (1.1 mmol) in THF (6.0 mL) was added while maintaining the temperature at −40 °C. The resulting mixture was allowed to stir for an additional 30 min and was poured into ice water (20 mL). The solution was neutralized with acetic acid (pH = 7) and the aqueous phase was extracted with dichloromethane (2 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford the crude product, which was filtered through a small plug of silica gel and used in the next step.</div><div class="NLM_p last">To a stirred solution of the resulting crude formamide in THF (10 mL) at −5 °C was added Et<sub>3</sub>N (1.39 mL, 10.0 mmol). The reaction mixture was cooled to −10 °C and POCl<sub>3</sub> (0.27 mL, 3.0 mmol) was added after 15 min. The solution was allowed to stir at −10 °C for an additional 30 min. The reaction mixture was poured into ice water (15 mL) and the aqueous layer was extracted with DCM (2 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude residue was dissolved in MeOH (5 mL). Appropriate amine (2.0 mmol) was added and the reaction mixture was stirred for 12 h at 25 °C. The solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography on silica gel to afford <b>15–20</b>.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> General Procedure for the Conversion of Esters to Amides (<b>23–24</b>)</h3><div class="NLM_p last">To the appropriate ester <b>16</b> or <b>17</b> (2.0 mmol) was added amine (2.0 M in MeOH or EtOH, 10.0 mmol, 5.0 mL). The resulting solution was allowed to stir for 24 h at rt until completion of the reaction was observed (TLC). In some cases, complete conversion required heating at 50 °C. The solvent was removed under reduced pressure to afford the crude product, which was purified by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH as the eluent to afford <b>23</b> or <b>24</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Alkylation of 2-(1<i>H</i>-Imidazol-4-yl)phenols (<b>26–35</b>, <b>47</b>)</h3><div class="NLM_p last">To a stirred solution of 2-(1-trityl-1<i>H</i>-imidazol-4-yl)phenol (0.5 mmol) in anhydrous DMF (3 mL) at 0 °C was added NaH (36.0 mg, 0.75 mmol). The resulting suspension was allowed to stir for 10 min. To the resulting solution was added the appropriate alkylating reagent. After stirring overnight, the reaction mixture was carefully diluted with water and extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with water, brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure and the crude product was taken to the next step without further purification. To a solution of crude ether was added acetic acid (2.0 mL) and MeOH (4.0 mL). The solution was stirred at 80 °C for 2 h. The solution was allowed to cool to room temperature and the pH was adjusted to ∼10 with 10% NaOH (aq). The aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic layer was washed with water, brine, and dried. The solvent was removed in vacuo to afford the crude residue, which was purified by flash column chromatography on silica gel to afford the desired products <b>26</b>–<b>35</b> and <b>47</b>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> General Procedure for the Synthesis of Dimethyl (2-Oxo)phosphonates <b>49(a-p)</b></h3><div class="NLM_p last">To a stirred solution of dimethyl methylphosphonate (3.14 g, 25.3 mmol) in 20 mL of anhydrous tetrahydrofuran at −78 °C was added dropwise a solution of <i>n</i>-butyl lithium (10.13 mL, 25.3 mmol, 2.5 M in hexanes) under an atmosphere of N<sub>2</sub>, and the mixture was stirred for 30 min. To this reaction mixture was added dropwise a solution of appropriate commercially available methyl or ethyl ester or compound <b>49(n-o)-SM</b> or <b>49p-SM</b> (12.7 mmol) as a solution in THF (5 mL). After being stirred for 30 min, the reaction mixture was allowed to warm to 0 °C and stirred for 1 h. The solvent was distilled off and the crude was diluted with saturated NH<sub>4</sub>Cl (10 mL) and 10 mL of water. The mixture was extracted with ethyl acetate (2 × 40 mL). The combined ethyl acetate layers were washed with water (1 × 20 mL), brine (1 × 20 mL), and dried over anhydrous sodium sulfate. The solution was filtered and concentrated under reduced pressure to afford the crude product. The crude was purified by column chromatography to afford <b>49(a-p)</b>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure for Suzuki Cross-Coupling for the Synthesis of <b>50(a-f)</b></h3><div class="NLM_p last">A suspension of 4-iodo-1-trityl-1<i>H</i>-imidazole (6.88 mmol), the appropriate 2-formyl boronic acid derivative (10.31 mmol) and K<sub>3</sub>PO<sub>4</sub> (20.63 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (30 mL) and water (6 mL) was purged with nitrogen for 5 min, followed by the addition of Pd(PPh<sub>3</sub>)<sub>4</sub> and the mixture was purged with nitrogen for another 5 min. The reaction mixture was stirred at 90 °C for 16 h under an atmosphere of N<sub>2</sub>. The solution was allowed to cool and was filtered through a plug of Celite. The mixture was diluted with water (50 mL) and EtOAc (25 mL). The organic layer was collected and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic extracts were washed with water (2 × 25 mL), brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solution was filtered and the solvent was removed under reduced pressure to afford the crude product, and chromatographic purification on silica gel afforded <b>50(a-f)</b>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure for the Synthesis of 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanones by Horner–Wadsworth–Emmons Reaction Followed by Cyclization</h3><div class="NLM_p last">To a suspension of 95% NaH (17.4 mg, 0.7 mmol) in THF (3 mL) at 0 °C was added the appropriate phosphonate reagent <b>49(a-p)</b> (0.75 mmol) as a solution in THF (2 mL) and the mixture was stirred for 40 min. The appropriate benzaldehyde (<b>50a</b>, <b>50b</b>, or <b>50f</b>) was added as a solution in THF (3 mL) dropwise over a period of 3 min. The reaction was allowed to warm to room temperature and stirred overnight. The solvent was removed under reduced pressure and the crude was diluted with saturated NH<sub>4</sub>Cl (10 mL) and water (10 mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL) and the combined organic extracts were washed with brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford the crude product. To the crude residue was added AcOH (1 mL) and MeOH (3 mL) and the solution was stirred at 90 °C for 2 h. After cooling to rt, the solvent was distilled off and the crude was stirred in a mixture of saturated K<sub>2</sub>CO<sub>3</sub> (5 mL) and EtOAc (25 mL). The organic layer was separated and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic layers were washed with water and brine, dried using Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under reduced pressure. The crude residue was purified by flash column chromatography on silica gel to afford <b>51</b>, <b>62</b>, <b>66</b>, <b>68</b>, <b>74</b>, <b>76</b>, <b>78</b>, <b>80</b>, <b>82</b>, <b>86</b>, <b>97</b>, <b>107</b>, <b>109</b>, <b>111</b>, <b>113</b>, <b>115</b>, <b>117</b>, or <b>125</b>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> General Procedure for Palladium-Catalyzed Negishi Cross-Coupling of Aryl Iodides with 4-Iodo-1-trityl-1<i>H</i>-imidazole</h3><div class="NLM_p last">To a stirred solution of 4-iodo-1-trityl-1<i>H</i>-imidazole (218 mg, 0.5 mmol) in anhydrous THF (4 mL) at rt was added EtMgBr (1.0 M in THF, 0.5 mmol, 0.5 mL) dropwise, under an atmosphere of N<sub>2</sub>. The resulting solution was allowed to stir for 90 min and anhydrous ZnCl<sub>2</sub> (0.5 mmol, 68.2 mg) was added. The resulting white suspension was allowed to stir for 90 min and a solution of appropriate aryl iodide <b>55a</b> or <b>55b</b> (0.5 mmol) in THF (1 mL) was added followed by immediate addition of Pd(PPh<sub>3</sub>)<sub>4</sub> (56 mg, 0.05 mmol). The reaction mixture was allowed to stir at 70 °C for 12 h under an atmosphere of N<sub>2</sub>. After cooling to room temperature, the solution was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and the organic layer was washed with an EDTA (aq) buffer (pH = 9) (2 × 5 mL) and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude residue was used in the next step without further purification. To a solution of crude imidazole from the previous step was added acetic acid (1.0 mL) and MeOH (4.0 mL). The solution was stirred at 80–90 °C for 3 h. The reaction mixture was allowed to cool to room temperature and the pH was adjusted to ∼10 with saturated K<sub>2</sub>CO<sub>3</sub> (aq). The aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic extract was washed with water, brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed in vacuo to afford the crude residue, which was purified by flash column chromatography on silica gel to afford <b>56</b> or <b>101</b>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for the Synthesis of 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanones by Aldol Condensation of 2-(1-Trityl-1<i>H</i>-imidazol-4-yl)benzaldehydes with Methyl Ketones Followed by Cyclization</h3><div class="NLM_p last">To a solution of appropriate aldehyde <b>50(a-e)</b> (0.97 mmol) and ketone <b>59(a-e)</b> (0.97 mmol) in anhydrous THF (5 mL) at rt was added NaOEt (1.25 mmol, 21 wt % solution in EtOH) and the yellow solution was allowed to stir for 3 h at rt. The solvent was distilled off and the crude was diluted with saturated NH<sub>4</sub>Cl (10 mL) and the aqueous layer was extracted with dichloromethane (3 × 20 mL). The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent evaporated under reduced pressure to afford the crude product. To the crude imidazole from the previous step was added acetic acid (1.0 mL) and MeOH (4.0 mL). The solution was stirred at 90 °C for 3–10 h. The reaction mixture was allowed to cool to room temperature and the pH was adjusted to ∼10 with saturated K<sub>2</sub>CO<sub>3</sub> (aq). The aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with water, brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed in vacuo to afford the crude residue, which was purified by flash column chromatography on silica gel to afford <b>60</b>, <b>64</b>, <b>70</b>, <b>72</b>, <b>95</b>, <b>99</b>, <b>103</b>, or <b>105</b>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure for the Reduction of 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanones to 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanols</h3><div class="NLM_p last">To a solution of appropriate ketone (0.25 mmol) in MeOH (2 mL) at 0 °C, was added NaBH<sub>4</sub> (0.75 mmol) and the solution was allowed to stir for 1 h. The solvent was removed under reduced pressure and 2 M HCl (2 mL) was added to the crude. The solution was allowed to stir for 10 min and was made basic by saturated K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 5 mL). The combined organic layers were washed with brine, dried using MgSO<sub>4</sub>, and concentrated under reduced pressure to afford the crude residue. The crude was purified by column chromatography using 1–10% MeOH/DCM gradient to afford <b>52</b>, <b>61</b>, <b>63</b>, <b>65</b>, <b>67</b>, <b>69</b>, <b>71</b>, <b>73</b>, <b>75</b>, <b>77</b>, <b>79</b>, <b>81</b>, <b>83</b>, <b>87</b>, <b>96</b>, <b>98</b>, <b>100</b>, <b>102</b>, <b>104</b>, <b>106</b>, <b>108</b>, <b>110</b>, <b>112</b>, <b>116</b>, <b>118</b>, or <b>120</b>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedure for the Synthesis of <b>88–93</b> Using HATU Coupling</h3><div class="NLM_p last">To a vial containing 2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(piperidin-4-yl)ethan-1-ol dihydrochloride (0.25 mmol) in DMF (4 mL) was added the corresponding carboxylic acid (0.26 mmol), DIPEA (1.5 mmol), and HATU (0.28 mmol). The reaction mixture was stirred at rt for 18 h and poured into water (10 mL) and the aqueous layer was extracted with dichloromethane (2 × 20 mL). The combined organic layers were washed with water (2 × 10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash column chromatography to afford <b>88–93</b>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Chiral Separation of <b>52</b></h3><div class="NLM_p last">Column: RegisPack #783104, 250 mm × 4.6 mm, 5 μm, hexane/ethanol (90/10) + 0.1% DEA, 1.5 mL/min, RT = 4.30 (<b>121</b>), RT = 5.4 (<b>122</b>), RT = 6.52 (<b>123</b>), RT = 8.19 (<b>124</b>). The SFC separation was carried out using the RegisPack5 column. Cosolvent: IPA + 0.2% DEA, CO<sub>2</sub> flow rate: 3.0, co-solvent flow rate: 1.0, 254 nm.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Chiral Separation of <b>126</b></h3><div class="NLM_p last">Column: RegisPack #783104, 250 mm × 4.6 mm, 5 μm, hexane/ethanol (90/10) + 0.1% DEA, 1.5 mL/min, RT = 11.68 (<b>128</b>), RT = 14.53 (<b>129</b>), RT = 15.75 (<b>130</b>), RT = 19.56 (<b>131</b>). The SFC separation was carried out using the RegisPack5 column (250 mm × 50 mm, 5 μm), isopropanol/CO<sub>2</sub> (27/73).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Chiral Separation of <b>127</b></h3><div class="NLM_p">Column: RegisPack #783104, 250 mm × 4.6 mm, 5 μm, hexane/2-propanol (90/10) + 0.1% DEA, 1.5 mL/min, RT = 12.0 (<b>132</b>), RT = 13.88 (<b>133</b>), RT = 16.56 (<b>NLG-919</b>), RT = 22.37 (<b>134</b>). The SFC separation was carried out in a two-step process: first, separation was done using the AD-H prep column, 250 × 50 mm, 5 μm, isopropanol/CO<sub>2</sub> 26/74 to separate <b>132</b> and <b>134</b>. For the second separation, the (<i>S</i>,<i>S</i>)-Whelk-O1 column (25 cm × 50 mm, 5 μm, isopropanol + 0.5% DEA/CO<sub>2</sub> (27/73), 280 nm) was used to separate <b>NLG-919</b> and <b>133</b>.</div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-Chloro-2-(1<i>H</i>-imidazol-5-yl)phenol (<b>4</b>)</h4><div class="NLM_p last">It is obtained in 48% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 195.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 6.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.02–7.04 (m, 1H), 7.72 (s, 1H), 7.81 (s, 1H), 7.89 (s, 1H).</div></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(1<i>H</i>-Imidazol-5-yl)-4-methylphenol (<b>5</b>)</h4><div class="NLM_p last">It is obtained in 51% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 175.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.29 (s, 3H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 6.97 (d, <i>J</i> = 8.2 Hz, 1H), 7.28 (s, 1H), 7.33 (s, 1H), 7.68 (s, 1H).</div></div><div id="sec4_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-Bromo-2-(1<i>H</i>-imidazol-5-yl)phenol (<b>6</b>)</h4><div class="NLM_p last">It is obtained in 59% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 239.2 [M]<sup>+</sup>. <sup>1</sup>H NMR: δ 6.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.34 (s, 1H), 7.56 (s, 1H), 7.71 (s, 1H), 8.87 (br s, 1H), 9.8 (br s, 1H).</div></div><div id="sec4_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-Fluoro-2-(1<i>H</i>-imidazol-5-yl)phenol (<b>7</b>)</h4><div class="NLM_p last">It is obtained in 33% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 179.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 6.84–6.95 (m, 2H), 7.13–7.17 (m, 1H), 7.36 (s, 1H), 7.76 (s, 1H).</div></div><div id="sec4_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2,4-Difluoro-6-(1<i>H</i>-imidazol-5-yl)phenol (<b>8</b>)</h4><div class="NLM_p last">It is obtained in 61% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 197.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 6.98–7.06 (m, 1H), 7.38–7.42 (m, 1H), 7.87 (s, 1H), 7.97 (s, 1H).</div></div><div id="sec4_14_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-Chloro-2-fluoro-6-(1<i>H</i>-imidazol-5-yl)phenol (<b>11</b>)</h4><div class="NLM_p last">To a stirred solution of 4-iodo-1-trityl-1<i>H</i>-imidazole (704.6 mg, 1.62 mmol) in anhydrous THF (8 mL) at rt was added EtMgBr (1.0 M in THF, 1.76 mL, 1.76 mmol) dropwise, under an atmosphere of N<sub>2</sub>. The resulting solution was allowed to stir for 90 min and anhydrous ZnCl<sub>2</sub> (240.2 mg, 1.76 mmol) was added. The resulting white suspension was allowed to stir for 90 min and a solution of aryl iodide (200 mg, 0.734 mmol) in THF (2 mL) was added followed by immediate addition of Pd(PPh<sub>3</sub>)<sub>4</sub> (84.8 mg, 0.073 mmol). The reaction mixture was allowed to stir at 70 °C for 12 h under an atmosphere of N<sub>2</sub>. After cooling to room temperature, EDTA (aq) buffer (pH = 9) of 10 mL was added and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford the crude product. To a solution of the crude product was added acetic acid (2.0 mL) and MeOH (4.0 mL). The solution was stirred at 80 °C for 2 h. The reaction mixture was allowed to cool to room temperature and the pH was adjusted to 7–8 with saturated NaHCO<sub>3</sub> solution. The aqueous phase was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with water, brine, and dried. The solvent was removed in vacuo to afford the crude residue, which was purified by flash column chromatography on silica gel to afford the desired product as off-white solid (57 mg, 37%). LCMS (ESI, <i>m</i>/<i>z</i>): 213.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.21 (d, <i>J</i> = 8.0 Hz, 1H), 7.63 (s, 1H), 7.94 (s, 1H), 8.01 (s, 1H), 12.78 (br s, 1H), 12.88 (br s, 1H).</div></div><div id="sec4_14_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-(2-Cyclohexylethoxy)-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one (<b>12c-SM2</b>)</h4><div class="NLM_p last">To a stirred solution of 5-hydroxy-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one (3.89 mmol), 2-cyclohexylethan-1-ol (3.89 mmol), and triphenyl phosphine (4.28 mmol) in anhydrous THF (15 mL) at 0 °C was added DEAD (40% in toluene, 4.28 mmol, 1.95 mL) dropwise. The yellow solution was allowed to warm to room temperature and stirring was continued overnight. After evaporating the solvent under reduced pressure, the crude residue was dissolved in DCM (15 mL). The organic layer was washed with 10% NaOH (2 × 10 mL), water, and brine. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under reduced pressure. The crude residue was purified by column chromatography on silica gel (69%). <sup>1</sup>H NMR: δ 1.10–2.20 (m, 13H), 1.70 (s, 6H), 4.06 (t, <i>J</i> = 6.8 Hz, 2H), 6.47 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 6.56 (d, <i>J</i> = 7.6 Hz, 1H), 6.47 (t, <i>J</i> = 7.6 Hz, 1H).</div></div><div id="sec4_14_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(2-Cyclohexylethoxy)-6-hydroxybenzaldehyde (<b>12c</b>)</h4><div class="NLM_p last">To a solution of 5-(2-cyclohexylethoxy)-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one (290 mg, 0.952 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) at −78 °C was added DIBAL-H (1.91 mmol, 1 M in CH<sub>2</sub>Cl<sub>2</sub>). After stirring for 1.5 h at −78 °C, the reaction was quenched by adding 1 M HCl (2 mL) and MeOH (2 mL) and the reaction was allowed to warm to room temperature. Water (10 mL) was added and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to afford the crude residue which was purified by flash column chromatography on silica gel to afford the desired product (83 mg, 35%). <sup>1</sup>H NMR: δ 1.09–0.91 (m, 1H), 1.17–1.32 (m, 3H), 1.45–1.54 (m, 1H), 1.65–1.80 (m, 7H), 4.09 (t, <i>J</i> = 6.5 Hz, 1H), 6.37 (d, <i>J</i> = 8.3 Hz, 1H), 6.51 (d, <i>J</i> = 8.5 Hz, 1H), 10.37 (s, 1H), 11.98 (s, 1H).</div></div><div id="sec4_14_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Chloro-6-(1<i>H</i>-imidazol-5-yl)phenol (<b>13</b>)</h4><div class="NLM_p last">It is obtained in 41% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 195.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 6.79 (t, <i>J</i> = 7.8 Hz, 1H), 7.24 (doublet merged with CHCl<sub>3</sub>, 1H), 7.40 (s, 2H), 7.76 (s, 1H), 9.36 (br s, 1H), 12.96 (br s, 1H).</div></div><div id="sec4_14_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-Chloro-4-fluoro-6-(1<i>H</i>-imidazol-5-yl)phenol (<b>14</b>)</h4><div class="NLM_p last">It is obtained in 62% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 213.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 6.95–6.99 (m, 1 H), 7.29–7.33 (m, 1H), 7.61 (s, 1H), 7.84 (s, 1H).</div></div><div id="sec4_14_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(5-Phenyl-1<i>H</i>-imidazol-1-yl)ethanol (<b>15</b>)</h4><div class="NLM_p last">It is obtained in 59% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 189.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 3.72 (t, <i>J</i> = 5.2 Hz, 2H), 4.01 (t, <i>J</i> = 5.2 Hz, 2H), 5.09 (br s, 1H), 6.83 (d, <i>J</i> = 0.8 Hz, 1H), 7.29–7.42 (m, 5H), 7.51 (d, <i>J</i> = 0.8 Hz, 1H).</div></div><div id="sec4_14_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 2-(5-Phenyl-1<i>H</i>-imidazol-1-yl)acetate (<b>16</b>)</h4><div class="NLM_p last">It is obtained in 36% yield. <sup>1</sup>H NMR: δ 3.7 (s, 3H), 4.66 (s, 2H), 7.07 (d, <i>J</i> = 1.2 Hz, 1H), 7.26–7.3 (m, 2H), 7.34–7.44 (m, 3H), 7.63 (d, <i>J</i> = 0.8 Hz, 1H).</div></div><div id="sec4_14_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Ethyl 3-(5-Phenyl-1<i>H</i>-imidazol-1-yl)propanoate (<b>17</b>)</h4><div class="NLM_p last">It is obtained in 30% yield. <sup>1</sup>H NMR: δ 1.21 (t, <i>J</i> = 7.1 Hz, 3H), 2.57 (t, <i>J</i> = 6.9 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.30 (t, <i>J</i> = 6.8 Hz, 2H), 7.06 (s, 1H), 7.37–7.47 (m, 5H), 7.61 (s, 1H).</div></div><div id="sec4_14_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-(2-(5-Phenyl-1<i>H</i>-imidazol-1-yl)ethyl)acetamide (<b>18</b>)</h4><div class="NLM_p last">It is obtained in 26% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 230.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.85 (s, 3H), 3.32–3.40 (m, 2H), 4.17 (t, <i>J</i> = 7.6 Hz, 2H), 7.02 (s, 1H), 7.33–7.45 (m, 5H), 7.50 (s, 1H).</div></div><div id="sec4_14_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-(3,3-Dimethylbutyl)-5-(2-methoxyphenyl)-1<i>H</i>-imidazole (<b>19</b>)</h4><div class="NLM_p last">It is obtained in 45% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 259.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.78 (s, 9H), 1.42–1.54 (m, 2H), 3.75–3.85 (m, 5H), 6.92–7.50 (m, 3H), 7.20–7.29 (m, 1H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 7.54 (s, 1H).</div></div><div id="sec4_14_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-(2-(Benzyloxy)-5-chlorophenyl)-1-cyclohexyl-1<i>H</i>-imidazole (<b>20</b>)</h4><div class="NLM_p last">It is obtained in 95% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 366.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.13–1.19 (m, 3H), 1.44–1.52 (m, 2H), 1.63–1.85 (m, 5H), 3.64–3.70 (m, 1H), 5.01 (s, 2H), 6.96 (s, 1H), 7.21 (d, <i>J</i> = 6.0 Hz, 2H), 7.25 (d, <i>J</i> = 2.5 Hz, 1H), 7.29–7.33 (m, 4H), 7.61 (s, 1H).</div></div><div id="sec4_14_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-(1-(3,3-Dimethylbutyl)-1<i>H</i>-imidazol-5-yl)phenol (<b>21</b>)</h4><div class="NLM_p last">A solution of 1-(3,3-dimethylbutyl)-5-(2-methoxyphenyl)-1<i>H</i>-imidazole 20 (150 mg, 0.580 mmol) in 48% HBr (3 mL) was stirred at 110 °C for 16 h. The solution was allowed to cool to rt and was poured into saturated NaHCO<sub>3</sub> (10 mL). The aqueous phase was extracted with ethyl acetate (2 × 30 mL). The combined organic layers were dried over sodium sulfate and concentrated under reduced pressure to afford the crude residue, which was purified by column chromatography on silica gel to afford the desired product (110 mg, 77%). LCMS (ESI, <i>m</i>/<i>z</i>): 245.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.40–1.53 (m, 2H), 3.93–4.10 (m 2H), 6.91 (t, <i>J</i> = 7.2 Hz, 1H), 7.02–7.15 (m, 2H), 7.27–7.45 (m 2H), 8.70 (s, 1H).</div></div><div id="sec4_14_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-Chloro-2-(1-cyclohexyl-1<i>H</i>-imidazol-5-yl)phenol (<b>22</b>)</h4><div class="NLM_p last">To a solution of 5-(2-(benzyloxy)-5-chlorophenyl)-1-cyclohexyl-1<i>H</i>-imidazole <b>20</b> (161 mg, 0.438 mmol) in MeOH (5 mL) at rt was added HCl (0.351 mL, 1.25 M in MeOH) followed by 10% Pd/C (0.043 mmol), and the mixture was evacuated and purged with H<sub>2</sub> balloon. The solution was stirred under a positive pressure of H<sub>2</sub> balloon overnight. After purging the reaction mixture with nitrogen, the reaction mixture was filtered through a Celite plug and the solvent was evaporated under reduced pressure to afford the crude residue. The crude residue was basified with saturated K<sub>2</sub>CO<sub>3</sub> solution and the product was extracted with EtOAc (3 × 30 mL). The combined organic extract was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford crude. Chromatographic purification afforded the desired product as off-white solid (92 mg, 75.7%). LCMS (ESI, <i>m</i>/<i>z</i>): 277.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.13–1.20 (m, 3H), 1.29–1.90 (m, 7H), 3.61–3.68 (m, 1H), 6.79 (s, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 1H), 7.15 (d, <i>J</i> = 1.8 Hz, 1H), 7.29 (d, <i>J</i> = 8.5 Hz, 1H), 7.85 (s, 1H), 10.1 (br s, 1H).</div></div><div id="sec4_14_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-Methyl-2-(5-phenyl-1<i>H</i>-imidazol-1-yl)acetamide (<b>23</b>)</h4><div class="NLM_p last">It is obtained in 54% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 216.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.66 (s, 3H), 4.67 (s, 2H), 6.99 (s, 1H), 7.3–7.45 (m, 5H), 7.73 (s, 1H).</div></div><div id="sec4_14_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-Methyl-3-(5-phenyl-1<i>H</i>-imidazol-1-yl)propanamide (<b>24</b>)</h4><div class="NLM_p last">It is obtained in 59% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 230.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.39–2.44 (t, <i>J</i> = 6.7 Hz, 2H), 2.73–2.74 (d, <i>J</i> = 4.8 Hz, 3H), 4.36 (t, <i>J</i> = 6.7 Hz, 2H), 5.96 (br s, 1H), 7.09 (br s, 1H), 7.27–7.47 (m, 5H), 7.61 (br s, 1H).</div></div><div id="sec4_14_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-(1-Trityl-1<i>H</i>-imidazol-4-yl)phenol (<b>25</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (2.0 g, 12.49 mmol) in anhydrous DMF (20 mL) at rt was added trimethylamine (1.58 g, 15.61 mmol). After stirring for 10 min, a solution of chlorotriphenylmethane (3.48 g, 12.49 mmol) in DMF (15 mL) was added dropwise over a period of 2–3 min and continued stirring for 5 h. The reaction mixture was poured into water (80 mL), and the solid was filtered-off and washed with water (2 × 50 mL). The crude solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), the organic layer was washed with brine, and the solvent was evaporated under reduced pressure to afford <b>25</b> as white solid (4.82 g, 95%). <sup>1</sup>H NMR: δ 6.79 (t, <i>J</i> = 7.5 Hz, 1H), 6.98–7.00 (m, 1H), 7.08–7.40 (m, 18H), 7.54 (s, 1H), 12.22 (br s, 1H).</div></div><div id="sec4_14_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 5-(2-(Benzyloxy)phenyl)-1<i>H</i>-imidazole (<b>26</b>)</h4><div class="NLM_p last">It is obtained in 65% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 251.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 5.14 (s, 2H), 7.00–7.03 (m, 2H), 7.19 (dt, <i>J</i> = 8.2, 2.3 Hz, 1H), 7.33–7.44 (m, 5H), 7.51 (s, 1H), 7.56 (s, 1H), 7.90 (d, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec4_14_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 5-(2-Phenethoxyphenyl)-1<i>H</i>-imidazole (<b>27</b>)</h4><div class="NLM_p last">It is obtained in 32% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 265.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 3.20 (t, <i>J</i> = 6.4 Hz, 2H), 4.40 (t, <i>J</i> = 6.4 Hz, 2H), 6.97–7.01 (m, 2H), 7.18–7.22 (m, 1H), 7.28–7.39 (m, 7H), 7.73 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H).</div></div><div id="sec4_14_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 5-(2-(3-Phenylpropoxy)phenyl)-1<i>H</i>-imidazole (<b>28</b>)</h4><div class="NLM_p last">It is obtained in 59% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 279.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.17–2.24 (m, 2H), 2.82 (t, <i>J</i> = 7.6 Hz, 2H), 4.09 (t, <i>J</i> = 6.4 Hz, 2H), 6.90 (d, <i>J</i> = 8.0 Hz, 1H), 6.97–7.01 (m, 1H), 7.16–7.19 (m, 4H), 7.24–7.29 (m, 2H), 7.59 (s, 1H), 7.65 (s, 1H), 7.89 (s, 1H).</div></div><div id="sec4_14_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 5-(2-(3,3-Dimethylbutoxy)phenyl)-1<i>H</i>-imidazole (<b>29</b>)</h4><div class="NLM_p last">It is obtained in 55% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 245.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.01 (s, 9H), 1.85 (t, <i>J</i> = 7.6 Hz, 2H), 4.15 (t, <i>J</i> = 7.6 Hz, 2H), 6.96–7.02 (m, 2H), 7.19–7.23 (m, 1H), 7.58 (s, 1H), 7.69 (s, 1H), 7.87 (d, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec4_14_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-(2-(Isopentyloxy)phenyl)-1<i>H</i>-imidazole (<b>30</b>)</h4><div class="NLM_p last">It is obtained in 21% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 231.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.99 (d, <i>J</i> = 6.2 Hz, 6H), 1.79–1.84 (m, 2H), 4.13 (t, <i>J</i> = 6.6 Hz, 2H), 6.96–7.04 (m, 2H), 7.19 (d, <i>J</i> = 1.6 Hz, 1H), 7.55 (s, 1H), 7.69 (s, 1H), 7.84 (d, <i>J</i> = 6.4 Hz, 1H).</div></div><div id="sec4_14_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-(2-(2-Cyclopropylethoxy)phenyl)-1<i>H</i>-imidazole (<b>31</b>)</h4><div class="NLM_p last">It is obtained in 72% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 229.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.13–0.19 (m, 2H), 0.50–0.57 (m, 2H), 0.84–0.89 (m, 1H), 1.77–1.84 (m, 2H), 4.16–4.20 (t, <i>J</i> = 6.6 Hz, 2H), 6.98–7.04 (m, 2H), 7.19–7.26 (m, 1H), 7.58 (s, 1H), 7.71 (s, 1H), 7.86 (d, <i>J</i> = 7.8 Hz, 2H).</div></div><div id="sec4_14_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 4-(2-(2-Cyclopentylethoxy)phenyl)-1<i>H</i>-imidazole (<b>32</b>)</h4><div class="NLM_p last">It is obtained in 69% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 257.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.10–1.25 (m, 2H), 1.47–1.70 (m, 4H), 1.75–2.00 (m, 5H), 4.09 (t, <i>J</i> = 6.4 Hz, 2H), 6.90–7.10 (m, 2H), 7.19 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.53 (s, 1H), 7.69 (s, 1H), 8.11 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 9.54 (s, 1H).</div></div><div id="sec4_14_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-(2-(2-Cyclohexylethoxy)phenyl)-1<i>H</i>-imidazole (<b>33</b>)</h4><div class="NLM_p last">It is obtained in 73% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 271.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.02–1.15 (m, 2H), 1.20–1.27 (m, 3H), 1.47–1.49 (m, 1H), 1.50–1.84 (m, 7H), 4.15 (t, <i>J</i> = 6.8 Hz, 2H), 6.97 (d, <i>J</i> = 8.3 Hz, 1H), 7.02 (d, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 7.2 Hz, 1H), 7.54 (s, 1H), 7.68 (s, 1H), 7.82 (s, 1H).</div></div><div id="sec4_14_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 5-(2-(2-(1<i>H</i>-Imidazol-4-yl)phenoxy)ethyl)pyrimidine (<b>34</b>)</h4><div class="NLM_p last">It is obtained in 42% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 267.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 3.24 (t, <i>J</i> = 6.0 Hz, 2H), 4.44 (t, <i>J</i> = 6.0 Hz, 2H), 7.02 (t, <i>J</i> = 7.5 Hz, 1H), 7.09 (t, <i>J</i> = 8.4 Hz, 1H), 7.21–7.26 (m, 1H), 7.30 (s, 2H), 7.71 (s, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 8.74 (s, 1H), 8.99 (s, 1H).</div></div><div id="sec4_14_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1-(2-(2-(1<i>H</i>-Imidazol-4-yl)phenoxy)ethyl)-1<i>H</i>-pyrazole (<b>35</b>)</h4><div class="NLM_p last">It is obtained in 15% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 255.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 4.35 (t, <i>J</i> = 4.5 Hz, 2H), 4.64 (t, <i>J</i> = 4.5 Hz, 2H), 6.33 (s, 1H), 6.85 (d, <i>J</i> = 8.2 Hz, 1H), 7.01 (t, <i>J</i> = 7.5 Hz, 1H), 7.45 (s, 1H), 7.49 (d, <i>J</i> = 1.6 Hz, 1H), 7.62 (s, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.77 (s, 1H).</div></div><div id="sec4_14_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-(2-Cyclohexylethoxy)-2-(1<i>H</i>-imidazol-4-yl)phenol (<b>36</b>)</h4><div class="NLM_p last">It is obtained in 46% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 287.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.90–1.05 (m, 2H), 1.10–1.30 (m, 3H), 1.42–1.58 (m, 1H), 1.66–1.82 (m, 7H), 4.09 (t, <i>J</i> = 6.8 Hz, 2H), 6.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.06 (t, <i>J</i> = 8.4 Hz, 1H), 7.66 (s, 1H), 7.69 (s, 1H), 9.69 (br s, 1H).</div></div><div id="sec4_14_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindole (<b>37</b>)</h4><div class="NLM_p last">It was synthesized as per the literature.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> LCMS (ESI, <i>m</i>/<i>z</i>): 157 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 7.13 (s, 1H), 7.22–7.26 (m, 1H), 7.34–7.39 (m, 2H), 7.53 (d, <i>J</i> = 7.4 Hz, 1H), 7.71 (s, 1H).</div></div><div id="sec4_14_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 1-(2-Iodo-3-methoxybenzyl)-1<i>H</i>-imidazole (<b>39</b>)</h4><div class="NLM_p last">To a solution of (2-iodo-3-methoxyphenyl)methanol<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (0.350 g, 1.33 mmol), imidazole (0.181 g, 2.65 mmol), and triphenyl phosphine (0.382 g, 1.46 mmol) in tetrahydrofuran (5 mL) at 0 °C was added diethyl azodicarboxylate (40% solution in toluene; 0.664 mL). The yellow solution was allowed to warm to room temperature and stirred at 60 °C overnight. After evaporating the solvent under reduced pressure, the crude was purified by column chromatography to yield <b>39</b> (179 mg, 43%). <sup>1</sup>H NMR: δ 3.90 (s, 3H), 5.19 (s, 2H), 6.43 (d, <i>J</i> = 5.7 Hz, 1H), 6.77 (d, <i>J</i> = 6.1 Hz, 1H), 6.93 (s, l H), 7.10 (s, 1H), 7.24 (t, <i>J</i> = 6.0 Hz, 1H).</div></div><div id="sec4_14_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 9-Methoxy-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindole (<b>40</b>)</h4><div class="NLM_p last">A mixture of l-(2-iodo-3-methoxybenzyl)-1<i>H</i>-imidazole (<b>39</b>) (0.180 g, 0.573 mmol) and potassium carbonate (1.146 mmol) in dimethyl sulfoxide was purged with nitrogen for 5 min to which triphenylphosphine (0.057 mmol) and Pd(OAC)<sub>2</sub> (0.0286 mmol) were added. The mixture was stirred under nitrogen atmosphere at 110 °C for 36 h. After cooling to room temperature, the reaction mixture was diluted with water (15 mL) and the aqueous layer was extracted with EtOAc (3 × 25 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford the crude product. Chromatographic purification afforded <b>40</b> (39.8 mg, 37%). <sup>1</sup>H NMR: δ 3.96 (s, 3H), 5.00 (s, 2H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 6.99 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (s, 1 H), 7.22 (t, <i>J</i> = 8.0 Hz, 1H), 7.69 (s, 1 H).</div></div><div id="sec4_14_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-9-ol (<b>41</b>)</h4><div class="NLM_p last">A solution of 9-methoxy-5H-imidazo[5,1-<i>a</i>]isoindole (<b>40</b>) (37 mg, 0.198 mmol) in hydrobromic acid (2 mL, 48% aq) was stirred at 100 °C overnight (14 h). After cooling to room temperature, the excess of hydrobromic acid was distilled off and the crude was diluted with 10% aqueous NaOH solution (15 mL) and washed with toluene (10 mL) to remove unreacted methyl ether. The aqueous layer was acidified with HCl and then basified with saturated K<sub>2</sub>CO<sub>3</sub> solution. The product was extracted with EtOAc (3 × 15 mL). The combined organic extract was dried over sodium sulfate and concentrated under reduced pressure to afford <b>41</b> (14 mg, 68% brsm). LCMS (ESI, <i>m</i>/<i>z</i>): 173.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 5.07 (s, 2H), 6.80 (d, <i>J</i> = 8.1 Hz, 1H), 6.94 (dd, <i>J</i> = 6.8, 0.72 Hz, 1H), 7.0 (s, 1H), 7.12 (t, <i>J</i> = 7.8 Hz, 1H), 7.80 (s, 1H).</div></div><div id="sec4_14_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 2-(1-(2-Hydroxyethyl)-1<i>H</i>-imidazol-5-yl)phenol (<b>43</b>)</h4><div class="NLM_p last">To a stirred solution of 2-amino-1-ethanol (282.6 mg, 4.63 mmol) in MeOH (5 mL) was added a solution of salicylaldehyde (565 mg, 4.63 mmol) in MeOH (5 mL). The reaction mixture was heated at 40 °C for 1 h and was concentrated to a give crude amine as a yellow liquid, which was used in the next step immediately. To a solution of crude imine in DME/MeOH (15 mL, 4:1) was added TosMIC (1.08 g, 5.55 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.41 g, 10.17 mmol). The solution was allowed to stir at room temperature for three days. The solvent was evaporated under reduced pressure and the crude product was purified by flash column chromatography on silica gel to afford <b>43</b> (438 mg, 46% yield). <sup>1</sup>H NMR: δ 3.32 (s, 1H), 3.57 (t, <i>J</i> = 5.6 Hz, 2H), 4.01 (t, <i>J</i> = 5.6 Hz, 2H), 6.86 (d, <i>J</i> = 5.6 Hz, 2H), 6.89 (s, 1H), 7.16 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.24 (td, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.75 (1H).</div></div><div id="sec4_14_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 5,6-Dihydrobenzo[<i>f</i>]imidazo[1,5-<i>d</i>][1,4]oxazepine (<b>44</b>)</h4><div class="NLM_p last">To a stirred solution of 2-(1-(2-hydroxyethyl)-1<i>H</i>-imidazol-5-yl)phenol (<b>43</b>) (100.0 mg, 0.490 mmol) and PPh<sub>3</sub> (154.1 mg, 0.587 mmol) in THF (4 mL) at 0 °C was added DEAD (0.22 mL, 40% solution in toluene, 0.75 mmol). The resulting yellow solution was allowed to warm to rt and stirred overnight. The solvent was removed under reduced pressure and the crude residue was purified by flash column chromatography on silica gel to afford <b>44</b> (76 mg, 83%). <sup>1</sup>H NMR: δ 4.35–4.45 (m, 4H), 6.94–7.05 (m, 2H), 7.11–7.19 (m, 1H), 7.43 (d, <i>J</i> = 0.8 Hz, 1H), 7.49 (s, 1H), 7.67 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H).</div></div><div id="sec4_14_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Imidazo[5,1-<i>a</i>]isoquinoline (<b>45</b>)</h4><div class="NLM_p last">It was synthesized as per the literature in 31% yield.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> LCMS (ESI, <i>m</i>/<i>z</i>): 169 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 6.78 (d, <i>J</i> = 7.4 Hz, 1H), 7.41 (t, <i>J</i> = 7.6 Hz, 1H), 7.50 (t, <i>J</i> = 7.7 Hz, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.73 (d, <i>J</i> = 7.3 Hz, 1H), 7.81 (s, 1H), 8.01 (d, <i>J</i> = 7.9 Hz, 1H), 8.07 (s, 1H).</div></div><div id="sec4_14_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 5-(2-Cyclohexylethyl)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindole (<b>46</b>)</h4><div class="NLM_p last">To a solution of <b>37</b> (858 mg, 5.49 mmol) in anhydrous THF (10 mL) at −40 °C was added <i>n</i>BuLi (2.20 mL, 5.49 mmol, 2.5 M solution hexanes). After stirring for 1.0 h at −40 °C, (2-bromoethyl)cyclohexane (700 mg, 3.66 mmol) was added and the reaction was allowed to warm to −30 °C and stirred overnight. The reaction was quenched by adding saturated NH<sub>4</sub>Cl (10 mL) and water (20 mL), and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 35 mL). The combined organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to afford the crude mixture, and the crude mixture was purified by CombiFlash chromatography to yield <b>46</b> (0.780 g, 80%). LCMS (ESI, <i>m</i>/<i>z</i>): 267.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.65–0.81 (m, 2H), 0.92–1.16 (m, 6H), 1.46–1.63 (m, 5H), 1.80 (ddt, <i>J</i> = 11.3, 8.9, 6.2 Hz, 1H), 1.95–2.09 (m, 1H), 4.98 (t, <i>J</i> = 5.7 Hz, 1H), 7.08 (s, 1H), 7.09–7.15 (m, 1H), 7.18–7.25 (m, 2H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.58 (s, 1H).</div></div><div id="sec4_14_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 2-(2-(1<i>H</i>-Imidazol-4-yl)phenoxy)-1-cyclohexylethan-1-one (<b>47</b>)</h4><div class="NLM_p last">It is obtained in 62% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 385.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.28–1.39 (m, 3H), 1.46–1.55 (m, 2H), 1.74 (d, <i>J</i> = 9.6 Hz, 1H), 1.84–1.93 (m, 4H), 2.49–2.54 (m, 1H), 4.91 (s, 2H), 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.05 (dt, <i>J</i> = 7.6, 0.8 Hz, 1H), 7.20 (dt, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.58 (s, 1H), 7.77 (d, <i>J</i> = 7.2 Hz, 1H), 7.80 (s, 1H).</div></div><div id="sec4_14_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 2-(2-(1<i>H</i>-Imidazol-4-yl)phenoxy)-1-cyclohexylethan-1-ol (<b>48</b>)</h4><div class="NLM_p last">To a mixture of 2-(2-(1<i>H</i>-imidazol-4-yl)phenoxy)-<span class="smallcaps smallerCapital">l</span>-cyclohexylethanone <b>47</b> (130 mg, 0.457 mmol) in MeOH (4 mL) at 0 °C was added NaBH<sub>4</sub> (52 mg, 1.37 mmol) and the solution was allowed to stir at room temperature for 1 h. The solvent was distilled off and the crude was acidified with dil HCl (2 N), again basified by using saturated aqueous NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc (3 × 15 mL). The combined organic extracts were washed with brine, dried, and concentrated under reduced pressure to afford <b>48</b> (118 mg, 90%). LCMS (ESI, <i>m</i>/<i>z</i>): 287.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.04–1.21 (m, 5H), 1.49–1.50 (m, 1H), 1.61–1.68 (m, 4H), 1.85 (d, <i>J</i> = 12.4 Hz, 1H), 3.62–3.65 (m, 1H), 3.96 (dd, <i>J</i> = 9.6, 6.4 Hz, 1H), 4.07 (dd, <i>J</i> = 10, 3.2 Hz, 1H), 4.97 (br s, 1H), 6.93 (t, <i>J</i> = 7.2 Hz, 1H), 7.03 (d, <i>J</i> = 7.6 Hz, 1H), 7.12 (d, <i>J</i> = 7.2 Hz, 1H), 7.67 (s, 1H), 7.70 (s, 1 H), 8.03 (s, 1H), 12.01 (br s, 1H).</div></div><div id="sec4_14_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Methyl (1<i>r</i>,4<i>r</i>)-4-Benzamidocyclohexane-1-carboxylate (<b>49n-SM</b>)</h4><div class="NLM_p last">To a suspension of (1<i>r</i>,4<i>r</i>)-methyl 4-aminocyclohexanecarboxylate hydrochloride (0.63 g, 3.26 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 °C was added diisopropylethylamine (1.71 mL, 9.79 mmol) and the suspension was stirred for 10 min. Benzoyl chloride (0.45 mL, 3.92 mmol) was added dropwise and the clear solution was allowed to warm to rt and stirred overnight. The reaction was diluted with water (15 mL) and CH<sub>2</sub>Cl<sub>2</sub> (15 mL), the organic layer was separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL). The combined organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to afford the crude product. Chromatographic purification afforded <b>49n-SM</b> as a white solid (200 mg, 23%). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 1.46 (q, <i>J</i> = 11.5 Hz, 2H), 1.60 (q, <i>J</i> = 12.0 Hz, 2H), 2.09 (d, <i>J</i> = 11.2 Hz, 4H), 2.37 (t, <i>J</i> = 12.0 Hz, 1H), 3.71 (s, 3H), 3.90 (t, <i>J</i> = 11.4 Hz, 1H), 7.46–7.57 (m, 3H), 7.83 (d, <i>J</i> = 7.1 Hz, 2H).</div></div><div id="sec4_14_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Methyl (1<i>s</i>,4<i>s</i>)-4-Benzamidocyclohexane-1-carboxylate (<b>49o-SM</b>)</h4><div class="NLM_p last">To a suspension of (1<i>s</i>,4<i>s</i>)-methyl 4-aminocyclohexanecarboxylate hydrochloride (0.63 g, 3.26 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 °C was added diisopropylethylamine (1.71 mL, 9.79 mmol) and the suspension was stirred for 10 min. Benzoyl chloride (0.45 mL, 3.92 mmol) was added dropwise and the clear solution was allowed to warm to rt and stirred overnight. The reaction was diluted with water (15 mL) and CH<sub>2</sub>Cl<sub>2</sub> (15 mL), the organic layer was separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL). The combined organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to afford the crude. Chromatographic purification afforded <b>49o-SM</b> (745 mg, 87%). <sup>1</sup>H NMR: δ 1.70–1.73 (m, 2H), 1.76–1.90 (m, 4H), 1.95–2.06 (m, 2H), 2.55–2.61 (m, 1H), 3.72 (s, 3H), 4.14–4.20 (m, 1H), 6.14 (d, <i>J</i> = 6.0 Hz, 1H), 7.43–7.47 (m, 2H), 7.49–7.51 (m, 1H), 7.76–7.78 (m, 2H).</div></div><div id="sec4_14_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Dimethyl (2-Cyclohexyl-2-oxoethyl)phosphonate (<b>49a</b>)</h4><div class="NLM_p last">It is obtained in 89% yield. <sup>1</sup>H NMR: δ 1.14–1.38 (m, 5H), 1.62–1.94 (m, 5H), 2.52–2.58 (m, 1H), 3.12 (d, <i>J</i> = 22.5 Hz, 2H), 3.76 (s, 3H), 3.79 (s, 3H).</div></div><div id="sec4_14_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Dimethyl 3-Cyclohexyl-2-oxopropylphosphonate (<b>49b</b>)</h4><div class="NLM_p last">It is obtained in 70% yield. <sup>1</sup>H NMR: δ 0.60–1.15 (m, 5H), 1.35–1.71 (m, 6H), 2.28 (d, <i>J</i> = 8.8 Hz, 2H), 2.86 (d, <i>J</i> = 22.8 Hz, 2H), 3.55 (s, 3H), 3.59 (s, 3H).</div></div><div id="sec4_14_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Dimethyl (2-Oxo-2-(pyridin-2-yl)ethyl)phosphonate (<b>49c</b>)</h4><div class="NLM_p last">It is obtained in 56% yield. <sup>1</sup>H NMR: δ 3.69–3.77 (m, 6H), 3.96–4.04 (m, 2H), 7.45–7.48 (m, 1H), 7.80–7.85 (m, 1H), 8.03–8.09 (m, 1H), 8.66–8.69 (m, 1H).</div></div><div id="sec4_14_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Dimethyl (2-Oxo-2-(pyridin-3-yl)ethyl)phosphonate (<b>49d</b>)</h4><div class="NLM_p last">It is obtained in 65% yield. <sup>1</sup>H NMR δ 3.60–3.80 (m, 8H), 7.41–7.45 (m, 1H), 8.26–8.29 (m, 1H), 8.78–8.79 (m, 1H), 9.18 (m, 1H).</div></div><div id="sec4_14_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Dimethyl (2-Oxo-2-(thiazol-5-yl)ethyl)phosphonate (<b>49e</b>)</h4><div class="NLM_p last">It is obtained in 18% yield. <sup>1</sup>H NMR δ 3.58 (d, <i>J</i> = 22.9 Hz, 2H), 3.74 (s, 3H), 3.79 (s, 3H), 8.52 (s, 1H), 9.04 (s, 1H).</div></div><div id="sec4_14_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Dimethyl (2-(1-Methyl-1<i>H</i>-imidazol-4-yl)-2-oxoethyl)phosphonate (<b>49f</b>)</h4><div class="NLM_p last">It is obtained in 29% yield. <sup>1</sup>H NMR: δ 7.63 (s, 1H), 7.44 (s, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 3.71 (s, 3H), 3.68 (d, <i>J</i> = 22.5 Hz, 2H).</div></div><div id="sec4_14_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Dimethyl (2-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-2-oxoethyl)phosphonate (<b>49g</b>)</h4><div class="NLM_p last">It is obtained in 78.5% yield. <sup>1</sup>H NMR: δ 2.41 (s, 3H), 3.46 (d, <i>J</i> = 22.5 Hz, 2H), 3.78 (s, 3H), 3.81 (s, 3H), 6.21 (dq, <i>J</i> = 3.5, 0.9 Hz, 1H), 7.24 (dd, <i>J</i> = 3.6, 0.7 Hz, 1H).</div></div><div id="sec4_14_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> <i>tert</i>-Butyl 3-(2-(Dimethoxyphosphoryl)acetyl)azetidine-1-carboxylate (<b>49h</b>)</h4><div class="NLM_p last">It is obtained in 99% yield. <sup>1</sup>H NMR: δ 1.43 (s, 9H), 3.11 (d, <i>J</i> = 22.9 Hz, 2H), 3.68–3.82 (m, 7H), 3.81–4.12 (m, 4H).</div></div><div id="sec4_14_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> <i>tert</i>-Butyl 4-(2-(Dimethoxyphosphoryl)acetyl)piperidine-1-carboxylate (<b>49i</b>)</h4><div class="NLM_p last">It is obtained in 61% yield. <sup>1</sup>H NMR: δ 1.44 (s, 9H), 1.47–1.57 (m, 2H), 1.65 (s, 2H), 1.85 (d, <i>J</i> = 13.2 Hz, 2H), 2.68–2.84 (m, 3H), 3.13 (d, <i>J</i> = 22.7 Hz, 2H), 3.77 (s, 3H), 3.80 (s, 3H).</div></div><div id="sec4_14_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Dimethyl (2-(1-Acetylpiperidin-4-yl)-2-oxoethyl)phosphonate (<b>49j</b>)</h4><div class="NLM_p last">It is obtained in 64% yield. <sup>1</sup>H NMR: δ 1.44–1.69 (m, 2H), 1.83–1.89 (m, 2H), 2.07 (s, 3H), 2.66–2.73 (m, 1H), 2.79–2.85 (m, 1H), 3.03–3.22 (m, 3H), 3.75 (s, 3H), 3.78 (s, 3H), 3.78–3.83 (m, 1H), 4.50–4.55 (m, 1H).</div></div><div id="sec4_14_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Dimethyl 2-(4,4-Difluorocyclohexyl)-2-oxoethylphosphonate (<b>49k</b>)</h4><div class="NLM_p last">It is obtained in 82% yield. <sup>1</sup>H NMR: δ 1.72–1.81 (m, 4H), 1.96–1.98 (m, 2H), 2.11–2.13 (m, 2H), 2.68–2.70 (m, 1H), 3.14 (d, <i>J</i> = 22.4 Hz, 2H), 3.77 (s, 3H), 3.80 (s, 3H).</div></div><div id="sec4_14_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Methyl (1<i>r</i>,4<i>r</i>)-4-(2-(Dimethoxyphosphoryl)acetyl)cyclohexane-1-carboxylate (<b>49l</b>)</h4><div class="NLM_p last">It is obtained in 70% yield. <sup>1</sup>H NMR: δ 1.31–1.53 (m, 4H), 2.00–2.20 (m, 4H), 2.23–2.31 (m, 1H), 2.53–2.61 (m, 1H), 3.13 (d, <i>J</i> = 22.6 Hz, 2H), 3.67 (s, 3H), 3.77 (s, 3H), 3.80 (s, 3H).</div></div><div id="sec4_14_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Dimethyl 2-Oxo-2-(1,4-dioxaspiro[4.5]decan-8-yl)ethylphosphonate (<b>49m</b>)</h4><div class="NLM_p last">It is obtained in 72% yield. <sup>1</sup>H NMR: δ 1.42–1.94 (m, 8H), 2.53–2.62 (m, 1H), 3.11 (d, <i>J</i> = 22.6 Hz, 2H), 3.73–3.75 (m, 3H), 3.76–3.78 (m, 3H), 3.90–3.92 (m, 4H).</div></div><div id="sec4_14_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Dimethyl (2-((1<i>r</i>,4<i>r</i>)-4-Benzamidocyclohexyl)-2-oxoethyl)phosphonate (<b>49n</b>)</h4><div class="NLM_p last">It is obtained in 54% yield. <sup>1</sup>H NMR: δ 1.29 (dq, <i>J</i> = 3.1, 12.1 Hz, 2H), 1.54 (dq, <i>J</i> = 11.5, 3.0 Hz, 2H), 2.04 (d, <i>J</i> = 12.9 Hz, 2H), 2.12 (dd, <i>J</i> = 12.6, 3.0 Hz, 2H), 2.60 (tt, <i>J</i> = 12.0, 3.4 Hz, 1H), 3.15 (d, <i>J</i> = 22.6 Hz, 2H), 3.78 (s, 3H), 3.80 (s, 3H), 3.93–3.99 (m, 1H), 5.98 (d, <i>J</i> = 7.7 Hz, 1H), 7.41–7.45 (m, 2H), 7.48–7.52 (m, 2H), 7.74 (d, <i>J</i> = 7.1 Hz, 2H).</div></div><div id="sec4_14_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Dimethyl (2-((1<i>s</i>,4<i>s</i>)-4-Benzamidocyclohexyl)-2-oxoethyl)phosphonate (<b>49o</b>)</h4><div class="NLM_p last">It is obtained in 83% yield. <sup>1</sup>H NMR: δ 1.76–1.85 (m, 8H), 2.78–2.79 (m, 1H), 3.18 (d, <i>J</i> = 22.8 Hz, 2H), 3.80 (s, 3H), 3.83 (s, 3H), 4.21–4.25 (m, 1H), 7.40–7.52 (m, 3H), 7.76–7.78 (m, 2H).</div></div><div id="sec4_14_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> Dimethyl (2-((1<i>r</i>,4<i>r</i>)-4-((<i>tert</i>-Butyldimethylsilyl)oxy)cyclohexyl)-2-oxoethyl)phosphonate (<b>49p</b>)</h4><div class="NLM_p last">It is obtained in 96% yield. <sup>1</sup>H NMR: δ 0.01 (s, 6H), 0.82 (s, 9H), 1.19–1.32 (m, 4H), 1.85–1.88 (m, 4H), 2.41–2.47 (m, 1H), 3.08 (d, <i>J</i> = 22.8 Hz, 2H), 3.49–3.51 (m, 1H), 3.72 (s, 3H), 3.74 (s, 3H).</div></div><div id="sec4_14_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 2-(1-Trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50a</b>)</h4><div class="NLM_p last">It is obtained in 52% yield. <sup>1</sup>H NMR: δ 7.03 (s, 1H), 7.18–7.20 (m, 6H), 7.36–7.39 (m, 10H), 7.53–7.58 (m, 3H), 7.64 (d, <i>J</i> = 7.8 Hz, 1H), 7.93 (d, <i>J</i> = 7.9 Hz, 1H).</div></div><div id="sec4_14_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 2-Fluoro-6-(1-trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50b</b>)</h4><div class="NLM_p last">It is obtained in 46% yield. <sup>1</sup>H NMR: δ 7.02–7.07 (m, 1H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 7.16–7.18 (m, 6H), 7.36–7.39 (m, 9H), 7.46–7.52 (m, 2H), 7.57 (s, 1H), 10.27 (s, 1H).</div></div><div id="sec4_14_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 4-Fluoro-2-(1-trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50c</b>)</h4><div class="NLM_p last">It is obtained in 89% yield. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 7.16–7.27 (m, 6H), 7.29–7.47 (m, 3H), 7.60–7.70 (m, 9H), 7.85–7.90 (m, 2H), 10.26 (s, 1H).</div></div><div id="sec4_14_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 5-Chloro-2-(1-trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50d</b>)</h4><div class="NLM_p last">It is obtained in 48% yield. <sup>1</sup>H NMR: δ 7.04 (d, <i>J</i> = 1.2 Hz, 1H), 7.10–7.19 (m, 5H), 7.32–7.38 (m, 12H), 7.58 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.57–7.59 (m, 2H), 7.89 (d, <i>J</i> = 2.0 Hz, 1H), 10.34 (s, 1H).</div></div><div id="sec4_14_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 4-Chloro-2-(1-trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50e</b>)</h4><div class="NLM_p last">It is obtained in 55% yield. <sup>1</sup>H NMR: δ 7.08–7.38 (m, 18 H), 7.60 (s, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 1H), 10.41 (s, 1H).</div></div><div id="sec4_14_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 5-Fluoro-2-(1-trityl-1<i>H</i>-imidazol-4-yl)benzaldehyde (<b>50f</b>)</h4><div class="NLM_p last">It is obtained in 87% yield. <sup>1</sup>H NMR: δ 7.02 (d, <i>J</i> = 1.4 Hz, 1H), 7.07–7.15 (m, 1H), 7.14–7.23 (m, 4H), 7.22–7.33 (m, 4H), 7.32–7.43 (m, 8H), 7.54–7.73 (m, 2H), 10.34 (d, <i>J</i> = 3.0 Hz, 1H).</div></div><div id="sec4_14_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 1-Cyclohexyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>51</b>)</h4><div class="NLM_p last">It is obtained in 86% yield. <sup>1</sup>H NMR: δ 1.21–1.50 (m, 5H), 1.62–1.91 (m, 5H), 2.28–2.45 (m, 1H), 2.89 (dd, <i>J</i> = 18.1, 9.0 Hz, 1H), 3.18 (dd, <i>J</i> = 18.1, 3.2 Hz, 1H), 5.61–5.64 (m, 1H), 7.16 (s, 1H), 7.21–7.28 (m, 2H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.53 (d, 1H, <i>J</i> = 6.2 Hz, 1H), 7.60 (s, 1H).</div></div><div id="sec4_14_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 1-Cyclohexyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>52</b>)</h4><div class="NLM_p last">It is obtained in 79% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 283.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.01–1.29 (m, 5H), 1.35–1.43 (m, 1H), 1.64–1.92 (m, 5H), 2.08 (ddd, <i>J</i> = 14.3, 7.0, 3.0 Hz, 1H), 2.26–2.14 (m, 1H), 2.30 (br s, 1H), 3.72–3.83 (two m, 1H), 5.39 (t, <i>J</i> = 6.2 Hz, 0.8H), 5.52 (dd, <i>J</i> = 10.8, 3.2 Hz, 0.2H), 7.19 and 7.20 (two s, 1H), 7.24–7.29 (m, 1H), 7.35–7.40 (m, 1H), 7.46 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (d, <i>J</i> = 7.6 Hz, 1H), 7.85 and 7.90 (two s, 1H).</div></div><div id="sec4_14_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 2-(1-Cyclohexyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)isoindoline-1,3-dione (<b>53</b>)</h4><div class="NLM_p last">To a solution of PPh<sub>3</sub> (255.4 mg, 0.973 mmol) in anhydrous THF (10 mL) at 0 °C was added phthalimide (143.3 mg, 0.974 mmol) and <b>52</b> (250 mg, 0.885 mmol). After stirring for 5 min, diethyl azodicarboxylate (0.444 mL) was added dropwise. The reaction mixture was allowed to warm to rt and stirred for 16 h. The solvent was distilled off and the crude was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with 10% aq NaOH solution (2 × 20 mL), water, and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent was removed under reduced pressure to afford the crude product. The crude was taken without purification to the next step. LCMS (ESI, <i>m</i>/<i>z</i>): 412.33 [M + H]<sup>+</sup>.</div></div><div id="sec4_14_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 1-Cyclohexyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanamine (<b>54</b>)</h4><div class="NLM_p last">To a solution of crude <b>53</b> in ethanol (10 mL) was added hydrazine monohydrate (177 mg, 3.54 mmol). After stirring the mixture for 6 h at 80 °C, the solution was cooled to rt and the solvent was distilled off. The crude product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and the organic phase was washed with water (2 × 10 mL). The crude was purified by column chromatography to afford <b>54</b> (50 mg, 20%). LCMS (ESI, <i>m</i>/<i>z</i>): 282.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (mixture of diastereomers): δ 0.94–1.27 (m, 7H), 1.62–2.06 (two m, 6H), 2.76–2.96 (two m, 1H), 5.36–5.58 (two m, 1H), 7.16–7.25 (m, 2H), 7.31–7.45 (m, 2H), 7.50–7.54 (m, 1H), 7.78 and 7.81 (two s, 1H).</div></div><div id="sec4_14_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Ethyl (<i>E</i>)-3-(2-Iodophenyl)acrylate (<b>55a</b>)</h4><div class="NLM_p last">It was synthesized in 92% yield according to the literature.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec4_14_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> (<i>E</i>)-3-(2-Chloro-6-iodophenyl)-1-cyclohexylprop-2-en-1-one (<b>55b</b>)</h4><div class="NLM_p last">To a solution of 2-chloro-6-iodobenzaldehyde (1.16 g, 4.36 mmol) in anhydrous MeOH (15 mL) at rt was added NaOMe (8.72 mL, 4.36 mmol, 0.5 M in MeOH), and the yellow solution was allowed to stir for 5 min. 1-Cyclohexylethan-1-one (0.550 g, 4.36 mmol) was added dropwise as a solution in MeOH (3 mL). After stirring overnight, the solvent was removed under reduced pressure and the crude was diluted with saturated NH<sub>4</sub>Cl (20 mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL) and the combined organic extracts were dried (MgSO<sub>4</sub>) and the solvent was distilled off under reduced pressure to afford a crude residue. The crude product was purified by silica flash chromatography to afford <b>55b</b> (1.03 g, 63%).<sup>1</sup>H NMR: δ 1.22–1.45 (m, 5 H), 1.70–174 (m, 1H), 1.79–1.85 (m, 2H), 1.93–1.99 (m, 2H), 2.61–2.65 (m, 1H), 6.67 (d, <i>J</i> = 16 Hz, 1H), 6.93 (t, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 8.0 Hz, 1H), 7.48 (d, <i>J</i> = 16.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H).</div></div><div id="sec4_14_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Ethyl 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetate (<b>56</b>)</h4><div class="NLM_p last">Yield: 23%. <sup>1</sup>H NMR: δ 1.31 (t, <i>J</i> = 7.5 Hz, 3H), 2.67 (dd, <i>J</i> = 20.0, 12.0 Hz, 1H), 3.07 (dd, <i>J</i> = 20.0, 4.0 Hz, 1H), 4.25 (q, <i>J</i> = 6.0 Hz, 2H), 5.53 (dd, <i>J</i> = 12.0 Hz, 4.0 Hz, 1H), 7.16 (s, 1H), 7.21–7.37 (m, 3H), 7.51 (d, <i>J</i> = 6.0 Hz, 1H), 7.75 (s, 1H).</div></div><div id="sec4_14_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>57</b>)</h4><div class="NLM_p last">To a solution of <b>56</b> (3.51 mmol) in a 1:2 mixture of THF/EtOH (24 mL) at rt was added NaBH<sub>4</sub> (12.28 mmol) and LiCl (12.28 mmol). After stirring overnight, the solvents were distilled off and the crude was diluted with saturated NH<sub>4</sub>Cl (20 mL). The aqueous layer was extracted with CH<sub>2</sub>CI<sub>2</sub> (3 × 40 mL). The combined organic extracts were dried over MgSO<sub>4</sub> and the solvent was distilled off under reduced pressure to afford the crude residue. The crude product was purified by silica flash chromatography to afford <b>57</b> (638 mg, 91%). LCMS (ESI, <i>m</i>/<i>z</i>): 201.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.04–2.08 (m, 1H), 2.36–2.40 (m, 1H), 3.84 (t, <i>J</i> = 6.3 Hz, 2H), 5.37–5.41 (m, 1H), 7.17 (s, 1H), 7.25–7.28 (m, 1H), 7.35 (d, <i>J</i> = 6.9 Hz, 1H), 7.38 (d, <i>J</i> = 7.2 Hz, 1H), 7.54 (d, <i>J</i> = 7.5 Hz, 1H), 7.76 (s, 1H).</div></div><div id="sec4_14_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> 1-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-2-methylpropan-2-ol (<b>58</b>)</h4><div class="NLM_p last">To a stirred solution of <b>56</b> (48 mg, 0.20 mmol) in THF at 0 °C was added MeMgBr 1.0 M in THF (0.4 mL) dropwise. The resulting solution was allowed to stir at rt for 2 h. The reaction was quenched by cautious addition of methanol to the reaction mixture. The crude mixture was concentrated and purified by column chromatography to afford <b>58</b> (24 mg, 52%). LCMS (ESI, <i>m</i>/<i>z</i>): 229.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.43 (s, 3H), 1.49 (s, 3H), 2.05–2.30 (m, 2H), 5.30–5.35 (m, 1H), 7.14 (s, 1H), 7.20–7.40 (m, 3H), 7.52 (d, <i>J</i> = 9.6 Hz, 1H), 8.02 (s, 1H).</div></div><div id="sec4_14_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> 1-Cyclopentyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>60</b>)</h4><div class="NLM_p last">It is obtained in 11% yield. The compound was taken as such to the next step without analysis.</div></div><div id="sec4_14_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 1-Cyclopentyl-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>61</b>)</h4><div class="NLM_p last">It is obtained in 91% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 269.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.11–1.41 (m, 2H), 1.55–1.70 (m, 4H), 1.83–2.17 (m, 4H), 3.74–3.79 (m, 1H), 5.38, 5.49 (one t and one d, <i>J</i><sub>1</sub> = 6.0 Hz, <i>J</i><sub>2</sub> = 6.0 Hz, 1H), 7.18 (s, 1H), 7.25 (d merged with CHCl<sub>3</sub>, 1H), 7.38 (t, <i>J</i> = 7.2 Hz, 1H), 7.46 (d, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.84 (s, 1H).</div></div><div id="sec4_14_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> 1-Cyclohexyl-3-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)propan-2-one (<b>62</b>)</h4><div class="NLM_p last">It is obtained in 82% yield. <sup>1</sup>H NMR: δ 0.85–1.35 (m, 5H), 1.55–1.18 (m, 5H), 1.80–1.95 (m, 1H), 2.25–2.38 (m, 2H), 2.70–2.80 (m, 1H), 3.16 (dd, <i>J</i> = 14.8, 2.4 Hz, 1H), 5.50–5.60 (m, 1H), 7.16 (s, 1H), 7.20–7.30 (m, 3H), 7.35 (t, <i>J</i> = 5.4 Hz, 1H), 7.41 (d, <i>J</i> = 5.4 Hz, 1H), 7.73 (s, 1H).</div></div><div id="sec4_14_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> 1-Cyclohexyl-3-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)propan-2-ol (<b>63</b>)</h4><div class="NLM_p last">It is obtained in 85% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 297.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 0.80–1.85 (m, 14H), 2.00–2.20 (m, 1H), 4.20–4.50 (m, 1H), 5.30–5.60 (m, 1H), 7.14 (s, 1H), 7.20–7.39 (m, 2H), 7.43 (d, <i>J</i> = 7.2 Hz, 1H), 7.43 (d, <i>J</i> = 7.2 Hz, 1H), 7.91 (s, 1H).</div></div><div id="sec4_14_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-phenylethan-1-one (<b>64</b>)</h4><div class="NLM_p last">It is obtained in 45% yield. <sup>1</sup>H NMR: δ 3.44 (dd, <i>J</i> = 20.0, 8.0 Hz, 1H), 3.72 (dd, <i>J</i> = 20.0, 4.0 Hz, 1H), 5.83 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (s, 1H), 7.25–7.29 (m, 1H), 7.40 (t, <i>J</i> = 10.0 Hz, 2H), 7.47 (t, <i>J</i> = 8.0 Hz, 2H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.61 (t, <i>J</i> = 6.0 Hz, 1H), 7.74 (s, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 2H).</div></div><div id="sec4_14_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-phenylethanol (<b>65</b>)</h4><div class="NLM_p last">It is obtained in 73% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 277.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.87–1.94 and 2.27–2.35 (two m, 1H), 2.40–2.57 (m, 1H), 5.06–5.11 (m, 1H), 5.33 (t, <i>J</i> = 6.1 Hz, 0.8H), 5.54 (dd, <i>J</i> = 10.6, 3.4 Hz, 0.2H), 7.08 and 7.12 (two s, 1H), 7.18–7.54 (m, 9H), 7.63 and 7.86 (two s, 1H).</div></div><div id="sec4_14_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-2-yl)ethanone (<b>66</b>)</h4><div class="NLM_p last">It is obtained in 75% yield. <sup>1</sup>H NMR: δ 3.60 (dd, <i>J</i> = 19.2, 10.0 Hz, 1H), 3.91 (dd, <i>J</i> = 19.2, 3.2 Hz, 1H), 5.65 (dd, <i>J</i> = 10, 3.2 Hz, 1H), 7.08 (s, 1H), 7.13–7.17 (m, 1H), 7.25–7.30 (m, 2H), 7.38–7.45 (m, 2H), 7.66 (s, 1H), 7.78–7.80 (m, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 8.51–8.53 (m, 1H).</div></div><div id="sec4_14_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-2-yl)ethanol (<b>67</b>)</h4><div class="NLM_p last">It is obtained in 82% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 278.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 2.25–2.33 (m, 2H), 5.06–5.07 (m, 1H), 5.09 (br s, 1H), 5.35–5.38 and 5.46–5.49 (two m, 1H), 7.02 (s, 1H), 7.13–7.24 (m, 4H), 7.44–7.48 (m, 2H), 7.57–7.62 (m, 2H), 8.46–8.47 (m, 1H).</div></div><div id="sec4_14_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-3-yl)ethanone (<b>68</b>)</h4><div class="NLM_p last">It is obtained in 89% yield. <sup>1</sup>H NMR: δ 3.57–3.67 (m, 1H), 3.80–3.95 (m, 1H), 6.01–6.05 (m, 1H), 7.27–7.73 (m, 6H), 8.29–8.36 (m, 1H), 8.61 (s, 1H), 8.86 (d, <i>J</i> = 3.0 Hz, 1H), 9.18 (s, 1H).</div></div><div id="sec4_14_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-3-yl)ethanol (<b>69</b>)</h4><div class="NLM_p last">It is obtained in 69% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 278.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.75–2.43 (m, 2H), 5.07–5.12 (m, 1H), 5.38–5.40 and 5.56–5.58 (two m, 2H), 6.98 and 7.11 (two s, 1H), 7.19–7.33 (m, 3H), 7.43–7.49 (m, 2H), 7.43–7.79 (m, 2H), 8.3–8.51 (m, 2H).</div></div><div id="sec4_14_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-4-yl)ethan-1-one (<b>70</b>)</h4><div class="NLM_p last">It is obtained in 21% yield. <sup>1</sup>H NMR: δ 3.42–3.49 (dd, <i>J</i> = 18.8, 9.2 Hz, 1H), 3.76 (dd, <i>J</i> = 18.8, 3.6 Hz, 1H), 5.83 (dd, <i>J</i> = 9.2, 3.2 Hz, 1H), 7.20 (s, 1H), 7.28–7.32 (m, 1H), 7.38–7.45 (m, 2H), 7.58–7.60 (m, 1H), 7.74–7.75 (m, 2H), 7.81 (s, 1H), 8.84–8.86 (m, 2H).</div></div><div id="sec4_14_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(pyridin-4-yl)ethan-1-ol (<b>71</b>)</h4><div class="NLM_p last">It is obtained in 30% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 278.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (mixture of diastereomers): δ 1.98–2.32 (m, 2H), 3.59 (br, 1H), 5.03–5.06 (m, 1H), 5.42–5.45 and 5.56–5.58 (two m, 1H), 7.20–7.23 (m, 1H), 7.24–7.25 (m, 4H), 7.34 (t, <i>J</i> = 7.0 Hz, 1H), 7.41 (d, <i>J</i> = 7.2 Hz, 1H), 7.49 (d, <i>J</i> = 7.6 Hz, 1H), 8.44–8.46 (m, 2H).</div></div><div id="sec4_14_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethanone (<b>72</b>)</h4><div class="NLM_p last">It is obtained in 61% yield. <sup>1</sup>H NMR: δ 1.75–1.84 (m, 4H), 2.58–2.62 (m, 1H), 2.90 (dd, <i>J</i> = 18.4, 9.6 Hz, 1H), 3.21 (dd, <i>J</i> = 18.4, 3.6 Hz, 1H), 3.38–3.45 (m, 2H), 3.99–4.01 (m, 2H), 5.65 (dd, <i>J</i> = 9.6, 3.6 Hz, 1H), 7.17 (s, 1H), 7.22–7.30 (m, 2H), 7.38 (dt, <i>J</i> = 7.2, 0.8 Hz, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.61 (s, 1H).</div></div><div id="sec4_14_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)ethanol (<b>73</b>)</h4><div class="NLM_p last">It is obtained in 92% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 285.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.39–1.51 (m, 2H), 1.59–1.65 (m, 1H), 1.71–1.75 (m, 1H), 2.11–2.17 (m, 1H), 3.32–3.39 (m, 3H), 3.69–3.73 (m, 1H), 3.96–4.05 (m, 3H), 5.39 and 5.49 (two m, 1H), 7.17 (s, 1H), 7.23–7.28 (m, 1H), 7.33–7.44 (m, 2H), 7.55 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (s, 1H).</div></div><div id="sec4_14_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(thiazol-5-yl)ethanone (<b>74</b>)</h4><div class="NLM_p last">It is obtained in 30% yield. <sup>1</sup>H NMR: δ 3.40 (dd, <i>J</i> = 9.6, 18.4 Hz, 1H), 3.71 (dd, <i>J</i> = 18.0, 3.2 Hz, 1H), 5.80 (dd, <i>J</i> = 2.8, 9.2 Hz, 1H), 7.21 (s, 1H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 7.36–7.41 (m, 2H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 8.41 (s, 1H), 7.73 (s, 1H), 9.0 (s, 1H).</div></div><div id="sec4_14_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(thiazol-5-yl)ethanol (<b>75</b>)</h4><div class="NLM_p last">It is obtained in 75% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 284.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.83–1.86, 1.99–2.06, 2.40–2.56 and 2.64–2.70 (m, 2H), 5.33–5.36 and 5.55–5.57 (two m, 1H), 5.39–5.44 (m, 1H), 7.07 (s, 1H), 7.22–7.34 (m, 1H, merged with chloroform), 7.37 (t, <i>J</i> = 7.6 Hz, 1H), 7.44 (d, <i>J</i> = 7.6 Hz, 1H), 7.52 (d, <i>J</i> = 7.5 Hz, 1H), 7.71 and 7.73 (two s, 1H), 7.84 (s, 1H), 8.71 and 8.72 (two s, 1H).</div></div><div id="sec4_14_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(1-methyl-1<i>H</i>-imidazol-4-yl)ethanone (<b>76</b>)</h4><div class="NLM_p last">It is obtained in 24% yield. <sup>1</sup>H NMR: δ 3.42 (d, <i>J</i> = 9.9 Hz, 1H), 3.48 (d, <i>J</i> = 8.7 Hz, 1H), 3.75 (s, 3H), 5.75 (dd, <i>J</i> = 9.8, 3.4 Hz, 1H), 7.26–7.19 (m, 1H), 7.14 (s, 1H), 7.35 (m, 2H), 7.41 (d, <i>J</i> = 1.0 Hz, 1H), 7.52 (dd, <i>J</i> = 7.35, 1.2 Hz, 1H), 7.71 (s, 1H), 7.67 (d, <i>J</i> = 1.2 Hz, 1H).</div></div><div id="sec4_14_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(1-methyl-1<i>H</i>-imidazol-4-yl)ethan-1-ol (<b>77</b>)</h4><div class="NLM_p last">It is obtained in 94% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 281.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.96–2.04, 2.48–2.53 and 2.66–2.71 (three m, 2H), 3.61 (s, 3H), 4.98–5.10 (m, 1H), 5.29–5.32 and 5.51–5.55 (two m, 1H), 6.70 and 6.75 (two s, 1H), 7.11 (s, 1H), 7.16–7.25 (m, 2H), 7.32 (m, 1H), 7.37 (s, 1H), 7.49 (t, <i>J</i> = 7.80 Hz, 1H), 7.67 and 7.88 (two s, 1H).</div></div><div id="sec4_14_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)ethan-1-one (<b>78</b>)</h4><div class="NLM_p last">It is obtained in 88% yield. <sup>1</sup>H NMR: δ 2.39 (s, 3H), 3.27 (dd, <i>J</i> = 17.9, 9.7 Hz, 1H), 3.52 (dd, <i>J</i> = 17.9, 3.7 Hz, 1H), 5.80 (dd, <i>J</i> = 9.7, 3.6 Hz, 1H), 6.20 (dd, <i>J</i> = 3.4, 1.0 Hz, 1H), 7.17 (d, <i>J</i> = 3.5 Hz, 1H), 7.18 (s, 1H), 7.24–7.31 (m, 1H), 7.36–7.44 (m, 2H), 7.56 (d, <i>J</i> = 7.6 Hz, 1H) 7.72 (s, 1H).</div></div><div id="sec4_14_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(1-methyl-1<i>H</i>-pyrazol-4-yl)ethan-1-ol (<b>79</b>)</h4><div class="NLM_p last">It is obtained in 77% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 281.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 2.27 and 2.28 (two s, 3H), 2.42–2.55 and 2.70–2.77 (two m, 2H), 3.53 (br s, 1H), 5.04 (dd, <i>J</i> = 8.2, 6.0 Hz, 1H), 5.30 (t, <i>J</i> = 6.3 Hz, 1H), 5.88–5.98 and 5.90–5.92 (two m, 1H), 6.13 and 6.15 (two d, <i>J</i> = 3.2 Hz, 1H), 7.12 and 7.14 (two s, 1H), 7.24–7.28 (m, 1H), 7.37 (t, <i>J</i> = 7.6 Hz, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.74 and 7.90 (two s, 1H).</div></div><div id="sec4_14_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i159" class="anchor-spacer"></div><h4 class="article-section__title" id="_i159"> <i>tert</i>-Butyl 3-(2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)azetidine-1-carboxylate (<b>80</b>)</h4><div class="NLM_p last">It is obtained in 77% yield. <sup>1</sup>H NMR: δ 1.38 (s, 9H), 2.85–2.92 (m, 1H), 3.20–3.25 (m, 1H), 3.44–3.48 (m, 1H), 3.65–3.70 (m, 2H), 4.01–4.28 (m, 2H), 5.63–5.66 (m, 1H), 7.16 (s, 1H), 7.21–7.31 (m, 2H), 7.36–7.40 (m, 1H), 7.53–7.55 (m, 1H), 7.66 (s, 1H).</div></div><div id="sec4_14_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> <i>tert</i>-Butyl 3-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)azetidine-1-carboxylate (<b>81</b>)</h4><div class="NLM_p last">It is obtained in 43% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 356.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.42 (s, 9H), 1.92–2.23 (m, 2H), 2.50–2.63 (m, 1H), 3.61–3.80 (m, 2H), 3.90–4.02 (m, 3H), 4.20–4.58 (br s, 1H), 5.33–5.41 and 5.52–5.58 (two m, 1H), 7.13 (s, 1H), 7.21–7.28 (m, 2H), 7.30–7.39 (m, 1H), 7.41–7.48 (m, 1H), 7.58 (d, <i>J</i> = 14.3 Hz, 1H), 7.93 and 7.99 (two s, 1H).</div></div><div id="sec4_14_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> <i>tert</i>-Butyl 4-(2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)piperidine-1-carboxylate (<b>82</b>)</h4><div class="NLM_p last">It is obtained in 89.1% yield. <sup>1</sup>H NMR: δ 1.44 (s, 9H), 1.50–1.82 (m, 4H), 2.72–2.76 (m, 2H), 2.90 (dd, <i>J</i> = 18.5, 9.4 Hz, 1H), 3.21 (dd, <i>J</i> = 18.57, 3.6 Hz, 1H), 5.63 (dd, <i>J</i> = 9.6, 3.6 Hz, 1H), 7.16 (s, 1H), 7.23 (m, 2H), 7.35–7.39 (m, 1H), 7.53 (d, <i>J</i> = 7.5 Hz, 1H), 7.59 (s, 1H).</div></div><div id="sec4_14_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> <i>tert</i>-Butyl 4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidine-1-carboxylate (<b>83</b>)</h4><div class="NLM_p last">It is obtained in 83% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 384.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.23–1.31 (m, 2H), 1.46 (s, 9H), 1.50–1.61 (m, 2H), 1.79–1.89 (m, 1H), 2.08 (ddd, <i>J</i> = 14.3, 6.7, 2.8 Hz, 1H), 2.15–2.21 (m, 1H), 2.57–2.74 (m, 2H), 3.74–3.84 (m, 1H), 4.05–4.28 (m, 2H), 5.39 (t, <i>J</i> = 6.1 Hz, 0.8H), 5.51–5.56 (m, 0.2H), 7.15 (s, 1H), 7.25 (t, <i>J</i> = 7.0 Hz, 1H), 7.35–7.40 (m, 1H), 7.43 (d, <i>J</i> = 6.4 Hz, 1H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.79 and 7.81 (two s, 1H).</div></div><div id="sec4_14_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i163" class="anchor-spacer"></div><h4 class="article-section__title" id="_i163"> 2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(piperidin-4-yl)ethan-1-ol dihydrochloride (<b>84</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(1-hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidine-1-carboxylate <b>83</b> (1.0 g, 2.61 mmol) in dichloromethane (20 mL) at rt was added trifluoroacetic acid (8.92 g, 78.23 mmol). The resulting solution was stirred at rt for 2 h and concentrated. The crude was dissolved in methanol (8 mL) and hydrogen chloride (4 M in dioxane, 7.82 mmol) was added. The mixture was concentrated and dried under high vacuum to give the desired product as a dihydrochloride salt in quantitative yield, which was used directly in the next step without further purification. LCMS (ESI, <i>m</i>/<i>z</i>): 284.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, a mixture of diastereomers): δ 1.51–1.58 (m, 3H), 1.68–1.71 (m, 1H), 1.84–1.97 (m, 1H), 2.02–2.16 (m, 2H), 2.68–2.83 (m, 2H), 3.15–3.29 (m, 2H), 3.78 (d, <i>J</i> = 10.1 Hz, 1H), 5.77–5.88 (m, 1H), 7.44–7.58 (m, 2H), 7.68 and 7.78 (two d, <i>J</i> = 7.2 Hz, 1H), 7.87 (d, <i>J</i> = 7.0 Hz, 1H), 7.95 and 7.96 (two s, 1H), 8.98–9.13 (m, 1H), 9.38 (d, <i>J</i> = 10.9 Hz, 1H), 9.43 and 9.67 (two s, 1H).</div></div><div id="sec4_14_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i164" class="anchor-spacer"></div><h4 class="article-section__title" id="_i164"> 5-(2-(Azetidin-1-ium-3-yl)-2-hydroxyethyl)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-2-ium Chloride (<b>85</b>)</h4><div class="NLM_p last">It was synthesized according to the same procedure used for synthesizing compound <b>84</b>. Yield: 82%. LCMS (ESI, <i>m</i>/<i>z</i>): 256.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR free base (a mixture of diastereomers): δ 1.56–1.78 (m, 1H), 1.80–2.11 (m, 2H), 3.56 (d, <i>J</i> = 12 Hz, 2H), 3.71–3.77 (m, 2H), 3.82–4.20 (m, 2H), 5.40–5.49 (m, 1H), 7.12–7.47 (m, 3H), 7.55–7.63 (m, 2H), 7.99 (s, 1H).</div></div><div id="sec4_14_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i165" class="anchor-spacer"></div><h4 class="article-section__title" id="_i165"> 1-(1-Acetylpiperidin-4-yl)-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>86</b>)</h4><div class="NLM_p last">It is obtained in 74% yield. <sup>1</sup>H NMR: δ 1.52–1.72 (m, 2H), 1.83–1.96 (m, 2H), 2.09 (s, 3H), 2.54–2.72 (m, 2H), 2.83–2.98 (m, 1H), 3.03–3.28 (two m, 2H), 3.80–3.92 (m, 1H), 4.56–4.61 (m, 1H), 5.60–5.66 (m, 1H), 7.16 (s, 1H), 7.22–7.30 (m, 2H), 7.38 (td, <i>J</i> = 7.2, 1.8 Hz, 1H), 7.54 (d, <i>J</i> = 7.7 Hz, 1H), 7.59 (d, <i>J</i> = 3.8 Hz, 1H).</div></div><div id="sec4_14_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i166" class="anchor-spacer"></div><h4 class="article-section__title" id="_i166"> 1-(4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)ethanone (<b>87</b>)</h4><div class="NLM_p last">It is obtained in 93% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 326.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.21–1.34 (m, 2H), 1.57–1.71 (m, 2H), 1.83–1.93 (m, 1H), 2.04–2.13 (m, 4H), 2.16–2.24 (m, 1H), 2.44–2.50 (m, 1H), 2.97–3.03 (m, 1H), 3.70–3.90 (two m, 2H), 4.64–4.72 (m, 1H), 5.36–5.41 and 5.47–5.56 (two m, 1H), 7.16 (s, 1H), 7.23–7.28 (m, 2H), 7.35–7.43 (m, 2H), 7.55 (d, <i>J</i> = 7.5 Hz, 1H), 7.81 and 7.82 (two s, 1H).</div></div><div id="sec4_14_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i167" class="anchor-spacer"></div><h4 class="article-section__title" id="_i167"> Cyclohexyl(4-(1-hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)methanone (<b>88</b>)</h4><div class="NLM_p last">It is obtained in 44% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 394.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.20–1.34 (m, 6H), 1.49–1.77 (m, 10H), 1.87–1.97 (m, 1H), 2.03–2.08 (m, 1H), 2.16–2.20 (m, 1H), 2.46 (t, <i>J</i> = 12.0 Hz, 2H), 3.76–3.79 (m, 1H), 3.97 (t, <i>J</i> = 16.2 Hz, 1H), 4.70 (t, <i>J</i> = 14.2 Hz, 1H), 5.38–5.41 and 5.51–5.56 (two m, 1H), 7.15 (s, 1H), 7.23–7.27 (m, 1H, merged with chloroform), 7.37 (t, <i>J</i> = 7.8 Hz, 1H), 7.44 (d, <i>J</i> = 7.6 Hz, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.79 and 7.82 (two s, 1H).</div></div><div id="sec4_14_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i168" class="anchor-spacer"></div><h4 class="article-section__title" id="_i168"> (4-Fluorophenyl)(4-(1-hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)methanone (<b>89</b>)</h4><div class="NLM_p last">It is obtained in 29% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 406.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.29–1.37 (m, 3H), 1.57–1.87 (m, 3H), 2.18–2.36 (m, 2H), 3.73–3.86 (m, 4H), 4.74 (br s, 1H), 5.44–5.49 and 5.58–5.63 (two m, 1H), 7.08 (t, <i>J</i> = 7.2 Hz, 2H), 7.23 (s, 1H), 7.31–7.48 (m, 5H), 7.59 (d, <i>J</i> = 7.2 Hz, 1H), 8.20 and 8.27 (two s, 1H).</div></div><div id="sec4_14_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i169" class="anchor-spacer"></div><h4 class="article-section__title" id="_i169"> 1-(4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)-2-phenylethan-1-one (<b>90</b>)</h4><div class="NLM_p last">It is obtained in 72% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 402.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.04–1.12 (m, 1H) 1.21–1.31 (m, 1H), 1.53–1.70 (m, 2H), 1.80–1.88 (m, 1H), 2.07–2.16 (m, 1H), 2.38–2.64 (m, 1H), 2.93 (td, <i>J</i> = 13.2, 2.7 Hz, 1H), 3.72–3.96 (m, 6H), 4.68–4.75 (m, 1H), 5.45–5.48 and 5.64–5.70 (two m, 1H), 7.21–7.44 (m, 10H), 7.53 (d, <i>J</i> = 7.8 Hz, 1H).</div></div><div id="sec4_14_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i170" class="anchor-spacer"></div><h4 class="article-section__title" id="_i170"> 2-(4-Fluorophenyl)-1-(4-(1-hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)ethanone (<b>91</b>)</h4><div class="NLM_p last">It is obtained in 80% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 420.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.08–1.13 (m, 1H), 1.23–1.30 (m, 1H), 1.54–1.63 (m, 2H), 1.78 and 1.86 (two d, <i>J</i> = 13.0 Hz, 1H), 1.99–2.12 (m, 2H), 2.49 (dt, <i>J</i> = 12.8, 2.4 Hz, 1H), 2.93 (dt, <i>J</i> = 12.8, 3.0 Hz, 1H), 3.66 (d, <i>J</i> = 4.4 Hz, 2H), 3.71–3.73 (m, 2H, merged with broad singlet of OH), 3.90 (t, <i>J</i> = 15.2 Hz, 1H), 4.68 (t, <i>J</i> = 13.6 Hz, 1H), 5.30–5.37 and 5.47–5.50 (two m, 1H), 6.94–7.00 (m, 2H), 7.13 (s, 1H), 7.15–7.20 (m, 2H), 7.22–7.31 (m, 1H, merged with chloroform), 7.35–7.41 (m, 2H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.84 (d, <i>J</i> = 5.2 Hz, 1H).</div></div><div id="sec4_14_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i171" class="anchor-spacer"></div><h4 class="article-section__title" id="_i171"> 1-(4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)-2-(pyridin-4-yl)ethan-1-one (<b>92</b>)</h4><div class="NLM_p last">It is obtained in 49% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 403.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.08–1.16 (m, 1H), 1.23–1.33 (m, 1H), 1.57–1.65 (m, 2H), 1.86 (t, <i>J</i> = 14.0 Hz, 1H), 1.99–2.17 (two m, 1H), 2.52 (dt, <i>J</i> = 12.8, 2.4 Hz, 1H), 2.97 (dt, <i>J</i> = 12.8, 4.0 Hz, 1H), 3.70 (d, <i>J</i> = 7.2 Hz, 2H), 3.70–3.76 (m, 1H, merged with doublet at 3.70), 3.83 (t, <i>J</i> = 13.8 Hz, 1H), 4.30 (br s, 1H), 4.69 (t, <i>J</i> = 14.0 Hz, 1H), 5.32–5.36 and 5.51–5.53 (two m, 1H), 7.10 and 7.12 (two s, 1H), 7.16–7.25 (m, 3H), 7.35–7.41 (m, 2H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.76 (d, <i>J</i> = 4.4 Hz, 1H), 8.49–8.52 (m, 2H).</div></div><div id="sec4_14_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i172" class="anchor-spacer"></div><h4 class="article-section__title" id="_i172"> 1-(4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)piperidin-1-yl)-2-(pyrimidin-5-yl)ethanone (<b>93</b>)</h4><div class="NLM_p last">It is obtained in 76% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 404.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.30–1.41 (m, 3H), 1.63–1.72 (m, 2H), 1.87–2.22 (m, 2H), 2.56 (t, <i>J</i> = 12.4 Hz, 1H), 3.01–3.15 (m, 2H), 3.67 (d, <i>J</i> = 6.0 Hz, 1H), 3.83–3.85 (m, 1H), 3.96 (t, <i>J</i> = 14.6 Hz, 1H), 4.66 (t, <i>J</i> = 14.6 Hz, 1H), 5.44–5.46 and 5.62–5.65 (two m, 1H), 7.17 and 7.19 (two s, 1H), 7.26–7.30 (m, 1H, merged with chloroform), 7.39 (t, <i>J</i> = 7.4 Hz, 1H), 7.46 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (d, <i>J</i> = 7.2 Hz, 1H), 8.14 (d, <i>J</i> = 13.2 Hz, 1H), 8.63 (d, <i>J</i> = 4.4 Hz, 2H), 9.08–9.10 (m, 1H).</div></div><div id="sec4_14_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i173" class="anchor-spacer"></div><h4 class="article-section__title" id="_i173"> 4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)-<i>N</i>-phenylpiperidine-1-carboxamide (<b>94</b>)</h4><div class="NLM_p last">To a vial containing 2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(piperidin-4-yl)ethan-1-ol dihydrochloride <b>84</b> (75 mg, 0.265 mmol) in dichloromethane (5 mL) was added DIPEA (1.06 mmol) and phenylisocyanate (0.265 mmol). The reaction mixture was stirred at rt for 30 min and concentrated. The residue was dissolved in dichloromethane (30 mL) and washed with water (3 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by flash column chromatography to afford <b>94</b> (66.30 mg, 62%). LCMS (ESI, <i>m</i>/<i>z</i>): 403.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 1.33–1.43 (m, 2H), 1.59–1.71 (m, 2H), 1.92–1.95 (m, 1H), 2.10–2.22 (m, 2H), 2.87 (t, <i>J</i> = 11.8 Hz, 2H), 3.79–3.83 (m, 1H), 4.25 (t, <i>J</i> = 15.2 Hz, 2H), 5.48 and 5.52–5.55 (t, <i>J</i> = 6.0 Hz and m, 1H), 7.03 (t, <i>J</i> = 7.4 Hz, 1H), 7.16 and 7.19 (two s, 1H), 7.28 (t, <i>J</i> = 8.0 Hz, 2H), 7.33–7.37 (m, 3H), 7.43 (t, <i>J</i> = 7.4 Hz, 1H), 7.62 (dd, <i>J</i> = 21.6, 7.6, Hz, 2H), 7.94 and 7.97 (two s, 1H), 8.01 (s, 1H).</div></div><div id="sec4_14_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i174" class="anchor-spacer"></div><h4 class="article-section__title" id="_i174"> 1-Cyclohexyl-2-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>95</b>)</h4><div class="NLM_p last">It is obtained in 50% yield. <sup>1</sup>H NMR: δ 1.20–1.48 (m, 5H), 1.66–1.69 (m, 1H), 1.78–1.92 (m, 4H), 2.36–2.44 (m, 1H), 2.79 (dd, <i>J</i> = 20.0, 12.0 Hz, 1H), 3.50 (dd, <i>J</i> = 20.0, 4.0 Hz, 1H), 5.77 (d, <i>J</i> = 8.0 Hz, 1H), 6.94 (t, <i>J</i> = 8.0 Hz, 1H), 7.18 (s, 1H), 7.31–7.37 (m, 2H), 7.62 (s, 1H).</div></div><div id="sec4_14_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i175" class="anchor-spacer"></div><h4 class="article-section__title" id="_i175"> 1-Cyclohexyl-2-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>96</b>)</h4><div class="NLM_p last">It is obtained in 96% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 301.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 0.98–1.39 (m, 6H), 1.65–1.79 (m, 5H), 2.03–2.07 (m, 1H) 2.34–2.50 (m, 2H), 3.54–3.73 (m, 1H), 5.46 and 5.67 (two dd, <i>J</i><sub>1</sub> = 8.0, 3.0 Hz, <i>J</i><sub>2</sub> = 10.4, 3.0 Hz, 1H), 6.93 (t, <i>J</i> = 8.0 Hz, 1H), 7.17 (d, <i>J</i> = 7.2 Hz, 1H), 7.30–7.37 (m, 2H), 7.82 and 7.88 (two s, 1H).</div></div><div id="sec4_14_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i176" class="anchor-spacer"></div><h4 class="article-section__title" id="_i176"> 1-Cyclohexyl-2-(7-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-one (<b>97</b>)</h4><div class="NLM_p last">It is obtained in 94% yield. <sup>1</sup>H NMR: δ 1.07–1.50 (m, 4H), 1.58–1.73 (m, 2H), 1.75–1.90 (m, 4H), 2.40 (tt, <i>J</i> = 11.5, 3.4 Hz, 1H), 2.96 (dd, <i>J</i> = 18.5, 9.3 Hz, 1H), 3.19 (dd, <i>J</i> = 18.5, 3.8 Hz, 1H), 5.65 (dd, <i>J</i> = 9.3, 3.7 Hz, 1H), 7.02–7.07 (m, 1H), 7.10 (td, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.16 (s, 1H), 7.51 (dd, <i>J</i> = 8.4, 4.8 Hz, 1H), 7.79 (s, 1H).</div></div><div id="sec4_14_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i177" class="anchor-spacer"></div><h4 class="article-section__title" id="_i177"> 1-Cyclohexyl-2-(7-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>98</b>)</h4><div class="NLM_p last">It is obtained in 93% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 301.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 0.91–1.30 (m, 5H), 1.33–1.42 (m, 1H), 1.55–1.95 (m, 5H), 1.95–2.05 (m, 1H), 2.17 (tdd, <i>J</i> = 14.2, 10.8, 6.8 Hz, 1H), 3.12 (br s, 1H), 3.67–3.84 (m, 1H), 5.34–5.37 and 5.47–5.5 (two m, 1H), 6.99–7.12 (m, 2H), 7.16 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.45 (dd, <i>J</i> = 8.4, 4.9 Hz, 1H), 7.85 and 7.90 (two s, 1H).</div></div><div id="sec4_14_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i178" class="anchor-spacer"></div><h4 class="article-section__title" id="_i178"> 1-Cyclohexyl-2-(8-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>99</b>)</h4><div class="NLM_p last">It is obtained in 58% yield. The compound was taken as such to the next step without analysis.</div></div><div id="sec4_14_116" class="NLM_sec NLM_sec_level_3"><div id="ac_i179" class="anchor-spacer"></div><h4 class="article-section__title" id="_i179"> 1-Cyclohexyl-2-(8-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>100</b>)</h4><div class="NLM_p last">It is obtained in 15% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 301.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, a mixture of diastereomers): δ 1.00–2.30 (m, 13H), 3.50–3.57 (m, 1H), 5.35 and 5.50 (m, 1H), 7.18–7.50 (m, 3H), 7.60–7.65 (m, 1H), 7.92 and 7.98 (two s, 1H).</div></div><div id="sec4_14_117" class="NLM_sec NLM_sec_level_3"><div id="ac_i180" class="anchor-spacer"></div><h4 class="article-section__title" id="_i180"> 2-(6-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanone (<b>101</b>)</h4><div class="NLM_p last">It is obtained in 25% yield. <sup>1</sup>H NMR: δ 1.18–1.36 (m, 5H), 1.68–1.88 (m, 5H), 2.37–2.40 (m, 1H), 2.64 (dd, <i>J</i> = 20.0, 10.0 Hz, 1H), 3.79 (dd, <i>J</i> = 16.0, 4.0 Hz, 1H), 5.70 (d, <i>J</i> = 8.0 Hz, 1H), 7.17–7.20 (m, 2H), 7.32 (t, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 7.61 (s, 1H).</div></div><div id="sec4_14_118" class="NLM_sec NLM_sec_level_3"><div id="ac_i181" class="anchor-spacer"></div><h4 class="article-section__title" id="_i181"> 2-(6-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanol (<b>102</b>)</h4><div class="NLM_p last">It is obtained in 98% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 0.96–1.35 (m, 6H), 1.60–1.86 (m, 5H), 1.97–2.10 (m, 1H), 2.52–2.69 (m, 1H), 3.58–3.69 (two m, 1H), 5.31 and 5.59 (two dd, <i>J</i><sub>1</sub> = 6.0, 2.80 Hz, <i>J</i><sub>2</sub> = 10.4, 2.80 Hz, 1H), 7.16–7.19 (m, 2H), 7.26–7.31 (m, 1H), 7.41 (t, <i>J</i> = 5.4 Hz, 1H), 7.82 and 7.94 (two s, 1H).</div></div><div id="sec4_14_119" class="NLM_sec NLM_sec_level_3"><div id="ac_i182" class="anchor-spacer"></div><h4 class="article-section__title" id="_i182"> 2-(7-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanone (<b>103</b>)</h4><div class="NLM_p last">It is obtained in 43% yield. <sup>1</sup>H NMR: δ 1.19–1.46 (m, 5H), 1.68–1.70 (m, 1H), 1.78–1.91 (m, 5H), 2.35–2.43 (m, 1H), 2.91 (dd, <i>J</i> = 20.0, 10.0 Hz, 1H), 3.18 (dd, <i>J</i> = 20.0, 4.0 Hz, 1H), 5.61 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 7.15 (s, 1H), 7.28 (s, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (s, 1H).</div></div><div id="sec4_14_120" class="NLM_sec NLM_sec_level_3"><div id="ac_i183" class="anchor-spacer"></div><h4 class="article-section__title" id="_i183"> 2-(7-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanol (<b>104</b>)</h4><div class="NLM_p last">It is obtained in 98% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.00–1.28 (m, 5H), 1.37–1.40 (m, 1H), 1.66–2.01 (m, 5H), 1.91–2.0 (m, 1H), 2.12–2.23 (m, 1H), 3.71–3.75 (m, 1H), 7.15 (s, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.79, 7.82 (two s, 1H).</div></div><div id="sec4_14_121" class="NLM_sec NLM_sec_level_3"><div id="ac_i184" class="anchor-spacer"></div><h4 class="article-section__title" id="_i184"> 2-(8-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanone (<b>105</b>)</h4><div class="NLM_p last">It is obtained in 21% yield. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 1.10–1.90 (m, 10H), 2.42–2.48 (m, 1H), 2.99 (dd, <i>J</i> = 18.9, 9.0 Hz, 1H), 3.40 (dd, <i>J</i> = 18.9, 3.6 Hz, 1H), 5.58–5.62 (m, 1H), 6.95–7.08 (m, 1H), 7.16–7.88 (m, 4H).</div></div><div id="sec4_14_122" class="NLM_sec NLM_sec_level_3"><div id="ac_i185" class="anchor-spacer"></div><h4 class="article-section__title" id="_i185"> 2-(8-Chloro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-cyclohexylethanol (<b>106</b>)</h4><div class="NLM_p last">It is obtained in 41% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 318.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (MeO<i>H</i>-<i>d</i><sub>4</sub>, a mixture of diastereomers): δ 1.00–2.30 (m, 13H), 3.60–3.70 (m, 1H), 5.35–5.50 (two m, 1H), 6.95–7.08 (m, 1H), 7.16–7.88 (m, 4H).</div></div><div id="sec4_14_123" class="NLM_sec NLM_sec_level_3"><div id="ac_i186" class="anchor-spacer"></div><h4 class="article-section__title" id="_i186"> 1-(4,4-Difluorocyclohexyl)-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>107</b>)</h4><div class="NLM_p last">It is obtained in 96% yield. <sup>1</sup>H NMR: δ 1.73–1.80 (m, 4H), 1.91–1.95 (m, 2H), 2.10–2.14 (m, 2H), 2.41–2.47 (m, 1H), 2.90 (dd, <i>J</i> = 18.8, 9.4 Hz, 1H), 3.21 (dd, <i>J</i> = 3.6, 18.4 Hz, 1H), 5.60 (dd, <i>J</i> = 3.4, 9.4 Hz, 1H), 7.13 (s, 1H), 7.22–7.28 (m, 2H), 7.36 (t, <i>J</i> = 7.2 Hz, 1H), 7.51 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (s, 1H).</div></div><div id="sec4_14_124" class="NLM_sec NLM_sec_level_3"><div id="ac_i187" class="anchor-spacer"></div><h4 class="article-section__title" id="_i187"> 1-(4,4-Difluorocyclohexyl)-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>108</b>)</h4><div class="NLM_p last">It is obtained in 61% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 319.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.26–1.36 (m, 3H), 1.63–1.97 (m, 5H), 2.02–2.08 (m, 3H), 3.69–3.72 (m, 1H), 5.02 and 5.12 (two d, <i>J</i> = 6.0 Hz, 1H), 5.34–5.53 and 5.41–5.43 (two m, 1H), 7.10 and 7.12 (two s, 1H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 7.36 (t, <i>J</i> = 7.4 Hz, 1H), 7.54–7.58 (m, 2H), 7.91 and 7.93 (two s, 1H).</div></div><div id="sec4_14_125" class="NLM_sec NLM_sec_level_3"><div id="ac_i188" class="anchor-spacer"></div><h4 class="article-section__title" id="_i188"> 1-(4,4-Difluorocyclohexyl)-2-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>109</b>)</h4><div class="NLM_p last">It is obtained in 81% yield. <sup>1</sup>H NMR: δ 1.65–1.82 (m, 4H), 1.90–2.01 (m, 2H), 2.11–2.16 (m, 2H), 2.44–2.48 (m, 1H), 2.79 (dd, <i>J</i> = 18.4, 10.4 Hz, 1H), 3.52 (dd, <i>J</i> = 18.4, 2.0 Hz, 1H), 5.72 (d, <i>J</i> = 10.4 Hz, 1H), 6.92 (t, <i>J</i> = 8.8 Hz, 1H), 7.15 (s, 1H), 7.28–7.35 (m, 2H), 7.58 (s, 1H).</div></div><div id="sec4_14_126" class="NLM_sec NLM_sec_level_3"><div id="ac_i189" class="anchor-spacer"></div><h4 class="article-section__title" id="_i189"> 1-(4,4-Difluorocyclohexyl)-2-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanol (<b>110</b>)</h4><div class="NLM_p last">It is obtained in 78% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 337.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, a mixture of diastereomers): δ 1.21–1.29 (m, 3H), 1.56–1.72 (m, 4H), 1.88–1.96 (m, 3H), 2.28 and 2.32 (two t, <i>J</i> = 5.0 Hz, 1H), 3.41–3.44 and 3.62–3.65 (two m, 1H), 4.73 and 5.17 (two d, <i>J</i> = 8.2 Hz, 1H), 5.56–5.59 and 5.61–5.64 (two m, 1H), 7.03–7.17 (m, 2H), 7.39–7.44 (m, 2H), 7.91 and 7.95 (two s, 1H).</div></div><div id="sec4_14_127" class="NLM_sec NLM_sec_level_3"><div id="ac_i190" class="anchor-spacer"></div><h4 class="article-section__title" id="_i190"> (<i>trans</i>)-Methyl 4-(2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)cyclohexanecarboxylate (<b>111</b>)</h4><div class="NLM_p last">It is obtained in 90% yield. <sup>1</sup>H NMR: δ 1.38–1.49 (m, 4H), 1.95–2.11 (m, 4H), 2.27–2.32 (m, 1H), 2.27–2.42 (m, 1H), 2.91 (dd, <i>J</i> = 18.5, 9.5 Hz, 1H), 3.21 (dd, <i>J</i> = 18.5, 3.5 Hz, 1H), 3.67 (s, 3H), 5.63 (dd, <i>J</i> = 9.5, 3.3 Hz, 1H), 7.17 (s, 1H), 7.22–7.29 (m, 2H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.60 (s, 1H).</div></div><div id="sec4_14_128" class="NLM_sec NLM_sec_level_3"><div id="ac_i191" class="anchor-spacer"></div><h4 class="article-section__title" id="_i191"> (<i>trans</i>)-Methyl-4-((1<i>R</i>)-1-hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)cyclohexanecarboxylate (<b>112</b>)</h4><div class="NLM_p last">It is obtained in 87% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 341.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.05–1.20 (m, 2H), 1.42 (qt, <i>J</i> = 12.7, 4.0 Hz, 3H), 1.63–1.82 (m, 1H), 1.92–2.10 (m, 4H), 2.11–2.31 (m, 2H), 3.65 (s, 3H), 3.72–3.83 (m, 1H), 5.36 (t, <i>J</i> = 6.2 Hz, 0.7H), 5.52 (dd, <i>J</i> = 10.8, 3.1 Hz, 0.3H), 7.14 (s, 1H), 7.23 (t, <i>J</i> = 7.4 Hz, 1H), 7.31–7.40 (m, 1H), 7.42 (d, <i>J</i> = 7.7 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.83 (s, 1H).</div></div><div id="sec4_14_129" class="NLM_sec NLM_sec_level_3"><div id="ac_i192" class="anchor-spacer"></div><h4 class="article-section__title" id="_i192"> 2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)ethanone (<b>113</b>)</h4><div class="NLM_p last">It is obtained in 84% yield. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 1.48–1.91 (m, 6H), 2.35–2.65 (m, 2H), 3.58–3.65 (m, 1H), 3.91 (s, 4H), 5.79–5.82 (m, 1H), 7.01–7.07 (m, 1H), 7.16 (m, 1H), 7.42–7.45 (m, 2H), 7.70 (s, 1H).</div></div><div id="sec4_14_130" class="NLM_sec NLM_sec_level_3"><div id="ac_i193" class="anchor-spacer"></div><h4 class="article-section__title" id="_i193"> 4-(2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-one (<b>114</b>)</h4><div class="NLM_p last">To a solution of ketone <b>113</b> (3.77 g, 10.56 mmol) in MeOH (50 mL) at 0 °C was added NaBH<sub>4</sub> (1.20 g, 31.69 mmol) portion wise and the solution was allowed to warm to rt and stirred for 1 h. HCl (3 N) was added cautiously until pH = 3–4. The mixture was stirred at 50 °C for 1.5 h. After cooling to rt, the solution was basified with saturated NaHCO<sub>3</sub> solution and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 40 mL). The combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by flash column chromatography to afford <b>114</b> (3.31 g, 99.7%). <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.56–2.46 (m, 11H), 3.73–3.82 (m, 1H), 5.48–5.50 and 5.62–5.65 (two m, 1H), 6.93–6.97 (m, 1H), 7.17 (s, 1H), 7.26–7.37 (m, 2H), 7.79 and 7.86 (two s, 1H).</div></div><div id="sec4_14_131" class="NLM_sec NLM_sec_level_3"><div id="ac_i194" class="anchor-spacer"></div><h4 class="article-section__title" id="_i194"> <i>N</i>-((<i>cis</i>)-4-(2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)cyclohexyl)benzamide (<b>115</b>)</h4><div class="NLM_p last">It is obtained in 53% yield. <sup>1</sup>H NMR: δ 1.25–1.34 (m, 2H), 1.53–1.63 (m, 2H), 1.98–2.08 (m, 2H), 2.20 (t, <i>J</i> = 11.6 Hz, 2H), 2.36 (t, <i>J</i> = 12.2 Hz, 1H), 2.90 (dd, <i>J</i> = 18.6, 9.4 Hz, 1H), 3.25 (dd, <i>J</i> = 18.4, 3.2 Hz, 1H), 3.93–4.00 (m, 1H), 5.63 (dd, <i>J</i> = 9.2, 3.2 Hz, 1H), 6.32 (d, <i>J</i> = 6.8 Hz, 1H), 7.19 (s, 1H), 7.26–7.35 (m, 2H, merged with chloroform), 7.38–7.43 (m, 3H), 7.48 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.71 (s, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec4_14_132" class="NLM_sec NLM_sec_level_3"><div id="ac_i195" class="anchor-spacer"></div><h4 class="article-section__title" id="_i195"> <i>N</i>-((<i>trans</i>)-4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)cyclohexyl)benzamide (<b>116</b>)</h4><div class="NLM_p last">It is obtained in 57% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 402.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.14–1.45 (m, 4H), 1.74 (d, <i>J</i> = 10.6 Hz, 1H), 1.97 (d, <i>J</i> = 10.6 Hz, 1H), 2.09–2.20 (m, 4H), 3.71–3.82 (m, 1H), 3.85–3.95 (m, 1H), 5.3–5.40 and 5.48–5.59 (two m, 1H), 6.03 (d, <i>J</i> = 7.6 Hz, 1H), 7.17 (s, 1H), 7.21–7.30 (m, 1H, merged with chloroform), 7.31–7.51 (m, 5H), 7.55 (d, <i>J</i> = 7.4 Hz, 1H), 7.74 (d, <i>J</i> = 7.6 Hz, 2H), 7.83 (s, 1H).</div></div><div id="sec4_14_133" class="NLM_sec NLM_sec_level_3"><div id="ac_i196" class="anchor-spacer"></div><h4 class="article-section__title" id="_i196"> <i>N</i>-((<i>trans</i>)-4-(2-(5<i>H</i>-Imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)cyclohexyl)benzamide (<b>117</b>)</h4><div class="NLM_p last">It is obtained in 69% yield. <sup>1</sup>H NMR: δ 1.19–1.36 (m, 2H), 1.48–1.65 (m, 2H), 1.93–2.07 (m, 2H), 2.18–2.23 (m, 2H), 2.35 (tt, <i>J</i> = 12.2, 3.2 Hz, 1H), 2.90 (dd, <i>J</i> = 18.4, 9.5 Hz, 1H), 3.22 (dd, <i>J</i> = 18.4, 3.6 Hz, 1H), 3.92–3.99 (m, 1H), 5.62 (dd, <i>J</i> = 9.4, 3.4 Hz, 1H), 6.23 (d, <i>J</i> = 7.6 Hz, 1H), 7.23–7.32 (m, 3H, merged with chloroform), 7.34–7.42 (m, 3H), 7.46–7.50 (m, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.63 (s, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec4_14_134" class="NLM_sec NLM_sec_level_3"><div id="ac_i197" class="anchor-spacer"></div><h4 class="article-section__title" id="_i197"> <i>N</i>-((<i>cis</i>)-4-(1-Hydroxy-2-(5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethyl)cyclohexyl)benzamide (<b>118</b>)</h4><div class="NLM_p last">It is obtained in 63% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 402.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.27–1.46 (m, 5H), 1.79 (d, <i>J</i> = 12.0 Hz, 1H), 2.04–2.22 (m, 5H), 3.78–3.88 (m, 2H), 5.47–5.49 and 5.53–5.54 (two m, 1H), 7.16 and 7.19 (two s, 1H), 7.35 (t, <i>J</i> = 7.4 Hz, 1H), 7.42–7.49 (m, 3H), 7.53 (d, <i>J</i> = 7.2 Hz, 1H), 7.59 (d, <i>J</i> = 7.6 Hz, 1H), 7.64 (d, <i>J</i> = 7.6 Hz, 1H), 7.82 (d, <i>J</i> = 7.6 Hz, 2H), 7.97 and 8.01 (two s, 1H).</div></div><div id="sec4_14_135" class="NLM_sec NLM_sec_level_3"><div id="ac_i198" class="anchor-spacer"></div><h4 class="article-section__title" id="_i198"> 4-(2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)acetyl)cyclohexan-1-one (<b>119</b>)</h4><div class="NLM_p last">To a solution of ketone <b>113</b> (270 mg, 0.757 mmol) in dioxane (10 mL) at 0 °C, was added 3 N HCl (2 mL) and the mixture was stirred at 40 °C for 2 h. The mixture was basified by adding Na<sub>2</sub>CO<sub>3</sub> and the product was extracted with DCM (3 × 30 mL). The combined organic extract was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford the crude; chromatographic purification afforded <b>119</b> as pale yellow oil (216 mg, 91%). <sup>1</sup>H NMR: δ 1.85–2.06 (m, 2H), 2.13–2.60 (m, 6H), 2.73–2.99 (m, 2H), 3.62 (dd, <i>J</i> = 18.6, 2.2 Hz, 1H), 5.78 (dd, <i>J</i> = 10.7, 2.1 Hz, 1H), 6.94–6.99 (m, 1H), 7.20 (s, 1H), 7.32–7.44 (m, 2H), 7.64 (s, 1H).</div></div><div id="sec4_14_136" class="NLM_sec NLM_sec_level_3"><div id="ac_i199" class="anchor-spacer"></div><h4 class="article-section__title" id="_i199"> 4-(2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>120</b>)</h4><div class="NLM_p last">It is obtained in 78% yield. LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 0.80–1.90 (m, 10H), 2.23–2.30 (m, 1H), 3.25–3.29 (m, 1H), 3.67–3.49 and 3.72–3.77 (two m, 1H), 4.23, 4.48 and 4.61 (three br s, 1H), 5.06 (br s, 1H), 5.55–5.59 and 5.62–5.67 (two m, 1H), 7.00–7.14 (m, 1H), 7.16, 7.19 and 7.20 (three s, 1H), 7.38–7.46 (m, 2H), 7.91, 7.92 and 7.95 (three s, 1H).</div></div><div id="sec4_14_137" class="NLM_sec NLM_sec_level_3"><div id="ac_i200" class="anchor-spacer"></div><h4 class="article-section__title" id="_i200"> (<i>R</i>)-1-Cyclohexyl-2-((<i>R</i>)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>121</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 283.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.95–1.30 (m, 5H), 1.35–1.43 (m, 1H), 1.61–1.83 (m, 5H), 1.88 (d, 1H, <i>J</i> = 12.7 Hz), 2.23 (ddd, <i>J</i> = 14.3, 11.0, 3.2 Hz, 1H), 2.86 (br s, 1H), 3.78 (ddd, <i>J</i> = 10.9, 5.9, 2.7 Hz, 1H), 5.49 (dd, <i>J</i> = 10.5, 2.8 Hz, 1H), 7.18 (s, 1H), 7.21–7.29 (m, 1H), 7.31–7.40 (m, 2H), 7.53 (d, <i>J</i> = 7.5 Hz, 1H), 7.80 (s, 1H).</div></div><div id="sec4_14_138" class="NLM_sec NLM_sec_level_3"><div id="ac_i201" class="anchor-spacer"></div><h4 class="article-section__title" id="_i201"> (<i>S</i>)-1-Cyclohexyl-2-((<i>R</i>)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>122</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 283.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 1.01–1.29 (m, 5H), 1.35–1.43 (m, 1H), 1.64–1.88 (m, 5H), 2.07 (ddd, <i>J</i> = 14.3, 7.1, 3.0 Hz, 1H), 2.18 (ddd, <i>J</i> = 14.2, 10.3, 5.4 Hz, 1H), 3.74 (ddd, <i>J</i> = 10.2, 5.6, 3.2 Hz, 1H), 5.39 (t, 1H, <i>J</i> = 6.3 Hz), 7.18 (s, 1H), 7.32–7.21 (m, 1H), 7.38 (t, <i>J</i> = 7.6 Hz, 1H), 7.46 (d, <i>J</i> = 7.7 Hz, 1H), 7.56 (d, <i>J</i> = 7.6 Hz, 1H), 7.82 (s, 1H).</div></div><div id="sec4_14_139" class="NLM_sec NLM_sec_level_3"><div id="ac_i202" class="anchor-spacer"></div><h4 class="article-section__title" id="_i202"> (<i>S</i>)-1-Cyclohexyl-2-((<i>S</i>)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>123</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 283.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.91–1.33 (m, 5H), 1.35–1.41 (m, 1H), 1.58–1.98 (m, 6H), 2.23 (ddd, <i>J</i> = 14.3, 11.0, 3.2 Hz, 1H), 2.45 (br s, 1H), 3.78 (ddd, <i>J</i> = 11.0, 5.9, 2.6 Hz, 1H), 5.48 (dd, <i>J</i> = 10.6, 3.2 Hz, 1H), 7.19 (s, 1H), 7.21–7.29 (m, 1H), 7.32–7.42 (m, 2H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.80 (s, 1H).</div></div><div id="sec4_14_140" class="NLM_sec NLM_sec_level_3"><div id="ac_i203" class="anchor-spacer"></div><h4 class="article-section__title" id="_i203"> (<i>R</i>)-1-Cyclohexyl-2-((<i>S</i>)-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethan-1-ol (<b>124</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 283.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR: δ 0.82–1.49 (m, 6H), 1.57–1.98 (m, 5H), 2.05 (ddd, <i>J</i> = 14.2, 7.1, 2.9 Hz, 1H), 2.17 (ddd, <i>J</i> = 14.1, 10.4, 5.5 Hz, 1H), 2.67 (br s, 1H), 3.76 (ddd, <i>J</i> = 10.2, 5.5, 2.9 Hz, 1H), 5.38 (t, <i>J</i> = 6.3 Hz, 1H), 7.16 (s, 1H), 7.21–7.27 (m, 1H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.45 (d, 1H, <i>J</i> = 7.6 Hz), 7.55 (d, 1H, <i>J</i> = 7.6 Hz), 7.82 (s, 1H).</div></div><div id="sec4_14_141" class="NLM_sec NLM_sec_level_3"><div id="ac_i204" class="anchor-spacer"></div><h4 class="article-section__title" id="_i204"> 1-((<i>trans</i>)-4-((<i>tert</i>-Butyldimethylsilyl)oxy)cyclohexyl)-2-(6-fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)ethanone (<b>125</b>)</h4><div class="NLM_p last">It is obtained in 79% yield. <sup>1</sup>H NMR: δ 0.028 (s, 6H), 0.88 (s, 9H), 11.27–1.96 (m, 8H), 2.32–2.38 (m, 1H), 2.80 (dd, <i>J</i> = 18.8, 10.6 Hz, 1H), 3.48–3.57 (m, 2H), 5.75 (d, <i>J</i> = 9.3 Hz, 1H), 6.91–6.95 (m, 1H), 7.17 (s, 1H), 7.23–7.39 (m, 2H), 7.59 and 7.64 (two s, 1H).</div></div><div id="sec4_14_142" class="NLM_sec NLM_sec_level_3"><div id="ac_i205" class="anchor-spacer"></div><h4 class="article-section__title" id="_i205"> (1<i>s</i>,4<i>s</i>)-4-(2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>126</b>)</h4><div class="NLM_p last">To a solution of <b>114</b> (3.31 g, 10.53 mmol) in dry THF (75 mL) at −78 °C under the nitrogen atmosphere was added LS-selectride (21.59 mL, 21.59 mmol) solution (1.0 M in THF). The resulting mixture was stirred vigorously for 3 h at −78 °C and then allowed to equilibrate to room temperature (1 h). The reaction mixture was hydrolyzed with 2 mL of water and 2 mL of ethanol. The reaction was acidified with 6 N HCl followed by basification with saturated potassium carbonate solution. The product was extracted with 5% trifluoroethanol/DCM (3 × 40 mL). The combined organic extract was dried over MgSO<sub>4</sub> and concentrated under reduced pressure to afford the crude. Chromatographic purification afforded <b>126</b> (2.63 g, 79%). LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.45–2.15 (m, 10H), 2.35–2.51 (m, 1H), 3.66–3.79 (two m, 1H), 4.03 (br s, 1H), 5.45–5.48 and 5.68–5.72 (two m), 5.67 (dd, <i>J</i> = 10.6, 2.8 Hz, 1H), 6.91–6.95 (m, 1H), 7.19 (d, <i>J</i> = 5.4 Hz, 1H), 7.25–7.39 (m, 2H), 7.88 (two, s, 1H).</div></div><div id="sec4_14_143" class="NLM_sec NLM_sec_level_3"><div id="ac_i206" class="anchor-spacer"></div><h4 class="article-section__title" id="_i206"> (<i>trans</i>)-4-(2-(6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol (<b>127</b>)</h4><div class="NLM_p last">To a solution of <b>125</b> (1.50 g, 3.50 mmol) in MeOH (15 mL) at 0 °C was added NaBH<sub>4</sub> (397.2 mg, 10.50 mmol) and the solution was allowed to stir for 1 h at room temperature. After cooling to 0 °C, 6 N HCl (5 mL) was added cautiously to the reaction mixture and the mixture was stirred for 45 min at 50 °C. After cooling to room temperature, the reaction mixture was made basic by saturated NaHCO<sub>3</sub> solution and the reaction was diluted with water (25 mL). The product was extracted with 5% trifluoroethanol/dichloromethane mixture CH<sub>2</sub>Cl<sub>2</sub> (4 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford the crude residue. The crude was purified by column chromatography to afford <b>127</b> as off-white solid (1.02 g, 92%). LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (a mixture of diastereomers): δ 1.07–2.52 (m, 11H), 3.48–3.68 (two m, 2H), 5.45 (t, <i>J</i> = 6.0 Hz, 1H), 5.65 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 6.89–6.96 (m, 1H), 7.16 (s, 1H), 7.29–7.38 (m, 2H), 7.80 and 7.88 (two s, 1H).</div></div><div id="sec4_14_144" class="NLM_sec NLM_sec_level_3"><div id="ac_i207" class="anchor-spacer"></div><h4 class="article-section__title" id="_i207"> (1<i>R</i>,4<i>s</i>)-4-((<i>S</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>128</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.05–1.80 (m, 10H), 2.26 (ddd, <i>J</i> = 14.0, 10.8, 3.1 Hz, 1H), 3.57–3.65 (m, 1H), 3.74 (br s, 1H), 4.21 (d, <i>J</i> = 3.4 Hz, 1H), 5.01 (d, <i>J</i> = 6.1 Hz, 1H), 5.66 (dd, <i>J</i> = 10.9, 2.9 Hz, 1H), 6.97–7.17 (m, 1H), 7.20 (s, 1H), 7.35–7.60 (m, 2H), 7.92 (s, 1H).</div></div><div id="sec4_14_145" class="NLM_sec NLM_sec_level_3"><div id="ac_i208" class="anchor-spacer"></div><h4 class="article-section__title" id="_i208"> (1<i>S</i>,4<i>s</i>)-4-((<i>R</i>)-2-((<i>R</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>129</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.14–1.74 (m, 10H), 2.26 (ddd, <i>J</i> = 14.2, 10.8, 3.0 Hz, 1H), 3.56–3.65 (m, 1H), 3.75 (br s, 1H), 4.21 (d, <i>J</i> = 3.4 Hz, 1H), 5.02 (d, <i>J</i> = 6.2 Hz, 1H), 5.66 (dd, <i>J</i> = 10.9, 2.9 Hz, 1H), 7.10 (ddd, <i>J</i> = 9.4, 6.9, 2.2 Hz, 1H), 7.20 (s, 1H), 7.31–7.59 (m, 2H), 7.92 (s, 1H).</div></div><div id="sec4_14_146" class="NLM_sec NLM_sec_level_3"><div id="ac_i209" class="anchor-spacer"></div><h4 class="article-section__title" id="_i209"> (1<i>S</i>,4<i>s</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>130</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.10–1.48 (m, 7H), 1.51–1.71 (m, 2H), 1.83–1.91 (m, 1H), 2.33 (dt, <i>J</i> = 14.7, 3.8 Hz, 1H), 3.34–3.44 (m, 1H), 3.71–3.79 (m, 1H), 4.21 (d, <i>J</i> = 3.1 Hz, 1H), 4.59 (d, <i>J</i> = 5.9 Hz, 1H), 5.58 (t, <i>J</i> = 5.0 Hz, 1H), 7.03–7.10 (m, 1H), 7.16 (s, 1H), 7.37–7.46 (m, 2H), 7.95 (s, 1H).</div></div><div id="sec4_14_147" class="NLM_sec NLM_sec_level_3"><div id="ac_i210" class="anchor-spacer"></div><h4 class="article-section__title" id="_i210"> (1<i>R</i>,4<i>s</i>)-4-((<i>S</i>)-2-((<i>R</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>131</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.12–1.46 (m, 7H), 1.56–1.63 (m, 2H), 1.83–1.91 (m, 1H), 2.33 (dt, <i>J</i> = 14.5, 3.7 Hz, 1H), 3.37–3.41 (m, 1H), 3.66–3.92 (m, 1H), 4.19 (d, <i>J</i> = 3.2 Hz, 1H), 4.58 (d, <i>J</i> = 5.8 Hz, 1H), 5.58 (t, <i>J</i> = 5.0 Hz, 1H), 7.0–7.10 (m, 1H), 7.16 (s, 1H), 7.40–7.46 (m, 2H), 7.95 (s, 1H).</div></div><div id="sec4_14_148" class="NLM_sec NLM_sec_level_3"><div id="ac_i211" class="anchor-spacer"></div><h4 class="article-section__title" id="_i211"> (1<i>S</i>,4<i>r</i>)-4-((<i>S</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>132</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.89–1.13 (m, 4H), 1.15–1.27 (m, 1H), 1.47–1.60 (m, 2H), 1.71–1.93 (m, 3H), 2.27 (ddd, <i>J</i> = 14.1, 10.8, 3.1 Hz, 1H), 3.22–3.31 (m, 1H), 3.52–3.61 (m, 1H), 4.47 (d, <i>J</i> = 4.4 Hz, 1H), 5.05 (d, <i>J</i> = 6.1 Hz, 1H), 5.64 (dd, <i>J</i> = 10.8, 2.9 Hz, 1H), 7.06–7.13 (m, 1H), 7.19 (s, 1H), 7.40–7.46 (m, 2H), 7.91 (s, 1H).</div></div><div id="sec4_14_149" class="NLM_sec NLM_sec_level_3"><div id="ac_i212" class="anchor-spacer"></div><h4 class="article-section__title" id="_i212"> (1<i>S</i>,4<i>r</i>)-4-((<i>S</i>)-2-((<i>R</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>133</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.92–1.16 (m, 5H), 1.50–1.69 (m, 2H), 1.75–1.93 (m, 3H), 2.29 (dt, <i>J</i> = 14.6, 4.1 Hz, 1H), 3.20–3.30 (m, 1H), 3.34–3.41 (m, 1H), 4.45 (d, <i>J</i> = 4.4 Hz, 1H), 4.59 (d, <i>J</i> = 5.7 Hz, 1H), 5.57 (t, <i>J</i> = 5.2 Hz, 1H), 7.03–7.17 (m, 1H), 7.16 (s, 1H), 7.38–7.47 (m, 2H), 7.94 (s, 1H).</div></div><div id="sec4_14_150" class="NLM_sec NLM_sec_level_3"><div id="ac_i213" class="anchor-spacer"></div><h4 class="article-section__title" id="_i213"> (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>R</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>134</b>)</h4><div class="NLM_p last">LCMS (ESI, <i>m</i>/<i>z</i>): 317.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.93–1.24 (m, 5H), 1.38–1.64 (m, 2H), 1.78–1.84 (m, 3H), 2.23–2.30 (m, 1H), 3.22–3.31 (m, 1H), 3.53–3.61 (m, 1H), 4.45 (d, <i>J</i> = 4.4 Hz, 1H), 5.04 (d, <i>J</i> = 6.2 Hz, 1H), 5.64 (dd, <i>J</i> = 10.8, 2.8 Hz, 1H), 7.07–7.13 (m, 1H), 7.19 (s, 1H), 7.37–7.48 (m, 2H), 7.91 (s, 1H).</div></div><div id="sec4_14_151" class="NLM_sec NLM_sec_level_3"><div id="ac_i214" class="anchor-spacer"></div><h4 class="article-section__title" id="_i214"> (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (<b>NLG-919</b>)</h4><div class="NLM_p last">HRMS (ESI, <i>m</i>/<i>z</i>): calcd for (C<sub>18</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>2</sub> + H)<sup><b>+</b></sup>, 317.1665; found, 317.1669. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.86–1.21 (m, 5H), 1.52–1.55 (m, 1H), 1.63–1.67 (m, 1H), 1.75–1.93 (m, 3H), 2.29 (dt, <i>J</i> = 14.6, 4.0 Hz, 1H), 3.22–3.29 (m, 1H), 3.35–3.40 (m, 1H), 4.45 (d, <i>J</i> = 4.4 Hz, 1H), 4.59 (d, <i>J</i> = 5.7 Hz, 1H), 5.57 (t, <i>J</i> = 5.1 Hz, 1H), 7.05–7.10 (m, 1H), 7.16 (s, 1H), 7.40–7.44 (m, 2H), 7.95 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 25.92, 27.45, 35.33, 35.49, 43.33, 58.43, 70.15, 71.75, 114.43, 114.63, 117.01, 117.04, 118.54, 131.33, 131.49, 131.81, 131.89, 132.46, 132.52, 133.95, 137.27, 157.07, 159.52.</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i215" class="anchor-spacer"></div><h3 class="article-section__title" id="_i215"> hIDO1 Enzymatic Assay Determination</h3><div class="NLM_p last">The IC<sub>50</sub> values for the IDO1 inhibitors were determined by testing the activity of IDO1 in a mixture containing 50 mM potassium phosphate buffer at pH 6.5; 70 nM purified human IDO1 protein, 200 μM <span class="smallcaps smallerCapital">l</span>-Trp, 20 mM ascorbate, 20 μM methylene blue, and 0.1% DMSO. The IDO1 inhibitors were initially diluted in DMSO at 100 mM and subsequently diluted in 50 mM potassium phosphate, added to the reaction mixture at final concentrations ranging from 100 μM to 200 pM, and preincubated with the enzyme for 5 min at 25 °C. The reaction was started by addition of Trp in the reaction mix and incubated 15 min at 37 °C. The reaction was stopped by addition of 0.5 vol of 30% trichloroacetic acid and incubated 30 min at 60 °C to hydrolyze <i>N</i>-formylkynurenine to Kyn. The reaction was centrifuged at 3400 g for 5 min to remove precipitated protein and the supernatant was reacted with 2% (w/v) of <i>p</i>-dimethylaminobenzaldehyde in acetic acid. The reaction was incubated 10 min at 25 °C and read at 480 nm in a spectrophotometer. Control samples with no IDO1 inhibitor or with no IDO1 enzyme or with the reference inhibitors 1-methyl-<span class="smallcaps smallerCapital">l</span>-Trp (200 μM) and menadione (1.2 μM) were used as controls to set the parameters for the nonlinear regressions necessary for determination of the IC<sub>50</sub> for each compound. At least 8–10 test compound concentrations were tested in duplicate for determination of the IC<sub>50</sub> curves. Blank samples were prepared for each concentration of the IDO inhibitor tested. Nonlinear regressions and determination of the IC<sub>50</sub> values were performed using the GraphPad Prism 4 software.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i216" class="anchor-spacer"></div><h3 class="article-section__title" id="_i216"> hIDO1 Cellular Potency Assay—Determination of EC<sub>50</sub></h3><div class="NLM_p last">293-T-Rex cells (Invitrogen) constitutively expressing a Tet-Off operator binding repressor protein were transfected with plasmid pcDNA-tetO-IDO1 expressing human IDO1 under the control of the doxycycline-inducible CMV-tet promoter, and selected in DBZ medium (DMEM, 10% FBS, 1× penicillin + streptomycin, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 5 μg/mL blasticidin and 25 μg/mL Zeocin) at 37 °C with a 5% CO<sub>2</sub> in air atmosphere. Individual clones were isolated by limiting dilution cloning from these populations. These clones were assayed for IDO1 activity and the clones that showed the highest levels of IDO1 activity inducible by doxycycline and low expression under noninduced conditions were used for subsequent cell-based IDO1 assays. To setup an IDO1 cell-based activity assay, IDO1-293-T-Rex cells were harvested and resuspended in DBZ media at 10<sup>6</sup> cells/mL, and split into poly-<span class="smallcaps smallerCapital">d</span>-lysine coated 96-well plates at 100 000 cells per well. Neutral medium (100 μL) (DBZ medium, 200 μM <span class="smallcaps smallerCapital">l</span>-Trp) or induction media (neutral medium supplemented with 5 μM doxycycline) were added to the cells and incubated 28 h at 37 °C. After the IDO1 induction period, medium was removed and replaced with induction or neutral medium containing different concentrations of each IDO1 inhibitor (3 μM to 50 pM). At least 8–10 concentrations were tested in triplicate for determination of EC<sub>50</sub> curves. The cells incubated in neutral medium serve as negative control of the assay. The cells incubated in induction medium and without inhibitor serve as the positive control of the assay. The incubation was carried out for 16 h at 37 °C in a cell culture incubator. The supernatant was precipitated with 30% TCA, the cleared supernatant was treated with of 4% (w/v) of <i>p</i>-dimethylaminobenzaldehyde in acetic acid and incubated for 10 min. Kyn concentration is determined by measuring the absorbance at 480 nm.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i217" class="anchor-spacer"></div><h3 class="article-section__title" id="_i217"> Computational Methods</h3><div class="NLM_p last">Small molecules were minimized with Molecular Operating Environment (MOE) software. The protein was prepared using standard parameters and the charge of Fe was adjusted to Fe<sup>2+</sup>. Minimization of ligands was done by fixing the nitrogen atom to the heme Fe<sup>2+</sup> at 2.1–2.2 Å. The Amber 10 EHT force field was used for energy minimizations. The molecular figures were rendered with PyMOL Version 2.3.0 (<a href="http://pymol.org" class="extLink">http://pymol.org</a>), Schrodinger LLC.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i218" class="anchor-spacer"></div><h3 class="article-section__title" id="_i218"> Crystallography Methods</h3><div class="NLM_p">IDO1 M1-G403 with a N terminal His tag was transformed into <i>Escherichia coli</i> BL21 (DE3) cells. The cells were cultured in LB medium supplied with 0.5 mM 5-aminolevulinic acid hydrochloride (5-ALA) at 37 °C until OD 600 reached 0.6 and then induced with 0.3 mM isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside. The cultures were then incubated at 16 °C for 20 h and the cells were harvested by centrifugation at 9000 rpm for 10 min. The cells were lysed in buffer of 25 mM Tris pH 7.5, 150 mM sodium chloride, 10 mM imidazole, 1 mM phenylmethane sulfonyl fluoride ,and ethylenediaminetetraacetic acid -free protease inhibitor tablets (Roche). The protein was purified using equilibrated NiNTA (Roche) beads by gravity flow. The protein was eluted by 300 mM imidazole, treated with Tev protease, and placed into a 3500 MWCO dialysis cassette while dialyzing against a buffer of 25 mM Tris pH 7.5, 150 mM sodium chloride, and 1 mM tris(2-carboxyethyl)phosphine. A reverse nickel column purification was done to capture the His-tagged protein while the cleaved protein was collected in the flow-through. The His-cleaved IDO1 protein was then concentrated with 10 000 MWCO concentrators (Amicon) and then injected into an equilibrated S75 26/60 gel filtration column (GE) for final purification. Fractions containing the protein were pooled, concentrated to 10 mg/mL, and flash frozen for storage at −80 °C. The protein concentration was determined by measuring <i>A</i><sub>280</sub> absorbance via a NanoDrop 2000c Spectrophotometer (Thermo Fisher Scientific). Heme incorporation was determined by measuring the ratio of <i>A</i><sub>406</sub>/<i>A</i><sub>280</sub>. Based on a reference value of 2.2 for 100% heme incorporation,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> IDO1 samples purified for crystallography were measured to have 70% heme.</div><div class="NLM_p">Single crystals of IDO1-heme were grown in a 1:1 ratio of protein/well solution of 0.1 M bis tris propane pH 6.5, 20% Peg 3350, and 0.2 M potassium thiocyanate. The crystals were then dehydrated by increasing the Peg 3350 concentration from 20 to 40% over a period of 4 days. Crystals were soaked in a cryobuffer of 10% xylitol then flash frozen in liquid nitrogen.</div><div class="NLM_p last">Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource beamline 12–2, reduced with autoPROC,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the structure was determined by molecular replacement methods as implemented in Phaser.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The final model was created using iterative rounds of manual rebuilding in COOT<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and refinement with BUSTER.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Coordinates and structure factors are deposited with the Protein Data Bank (PDB) under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3I">6O3I</a>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i219" class="anchor-spacer"></div><h3 class="article-section__title" id="_i219"> Pharmacokinetics</h3><div class="NLM_p last">All pharmacokinetic experiments in animals were carried out in conformance with AAALAC International and NIH guidelines as reported in the “Guide for the Care and Use of Laboratory Animals,” National Research Council-ILAR, 8th edition 2011. All animal procedures were approved by Iowa State University IACUC.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i220" class="anchor-spacer"></div><h3 class="article-section__title" id="_i220"> In Vivo Pharmacodynamics</h3><div class="NLM_p last">See the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i221"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00662" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00662" class="ext-link">10.1021/acs.jmedchem.9b00662</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Calculation of <i>K</i><sub><i>i</i></sub>, mode of inhibition of <b>NLG-919</b>, in vivo pharmacodynamics, single crystal X-ray data for <b>122–124</b>, <b>132</b> and <b>NLG-919</b>, co-crystal data for <b>NLG-919</b> bound in hIDO, chiral and achiral HPLC of selected final compounds, <sup>1</sup>H NMR spectra of <b>121–124</b>, <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>NLG-919</b>, and <b>123</b> minimized in 2D0T (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Compound <b>11</b> minimized in 2D0T (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Compound <b>37</b> minimized in 2D0T (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Compound <b>46</b> minimized in 2D0T (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Compound <b>124</b> minimized in 2D0T (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_006.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf">jm9b00662_si_001.pdf (3.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_002.csv">jm9b00662_si_002.csv (5.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_003.pdb">jm9b00662_si_003.pdb (479.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_004.pdb">jm9b00662_si_004.pdb (648.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_005.pdb">jm9b00662_si_005.pdb (650.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_006.pdb">jm9b00662_si_006.pdb (650.95 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">CCDC accession code: <b>NLG-919</b>, 1905358; <b>132</b>, 1905087; <b>124·HCl</b>, 1905094; <b>123·HBr</b>, 1905089; <b>122·HBr</b>, 1905093.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00662" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario R. Mautino</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2729-4996" title="Orcid link">http://orcid.org/0000-0003-2729-4996</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d20202c38392423220d212423263d632e2220"><span class="__cf_email__" data-cfemail="ed80808c9899848382ad818483869dc38e8280">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanjeev Kumar</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesse P. Waldo</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span>; 
    <span>Present Address:
                        Discovery Chemistry, Janssen Research and Development, LLC, Welsh and McKean Roads, Spring House, PA 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Firoz A. Jaipuri</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span>; 
    <span>Present Address:
                        Medicinal Chemistry, Biocon Bristol-Myers Squibb R&D Center, Biocon Park, Bommasandra Industrial Area, Bengaluru, KA 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnieszka Marcinowicz</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clarissa Van Allen</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Adams</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanay Kesharwani</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span>; 
    <span>Present Address:
                        Department of Chemistry, University of West Florida, Pensacola, FL 32514</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8193-0004" title="Orcid link">http://orcid.org/0000-0001-8193-0004</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxia Zhang</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Metz</span> - <span class="hlFld-Affiliation affiliation">NewLink
Genetics Corporation, Ames, Iowa 50010, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela J. Oh</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth F. Harris</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.K., J.P.W., and F.A.J. contributed equally. All medicinal chemistry performed at NewLink Genetics Corporation. and all protein crystallography performed at Genentech, Inc. The manuscript was written through contributions of all the authors. All authors the have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was funded by NewLink Genetics Corporation (chemistry and biochemistry) and Genentech, Inc. (protein crystallography).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): I am or was an employee and shareholder of NewLink Genetics Corporation, which sponsored and funded this work.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i227">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Arkady Ellern of Iowa State University for small-molecule single crystal X-ray crystallography data. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">GCN2</td><td class="NLM_def"><p class="first last">general control nonderepressible 2</p></td></tr><tr><td class="NLM_term">FoxP3</td><td class="NLM_def"><p class="first last">forkhead box P3</p></td></tr><tr><td class="NLM_term">hIDO1</td><td class="NLM_def"><p class="first last">human indoleamine 2,3-dioxygenase 1</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">fu</td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">CTX</td><td class="NLM_def"><p class="first last">cyclophospamide</p></td></tr><tr><td class="NLM_term">TosMIC</td><td class="NLM_def"><p class="first last">toluenesulfonylmethyl isocyanide</p></td></tr><tr><td class="NLM_term">brsm</td><td class="NLM_def"><p class="first last">based on recovered starting material</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">Ph1</td><td class="NLM_def"><p class="first last">phase 1</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague Dawley</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i229">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondarev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span> <span> </span><span class="NLM_article-title">Prevention of allogeneic fetal rejection by tryptophan catabolism</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1126/science.281.5380.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1126%2Fscience.281.5380.1191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=9712583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Cqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1191-1193&author=D.+H.+Munnauthor=M.+Zhouauthor=J.+T.+Attwoodauthor=I.+Bondarevauthor=S.+J.+Conwayauthor=B.+Marshallauthor=C.+Brownauthor=A.+L.+Mellor&title=Prevention+of+allogeneic+fetal+rejection+by+tryptophan+catabolism&doi=10.1126%2Fscience.281.5380.1191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of allogeneic fetal rejection by tryptophan catabolism</span></div><div class="casAuthors">Munn, David H.; Zhou, Min; Attwood, John T.; Bondarev, Igor; Conway, Simon J.; Marshall, Brendan; Brown, Corrie; Mellor, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5380</span>),
    <span class="NLM_cas:pages">1191-1193</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In 1953 Medawar pointed out that survival of the genetically disparate (allogeneic) mammalian conceptus contradicts the laws of tissue transplantation.  Rapid T cell-induced rejection of all allogeneic concepti occurred when pregnant mice were treated with a pharmacol. inhibitor of indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing enzyme expressed by trophoblasts and macrophages.  Thus, by catabolizing tryptophan, the mammalian conceptus suppresses T cell activity and defends itself against rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEbmX105sj7Vg90H21EOLACvtfcHk0lhuZZXV6hFIyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Cqu7c%253D&md5=d41cbe1943b4eedf7b5b4a398ad6b81e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5380.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5380.1191%26sid%3Dliteratum%253Aachs%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DAttwood%26aufirst%3DJ.%2BT.%26aulast%3DBondarev%26aufirst%3DI.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DMellor%26aufirst%3DA.%2BL.%26atitle%3DPrevention%2520of%2520allogeneic%2520fetal%2520rejection%2520by%2520tryptophan%2520catabolism%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1191%26epage%3D1193%26doi%3D10.1126%2Fscience.281.5380.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1038/83183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2F83183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11135580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=64-68&author=A.+L.+Mellorauthor=J.+Sivakumarauthor=P.+Chandlerauthor=K.+Smithauthor=H.+Molinaauthor=D.+Maoauthor=D.+H.+Munn&title=Prevention+of+T+cell-driven+complement+activation+and+inflammation+by+tryptophan+catabolism+during+pregnancy&doi=10.1038%2F83183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy</span></div><div class="casAuthors">Mellor, Andrew L.; Sivakumar, Jayabalan; Chandler, Phillip; Smith, Kimberly; Molina, Hector; Mao, Dailing; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-68</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Indoleamine 2,3 dioxygenase (IDO) activity during pregnancy protects developing fetuses from maternal immune responses in CBA mice.  The authors show here that fetal allografts were rejected only in mating combinations where paternally inherited tissue antigens elicited potent maternal T cell responses after exposure to IDO inhibitor.  IDO inhibitor treatment triggered extensive inflammation at the maternal-fetal interface in susceptible mating combinations, which was characterized by complement deposition and hemorrhagic necrosis.  Identical inflammatory responses occurred in B cell-deficient (RAG-I-/-) mothers that carried a monoclonal cohort of CD8+ T cells specific for a single paternally inherited fetal major histocompatibility complex antigen.  Thus, fetal allograft rejection was accompanied by a unique form of inflammation that was characterized by T cell-dependent, antibody-independent activation of complement.  In contrast, no inflammation, complement deposition or T cell infiltration was elicited when mice carrying syngeneic fetuses were exposed to IDO inhibitor.  These data show that IDO activity protects the fetus by suppressing T cell-driven local inflammatory responses to fetal alloantigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokEs6XgjSI4LVg90H21EOLACvtfcHk0lhuZZXV6hFIyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslylsw%253D%253D&md5=88940e78aa4bbb979e327e498c85d5c0</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2F83183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F83183%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DSivakumar%26aufirst%3DJ.%26aulast%3DChandler%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DMolina%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DD.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DPrevention%2520of%2520T%2520cell-driven%2520complement%2520activation%2520and%2520inflammation%2520by%2520tryptophan%2520catabolism%2520during%2520pregnancy%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D64%26epage%3D68%26doi%3D10.1038%2F83183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Extinguishing maternal immune responses during pregnancy: implications for immunosuppression</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1006/smim.2000.0317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1006%2Fsmim.2000.0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11437628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=213-218&author=A.+L.+Mellorauthor=D.+H.+Munn&title=Extinguishing+maternal+immune+responses+during+pregnancy%3A+implications+for+immunosuppression&doi=10.1006%2Fsmim.2000.0317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Extinguishing maternal immune responses during pregnancy: implications for immunosuppression</span></div><div class="casAuthors">Mellor, Andrew L.; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Mammals owe their existence to immunosuppressive processes that prevent fetal rejection in utero.  Blocking tryptophan catabolism during murine pregnancy allows maternal T cells to provoke fetal allograft rejection.  Cells expressing indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan, prevent T cell cycle progression and enhance activation induced T cell death.  Here, we discuss the role of cells expressing IDO in regulating maternal T cell immunity during pregnancy and consider whether this mechanism might contribute to immunol. discrimination by promoting T cell tolerance in other circumstances.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi_mkDEcBEeLVg90H21EOLACvtfcHk0lhW7Rb_EWqFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVOkur0%253D&md5=215cfc2b584ca84b554474e37953f253</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0317%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DExtinguishing%2520maternal%2520immune%2520responses%2520during%2520pregnancy%253A%2520implications%2520for%2520immunosuppression%26jtitle%3DSemin.%2520Immunol.%26date%3D2001%26volume%3D13%26spage%3D213%26epage%3D218%26doi%3D10.1006%2Fsmim.2000.0317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keskin, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy</span>. <i>J. Reprod. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/s0165-0378(02)00040-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs0165-0378%2802%2900040-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=12385839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2002&pages=143-150&author=A.+L.+Mellorauthor=P.+Chandlerauthor=G.+K.+Leeauthor=T.+Johnsonauthor=D.+B.+Keskinauthor=J.+Leeauthor=D.+H.+Munn&title=Indoleamine+2%2C3-dioxygenase%2C+immunosuppression+and+pregnancy&doi=10.1016%2Fs0165-0378%2802%2900040-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Indolamine 2,3-dioxygenase, immunosuppression and pregnancy</span></div><div class="casAuthors">Mellor, Andrew L.; Chandler, Phillip; Lee, Geon Kook; Johnson, Theodore; Keskin, Derin B.; Lee, Jeffrey; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Reproductive Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">JRIMDR</span>;
        ISSN:<span class="NLM_cas:issn">0165-0378</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. inhibition of indolamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses.  Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface.  Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQn3ey-h-Q7Vg90H21EOLACvtfcHk0lhW7Rb_EWqFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOmsrs%253D&md5=b17bf9555775083dc159516b7b2f6c7d</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fs0165-0378%2802%2900040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0165-0378%252802%252900040-2%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DChandler%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKeskin%26aufirst%3DD.%2BB.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%252C%2520immunosuppression%2520and%2520pregnancy%26jtitle%3DJ.%2520Reprod.%2520Immunol.%26date%3D2002%26volume%3D57%26spage%3D143%26epage%3D150%26doi%3D10.1016%2Fs0165-0378%2802%2900040-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wek, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, T. G.</span></span> <span> </span><span class="NLM_article-title">Coping with stress: eIF2 kinases and translational control</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1042/bst0340007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1042%2Fbst0340007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16246168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=7-11&author=R.+C.+Wekauthor=H.-Y.+Jiangauthor=T.+G.+Anthony&title=Coping+with+stress%3A+eIF2+kinases+and+translational+control&doi=10.1042%2Fbst0340007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Coping with stress: eIF2 kinases and translational control</span></div><div class="casAuthors">Wek, R. C.; Jiang, H.-Y.; Anthony, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-11</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  In response to environmental stresses, a family of protein kinases phosphorylate eIF2 (eukaryotic initiation factor 2) to alleviate cellular injury or alternatively induce apoptosis.  Phosphorylation of eIF2 reduces global translation, allowing cells to conserve resources and to initiate a reconfiguration of gene expression to effectively manage stress conditions.  Accompanying this general protein synthesis control, eIF2 phosphorylation induces translation of specific mRNAs, such as that encoding the bZIP (basic leucine zipper) transcriptional regulator ATF4 (activating transcription factor 4).  ATF4 also enhances the expression of addnl. transcription factors, ATF3 and CHOP (CCAAT/enhancer-binding protein homologous protein)/GADD153 (growth arrest and DNA-damage-inducible protein), that assist in the regulation of genes involved in metab., the redox status of the cells and apoptosis.  Reduced translation by eIF2 phosphorylation can also lead to activation of stress-related transcription factors, such as NF-κB (nuclear factor κB), by lowering the steady-state levels of short-lived regulatory proteins such as IκB (inhibitor of NF-κB).  While many of the genes induced by eIF2 phosphorylation are shared between different environmental stresses, eIF2 kinases function in conjunction with other stress-response pathways, such as those regulated by mitogen-activated protein kinases, to elicit gene expression programs that are tailored for the specific stress condition.  Loss of eIF2 kinase pathways can have important health consequences.  Mice devoid of the eIF2 kinase GCN2 [general control non-derepressible-2 or EIF2AK4 (eIF2α kinase 4)] show sensitivity to nutritional deficiencies and aberrant eating behaviors, and deletion of PEK [pancreatic eIF2α kinase or PERK (RNA-dependent protein kinase-like endoplasmic reticulum kinase) or EIF2AK3] leads to neonatal insulin-dependent diabetes, epiphyseal dysplasia and hepatic and renal complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNXgHJoO96crVg90H21EOLACvtfcHk0lhW7Rb_EWqFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsLbF&md5=3454048d2ad14311acd82f5c06635e54</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2Fbst0340007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0340007%26sid%3Dliteratum%253Aachs%26aulast%3DWek%26aufirst%3DR.%2BC.%26aulast%3DJiang%26aufirst%3DH.-Y.%26aulast%3DAnthony%26aufirst%3DT.%2BG.%26atitle%3DCoping%2520with%2520stress%253A%2520eIF2%2520kinases%2520and%2520translational%2520control%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D7%26epage%3D11%26doi%3D10.1042%2Fbst0340007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinetti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. R.</span></span> <span> </span><span class="NLM_article-title">Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">118ra11</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3002629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1126%2Fscitranslmed.3002629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22277968" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=118ra11&author=W.+Pengauthor=L.+Robertsonauthor=J.+Gallinettiauthor=P.+Mejiaauthor=S.+Voseauthor=A.+Charlipauthor=T.+Chuauthor=J.+R.+Mitchell&title=Surgical+stress+resistance+induced+by+single+amino+acid+deprivation+requires+Gcn2+in+mice&doi=10.1126%2Fscitranslmed.3002629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002629%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DRobertson%26aufirst%3DL.%26aulast%3DGallinetti%26aufirst%3DJ.%26aulast%3DMejia%26aufirst%3DP.%26aulast%3DVose%26aufirst%3DS.%26aulast%3DCharlip%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DMitchell%26aufirst%3DJ.%2BR.%26atitle%3DSurgical%2520stress%2520resistance%2520induced%2520by%2520single%2520amino%2520acid%2520deprivation%2520requires%2520Gcn2%2520in%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D118ra11%26doi%3D10.1126%2Fscitranslmed.3002629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mezrich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingham, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfield, C. A.</span></span> <span> </span><span class="NLM_article-title">An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">3190</span>– <span class="NLM_lpage">3198</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0903670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.4049%2Fjimmunol.0903670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=20720200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSntL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=3190-3198&author=J.+D.+Mezrichauthor=J.+H.+Fechnerauthor=X.+Zhangauthor=B.+P.+Johnsonauthor=W.+J.+Burlinghamauthor=C.+A.+Bradfield&title=An+interaction+between+kynurenine+and+the+aryl+hydrocarbon+receptor+can+generate+regulatory+T+cells&doi=10.4049%2Fjimmunol.0903670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells</span></div><div class="casAuthors">Mezrich, Joshua D.; Fechner, John H.; Zhang, Xiaoji; Johnson, Brian P.; Burlingham, William J.; Bradfield, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3190-3198</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The aryl hydrocarbon receptor (AHR) has been known to cause immunosuppression after binding dioxin.  It has recently been discovered that the receptor may be central to T cell differentiation into FoxP3+ regulatory T cells (Tregs) vs. Th17 cells.  In this paper, we demonstrate that kynurenine, the first breakdown product in the IDO-dependent tryptophan degrdn. pathway, activates the AHR.  We furthermore show that this activation leads to AHR-dependent Treg generation.  We addnl. investigate the dependence of TGF-β on the AHR for optimal Treg generation, which may be secondary to the upregulation of this receptor that is seen in T cells postexposure to TGF-β.  These results shed light on the relationship of IDO to the generation of Tregs, in addn. to highlighting the central importance of the AHR in T cell differentiation.  All tissues and cells were derived from mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnTjsPCkL97Vg90H21EOLACvtfcHk0lianolks4awPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSntL7F&md5=441b434b32547eb126c64a6d995f8081</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0903670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0903670%26sid%3Dliteratum%253Aachs%26aulast%3DMezrich%26aufirst%3DJ.%2BD.%26aulast%3DFechner%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DB.%2BP.%26aulast%3DBurlingham%26aufirst%3DW.%2BJ.%26aulast%3DBradfield%26aufirst%3DC.%2BA.%26atitle%3DAn%2520interaction%2520between%2520kynurenine%2520and%2520the%2520aryl%2520hydrocarbon%2520receptor%2520can%2520generate%2520regulatory%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D3190%26epage%3D3198%26doi%3D10.4049%2Fjimmunol.0903670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, T.</span></span> <span> </span><span class="NLM_article-title">Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">19961</span>– <span class="NLM_lpage">19966</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014465107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.1014465107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21041655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyisLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=19961-19966&author=N.+T.+Nguyenauthor=A.+Kimuraauthor=T.+Nakahamaauthor=I.+Chinenauthor=K.+Masudaauthor=K.+Noharaauthor=Y.+Fujii-Kuriyamaauthor=T.+Kishimoto&title=Aryl+hydrocarbon+receptor+negatively+regulates+dendritic+cell+immunogenicity+via+a+kynurenine-dependent+mechanism&doi=10.1073%2Fpnas.1014465107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism</span></div><div class="casAuthors">Nguyen, Nam Trung; Kimura, Akihiro; Nakahama, Taisuke; Chinen, Ichino; Masuda, Kazuya; Nohara, Keiko; Fujii-Kuriyama, Yoshiaki; Kishimoto, Tadamitsu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">19961-19966, S19961/1-S19961/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although an immunoregulatory role of aryl hydrocarbon receptor (Ahr) has been demonstrated in T cells and macrophages, little is known about its function in dendritic cells (DC).  Here, we show that lipopolysaccharide (LPS) and CpG stimulate Ahr expression in bone marrow-derived dendritic cells (BMDC).  Furthermore, we found that Ahr is required to induce indoleamine 2,3-dioxygenase (IDO) expression, an immunosuppressive enzyme that catabolizes tryptophan into kynurenine (Kyn) and other metabolites in DC.  In the presence of LPS or CpG, Ahr-deficient (Ahr-/-) mature BMDC induced immune responses characterized by reduced Kyn and IL-10 prodn. compared with results obsd. with tolerogenic mature WT BMDC.  In a coculture system with LPS- or CpG-stimulated BMDC and naive T cells, Ahr-/- BMDC inhibited naive T-cell differentiation into regulatory T (Treg) cells, which likely facilitated Th17 cell development and promoted naive T-cell proliferation.  Addn. of synthetic L-Kyn to the coculture system skewed the differentiation of naive T cells to Treg cells rather than Th17 cells.  Taken together, our results demonstrate a previously unknown neg. regulatory role for Ahr in DC-mediated immunogenesis in the presence of LPS or CpG, which, in turn, alters the Kyn-dependent generation of Treg cells and Th17 cells from naive T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXN00-SINf47Vg90H21EOLACvtfcHk0lianolks4awPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyisLzE&md5=2f3a4ce4b8ae94272340de48a8f653cf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014465107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014465107%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DN.%2BT.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DNakahama%26aufirst%3DT.%26aulast%3DChinen%26aufirst%3DI.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DNohara%26aufirst%3DK.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DAryl%2520hydrocarbon%2520receptor%2520negatively%2520regulates%2520dendritic%2520cell%2520immunogenicity%2520via%2520a%2520kynurenine-dependent%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D19961%26epage%3D19966%26doi%3D10.1073%2Fpnas.1014465107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spits, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mjösberg, J.</span></span> <span> </span><span class="NLM_article-title">The aryl hydrocarbon receptor: a sentinel safeguarding the survival of immune cells in the gut</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.immuni.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22284414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=5-7&author=H.+Spitsauthor=J.+Mj%C3%B6sberg&title=The+aryl+hydrocarbon+receptor%3A+a+sentinel+safeguarding+the+survival+of+immune+cells+in+the+gut&doi=10.1016%2Fj.immuni.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Aryl Hydrocarbon Receptor: A Sentinel Safeguarding the Survival of Immune Cells in the Gut</span></div><div class="casAuthors">Spits, Hergen; Mjoesberg, Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-7</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Innate lymphoid cells (ILCs) regulate the epithelial barrier function and immunity in the gut.  How ILC nos. are maintained is unknown.  In this issue of Immunity, Qiu et al. (2012) report that the transcription factor aryl hydrocarbon receptor controls survival and function of gut-residing ILCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LglJQmUacLVg90H21EOLACvtfcHk0lianolks4awPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKhs7Y%253D&md5=971e58e1fc05052705f9f2e9638d0807</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSpits%26aufirst%3DH.%26aulast%3DMj%25C3%25B6sberg%26aufirst%3DJ.%26atitle%3DThe%2520aryl%2520hydrocarbon%2520receptor%253A%2520a%2520sentinel%2520safeguarding%2520the%2520survival%2520of%2520immune%2520cells%2520in%2520the%2520gut%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D5%26epage%3D7%26doi%3D10.1016%2Fj.immuni.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uyttenhove, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Théate, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Eynde, B. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1038/nm934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fnm934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=14502282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Clu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1269-1274&author=C.+Uyttenhoveauthor=L.+Pilotteauthor=I.+Th%C3%A9ateauthor=V.+Stroobantauthor=D.+Colauauthor=N.+Parmentierauthor=T.+Boonauthor=B.+J.+Van+den%0AEynde&title=Evidence+for+a+tumoral+immune+resistance+mechanism+based+on+tryptophan+degradation+by+indoleamine+2%2C3-dioxygenase&doi=10.1038%2Fnm934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Uyttenhove, Catherine; Pilotte, Luc; Theate, Ivan; Stroobant, Vincent; Colau, Didier; Parmentier, Nicolas; Boon, Thierry; Van den Eynde, Benoit J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1269-1274</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">T lymphocytes undergo proliferation arrest when exposed to tryptophan shortage, which can be provoked by indoleamine 2,3-dioxygenase (IDO), an enzyme that is expressed in placenta and catalyzes tryptophan degrdn.  Here we show that most human tumors constitutively express IDO.  We also obsd. that expression of IDO by immunogenic mouse tumor cells prevents their rejection by preimmunized mice.  This effect is accompanied by a lack of accumulation of specific T cells at the tumor site and can be partly reverted by systemic treatment of mice with an inhibitor of IDO, in the absence of noticeable toxicity.  These results suggest that the efficacy of therapeutic vaccination of cancer patients might be improved by concomitant administration of an IDO inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2g0Nw1Orz7rVg90H21EOLACvtfcHk0lhOn-X3lCvQJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Clu7c%253D&md5=c2be3620862064fb40da547f976ccf95</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm934%26sid%3Dliteratum%253Aachs%26aulast%3DUyttenhove%26aufirst%3DC.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ate%26aufirst%3DI.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DParmentier%26aufirst%3DN.%26aulast%3DBoon%26aufirst%3DT.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520tumoral%2520immune%2520resistance%2520mechanism%2520based%2520on%2520tryptophan%2520degradation%2520by%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D1269%26epage%3D1274%26doi%3D10.1038%2Fnm934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span> <span> </span><span class="NLM_article-title">Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients</span>. <i>Dermatology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1159/000096906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1159%2F000096906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17191041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A280%3ADC%252BD28jltlWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2007&pages=8-14&author=G.+Weinlichauthor=C.+Murrauthor=L.+Richardsenauthor=C.+Winklerauthor=D.+Fuchs&title=Decreased+serum+tryptophan+concentration+predicts+poor+prognosis+in+malignant+melanoma+patients&doi=10.1159%2F000096906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients</span></div><div class="casAuthors">Weinlich Georg; Murr Christian; Richardsen Laura; Winkler Christiana; Fuchs Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Dermatology (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>
        ISSN:<span class="NLM_cas:issn">1018-8665</span>.
    </div><div class="casAbstract">BACKGROUND:  Indoleamine (2,3)-dioxygenase (IDO) catalyses the initial, rate-limiting step in the degradation of the essential amino acid tryptophan.  Via tryptophan deprivation, IDO activity suppresses T cell proliferation and differentiation and is thought to be a fundamental immune escape mechanism for tumor cells.  OBJECTIVE AND METHODS:  To investigate the potential role of tryptophan degradation as a prognostic marker, serum tryptophan and kynurenine concentrations and the kynurenine-to-tryptophan ratio (kyn/trp) in 87 patients with malignant melanoma were compared to the course of the disease and to concentrations of the immune activation marker neopterin.  RESULTS:  Compared to 49 healthy volunteers, the melanoma patients presented with lower tryptophan levels due to accelerated degradation.  This was especially true for the subgroups of patients with distant metastases (p = 0.01), though not in patients with lymph node metastases or in patients who had not yet progressed.  There existed a positive correlation between kyn/trp and neopterin concentrations (r(s) = 0.587, p <0.001).  In patients who died due to dissemination of the tumor, median tryptophan concentrations were significantly decreased (p = 0.006) and kyn/trp (p = 0.03) and neopterin concentrations (p = 0.002) were higher compared to survivors.  In addition, lower tryptophan concentrations as well as higher kyn/trp and neopterin concentrations predicted a shorter survival.  CONCLUSION:  Decreased serum tryptophan concentrations and elevated serum neopterin levels can be used as predictive markers for the future course in melanoma patients.  Moreover, our data support previous speculations that a higher degree of IDO expression could play a crucial role for tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTojRzUHU0-AIMcDoIzZtNkfW6udTcc2eZbdQdm2-zxirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jltlWnsQ%253D%253D&md5=0fc93897eb632cd07692e321fd501d6c</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1159%2F000096906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000096906%26sid%3Dliteratum%253Aachs%26aulast%3DWeinlich%26aufirst%3DG.%26aulast%3DMurr%26aufirst%3DC.%26aulast%3DRichardsen%26aufirst%3DL.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DFuchs%26aufirst%3DD.%26atitle%3DDecreased%2520serum%2520tryptophan%2520concentration%2520predicts%2520poor%2520prognosis%2520in%2520malignant%2520melanoma%2520patients%26jtitle%3DDermatology%26date%3D2007%26volume%3D214%26spage%3D8%26epage%3D14%26doi%3D10.1159%2F000096906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Corm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbenotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhermitte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesnel, B.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-gamma</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1016/j.leukres.2008.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.leukres.2008.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=18639339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=490-494&author=S.+Cormauthor=C.+Berthonauthor=M.+Imbenotteauthor=V.+Biggioauthor=M.+Lhermitteauthor=C.+Dupontauthor=I.+Bricheauthor=B.+Quesnel&title=Indoleamine+2%2C3-dioxygenase+activity+of+acute+myeloid+leukemia+cells+can+be+measured+from+patients%E2%80%99+sera+by+HPLC+and+is+inducible+by+IFN-gamma&doi=10.1016%2Fj.leukres.2008.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-γ</span></div><div class="casAuthors">Corm, Selim; Berthon, Celine; Imbenotte, Michel; Biggio, Valeria; Lhermitte, Michel; Dupont, Caroline; Briche, Isabelle; Quesnel, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">490-494</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The enzyme indoleamine 2,3-dioxygenase (IDO) converts tryptophan to kynurenine, blocking T-cell activation and inducing immunosuppression.  In patients with acute myeloid leukemia (AML), the serum kynurenine/tryptophan ratio (Kyn/Trp) was raised, suggesting a higher IDO activity than in healthy people.  Patients with higher Kyn/Trp ratios showed lower survival.  IDO activity was also detected in AML cells after exposure to IFN-γin vitro, suggesting that the higher Kyn/Trp ratio in serum of AML patients might have resulted from stimulated leukemic blast cells.  Thus, in AML, the activity of IDO can be easily monitored, providing a tool for future clin. testing of IDO-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorMbStcuzqLrVg90H21EOLACvtfcHk0lhOn-X3lCvQJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCqsrY%253D&md5=34af1b03d71d94f575ab2e3aa028b26c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DCorm%26aufirst%3DS.%26aulast%3DBerthon%26aufirst%3DC.%26aulast%3DImbenotte%26aufirst%3DM.%26aulast%3DBiggio%26aufirst%3DV.%26aulast%3DLhermitte%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DC.%26aulast%3DBriche%26aufirst%3DI.%26aulast%3DQuesnel%26aufirst%3DB.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520activity%2520of%2520acute%2520myeloid%2520leukemia%2520cells%2520can%2520be%2520measured%2520from%2520patients%25E2%2580%2599%2520sera%2520by%2520HPLC%2520and%2520is%2520inducible%2520by%2520IFN-gamma%26jtitle%3DLeuk.%2520Res.%26date%3D2009%26volume%3D33%26spage%3D490%26epage%3D494%26doi%3D10.1016%2Fj.leukres.2008.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span> <span> </span><span class="NLM_article-title">Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.3892/or.17.6.1333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.3892%2For.17.6.1333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17487387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvF2isLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1333-1339&author=M.+Takaoauthor=A.+Okamotoauthor=T.+Nikaidoauthor=M.+Urashimaauthor=S.+Takakuraauthor=M.+Saitoauthor=S.+Okamotoauthor=O.+Takikawaauthor=H.+Sasakiauthor=M.+Yasudaauthor=K.+Ochiaiauthor=T.+Tanaka&title=Increased+synthesis+of+indoleamine-2%2C3-dioxygenase+protein+is+positively+associated+with+impaired+survival+in+patients+with+serous-type%2C+but+not+with+other+types+of%2C+ovarian+cancer&doi=10.3892%2For.17.6.1333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer</span></div><div class="casAuthors">Takao, Miho; Okamoto, Aikou; Nikaido, Takashi; Urashima, Mitsuyoshi; Takakura, Satoshi; Saito, Misato; Saito, Motoaki; Okamoto, Sanshiro; Takikawa, Osamu; Sasaki, Hiroshi; Yasuda, Makoto; Ochiai, Kazunori; Tanaka, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1333-1339</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">We previously reported that indoleamine-2,3-dioxygenase (IDO) is assocd. with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA).  In this study, to explore the role of IDO in the development of various histol. types of ovarian cancer, we further examd. IDO expression not only in SA but also in other types of ovarian cancers.  Expression of IDO protein was analyzed by immunohistochem. for a total of 122 ovarian cancers including 40 SA, 67 clear cell adenocarcinomas (CCA), and 15 endometrioid adenocarcinomas (EA) with informed consent.  Among these cases, there were 11 CCA accompanied with endometriosis and 60 cases with lymph node metastasis.  We classified the samples into four categories by IDO staining pattern.  IDO staining was pos. in 57.5% of SA, 49.2% of CCA, and 73.3% of EA, resp.  The Kaplan-Meier survival curve showed a clear relationship between staining score and overall survival for patients with advanced (stages III and IV) SA (n = 33) who underwent optimal surgery and paclitaxel-carboplatin (TC) chemotherapy as a first-line regimen.  There was no assocn. between IDO staining score and overall survival in the CCA cases.  Eight of 11 cases (72.7%) of CCA accompanied by endometriosis presented identical staining patterns of IDO between CCA and endometriosis.  In 43 of 60 cases (71.6%) with lymph node metastasis, the staining patterns of IDO showed a correspondence between the primary lesion and metastatic site.  These results suggested that the increased synthesis of IDO protein was pos. assocd. with impaired survival only in the serous type of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRDgeRRyeADrVg90H21EOLACvtfcHk0lhiR0vAMu_fSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvF2isLs%253D&md5=1b32496ba3260be755569d051b8985c9</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.3892%2For.17.6.1333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.17.6.1333%26sid%3Dliteratum%253Aachs%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DYasuda%26aufirst%3DM.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26atitle%3DIncreased%2520synthesis%2520of%2520indoleamine-2%252C3-dioxygenase%2520protein%2520is%2520positively%2520associated%2520with%2520impaired%2520survival%2520in%2520patients%2520with%2520serous-type%252C%2520but%2520not%2520with%2520other%2520types%2520of%252C%2520ovarian%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2007%26volume%3D17%26spage%3D1333%26epage%3D1339%26doi%3D10.3892%2For.17.6.1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanaihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isonishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6030</span>– <span class="NLM_lpage">6039</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-04-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.ccr-04-2671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16115948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6030-6039&author=A.+Okamotoauthor=T.+Nikaidoauthor=K.+Ochiaiauthor=S.+Takakuraauthor=M.+Saitoauthor=Y.+Aokiauthor=N.+Ishiiauthor=N.+Yanaiharaauthor=K.+Yamadaauthor=O.+Takikawaauthor=R.+Kawaguchiauthor=S.+Isonishiauthor=T.+Tanakaauthor=M.+Urashima&title=Indoleamine+2%2C3-dioxygenase+serves+as+a+marker+of+poor+prognosis+in+gene+expression+profiles+of+serous+ovarian+cancer+cells&doi=10.1158%2F1078-0432.ccr-04-2671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells</span></div><div class="casAuthors">Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu; Yamada, Kyosuke; Takikawa, Osamu; Kawaguchi, Rie; Isonishi, Seiji; Tanaka, Tadao; Urashima, Mitsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6030-6039</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We aimed to find key mols. assocd. with chemoresistance in ovarian cancer using gene expression profiling as a screening tool.  Exptl. Design: Using two newly established paclitaxel-resistant ovarian cancer cell lines from an original paclitaxel-sensitive cell line and four supersensitive and four refractory surgical ovarian cancer specimens from paclitaxel-based chemotherapy, mols. assocd. with chemoresistance were screened with gene expression profiling arrays contg. 39,000 genes.  We further analyzed 44 genes that showed significantly different expressions between paclitaxel-sensitive samples and paclitaxel-resistant samples with permutation tests, which were common in cell lines and patients' tumors.  Results: Eight of these genes showed reproducible results with real-time reverse transcription-PCR, of which indoleamine 2,3-dioxygenase gene expression was the most prominent and consistent.  Moreover, by immunohistochem. anal. using a total of 24 serous-type ovarian cancer surgical specimens (stage III, n = 21; stage IV, n = 7), excluding samples used for GeneChip anal., the Kaplan-Meier survival curve showed a clear relationship between indoleamine 2,3-dioxygenase staining patterns and overall survival (log-rank test, P = 0.0001).  All patients classified as neg. survived without relapse.  The 50% survival of patients classified as sporadic, focal, and diffuse was 41, 17, and 11 mo, resp.  Conclusion: The indoleamine 2,3-dioxygenase screened with the GeneChip was pos. assocd. with paclitaxel resistance and with impaired survival in patients with serous-type ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKy6bi9608B7Vg90H21EOLACvtfcHk0lhiR0vAMu_fSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D&md5=b8b8784e723cd5c337cec2c4e159d865</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-04-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-04-2671%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DYanaihara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKawaguchi%26aufirst%3DR.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520serves%2520as%2520a%2520marker%2520of%2520poor%2520prognosis%2520in%2520gene%2520expression%2520profiles%2520of%2520serous%2520ovarian%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6030%26epage%3D6039%26doi%3D10.1158%2F1078-0432.ccr-04-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brandacher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perathoner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladurner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obrist, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner-Felmayer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margreiter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Königsrainer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amberger, A.</span></span> <span> </span><span class="NLM_article-title">Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-05-1966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.ccr-05-1966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16489067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1144-1151&author=G.+Brandacherauthor=A.+Perathonerauthor=R.+Ladurnerauthor=S.+Schneebergerauthor=P.+Obristauthor=C.+Winklerauthor=E.+R.+Wernerauthor=G.+Werner-Felmayerauthor=H.+G.+Weissauthor=G.+G%C3%B6belauthor=R.+Margreiterauthor=A.+K%C3%B6nigsrainerauthor=D.+Fuchsauthor=A.+Amberger&title=Prognostic+value+of+indoleamine+2%2C3-dioxygenase+expression+in+colorectal+cancer%3A+effect+on+tumor-infiltrating+T+cells&doi=10.1158%2F1078-0432.ccr-05-1966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span></div><div class="casAuthors">Brandacher, Gerald; Perathoner, Alexander; Ladurner, Ruth; Schneeberger, Stefan; Obrist, Peter; Winkler, Christiana; Werner, Ernst R.; Werner-Felmayer, Gabriele; Weiss, Helmut G.; Goebel, Georg; Margreiter, Raimund; Koenigsrainer, Alfred; Fuchs, Dietmar; Amberger, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1144-1151</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pathol. interactions between tumor and host immune cells within the tumor microenvironment create an immunosuppressive network that promotes tumor growth and protects the tumor from immune attack.  In this study, we examd. the contribution of the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) on this phenomenon.  Exptl. Design: Expression of IDO was analyzed in colorectal cancer cell lines by reverse transcription-PCR and functional enzyme activity was assessed by high-pressure liq. chromatog.  Semiquant. immunohistochem. was used to evaluate IDO expression in the tissue samples of 143 patients with colorectal carcinoma, and was then correlated with the no. of tumor-infiltrating T cells and clin. variables.  RESULTS: In vitro IDO expression and functional enzyme activity in colorectal cancer cells was found to be strictly dependent on IFN-γ stimulation.  Immunohistochem. scores revealed IDO-high expression in 56 of 143 (39.2%) tumor specimens, whereas 87 of 143 (60.8%) cases showed low IDO expression levels.  IDO-high expression was assocd. with a significant redn. of CD3+ infiltrating T cells (46.02 ± 7.25) as compared with tissue samples expressing low IDO (19.42 ± 2.50; P = 0.0003).  Furthermore, IDO-high immunoreactivity significantly correlated with the frequency of liver metastases (P = 0.003).  Kaplan-Meier anal. showed the crossing of survival curves at 45 mo.  By multivariate Cox's anal., IDO-high expression emerged as an independent prognostic variable (<45 mo, P = 0.006; >45 mo, P = 0.04).  CONCLUSION: IDO-high expression by colorectal tumor cells enables certain cancer subsets to initially avoid immune attack and defeat the invasion of T cells via local tryptophan depletion and the prodn. of proapoptotic tryptophan catabolites.  Thus, IDO significantly contributes to disease progression and overall survival in patients with colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuBdys9PLf7Vg90H21EOLACvtfcHk0lhiR0vAMu_fSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D&md5=623837bb245e71dd4fe137e790ddbfe9</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-05-1966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-05-1966%26sid%3Dliteratum%253Aachs%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DPerathoner%26aufirst%3DA.%26aulast%3DLadurner%26aufirst%3DR.%26aulast%3DSchneeberger%26aufirst%3DS.%26aulast%3DObrist%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DWerner%26aufirst%3DE.%2BR.%26aulast%3DWerner-Felmayer%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DH.%2BG.%26aulast%3DG%25C3%25B6bel%26aufirst%3DG.%26aulast%3DMargreiter%26aufirst%3DR.%26aulast%3DK%25C3%25B6nigsrainer%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DAmberger%26aufirst%3DA.%26atitle%3DPrognostic%2520value%2520of%2520indoleamine%25202%252C3-dioxygenase%2520expression%2520in%2520colorectal%2520cancer%253A%2520effect%2520on%2520tumor-infiltrating%2520T%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1144%26epage%3D1151%26doi%3D10.1158%2F1078-0432.ccr-05-1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen-Mersh, T. G.</span></span> <span> </span><span class="NLM_article-title">Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6600336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fsj.bjc.6600336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=12087451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=1691-1696&author=A.+Huangauthor=D.+Fuchsauthor=B.+Widnerauthor=C.+Gloverauthor=D.+C.+Hendersonauthor=T.+G.+Allen-Mersh&title=Serum+tryptophan+decrease+correlates+with+immune+activation+and+impaired+quality+of+life+in+colorectal+cancer&doi=10.1038%2Fsj.bjc.6600336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer</span></div><div class="casAuthors">Huang, A.; Fuchs, D.; Widner, B.; Glover, C.; Henderson, D. C.; Allen-Mersh, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1696</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer-related indoleamine (2,3)-dioxygenase up-regulation by interferon-γ might influence quality of life by depleting serum tryptophan.  The authors correlated serum tryptophan levels with immune activation and quality of life in patients with colorectal liver metastases.  Venous blood was sampled from patients with primary colorectal cancer and from patients with metachronous colorectal liver metastases who completed quality of life and psychol. questionnaires.  Serum tryptophan, kynurenine, neopterin, interleukin 2 sol. receptor α (IL-2 sRα), sol. tumor necrosis factor receptor I (sTNF RI), interleukin 6, and C-reactive protein were measured.  Liver metastasis vol. was estd. by computerized tomog., and survival from blood sampling was noted.  Sixty-six patients with colorectal cancer were studied (39 males; median age 66 yr) of whom 25 had colorectal liver metastases only (17 males; median age 62 yr; median liver metastasis vol. 208 mL; median survival 234 days).  Reduced serum tryptophan was significantly assocd. with Rotterdam Symptom Checklist phys. symptom (r=-0.51) and Sickness Impact Profile (r=-0.42) scores, and correlated with increased serum neopterin (r=-0.36), IL-2 sRα (r=-0.51) and sTNF RI (r=-0.45) levels.  Stepwise regression analyses suggested that serum tryptophan was an independent predictor of Rotterdam Symptom Checklist phys. symptom (regression coeff. -20.78) and Sickness Impact Profile (regression coeff. -109.09) scores.  The results supported a role for interferon-γ-mediated serum tryptophan decrease in cancer-induced quality of life deterioration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPqTqopr5DbVg90H21EOLACvtfcHk0ljz4ZKtuZxBvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVait7c%253D&md5=08fb2ac4be5b357d658dfdaeb7802f22</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600336%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DWidner%26aufirst%3DB.%26aulast%3DGlover%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DD.%2BC.%26aulast%3DAllen-Mersh%26aufirst%3DT.%2BG.%26atitle%3DSerum%2520tryptophan%2520decrease%2520correlates%2520with%2520immune%2520activation%2520and%2520impaired%2520quality%2520of%2520life%2520in%2520colorectal%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D1691%26epage%3D1696%26doi%3D10.1038%2Fsj.bjc.6600336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, F.</span></span> <span> </span><span class="NLM_article-title">Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2317</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-4144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.CCR-07-4144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=18413819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=2310-2317&author=K.+Inoauthor=E.+Yamamotoauthor=K.+Shibataauthor=H.+Kajiyamaauthor=N.+Yoshidaauthor=M.+Terauchiauthor=A.+Nawaauthor=T.+Nagasakaauthor=O.+Takikawaauthor=F.+Kikkawa&title=Inverse+correlation+between+tumoral+indoleamine+2%2C3-dioxygenase+expression+and+tumor-infiltrating+lymphocytes+in+endometrial+cancer%3A+its+association+with+disease+progression+and+survival&doi=10.1158%2F1078-0432.ccr-07-4144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival</span></div><div class="casAuthors">Ino, Kazuhiko; Yamamoto, Eiko; Shibata, Kiyosumi; Kajiyama, Hiroaki; Yoshida, Norio; Terauchi, Mikio; Nawa, Akihiro; Nagasaka, Tetsuro; Takikawa, Osamu; Kikkawa, Fumitaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2310-2317</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Tumor escape from host immune systems is a crucial mechanism for disease progression.  We recently showed that the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO) is a prognostic indicator for endometrial cancer.  The purpose of the present study was to investigate the relationship between IDO expression and tumor-infiltrating lymphocytes (TIL) or natural killer (NK) cells and to clarify their prognostic effect in endometrial cancer.  Exptl. Design: Immunohistochem. staining for IDO expression in endometrial cancer tissues (n = 65) was done.  Tumor-infiltrating CD3+ and CD8+ lymphocytes, as well as CD57+ NK cells, were counted in serial tissue sections.  RESULTS: High IDO expression in tumor cells was found in 32 of 65 cases and was pos. correlated with myometrial invasion, nodal metastasis, and lymph-vascular space involvement.  We also found a significant correlation between high IDO expression and reduced nos. of CD3+, CD8+, and CD57+ cells infiltrating into both the tumor epithelium and stroma.  Patients with high IDO expression, a low no. of stromal CD3 (<60), low intraepithelial CD8 (<25), or low stromal CD8 (<40) had significantly impaired progression-free survival.  On multivariate anal., IDO expression and the no. of stromal CD3+ TILs were independent prognostic factors for impaired progression-free survival.  CONCLUSIONS: Tumoral IDO expression correlated with a reduced no. of TILs and NK cells in endometrial cancer, possibly contributing to disease progression and impaired clin. outcome.  These findings suggest that targeting IDO to restore host antitumor immunity may be a therapeutic strategy for endometrial cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZtHpmlR407Vg90H21EOLACvtfcHk0ljz4ZKtuZxBvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFGmtL0%253D&md5=6baa8848c1ba82c24fd749f907c4acef</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4144%26sid%3Dliteratum%253Aachs%26aulast%3DIno%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DM.%26aulast%3DNawa%26aufirst%3DA.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKikkawa%26aufirst%3DF.%26atitle%3DInverse%2520correlation%2520between%2520tumoral%2520indoleamine%25202%252C3-dioxygenase%2520expression%2520and%2520tumor-infiltrating%2520lymphocytes%2520in%2520endometrial%2520cancer%253A%2520its%2520association%2520with%2520disease%2520progression%2520and%2520survival%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D2310%26epage%3D2317%26doi%3D10.1158%2F1078-0432.ccr-07-4144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidokoro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, F.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6603477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fsj.bjc.6603477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17117179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cntr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1555-1561&author=K.+Inoauthor=N.+Yoshidaauthor=H.+Kajiyamaauthor=K.+Shibataauthor=E.+Yamamotoauthor=K.+Kidokoroauthor=N.+Takahashiauthor=M.+Terauchiauthor=A.+Nawaauthor=S.+Nomuraauthor=T.+Nagasakaauthor=O.+Takikawaauthor=F.+Kikkawa&title=Indoleamine+2%2C3-dioxygenase+is+a+novel+prognostic+indicator+for+endometrial+cancer&doi=10.1038%2Fsj.bjc.6603477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer</span></div><div class="casAuthors">Ino, K.; Yoshida, N.; Kajiyama, H.; Shibata, K.; Yamamoto, E.; Kidokoro, K.; Takahashi, N.; Terauchi, M.; Nawa, A.; Nomura, S.; Nagasaka, T.; Takikawa, O.; Kikkawa, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-1561</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolizing enzyme inducing immune tolerance.  The present study aimed to investigate IDO expression and its prognostic significance in endometrial cancer.  Indoleamine 2,3-dioxygenase expression in endometrial cancer tissues (n=80) was immunohistochem. scored as four groups (IDO-, 1+, 2+, and 3+).  The high IDO expression (IDO2+ or 3+) in tumor cells was found in 37 (46.3%) of the 80 cases, and was pos. correlated with surgical stage, myometrial invasion, lymph-vascular space involvement, and lymph node metastasis, but not with the histol. grade.  Patients with high IDO expression had significantly impaired overall survival and progression-free survival (PFS) (P=0.002 and P=0.001, resp.) compared to patients with no or weak expression of IDO (IDO- or 1+).  The 5-yr PFS for IDO-/1+, 2+, and 3+ were 97.7, 72.9, and 36.4%, resp.  Even in patients with early-stage disease (International Federation of Gynecol. and Obstetrics I/II, n=64), the PFS for IDO2+/3+ was significantly poor (P=0.001) compared to that for IDO-/1+.  On multivariate anal., IDO expression was an independent prognostic factor for PFS (P=0.020).  These results indicated that the high IDO expression was involved in the progression of endometrial cancer and correlated with the impaired clin. outcome, suggesting that IDO is a novel and reliable prognostic indicator for endometrial cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUeJItF1I2LVg90H21EOLACvtfcHk0ljz4ZKtuZxBvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cntr3F&md5=eb86788d5aad3ff319d03439b617022c</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603477%26sid%3Dliteratum%253Aachs%26aulast%3DIno%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DE.%26aulast%3DKidokoro%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DM.%26aulast%3DNawa%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKikkawa%26aufirst%3DF.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520a%2520novel%2520prognostic%2520indicator%2520for%2520endometrial%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D95%26spage%3D1555%26epage%3D1561%26doi%3D10.1038%2Fsj.bjc.6603477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brant, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin-Tindall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohnig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span> <span> </span><span class="NLM_article-title">Identification of potent indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors based on a phenylimidazole scaffold</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00488</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00488" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=131-136&author=M.+G.+Brantauthor=J.+Goodwin-Tindallauthor=K.+R.+Stoverauthor=P.+M.+Staffordauthor=F.+Wuauthor=A.+R.+Meekauthor=P.+Schiaviniauthor=S.+Wohnigauthor=D.+F.+Weaver&title=Identification+of+potent+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitors+based+on+a+phenylimidazole+scaffold&doi=10.1021%2Facsmedchemlett.7b00488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold</span></div><div class="casAuthors">Brant, Michael G.; Goodwin-Tindall, Jake; Stover, Kurt R.; Stafford, Paul M.; Wu, Fan; Meek, Autumn R.; Schiavini, Paolo; Wohnig, Stephanie; Weaver, Donald F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-136</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of indoleamine 2,3-dioxygenase (IDO1) is an attractive immunotherapeutic approach for the treatment of a variety of cancers.  Dysregulation of this enzyme has also been implicated in other disorders including Alzheimer's disease and arthritis.  Herein, the authors report the structure-based design of two related series of mols.: N1-substituted 5-indoleimidazoles and N1-substituted 5-phenylimidazoles.  The latter (and more potent) series was accessed through an unexpected rearrangement of an imine intermediate during a Van Leusen imidazole synthesis reaction.  Evidence for the binding modes for both inhibitor series is supported by computational and structure-activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjv6cCPCyqrVg90H21EOLACvtfcHk0lg056CpwisJJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gsg%253D%253D&md5=f83e9d7dce45932e5f94818cebd2b3c8</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00488%26sid%3Dliteratum%253Aachs%26aulast%3DBrant%26aufirst%3DM.%2BG.%26aulast%3DGoodwin-Tindall%26aufirst%3DJ.%26aulast%3DStover%26aufirst%3DK.%2BR.%26aulast%3DStafford%26aufirst%3DP.%2BM.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DMeek%26aufirst%3DA.%2BR.%26aulast%3DSchiavini%26aufirst%3DP.%26aulast%3DWohnig%26aufirst%3DS.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26atitle%3DIdentification%2520of%2520potent%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitors%2520based%2520on%2520a%2520phenylimidazole%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D131%26epage%3D136%26doi%3D10.1021%2Facsmedchemlett.7b00488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crosignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannelle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwenberghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordonnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Négrerie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eynde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel and selective indoleamine 2,3-dioxygenase (IDO-1) inhibitor 3-(5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and its characterization as a potential clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9617</span>– <span class="NLM_lpage">9629</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9617-9629&author=S.+Crosignaniauthor=P.+Binghamauthor=P.+Bottemanneauthor=H.+Cannelleauthor=S.+Cauwenberghsauthor=M.+Cordonnierauthor=D.+Dalvieauthor=F.+Derooseauthor=J.+L.+Fengauthor=B.+Gomesauthor=S.+Greasleyauthor=S.+E.+Kaiserauthor=M.+Krausauthor=M.+N%C3%A9grerieauthor=K.+Maegleyauthor=N.+Millerauthor=B.+W.+Murrayauthor=M.+Schneiderauthor=J.+Soloweijauthor=A.+E.+Stewartauthor=J.+Tumangauthor=V.+R.+Tortiauthor=B.+Van+Den+Eyndeauthor=M.+Wythes&title=Discovery+of+a+novel+and+selective+indoleamine+2%2C3-dioxygenase+%28IDO-1%29+inhibitor+3-%285-fluoro-1H-indol-3-yl%29pyrrolidine-2%2C5-dione+%28EOS200271%2FPF-06840003%29+and+its+characterization+as+a+potential+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate</span></div><div class="casAuthors">Crosignani, Stefano; Bingham, Patrick; Bottemanne, Pauline; Cannelle, Helene; Cauwenberghs, Sandra; Cordonnier, Marie; Dalvie, Deepak; Deroose, Frederik; Feng, Jun Li; Gomes, Bruno; Greasley, Samantha; Kaiser, Stephen E.; Kraus, Manfred; Negrerie, Michel; Maegley, Karen; Miller, Nichol; Murray, Brion W.; Schneider, Manfred; Soloweij, James; Stewart, Albert E.; Tumang, Joseph; Torti, Vince R.; Van Den Eynde, Benoit; Wythes, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9617-9629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment.  IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function.  As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncol.  Starting from HTS hit I, IDO-1 inhibitor II has been developed.  The structure-activity relationship around II is described and rationalized using the x-ray crystal structure of II bound to human IDO-1, which shows that II, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode.  Clin. candidate II shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16-19 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfHmZRAC-dLVg90H21EOLACvtfcHk0lg056CpwisJJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK&md5=dc2e45c243aa22c100ccc39db9b5918a</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00974%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DCannelle%26aufirst%3DH.%26aulast%3DCauwenberghs%26aufirst%3DS.%26aulast%3DCordonnier%26aufirst%3DM.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeroose%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DS.%2BE.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DN%25C3%25A9grerie%26aufirst%3DM.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSoloweij%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTumang%26aufirst%3DJ.%26aulast%3DTorti%26aufirst%3DV.%2BR.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%26aulast%3DWythes%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO-1%2529%2520inhibitor%25203-%25285-fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2520%2528EOS200271%252FPF-06840003%2529%2520and%2520its%2520characterization%2520as%2520a%2520potential%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9617%26epage%3D9629%26doi%3D10.1021%2Facs.jmedchem.7b00974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takvorian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bower, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansbury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span></span> <span> </span><span class="NLM_article-title">INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immuno-oncology</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00391</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00391" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Gqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=486-491&author=E.%0AW.+Yueauthor=R.+Sparksauthor=P.+Polamauthor=D.+Modiauthor=B.+Doutyauthor=B.+Waylandauthor=B.+Glassauthor=A.+Takvorianauthor=J.+Glennauthor=W.+Zhuauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=T.+Emmauthor=P.+A.+Scherleauthor=B.+Metcalfauthor=A.+P.+Combs&title=INCB24360+%28Epacadostat%29%2C+a+highly+potent+and+selective+indoleamine-2%2C3-dioxygenase+1+%28IDO1%29+inhibitor+for+immuno-oncology&doi=10.1021%2Facsmedchemlett.6b00391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology</span></div><div class="casAuthors">Yue, Eddy W.; Sparks, Richard; Polam, Padmaja; Modi, Dilip; Douty, Brent; Wayland, Brian; Glass, Brian; Takvorian, Amy; Glenn, Joseph; Zhu, Wenyu; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Emm, Tom; Scherle, Peggy A.; Metcalf, Brian; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">486-491</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A data-centric medicinal chem. approach led to the invention of a potent and selective IDO1 inhibitor 4f, INCB24360 (epacadostat).  The mol. structure of INCB24360 contains several previously unknown or underutilized functional groups in drug substances, including a hydroxyamidine, furazan, bromide and sulfamide.  These moieties taken together in a single structure afford a compd. which falls outside of "drug-like" space.  Nevertheless, the in vitro ADME data is consistent with the good cell permeability and oral bioavailability obsd. in all species (rat, dog, monkey) tested.  The extensive intramol. hydrogen bonding obsd. in the small mol. crystal structure of 4f is believed to significantly contribute to the obsd. permeability and PK.  Epacadostat in combination with anti-PD1 mAb pembrolizumab is currently being studied in a phase 3 clin. trial in patients with unresectable or metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpm79ArpY1yLVg90H21EOLACvtfcHk0lhF42eRj94KbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Gqsb0%253D&md5=92bebde519334e9e2a776250bb0258ac</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00391%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DSparks%26aufirst%3DR.%26aulast%3DPolam%26aufirst%3DP.%26aulast%3DModi%26aufirst%3DD.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DGlass%26aufirst%3DB.%26aulast%3DTakvorian%26aufirst%3DA.%26aulast%3DGlenn%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DEmm%26aufirst%3DT.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DINCB24360%2520%2528Epacadostat%2529%252C%2520a%2520highly%2520potent%2520and%2520selective%2520indoleamine-2%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitor%2520for%2520immuno-oncology%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D486%26epage%3D491%26doi%3D10.1021%2Facsmedchemlett.6b00391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passacantilli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famiglini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patsilinakos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoccoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisinni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regina, G.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of indoleamine 2,3-dioxygenase 1: molecular modeling studies, synthesis, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9760</span>– <span class="NLM_lpage">9773</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9760-9773&author=A.+Colucciaauthor=S.+Passacantilliauthor=V.+Famigliniauthor=M.+Sabatinoauthor=A.+Patsilinakosauthor=R.+Ragnoauthor=C.+Mazzoccoliauthor=L.+Sisinniauthor=A.+Okunoauthor=O.+Takikawaauthor=R.+Silvestriauthor=G.+Regina&title=New+inhibitors+of+indoleamine+2%2C3-dioxygenase+1%3A+molecular+modeling+studies%2C+synthesis%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.6b00718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation</span></div><div class="casAuthors">Coluccia, Antonio; Passacantilli, Sara; Famiglini, Valeria; Sabatino, Manuela; Patsilinakos, Alexandros; Ragno, Rino; Mazzoccoli, Carmela; Sisinni, Lorenza; Okuno, Alato; Takikawa, Osamu; Silvestri, Romano; La Regina, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9760-9773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1) is an attractive target for anticancer therapy.  Herein, we report a virtual screening study which led to the identification of compd. I as a new IDO1 inhibitor.  In order to improve the biol. activity of the identified hit, arylthioindoles were synthesized and tested.  Among these, deriv. II exhibited an IC50 value of 7 μM, being the most active compd. of the series.  Furthermore, compds. I and II induced a dose-dependent growth inhibition in IDO1 expressing cancer cell lines HTC116 and HT29.  3-D QSAR studies were carried out in order to rationalize obtained results and suggest new chem. modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfHwAbMNZXrVg90H21EOLACvtfcHk0lhF42eRj94KbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtL7I&md5=9a1267db6fdeadfbbb693464ba4dddd6</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00718%26sid%3Dliteratum%253Aachs%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DPassacantilli%26aufirst%3DS.%26aulast%3DFamiglini%26aufirst%3DV.%26aulast%3DSabatino%26aufirst%3DM.%26aulast%3DPatsilinakos%26aufirst%3DA.%26aulast%3DRagno%26aufirst%3DR.%26aulast%3DMazzoccoli%26aufirst%3DC.%26aulast%3DSisinni%26aufirst%3DL.%26aulast%3DOkuno%26aufirst%3DA.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DRegina%26aufirst%3DG.%26atitle%3DNew%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%25201%253A%2520molecular%2520modeling%2520studies%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9760%26epage%3D9773%26doi%3D10.1021%2Facs.jmedchem.6b00718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La Regina, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S.-H.</span></span> <span> </span><span class="NLM_article-title">Phenyl benzenesulfonylhydrazides exhibit selective indoleamine 2,3-dioxygenase inhibition with potent <i>in vivo</i> pharmacodynamic activity and antitumor efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01640</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01640" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=419-430&author=S.-Y.+La+Reginaauthor=T.-K.+Yehauthor=C.-C.+Kuoauthor=J.-S.+Songauthor=M.-F.+Chengauthor=F.-Y.+Liaoauthor=M.-W.+Chaoauthor=H.-L.+Huangauthor=Y.-L.+Chenauthor=C.-Y.+Yangauthor=M.-H.+Wuauthor=C.-L.+Hsiehauthor=W.+Hsiaoauthor=Y.-H.+Pengauthor=J.-S.+Wuauthor=L.-M.+Linauthor=M.+Sunauthor=Y.-S.+Chaoauthor=C.+Shihauthor=S.-Y.+Wuauthor=S.-L.+Panauthor=M.-S.+Hungauthor=S.-H.+Ueng&title=Phenyl+benzenesulfonylhydrazides+exhibit+selective+indoleamine+2%2C3-dioxygenase+inhibition+with+potent+in+vivo+pharmacodynamic+activity+and+antitumor+efficacy&doi=10.1021%2Facs.jmedchem.5b01640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01640%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BRegina%26aufirst%3DS.-Y.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DKuo%26aufirst%3DC.-C.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DCheng%26aufirst%3DM.-F.%26aulast%3DLiao%26aufirst%3DF.-Y.%26aulast%3DChao%26aufirst%3DM.-W.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DWu%26aufirst%3DM.-H.%26aulast%3DHsieh%26aufirst%3DC.-L.%26aulast%3DHsiao%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DY.-H.%26aulast%3DWu%26aufirst%3DJ.-S.%26aulast%3DLin%26aufirst%3DL.-M.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DChao%26aufirst%3DY.-S.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DS.-Y.%26aulast%3DPan%26aufirst%3DS.-L.%26aulast%3DHung%26aufirst%3DM.-S.%26aulast%3DUeng%26aufirst%3DS.-H.%26atitle%3DPhenyl%2520benzenesulfonylhydrazides%2520exhibit%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520inhibition%2520with%2520potent%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520antitumor%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D419%26epage%3D430%26doi%3D10.1021%2Facs.jmedchem.5b01640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dounay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8762</span>– <span class="NLM_lpage">8782</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00461</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8762-8782&author=A.+B.+Dounayauthor=J.+B.+Tuttleauthor=P.+R.+Verhoest&title=Challenges+and+opportunities+in+the+discovery+of+new+therapeutics+targeting+the+kynurenine+pathway&doi=10.1021%2Facs.jmedchem.5b00461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway</span></div><div class="casAuthors">Dounay, Amy B.; Tuttle, Jamison B.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8762-8782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The kynurenine pathway is responsible for the metab. of more than 95% of dietary tryptophan (TRP) and produces numerous bioactive metabolites.  Recent studies have focused on three enzymes in this pathway: indoleamine dioxygenase (IDO1), kynurenine monooxygenase (KMO), and kynurenine aminotransferase II (KAT II).  IDO1 inhibitors are currently in clin. trials for the treatment of cancer, and these agents may also have therapeutic utility in neurol. disorders, including multiple sclerosis.  KMO inhibitors are being investigated as potential treatments for neurodegenerative diseases, such as Huntington's and Alzheimer's diseases.  KAT II inhibitors have been proposed in new therapeutic approaches toward psychiatric and cognitive disorders, including cognitive impairment assocd. with schizophrenia.  Numerous medicinal chem. studies are currently aimed at the design of novel, potent, and selective inhibitors for each of these enzymes.  The emerging opportunities and significant challenges assocd. with pharmacol. modulation of these enzymes will be explored in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNTjn9vtU54bVg90H21EOLACvtfcHk0lhpa3eNASCTnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FJ&md5=8d2bcd65935fc25ae013559e583c144e</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00461%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DChallenges%2520and%2520opportunities%2520in%2520the%2520discovery%2520of%2520new%2520therapeutics%2520targeting%2520the%2520kynurenine%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8762%26epage%3D8782%26doi%3D10.1021%2Facs.jmedchem.5b00461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in lewis lung cancer (LLC) tumor-bearing mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8321</span>– <span class="NLM_lpage">8331</span>, <span class="refDoi"> DOI: 10.1021/jm401195n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401195n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8321-8331&author=S.+Yangauthor=X.+Liauthor=F.+Huauthor=Y.+Liauthor=Y.+Yangauthor=J.+Yanauthor=C.+Kuangauthor=Q.+Yang&title=Discovery+of+tryptanthrin+derivatives+as+potent+inhibitors+of+indoleamine+2%2C3-dioxygenase+with+therapeutic+activity+in+lewis+lung+cancer+%28LLC%29+tumor-bearing+mice&doi=10.1021%2Fjm401195n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tryptanthrin Derivatives as Potent Inhibitors of Indoleamine 2,3-Dioxygenase with Therapeutic Activity in Lewis Lung Cancer (LLC) Tumor-Bearing Mice</span></div><div class="casAuthors">Yang, Shuangshuang; Li, Xishuai; Hu, Fangfang; Li, Yinlong; Yang, Yunyun; Yan, Junkai; Kuang, Chunxiang; Yang, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8321-8331</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO-1) is emerging as an important new therapeutic target for the treatment of cancer, neurol. disorders, and other diseases that are characterized by pathol. tryptophan metab.  However, only a few structural classes are known to be IDO-1 inhibitors.  In this study, a natural compd. tryptanthrin was discovered to be a novel potent IDO-1 inhibitor by screening of indole-based structures.  Three series of 13 tryptanthrin derivs. were synthesized, and the structure-activity anal. was undertaken.  The optimization led to the identification of 5c, which exhibited the inhibitory activity at a nanomolar level.  In vitro 5c dramatically augmented the proliferation of T cells.  When administered to Lewis lung cancer (LLC) tumor-bearing mice, 5c significantly inhibited IDO-1 activity and suppressed tumor growth.  In addn., 5c reduced the nos. of Foxp3+ regulatory T cells (Tregs), which are known to prevent the development of efficient antitumor immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ioPL3rWy1bVg90H21EOLACvtfcHk0lhpa3eNASCTnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynsrjL&md5=ac744f81ce97b0435f2bfd240e1393a1</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Fjm401195n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401195n%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520tryptanthrin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520with%2520therapeutic%2520activity%2520in%2520lewis%2520lung%2520cancer%2520%2528LLC%2529%2520tumor-bearing%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8321%26epage%3D8331%26doi%3D10.1021%2Fjm401195n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasceri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Aminophenoxazinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis of exfoliazone and chandrananimycin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3310</span>– <span class="NLM_lpage">3317</span>, <span class="refDoi"> DOI: 10.1021/jm400049z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400049z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFSru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3310-3317&author=R.+Pasceriauthor=D.+Siegelauthor=D.+Rossauthor=C.+J.+Moody&title=Aminophenoxazinones+as+inhibitors+of+indoleamine+2%2C3-dioxygenase+%28IDO%29.+Synthesis+of+exfoliazone+and+chandrananimycin+A&doi=10.1021%2Fjm400049z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">Aminophenoxazinones as Inhibitors of Indoleamine 2,3-Dioxygenase (IDO). Synthesis of Exfoliazone and Chandrananimycin A</span></div><div class="casAuthors">Pasceri, Raffaele; Siegel, David; Ross, David; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3310-3317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of 2-aminophenoxazin-3-ones has been prepd. by oxidative cyclocondensation of 2-aminophenols, including the natural products exfoliazone (I) and chandrananimycin A (II), both synthesized for the first time.  The compds. were evaluated for their ability to inhibit indoleamine 2,3-dioxygenase.  Compds. contg. addnl. electron-withdrawing carboxylate groups, such as cinnabarinic acid, showed modest inhibitory activity with a dose response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE1AFH8y_k1LVg90H21EOLACvtfcHk0lhpa3eNASCTnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFSru7s%253D&md5=6498cacf5e76b962baa7222677bcf407</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Fjm400049z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400049z%26sid%3Dliteratum%253Aachs%26aulast%3DPasceri%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DAminophenoxazinones%2520as%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529.%2520Synthesis%2520of%2520exfoliazone%2520and%2520chandrananimycin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3310%26epage%3D3317%26doi%3D10.1021%2Fjm400049z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Röhrig, U. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majjigapu, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Eynde, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5270</span>– <span class="NLM_lpage">5290</span>, <span class="refDoi"> DOI: 10.1021/jm300260v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300260v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5270-5290&author=U.+F.+R%C3%B6hrigauthor=S.+R.+Majjigapuauthor=A.+Grosdidierauthor=S.+Bronauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=P.+Vogelauthor=B.+J.+Van+den%0AEyndeauthor=V.+Zoeteauthor=O.+Michielin&title=Rational+design+of+4-aryl-1%2C2%2C3-triazoles+for+indoleamine+2%2C3-dioxygenase+1+inhibition&doi=10.1021%2Fjm300260v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition</span></div><div class="casAuthors">Rohrig, Ute F.; Majjigapu, Somi Reddy; Grosdidier, Aurelien; Bron, Sylvian; Stroobant, Vincent; Pilotte, Luc; Colau, Didier; Vogel, Pierre; Van den Eynde, Benoit J.; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5270-5290</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target for the treatment of diseases such as cancer that involve pathol. immune escape.  Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands.  This approach yielded highly efficient low mol. wt. inhibitors, the most active being of nanomolar potency both in an enzymic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO).  A quant. structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chem. derived charges of the triazole ring demonstrated a good explanatory power for the obsd. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CFYZnWiLSLVg90H21EOLACvtfcHk0ljd3pLr1jhmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yiu7c%253D&md5=6ba6c0b628165673cd49c7a950ed885e</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1021%2Fjm300260v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300260v%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DBron%26aufirst%3DS.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DRational%2520design%2520of%25204-aryl-1%252C2%252C3-triazoles%2520for%2520indoleamine%25202%252C3-dioxygenase%25201%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5270%26epage%3D5290%26doi%3D10.1021%2Fjm300260v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Röhrig, U. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerundolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, A. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eynde, B. J. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Rational design of indoleamine 2,3-dioxygenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1172</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1021/jm9014718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9014718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1172-1189&author=U.+F.+R%C3%B6hrigauthor=L.+Awadauthor=A.+Grosdidierauthor=P.+Larrieuauthor=V.+Stroobantauthor=D.+Colauauthor=V.+Cerundoloauthor=A.+J.+G.+Simpsonauthor=P.+Vogelauthor=B.+J.+V.+D.+Eyndeauthor=V.+Zoeteauthor=O.+Michielin&title=Rational+design+of+indoleamine+2%2C3-dioxygenase+inhibitors&doi=10.1021%2Fjm9014718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9jR"><div class="casContent"><span class="casTitleNuber">9j</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors</span></div><div class="casAuthors">Rohrig, Ute F.; Awad, Loay; Grosdidier, Aurelien; Larrieu, Pierre; Stroobant, Vincent; Colau, Didier; Cerundolo, Vincenzo; Simpson, Andrew J. G.; Vogel, Pierre; Van den Eynde, Benoit J.; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1172-1189</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is an important therapeutic target for the treatment of diseases such as cancer that involve pathol. immune escape.  We have used the evolutionary docking algorithm EADock to design new inhibitors of this enzyme.  First, we investigated the modes of binding of all known IDO inhibitors.  On the basis of the obsd. docked conformations, we developed a pharmacophore model, which was then used to devise new compds. to be tested for IDO inhibition.  We also used a fragment-based approach to design and to optimize small org. mol. inhibitors.  Both approaches yielded several new low-mol. wt. inhibitor scaffolds, the most active being of nanomolar potency in an enzymic assay.  Cellular assays confirmed the potential biol. relevance of four different scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9k4hgz-V8J7Vg90H21EOLACvtfcHk0ljd3pLr1jhmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1emsA%253D%253D&md5=be50f3dff0bcee6ae59f19d2fc4e5552</span></div><a href="/servlet/linkout?suffix=cit9j&amp;dbid=16384&amp;doi=10.1021%2Fjm9014718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014718%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DAwad%26aufirst%3DL.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DCerundolo%26aufirst%3DV.%26aulast%3DSimpson%26aufirst%3DA.%2BJ.%2BG.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DEynde%26aufirst%3DB.%2BJ.%2BV.%2BD.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DRational%2520design%2520of%2520indoleamine%25202%252C3-dioxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1172%26epage%3D1189%26doi%3D10.1021%2Fjm9014718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bower, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansbury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7364</span>– <span class="NLM_lpage">7367</span>, <span class="refDoi"> DOI: 10.1021/jm900518f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900518f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7364-7367&author=E.+W.+Yueauthor=B.+Doutyauthor=B.+Waylandauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=C.+Liuauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=B.+Metcalfauthor=P.+A.+Scherleauthor=A.+P.+Combs&title=Discovery+of+potent+competitive+inhibitors+of+indoleamine+2%2C3-dioxygenase+with+in+vivo+pharmacodynamic+activity+and+efficacy+in+a+mouse+melanoma+model&doi=10.1021%2Fjm900518f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9kR"><div class="casContent"><span class="casTitleNuber">9k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model</span></div><div class="casAuthors">Yue, Eddy W.; Douty, Brent; Wayland, Brian; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Liu, Changnian; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Metcalf, Brian; Scherle, Peggy A.; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7364-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydroxyamidine chemotype has been discovered as a key pharmacophore in novel inhibitors of indoleamine 2,3-dioxygenase (IDO).  Optimization led to the identification of (I), which is a potent (HeLa IC50 = 19 nM) competitive inhibitor of IDO.  Testing of I in mice demonstrated pharmacodynamic inhibition of IDO, as measured by decreased kynurenine levels (>50%) in plasma and dose dependent efficacy in mice bearing GM-CSF-secreting B16 melanoma tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsq88hx0J77Vg90H21EOLACvtfcHk0ljd3pLr1jhmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D&md5=328d92bffb88a86da030c31eff707dc6</span></div><a href="/servlet/linkout?suffix=cit9k&amp;dbid=16384&amp;doi=10.1021%2Fjm900518f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900518f%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520competitive%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520with%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520efficacy%2520in%2520a%2520mouse%2520melanoma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7364%26epage%3D7367%26doi%3D10.1021%2Fjm900518f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malachowski, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1021/jm7014155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1706-1718&author=S.+Kumarauthor=W.+P.+Malachowskiauthor=J.+B.+DuHadawayauthor=J.+M.+LaLondeauthor=P.+J.+Carrollauthor=D.+Jallerauthor=R.+Metzauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Indoleamine+2%2C3-dioxygenase+is+the+anticancer+target+for+a+novel+series+of+potent+naphthoquinone-based+inhibitors&doi=10.1021%2Fjm7014155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9lR"><div class="casContent"><span class="casTitleNuber">9l</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Is the Anticancer Target for a Novel Series of Potent Naphthoquinone-Based Inhibitors</span></div><div class="casAuthors">Kumar, Sanjeev; Malachowski, William P.; DuHadaway, James B.; LaLonde, Judith M.; Carroll, Patrick J.; Jaller, Daniel; Metz, Richard; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1706-1718</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  While small mol. inhibitors of IDO exist, there remains a dearth of high-potency compds. offering in vivo efficacy and clin. translational potential.  In this study, the authors address this gap by defining a new class of naphthoquinone-based IDO inhibitors exemplified by the natural product menadione, which is shown in mouse tumor models to have similar antitumor activity to previously characterized IDO inhibitors.  Genetic validation that IDO is the crit. in vivo target is demonstrated using IDO-null mice.  Elaboration of menadione to a pyranonaphthoquinone has yielded low nanomolar potency inhibitors, including new compds. which are the most potent reported to date (Ki = 61-70 nM).  Synthetic accessibility of this class will facilitate preclin. chem.-genetic studies as well as further optimization of pharmacol. parameters for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ZM1JKuRtPbVg90H21EOLACvtfcHk0lj4EZds_DcDzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKqtL4%253D&md5=9d3c1bc16796927ab88fc5d6b6ef065a</span></div><a href="/servlet/linkout?suffix=cit9l&amp;dbid=16384&amp;doi=10.1021%2Fjm7014155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014155%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DCarroll%26aufirst%3DP.%2BJ.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DR.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520the%2520anticancer%2520target%2520for%2520a%2520novel%2520series%2520of%2520potent%2520naphthoquinone-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1706%26epage%3D1718%26doi%3D10.1021%2Fjm7014155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, S.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiro, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O<sub>2</sub> incorporation by a heme-containing dioxygenase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2611</span>– <span class="NLM_lpage">2616</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508996103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.0508996103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16477023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2rsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2611-2616&author=H.+Sugimotoauthor=S.-i.+Odaauthor=T.+Otsukiauthor=T.+Hinoauthor=T.+Yoshidaauthor=Y.+Shiro&title=Crystal+structure+of+human+indoleamine+2%2C3-dioxygenase%3A+catalytic+mechanism+of+O2+incorporation+by+a+heme-containing+dioxygenase&doi=10.1073%2Fpnas.0508996103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase</span></div><div class="casAuthors">Sugimoto, Hiroshi; Oda, Shun-ichiro; Otsuki, Takashi; Hino, Tomoya; Yoshida, Tadashi; Shiro, Yoshitsugu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2611-2616</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human indoleamine 2,3-dioxygenase (IDO) catalyzes the cleavage of the pyrrole ring of L-tryptophan and incorporates both atoms of an O2 mol.  Here, the authors report on the x-ray crystal structure of human IDO, complexed with the inhibitors, 4-phenylimidazole and cyanide.  The overall structure of IDO showed 2 α-helical domains with the heme between them.  Residue Ala-264 of the flexible loop on the heme distal side was in close proximity to the Fe.  A mutant anal. showed that none of the polar amino acid residues in the distal heme pocket were essential for activity, suggesting that, unlike the heme-contg. monooxygenases (e.g., peroxidase and cytochrome P 450), no protein group of IDO is essential in O2 activation or proton abstraction.  These characteristics of the IDO structure provided support for a reaction mechanism involving the abstraction of a proton from the substrate by Fe-bound O2.  The inactive mutants (F226A, F227A, and R231A) retained substrate-binding affinity, and an electron d. map revealed that 2-(N-cyclohexylamino)ethanesulfonic acid (CHES), a component of the crystn. buffer, was bound to these residues, mimicking the substrate.  These findings suggest that strict shape complementarities between the indole ring of the substrate and the protein side-chains are required, not for binding, but, rather, to permit the interaction between the substrate and Fe-bound O2 in the 1st step of the reaction.  This study provides the structural basis for a heme-contg. dioxygenase mechanism, a missing piece in the understanding of heme chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdrCQcNUKrrVg90H21EOLACvtfcHk0lj4EZds_DcDzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2rsb4%253D&md5=aaf94d532920b2b855bf6fe1a58dfa92</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508996103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508996103%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DS.-i.%26aulast%3DOtsuki%26aufirst%3DT.%26aulast%3DHino%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DShiro%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520human%2520indoleamine%25202%252C3-dioxygenase%253A%2520catalytic%2520mechanism%2520of%2520O2%2520incorporation%2520by%2520a%2520heme-containing%2520dioxygenase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2611%26epage%3D2616%26doi%3D10.1073%2Fpnas.0508996103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malachowski, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-Dioxygenase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4977</span>, <span class="refDoi"> DOI: 10.1021/jm800512z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800512z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4968-4977&author=S.+Kumarauthor=D.+Jallerauthor=B.+Patelauthor=J.+M.+LaLondeauthor=J.+B.+DuHadawayauthor=W.+P.+Malachowskiauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Structure+based+development+of+phenylimidazole-derived+inhibitors+of+indoleamine+2%2C3-Dioxygenase&doi=10.1021%2Fjm800512z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase</span></div><div class="casAuthors">Kumar, Sanjeev; Jaller, Daniel; Patel, Bhumika; LaLonde, Judith M.; DuHadaway, James B.; Malachowski, William P.; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4968-4977</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  With the goal of developing more potent IDO inhibitors, a systematic study of 4-phenylimidazole (4-PI) derivs. was undertaken.  Computational docking expts. guided design and synthesis efforts with analogs of 4-PI.  In particular, three interactions of 4-PI analogs with IDO were studied: the active site entrance, the interior of the active site, and the heme iron binding.  The three most potent inhibitors I (R = 4-HOC6H4, 3-HSC6H4, 4-HSC6H4) appear to exploit interactions with C129 and S167 in the interior of the active site.  All three inhibitors are approx. 10-fold more potent than 4-PI.  The study represents the first example of enzyme inhibitor development with the recently reported crystal structure of IDO and offers important lessons in the search for more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTIIEf7DjmLVg90H21EOLACvtfcHk0lj4EZds_DcDzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D&md5=6e232cb983d0ba2396bea16060a5b7a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800512z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800512z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DStructure%2520based%2520development%2520of%2520phenylimidazole-derived%2520inhibitors%2520of%2520indoleamine%25202%252C3-Dioxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4968%26epage%3D4977%26doi%3D10.1021%2Fjm800512z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lik6I4bc76xLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Magdalou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel-Gigleux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouzzine, M.</span></span> <span> </span><span class="NLM_article-title">Insights on membrane topology and structure/function of UDP-glucuronosyltransferases</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.3109/03602530903209270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.3109%2F03602530903209270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=19807219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=159-166&author=J.+Magdalouauthor=S.+Fournel-Gigleuxauthor=M.+Ouzzine&title=Insights+on+membrane+topology+and+structure%2Ffunction+of+UDP-glucuronosyltransferases&doi=10.3109%2F03602530903209270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on membrane topology and structure/function of UDP-glucuronosyltransferases</span></div><div class="casAuthors">Magdalou, Jacques; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-166</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The main characteristic of uridine diphosphate (UDP)-glucuronosyltransferases is their potency to glucuronidate a large array of structurally unrelated substances with various nucleophilic groups.  The activity of these enzymes strongly depends on their tight assocn. to the membrane of the endoplasmic reticulum.  In light of recent data, this review is focused on the membrane-assembly process, which is a prerequisite for activity, and on the amino acids that govern substrate recognition and catalysis at the active site.  The major implication of the highly variable N-terminal domain of UDP-glucuronosyltransferases in the substrate specificity of these enzymes is highlighted.  In the absence of crystal data of the N-terminal domain, multidisciplinary approaches of genetic-/protein-engineering techniques, homol. modeling with glycosyltransferases, and quant. structure-activity relationships allowed us to point out crucial amino acids.  On the basis of these results, possible reaction mechanisms for the glucuronidation of xenobiotics, involving histidine and aspartic acid residues, have been built and are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ1jNLDZdQPrVg90H21EOLACvtfcHk0lik6I4bc76xLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFantw%253D%253D&md5=28cae4aa50f41e218d4dd85940389c2a</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.3109%2F03602530903209270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903209270%26sid%3Dliteratum%253Aachs%26aulast%3DMagdalou%26aufirst%3DJ.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26aulast%3DOuzzine%26aufirst%3DM.%26atitle%3DInsights%2520on%2520membrane%2520topology%2520and%2520structure%252Ffunction%2520of%2520UDP-glucuronosyltransferases%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26spage%3D159%26epage%3D166%26doi%3D10.3109%2F03602530903209270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>– <span class="NLM_lpage">6652</span>, <span class="refDoi"> DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup</span></div><div class="casAuthors">Glossop, Paul A.; Lane, Charlotte A. L.; Price, David A.; Bunnage, Mark E.; Lewthwaite, Russell A.; James, Kim; Brown, Alan D.; Yeadon, Michael; Perros-Huguet, Christelle; Trevethick, Michael A.; Clarke, Nicholas P.; Webster, Robert; Jones, Rhys M.; Burrows, Jane L.; Feeder, Neil; Taylor, Stefan C. J.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6640-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of potent and selective sulfonamide derived β2-adrenoreceptor agonists are described that exhibit potential as inhaled ultra-long-acting bronchodilators for the treatment of asthma and chronic obstructive pulmonary disease.  Analogs from this series mediate very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  The sulfonamide agonist headgroup confers high levels of intrinsic crystallinity that could relate to the acidic sulfonamide motif supporting a zwitterionic form in the solid state.  Optimization of pharmacokinetic properties was achieved through targeted introduction of a phenolic moiety to support rapid phase II clearance, thereby minimizing systemic exposure following inhalation and reducing systemically mediated adverse events.  Compd. 38 (PF-610355) is identified as a clin. candidate from this series, with in vivo duration of action studies confirming its potential for once-daily use in humans.  Compd. 38 is currently in advanced phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGaBcfoYeu7Vg90H21EOLACvtfcHk0lik6I4bc76xLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ&md5=34cf266aa0f796ee5ec370369c726f6e</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entwistle, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel tertiary amine muscarinic M3 receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6888</span>– <span class="NLM_lpage">6904</span>, <span class="refDoi"> DOI: 10.1021/jm200884j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200884j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SltbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6888-6904&author=P.%0AA.+Glossopauthor=C.+A.+L.+Watsonauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=D.+S.+Middletonauthor=A.+Woodauthor=K.+Jamesauthor=D.+Robertsauthor=R.+S.+Strangauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=N.+P.+Clarkeauthor=M.+A.+Trevethickauthor=I.+Machinauthor=E.+F.+Stuartauthor=S.+M.+Evansauthor=A.+C.+Harrisonauthor=D.+A.+Fairmanauthor=B.+Agoramauthor=J.+L.+Burrowsauthor=N.+Feederauthor=C.+K.+Fultonauthor=B.+R.+Dillonauthor=D.+A.+Entwistleauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+tertiary+amine+muscarinic+M3+receptor+antagonists+with+slow+off-rate+binding+kinetics+for+inhaled+once-daily+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200884j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Glossop, Paul A.; Watson, Christine A. L.; Price, David A.; Bunnage, Mark E.; Middleton, Donald S.; Wood, Anthony; James, Kim; Roberts, Dannielle; Strang, Ross S.; Yeadon, Michael; Perros-Huguet, Christelle; Clarke, Nicholas P.; Trevethick, Michael A.; Machin, Ian; Stuart, Emilio F.; Evans, Steven M.; Harrison, Anthony C.; Fairman, David A.; Agoram, Balaji; Burrows, Jane L.; Feeder, Neil; Fulton, Craig K.; Dillon, Barry R.; Entwistle, David A.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6888-6904</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel tertiary amine series of potent muscarinic M3 receptor antagonists are described that exhibit potential as inhaled long-acting bronchodilators for the treatment of chronic obstructive pulmonary disease.  Geminal di-Me functionality present in this series of compds. confers very long dissociative half-life (slow off-rate) from the M3 receptor that mediates very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  Optimization of pharmacokinetic properties was achieved by combining rapid oxidative clearance with targeted introduction of a phenolic moiety to secure rapid glucuronidation.  Together, these attributes minimize systemic exposure following inhalation, mitigate potential drug-drug interactions, and reduce systemically mediated adverse events.  Compd. 47 (PF-3635659) is identified as a Phase II clin. candidate from this series with in vivo duration of action studies confirming its potential for once-daily use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8Q4T5oR53bVg90H21EOLACvtfcHk0lgE6yA1La3aVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SltbzM&md5=ca9b632b4c7982fb44c0d5dd17a056bf</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm200884j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200884j%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DMachin%26aufirst%3DI.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DEvans%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DAgoram%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DDillon%26aufirst%3DB.%2BR.%26aulast%3DEntwistle%26aufirst%3DD.%2BA.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520tertiary%2520amine%2520muscarinic%2520M3%2520receptor%2520antagonists%2520with%2520slow%2520off-rate%2520binding%2520kinetics%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6888%26epage%3D6904%26doi%3D10.1021%2Fjm200884j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaitre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahnke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7797</span>– <span class="NLM_lpage">7814</span>, <span class="refDoi"> DOI: 10.1021/jm200677b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200677b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7797-7814&author=D.+S.+Millanauthor=M.+E.+Bunnageauthor=J.+L.+Burrowsauthor=K.+J.+Butcherauthor=P.+G.+Doddauthor=T.+J.+Evansauthor=D.+A.+Fairmanauthor=S.+J.+Hughesauthor=I.+C.+Kiltyauthor=A.+Lemaitreauthor=R.+A.+Lewthwaiteauthor=A.+Mahnkeauthor=J.+P.+Mathiasauthor=J.+Philipauthor=R.+T.+Smithauthor=M.+H.+Stefaniakauthor=M.+Yeadonauthor=C.+Phillips&title=Design+and+synthesis+of+inhaled+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200677b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Millan, David S.; Bunnage, Mark E.; Burrows, Jane L.; Butcher, Kenneth J.; Dodd, Peter G.; Evans, Timothy J.; Fairman, David A.; Hughes, Samantha J.; Kilty, Iain C.; Lemaitre, Arnaud; Lewthwaite, Russell A.; Mahnke, Axel; Mathias, John P.; Philip, James; Smith, Robert T.; Stefaniak, Mark H.; Yeadon, Michael; Phillips, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7797-7814</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease.  Structure based drug design and "inhalation by design" principles have been applied to the optimization of the lead series exemplified by compd. I.  Analogs have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissocn. kinetics to deliver prolonged lung p38 inhibition.  Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events.  High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug-drug interactions.  Furthermore, pharmaceutical properties such as stability, crystallinity, and soly. were considered to ensure compatibility with a dry powder inhaler.  P38 Inhibitor II (PF-03715455) was subsequently identified as a clin. candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzy5ivwDBL6rVg90H21EOLACvtfcHk0lgE6yA1La3aVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E&md5=9bc6cccf04a78831f50fb402bf7cb4b1</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200677b%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DEvans%26aufirst%3DT.%2BJ.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMahnke%26aufirst%3DA.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DPhilip%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520inhaled%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7797%26epage%3D7814%26doi%3D10.1021%2Fjm200677b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.</span></span> <i>Drug-like Properties: Concepts, Structure Design and Methods 1st Edition from ADME to Toxicity Optimization</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Di&author=E.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+1st+Edition+from+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%25201st%2520Edition%2520from%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DAcademic%2520Press%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span> <span> </span><span class="NLM_article-title">Recognizing molecules with drug-like properties</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/s1367-5931(99)80058-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs1367-5931%2899%2980058-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10419858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1ejtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=384-387&author=W.+P.+Waltersauthor=A.+A.+Murckoauthor=M.+A.+Murcko&title=Recognizing+molecules+with+drug-like+properties&doi=10.1016%2Fs1367-5931%2899%2980058-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Recognizing molecules with drug-like properties</span></div><div class="casAuthors">Walters, W. Patrick; Ajay; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-387</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 36 refs.  A variety of successful approaches to the problem of recognizing "drug-like" mols. have been employed.  These range from simple counting schemes such as the Lipinski "rule of five" to the anal. of the multidimensional "chem. space" occupied by drugs, to neural network learning systems.  With this variety of tools, it now appears possible to design libraries that are enriched in compds. which have desirable or "drug-like" properties.  Verifying the robustness of these methods, and extending them, will form the basis of research in this field during the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAWoMBJtUuE7Vg90H21EOLACvtfcHk0liwf8IurcrNoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1ejtb0%253D&md5=d3ccb8e38e1e0a3981fad87d10ed66e2</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fs1367-5931%2899%2980058-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1367-5931%252899%252980058-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DMurcko%26aufirst%3DA.%2BA.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DRecognizing%2520molecules%2520with%2520drug-like%2520properties%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D1999%26volume%3D3%26spage%3D384%26epage%3D387%26doi%3D10.1016%2Fs1367-5931%2899%2980058-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/s1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2Fs1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eZXzmLucrDxarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2Fs1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boose, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, D. J.</span></span> <span> </span><span class="NLM_article-title">Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/0006-291x(74)90948-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2F0006-291x%2874%2990948-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=4151402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE2cXksleiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1974&pages=426-433&author=H.+E.+Mayauthor=R.+Booseauthor=D.+J.+Reed&title=Hydroxylation+of+the+carcinostatic+1-%282-chloroethyl%29-3-cyclohexyl-1-nitrosourea+%28CCNU%29+by+rat+liver+microsomes&doi=10.1016%2F0006-291x%2874%2990948-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes</span></div><div class="casAuthors">May, Hubert E.; Boose, Richard; Reed, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">426-33</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Ring hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (I) [13010-47-4] occurred in the presence of liver microsomes prepd. from both normal and phenobarbital [50-06-6]-treated rats.  The metabolite was identified by mass spectrometry after selective, extn. and purifn.  The microsomal catalyzed reaction was O2- and NADPH-dependent, inhibited by CO, and induced 4-5 fold by in vivo phenobarbital pretreatment.  Microsomes isolated from the liver of phenobarbital-treated animals hydroxylated the substrate at 17.6 nmoles/min/mg protein at 37.deg..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-F-T_qxlgI7Vg90H21EOLACvtfcHk0liwf8IurcrNoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXksleiu78%253D&md5=d5054fa144b863a57a885dd114aa6aee</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0006-291x%2874%2990948-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291x%252874%252990948-6%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BE.%26aulast%3DBoose%26aufirst%3DR.%26aulast%3DReed%26aufirst%3DD.%2BJ.%26atitle%3DHydroxylation%2520of%2520the%2520carcinostatic%25201-%25282-chloroethyl%2529-3-cyclohexyl-1-nitrosourea%2520%2528CCNU%2529%2520by%2520rat%2520liver%2520microsomes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D57%26spage%3D426%26epage%3D433%26doi%3D10.1016%2F0006-291x%2874%2990948-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Montogomery, J. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry and structure-activity studies of the nitrosoureas</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=954007" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1976&pages=651-664&author=J.+A.+Montogomery&title=Chemistry+and+structure-activity+studies+of+the+nitrosoureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontogomery%26aufirst%3DJ.%2BA.%26atitle%3DChemistry%2520and%2520structure-activity%2520studies%2520of%2520the%2520nitrosoureas%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1976%26volume%3D60%26spage%3D651%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boose, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, D. J.</span></span> <span> </span><span class="NLM_article-title">Microsomal monooxygenation of the rcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Synthesis and identification of <i>cis</i> and <i>trans</i> monohydroxylated products</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4723</span>– <span class="NLM_lpage">4730</span>, <span class="refDoi"> DOI: 10.1021/bi00692a025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00692a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE28XpsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=4723-4730&author=H.+E.+Mayauthor=R.+Booseauthor=D.+J.+Reed&title=Microsomal+monooxygenation+of+the+rcinostatic+1-%282-chloroethyl%29-3-cyclohexyl-1-nitrosourea.+Synthesis+and+identification+of+cis+and+trans+monohydroxylated+products&doi=10.1021%2Fbi00692a025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Microsomal monooxygenation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.  Synthesis and identification of cis and trans monohydroxylated products</span></div><div class="casAuthors">May, Hubert E.; Boose, Richard; Reed, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4723-30</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Liver microsomal hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (I)t [13010-47-4] occurred on the cyclohexyl ring at positions 3 and 4.  Four metabolites were isolated and synthesized:the cis-4 [52049-26-0], trans-4- [56239-24-8], cis-3- [56323-45-6], and trans-3-OH [56323-44-5] derivs. of I.  Microsomes from rats pretreated with phenobarbital showed a sixfold increase in hydroxylation rate (19.8 vs. 3.3 nomole/mg/min).  The induction was selective for cis-4 hydroxylation (19-fold); however, induction of trans-4 (threefold), cis-3 (threefold), and trans-3 (twofold) hydroxylation did occur.  The cis-4-hydroxy metabolite was 67% of the total product by phenobarbital-induced microsomes and 21% for normal microsomes.  Microsomes from animals pretreated with 3-methylcholanthrene gave about the same rate and product distribution that normal microsomes gave.  A mixt. of 80% CO-20% O inhibited formation of all 4 hydroxy metabolites with the inhibition ranging from 55 to 78%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpINOijcdGQtLVg90H21EOLACvtfcHk0liwf8IurcrNoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XpsA%253D%253D&md5=d2aed2d8a2238aed184227fd2f41c480</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fbi00692a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00692a025%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BE.%26aulast%3DBoose%26aufirst%3DR.%26aulast%3DReed%26aufirst%3DD.%2BJ.%26atitle%3DMicrosomal%2520monooxygenation%2520of%2520the%2520rcinostatic%25201-%25282-chloroethyl%2529-3-cyclohexyl-1-nitrosourea.%2520Synthesis%2520and%2520identification%2520of%2520cis%2520and%2520trans%2520monohydroxylated%2520products%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D4723%26epage%3D4730%26doi%3D10.1021%2Fbi00692a025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roychowdhury, A.</span></span> <span> </span><span class="NLM_article-title">Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3621</span>, <span class="refDoi"> DOI: 10.2174/092986712801323180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.2174%2F092986712801323180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22680629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2itbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3605-3621&author=S.+Kumarauthor=R.+Sharmaauthor=A.+Roychowdhury&title=Modulation+of+cytochrome-P450+inhibition+%28CYP%29+in+drug+discovery%3A+a+medicinal+chemistry+perspective&doi=10.2174%2F092986712801323180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective</span></div><div class="casAuthors">Kumar, Sanjay; Sharma, Rajiv; Roychowdhury, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3605-3621</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP450) has widely been implicated for drug-drug interactions (DDI) in the pharmaceutical industry.  Inhibition or induction of this enzyme family has led to withdrawal of multiple drugs from the market leading to major time and financial losses for the pharmaceutical industry.  CYP450 plays a prevailing role in the biotransformation of a large no. of structurally diverse drugs.  Few isoenzymes of the CYP enzyme family (CYP3A4, 2D6 and 2C9 family) are mainly involved in metab. of most of the drugs.  To avoid such interactions and potentially minimize DDI, major pharmaceutical organizations prefer to incorporate CYP enzyme screening at an early stage of their discovery program.  While this has been a prevalent practice in the pharmaceutical industry lately, there is very limited literature available reviewing the relationship between chemotypes and CYP isoforms.  This review will collate literature pertaining to CYP-inhibition modulation through physicochem. parameters and chem. modification and thus bring to focus commonly used trends by medicinal chemists world-wide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVIogYUZJywLVg90H21EOLACvtfcHk0lg53oUaryptEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2itbrF&md5=1f675ef0f7cd31a254b82d8b2eaac44b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986712801323180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712801323180%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DRoychowdhury%26aufirst%3DA.%26atitle%3DModulation%2520of%2520cytochrome-P450%2520inhibition%2520%2528CYP%2529%2520in%2520drug%2520discovery%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3605%26epage%3D3621%26doi%3D10.2174%2F092986712801323180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patick, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borer, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayyar, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovalsantos, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohajeri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batugo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J.-P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meador, J. W.,  3rd.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4572</span>– <span class="NLM_lpage">4585</span>, <span class="refDoi"> DOI: 10.1021/jm030166l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030166l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Ojs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4572-4585&author=P.+S.+Dragovichauthor=T.+J.+Prinsauthor=R.+Zhouauthor=T.+O.+Johnsonauthor=Y.+Huaauthor=H.+T.+Luuauthor=S.+K.+Sakataauthor=E.+L.+Brownauthor=F.+C.+Maldonadoauthor=T.+Tuntlandauthor=C.+A.+Leeauthor=S.+A.+Fuhrmanauthor=L.+S.+Zalmanauthor=A.+K.+Patickauthor=D.+A.+Matthewsauthor=E.+Y.+Wuauthor=M.+Guoauthor=B.+C.+Borerauthor=N.+K.+Nayyarauthor=T.+Moranauthor=L.+Chenauthor=P.+A.+Rejtoauthor=P.+W.+Roseauthor=M.+C.+Guzmanauthor=E.+Z.+Dovalsantosauthor=S.+Leeauthor=K.+McGeeauthor=M.+Mohajeriauthor=A.+Lieseauthor=J.+Taoauthor=M.+B.+Kosaauthor=B.+Liuauthor=M.+R.+Batugoauthor=J.-P.+R.+Gleesonauthor=Z.+P.+Wuauthor=J.+Liuauthor=J.+W.+Meadorauthor=R.+A.+Ferre&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+irreversible+human+rhinovirus+3C+protease+inhibitors.+8.+Pharmacological+optimization+of+orally+bioavailable+2-pyridone-containing+peptidomimetics&doi=10.1021%2Fjm030166l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics</span></div><div class="casAuthors">Dragovich, Peter S.; Prins, Thomas J.; Zhou, Ru; Johnson, Theodore O.; Hua, Ye; Luu, Hiep T.; Sakata, Sylvie K.; Brown, Edward L.; Maldonado, Fausto C.; Tuntland, Tove; Lee, Caroline A.; Fuhrman, Shella A.; Zalman, Leora S.; Patick, Amy K.; Matthews, David A.; Wu, Ellen Y.; Guo, Ming; Borer, Bennett C.; Nayyar, Naresh K.; Moran, Terence; Chen, Lijian; Rejto, Paul A.; Rose, Peter W.; Guzman, Mark C.; Dovalsantos, Elena Z.; Lee, Steven; McGee, Kevin; Mohajeri, Michael; Liese, Andreas; Tao, Junhua; Kosa, Maha B.; Liu, Bo; Batugo, Minerva R.; Gleeson, Jean-Paul R.; Wu, Zhen Ping; Liu, Jia; Meador, James W., III; Ferre, Rose Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4572-4585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of the pharmacokinetic performance of various 2-pyridone-contg. human rhinovirus (HRV) 3C protease (3CP) inhibitors following oral administration to either beagle dogs or CM-monkeys is described.  The mols. described in this work are composed of a 2-pyridone-contg. peptidomimetic binding determinant and an α,β-unsatd. ester Michael acceptor moiety which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme.  Modification of the ester contained within these compds. is detailed along with alteration of the P2 substituent present in the peptidomimetic portion of the inhibitors.  The pharmacokinetics of several inhibitors in both dogs and monkeys are described (7 h plasma concns. after oral administration) along with their human plasma stabilities, stabilities in incubations with human, dog, and monkey microsomes and hepatocytes, Caco-2 permeabilities, and aq. solubilities.  Compds. contg. an α,β-unsatd. Et ester fragment and either an Et or propargyl P2 moiety displayed the most promising combination of 3C enzyme inhibition (kobs/[I] 170 000-223 000 M-1 s-1), antiviral activity (EC50 = 0.047-0.058 μM, mean vs. seven HRV serotypes), and pharmacokinetics following oral administration (7 h dog plasma levels = 0.248-0.682 μM; 7 h CM-monkey plasma levels = 0.057-0.896 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom7ef81WRYlrVg90H21EOLACvtfcHk0ljwAWXvxxI75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Ojs78%253D&md5=c4b964698cce3c97c107076f24692056</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm030166l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030166l%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DPrins%26aufirst%3DT.%2BJ.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DH.%2BT.%26aulast%3DSakata%26aufirst%3DS.%2BK.%26aulast%3DBrown%26aufirst%3DE.%2BL.%26aulast%3DMaldonado%26aufirst%3DF.%2BC.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DFuhrman%26aufirst%3DS.%2BA.%26aulast%3DZalman%26aufirst%3DL.%2BS.%26aulast%3DPatick%26aufirst%3DA.%2BK.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DE.%2BY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DBorer%26aufirst%3DB.%2BC.%26aulast%3DNayyar%26aufirst%3DN.%2BK.%26aulast%3DMoran%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26aulast%3DGuzman%26aufirst%3DM.%2BC.%26aulast%3DDovalsantos%26aufirst%3DE.%2BZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DMcGee%26aufirst%3DK.%26aulast%3DMohajeri%26aufirst%3DM.%26aulast%3DLiese%26aufirst%3DA.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DKosa%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DBatugo%26aufirst%3DM.%2BR.%26aulast%3DGleeson%26aufirst%3DJ.-P.%2BR.%26aulast%3DWu%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMeador%26aufirst%3DJ.%2BW.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520irreversible%2520human%2520rhinovirus%25203C%2520protease%2520inhibitors.%25208.%2520Pharmacological%2520optimization%2520of%2520orally%2520bioavailable%25202-pyridone-containing%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4572%26epage%3D4585%26doi%3D10.1021%2Fjm030166l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tagat, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCombie, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazareno, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neustadt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vantuno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strizki, J. M.</span></span> <span> </span><span class="NLM_article-title">Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3343</span>– <span class="NLM_lpage">3346</span>, <span class="refDoi"> DOI: 10.1021/jm0155401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0155401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3343-3346&author=J.+R.+Tagatauthor=R.+W.+Steensmaauthor=S.+W.+McCombieauthor=D.+V.+Nazarenoauthor=S.-I.+Linauthor=B.+R.+Neustadtauthor=K.+Coxauthor=S.+Xuauthor=L.+Wojcikauthor=M.+G.+Murrayauthor=N.+Vantunoauthor=B.+M.+Baroudyauthor=J.+M.+Strizki&title=Piperazine-based+CCR5+antagonists+as+HIV-1+inhibitors.+II.+Discovery+of+1-%5B%282%2C4-dimethyl-3-pyridinyl%29carbonyl%5D-4-+methyl-4-%5B3%28S%29-methyl-4-%5B1%28S%29-%5B4-%28trifluoromethyl%29phenyl%5Dethyl%5D-1-piperazinyl%5D-piperidine+N1-oxide+%28Sch-350634%29%2C+an+orally+bioavailable%2C+potent+CCR5+antagonist&doi=10.1021%2Fjm0155401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist</span></div><div class="casAuthors">Tagat, Jayaram R.; Steensma, Ruo W.; McCombie, Stuart W.; Nazareno, Dennis V.; Lin, Sue-Ing; Neustadt, Bernard R.; Cox, Kathleen; Xu, Serena; Wojcik, Lisa; Murray, Michael G.; Vantuno, Nicole; Baroudy, Bahige M.; Strizki, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3343-3346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Truncation of the original piperidino-2(S)-Me piperazine lead structure, from a family of muscarinic antagonists, gave a compd. which has improved selectivity for the HIV-1 co-receptor CCR5 over muscarinic receptors.  Further optimization for pharmacokinetic properties afforded Sch-350634, a prototypical piperazine-based CCR5 antagonist, which is a potent inhibitor of HIV-1 entry and replication in PBMCs.  The title compd. Sch-350634 has excellent oral bioavailability in rat, dog, and monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFljx4tHdwt7Vg90H21EOLACvtfcHk0ljwAWXvxxI75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFejtLc%253D&md5=03c6ca2481017857a9b737ce24d0eb66</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm0155401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0155401%26sid%3Dliteratum%253Aachs%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DSteensma%26aufirst%3DR.%2BW.%26aulast%3DMcCombie%26aufirst%3DS.%2BW.%26aulast%3DNazareno%26aufirst%3DD.%2BV.%26aulast%3DLin%26aufirst%3DS.-I.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWojcik%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DM.%2BG.%26aulast%3DVantuno%26aufirst%3DN.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DStrizki%26aufirst%3DJ.%2BM.%26atitle%3DPiperazine-based%2520CCR5%2520antagonists%2520as%2520HIV-1%2520inhibitors.%2520II.%2520Discovery%2520of%25201-%255B%25282%252C4-dimethyl-3-pyridinyl%2529carbonyl%255D-4-%2520methyl-4-%255B3%2528S%2529-methyl-4-%255B1%2528S%2529-%255B4-%2528trifluoromethyl%2529phenyl%255Dethyl%255D-1-piperazinyl%255D-piperidine%2520N1-oxide%2520%2528Sch-350634%2529%252C%2520an%2520orally%2520bioavailable%252C%2520potent%2520CCR5%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3343%26epage%3D3346%26doi%3D10.1021%2Fjm0155401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span> <span> </span><span class="NLM_article-title">Important hydrogen bond networks in indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=282-293&author=Y.-H.+Pengauthor=S.-H.+Uengauthor=C.-T.+Tsengauthor=M.-S.+Hungauthor=J.-S.+Songauthor=J.-S.+Wuauthor=F.-Y.+Liaoauthor=Y.-S.+Fanauthor=M.-H.+Wuauthor=W.-C.+Hsiaoauthor=C.-C.+Hsuehauthor=S.-Y.+Linauthor=C.-Y.+Chengauthor=C.-H.+Tuauthor=L.-C.+Leeauthor=M.-F.+Chengauthor=K.-S.+Shiaauthor=C.+Shihauthor=S.-Y.+Wu&title=Important+hydrogen+bond+networks+in+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitor+design+revealed+by+crystal+structures+of+imidazoleisoindole+derivatives+with+IDO&doi=10.1021%2Facs.jmedchem.5b01390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1</span></div><div class="casAuthors">Peng, Yi-Hui; Ueng, Shau-Hua; Tseng, Chen-Tso; Hung, Ming-Shiu; Song, Jen-Shin; Wu, Jian-Sung; Liao, Fang-Yu; Fan, Yu-Shiou; Wu, Mine-Hsine; Hsiao, Wen-Chi; Hsueh, Ching-Cheng; Lin, Shu-Yu; Cheng, Chia-Yi; Tu, Chih-Hsiang; Lee, Lung-Chun; Cheng, Ming-Fu; Shia, Kak-Shan; Shih, Chuan; Wu, Su-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-293</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1), promoting immune escape of tumors, is a therapeutic target for the cancer immunotherapy.  A no. of IDO1 inhibitors have been identified, but only limited structural biol. studies of IDO1 inhibitors are available to provide insights on the binding mechanism of IDO1.  In this study, we present the structure of IDO1 in complex with 24, a NLG919 analog with potent activity.  The complex structure revealed the imidazole nitrogen atom of 24 to coordinate with the heme iron, and the imidazoleisoindole core situated in pocket A with the 1-cyclohexylethanol moiety extended to pocket B to interact with the surrounding residues.  Most interestingly, 24 formed an extensive hydrogen bond network with IDO1, which is a distinct feature of IDO1/24 complex structure and is not obsd. in the other IDO1 complex structures.  Further structure-activity relationship, UV spectra, and structural biol. studies of several analogs of 24 demonstrated that extensive hydrophobic interactions and the unique hydrogen bonding network contribute to the great potency of imidazoleisoindole derivs.  These results are expected to facilitate the structure-based drug design of new IDO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJqtuECqcsrVg90H21EOLACvtfcHk0liUToeLumVhMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtLnJ&md5=2258be36595a3fa8e6c9064b2f15e1de</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01390%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.-H.%26aulast%3DUeng%26aufirst%3DS.-H.%26aulast%3DTseng%26aufirst%3DC.-T.%26aulast%3DHung%26aufirst%3DM.-S.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DWu%26aufirst%3DJ.-S.%26aulast%3DLiao%26aufirst%3DF.-Y.%26aulast%3DFan%26aufirst%3DY.-S.%26aulast%3DWu%26aufirst%3DM.-H.%26aulast%3DHsiao%26aufirst%3DW.-C.%26aulast%3DHsueh%26aufirst%3DC.-C.%26aulast%3DLin%26aufirst%3DS.-Y.%26aulast%3DCheng%26aufirst%3DC.-Y.%26aulast%3DTu%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DL.-C.%26aulast%3DCheng%26aufirst%3DM.-F.%26aulast%3DShia%26aufirst%3DK.-S.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DS.-Y.%26atitle%3DImportant%2520hydrogen%2520bond%2520networks%2520in%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitor%2520design%2520revealed%2520by%2520crystal%2520structures%2520of%2520imidazoleisoindole%2520derivatives%2520with%2520IDO%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D282%26epage%3D293%26doi%3D10.1021%2Facs.jmedchem.5b01390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Enzyme Inhibitors in Drug Discovery</span>.  <i>A Guide for Medicinal Chemists and Pharmacologists</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26btitle%3DA%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayaishi, O.</span></span> <span> </span><span class="NLM_article-title">Induction of pulmonary indoleamine 2,3-dioxygenase by interferon</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1073/pnas.78.1.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.78.1.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=6165986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL3MXhtF2gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1981&pages=129-132&author=R.+Yoshidaauthor=J.+Imanishiauthor=T.+Okuauthor=T.+Kishidaauthor=O.+Hayaishi&title=Induction+of+pulmonary+indoleamine+2%2C3-dioxygenase+by+interferon&doi=10.1073%2Fpnas.78.1.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pulmonary indoleamine 2,3-dioxygenase by interferon</span></div><div class="casAuthors">Yoshida, Ryotaro; Imanishi, Jiro; Oku, Tohru; Kishida, Tsunataro; Hayaishi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">An in vitro system with mouse lung slices was developed in which bacterial endotoxin (5 μg/mL) produced an induction (approx. 10-fold) of indoleamine 2,3-dioxygenase.  The endotoxin was substituted by interferon from mouse L cells or mouse brain.  The pulmonary enzyme activity increased almost linearly for 48 h after addn. of mouse interferon (104 units/mL) to lung slices.  Interferon from mouse L cells or mouse brain produced a 10- to 15-fold increase in the enzyme activity, whereas that from human leukocytes was all but ineffective.  The effect also was obsd. using highly purified L-cell interferon, prepd. by poly(U) affinity column chromatog.  When interferon was treated either by heat, α-chymotrypsin, or anti-interferon serum, such increase in the enzyme activity was diminished essentially to the same extent as seen in the antiviral activity.  The increase in the enzyme activity was blocked when actinomycin D or cycloheximide was added to the slices before interferon treatment.  Thus, the enzyme induction was produced by interferon and not by possible contaminants in the interferon prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqscIenhGY1bbVg90H21EOLACvtfcHk0liUToeLumVhMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtF2gs7w%253D&md5=b5b00406098a81610504cab35e1fff67</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.78.1.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.78.1.129%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DImanishi%26aufirst%3DJ.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DInduction%2520of%2520pulmonary%2520indoleamine%25202%252C3-dioxygenase%2520by%2520interferon%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1981%26volume%3D78%26spage%3D129%26epage%3D132%26doi%3D10.1073%2Fpnas.78.1.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayaishi, O.</span></span> <span> </span><span class="NLM_article-title">Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase</span>. <i>J. Bio. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">3648</span>– <span class="NLM_lpage">3653</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=2419335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL28XitVCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=3648-3653&author=O.+Takikawaauthor=R.+Yoshidaauthor=R.+Kidoauthor=O.+Hayaishi&title=Tryptophan+degradation+in+mice+initiated+by+indoleamine+2%2C3-dioxygenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Takikawa, Osamu; Yoshida, Ryotaro; Kido, Ryo; Hayaishi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3648-53</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Tryptophan (I) degrdn. in mice initiated by indoleamine 2,3-dioxygenase (II) was characterized, taking advantage of its induction by bacterial lipopolysaccharide.  In various tissues, N-formylkynurenine produced by II from I was rapidly hydrolyzed into kynurenine (III) by a kynurenine formamidase, but it was not further metabolized.  The localization in the liver and kidney of the III-metabolizing enzymes suggested that III thus formed was transported by the bloodstream of these 2 organs to be metabolized.  In fact, the plasma III level increased in parallel with the induction of II by lipopolysaccharide, and kinetic anal. indicated that at the maximal induction of the enzyme there was a 3-fold increase in III prodn.  The major metabolic route of III was excretion in urine as xanthurenic acid.  This increase in III prodn. was not explained by L-tryptophan 2,3-dioxygenase in the liver, because during the induction of II, the hepatic enzyme level was substantially suppressed.  Thus, II actively oxidized I in mice, and its induction resulted in an increase in I degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTdpt5zY14brVg90H21EOLACvtfcHk0liUToeLumVhMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVCnsrs%253D&md5=dddaa22122b6da9105a779497252c22b</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DKido%26aufirst%3DR.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DTryptophan%2520degradation%2520in%2520mice%2520initiated%2520by%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DJ.%2520Bio.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D3648%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span> <span> </span><span class="NLM_article-title">Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1845</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-09-3613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F0008-5472.can-09-3613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=20160032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1845-1853&author=A.+J.+Mullerauthor=J.+B.+DuHadawayauthor=D.+Jallerauthor=P.+Curtisauthor=R.+Metzauthor=G.+C.+Prendergast&title=Immunotherapeutic+suppression+of+indoleamine+2%2C3-dioxygenase+and+tumor+growth+with+ethyl+pyruvate&doi=10.1158%2F0008-5472.can-09-3613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate</span></div><div class="casAuthors">Muller, Alexander J.; DuHadaway, James B.; Jaller, Daniel; Curtis, Peter; Metz, Richard; Prendergast, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1845-1853</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Efforts to improve cancer care in the developing world will benefit from the identification of simple, inexpensive, and broadly applicable medical modalities based on emergent innovations in treatment, such as targeting mechanisms of tumoral immune tolerance.  In this report, we offer preclin. evidence that the low-cost, anti-inflammatory agent Et pyruvate elicits a potent immune-based antitumor response through inhibition of indoleamine 2,3-dioxygenase (IDO), a key tolerogenic enzyme for many human tumors.  Consistent with its reported ability to interfere with NF-κB function, Et pyruvate blocks IDO induction both in vitro and in vivo.  Antitumor activity was achieved in mice with a noncytotoxic dosing regimen of Et pyruvate shown previously to protect against lethality from sepsis.  Similar outcomes were obtained with the functional Et pyruvate analog 2-acetamidoacrylate.  Et pyruvate was ineffective at suppressing tumor outgrowth in both athymic and Ido1-deficient mice, providing in vivo corroboration of the importance of T-cell-dependent immunity and IDO targeting for Et pyruvate to achieve antitumor efficacy.  Although Et pyruvate has undergone early-phase clin. testing, this was done without consideration of its possible applicability to cancer.  Our findings that IDO is effectively blocked by Et pyruvate treatment deepen emerging links between IDO and inflammatory processes.  Further, these findings rationalize oncol. applications for this agent by providing a compelling basis to reposition Et pyruvate as a low-cost immunochemotherapy for clin. evaluation in cancer patients.  Cancer Res; 70(5); 1845-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohkSC_ZW9ndLVg90H21EOLACvtfcHk0liUToeLumVhMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWju78%253D&md5=3d6e683754a5f97ef5215319ad454e2c</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-09-3613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-09-3613%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DCurtis%26aufirst%3DP.%26aulast%3DMetz%26aufirst%3DR.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26atitle%3DImmunotherapeutic%2520suppression%2520of%2520indoleamine%25202%252C3-dioxygenase%2520and%2520tumor%2520growth%2520with%2520ethyl%2520pyruvate%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1845%26epage%3D1853%26doi%3D10.1158%2F0008-5472.can-09-3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astola, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">13033</span>– <span class="NLM_lpage">13038</span>, <span class="refDoi"> DOI: 10.1073/pnas.1517820112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.1517820112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=26438837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=13033-13038&author=J.+E.+Coleauthor=N.+Astolaauthor=A.+P.+Cribbsauthor=M.+E.+Goddardauthor=I.+Parkauthor=P.+Greenauthor=A.+H.+Daviesauthor=R.+O.+Williamsauthor=M.+Feldmannauthor=C.+Monaco&title=Indoleamine+2%2C3-dioxygenase-1+is+protective+in+atherosclerosis+and+its+metabolites+provide+new+opportunities+for+drug+development&doi=10.1073%2Fpnas.1517820112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development</span></div><div class="casAuthors">Cole, Jennifer E.; Astola, Nagore; Cribbs, Adam P.; Goddard, Michael E.; Park, Inhye; Green, Patricia; Davies, Alun H.; Williams, Richard O.; Feldmann, Marc; Monaco, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13033-13038</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide.  Despite much focus on lipid abnormalities in atherosclerosis, it is clear that the immune system also has important pro- and antiatherogenic functions.  The enzyme indoleamine-2,3-dioxygenase (IDO) catalyzes degrdn. of the essential amino acid tryptophan into immunomodulatory metabolites.  How IDO deficiency affects immune responses during atherogenesis is unknown and we explored potential mechanisms in models of murine and human atherosclerosis.  IDO deficiency in hypercholesterolemic ApoE-/- mice caused a significant increase in lesion size and surrogate markers of plaque vulnerability.  No significant changes in cholesterol levels were obsd. but decreases in IL-10 prodn. were found in the peripheral blood, spleen and lymph node B cells of IDO-deficient compared with IDO-competent ApoE-/- mice.  3,4,-Dimethoxycinnamoyl anthranilic acid (3,4-DAA), an orally active synthetic deriv. of the tryptophan metabolite anthranilic acid, but not l-kynurenine, enhanced prodn. of IL-10 in cultured splenic B cells.  Finally, 3,4-DAA treatment reduced lesion formation and inflammation after collar-induced arterial injury in ApoE-/- mice, and reduced cytokine and chemokine prodn. in ex vivo human atheroma cell cultures.  Our data demonstrate that endogenous prodn. of tryptophan metabolites via IDO is an essential feedback loop that controls atherogenesis and athero-inflammation.  We show that the IDO pathway induces prodn. of IL-10 in B cells in vivo and in vitro, suggesting that IDO may induce immunoregulatory functions of B cells in atherosclerosis.  The favorable effects of anthranilic acid derivs. in atherosclerosis indicate a novel approach toward therapy of CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWCuNzxk2Po7Vg90H21EOLACvtfcHk0lgihI_u4339DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7nE&md5=3108cf2a1db341a946359ba644c43be8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1517820112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1517820112%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BE.%26aulast%3DAstola%26aufirst%3DN.%26aulast%3DCribbs%26aufirst%3DA.%2BP.%26aulast%3DGoddard%26aufirst%3DM.%2BE.%26aulast%3DPark%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DA.%2BH.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMonaco%26aufirst%3DC.%26atitle%3DIndoleamine%25202%252C3-dioxygenase-1%2520is%2520protective%2520in%2520atherosclerosis%2520and%2520its%2520metabolites%2520provide%2520new%2520opportunities%2520for%2520drug%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D13033%26epage%3D13038%26doi%3D10.1073%2Fpnas.1517820112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Jaipuri, F.</span>; <span class="NLM_string-name">Kumar, S.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Pavana, R.</span>; <span class="NLM_string-name">Potturi, H.</span>; <span class="NLM_string-name">Velvadapu, V.</span>; <span class="NLM_string-name">Waldo, J.</span>; <span class="NLM_string-name">Zhang, Z.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 Inhibitors</span>. PCT <span class="NLM_patent">WO2017107979A1</span>, June 29, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+Mendonca&author=B.+Parr&author=R.+Pastor&author=Z.+Pei&author=L.+Gazzard&author=F.+Jaipuri&author=S.+Kumar&author=X.+Li&author=R.+Pavana&author=H.+Potturi&author=V.+Velvadapu&author=J.+Waldo&author=Z.+Zhang&author=G.+Wu&author=X.+Lin&author=P.-W.+Yuen&title=Tdo2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMendonca%26aufirst%3DR.%26atitle%3DTdo2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Mendonca, R.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 and Ido1 Inhibitors</span>. PCT <span class="NLM_patent">WO2019005559</span>, March 1, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Z.+Pei&author=R.+Pastor&author=L.+Gazzard&author=B.+Parr&author=W.+Liu&author=R.+Mendonca&author=G.+Wu&author=P.-W.+Yuen&title=Tdo2+and+Ido1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DTdo2%2520and%2520Ido1%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Jaipuri, F.</span>; <span class="NLM_string-name">Kumar, S.</span>; <span class="NLM_string-name">Potturi, H.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Chu, Y.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 and Ido1 Inhibitors</span>. PCT <span class="NLM_patent">WO2019006047</span>. March 1, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Z.+Pei&author=B.+Parr&author=W.+Liu&author=R.+Pastor&author=L.+Gazzard&author=F.+Jaipuri&author=S.+Kumar&author=H.+Potturi&author=G.+Wu&author=X.+Lin&author=Y.+Chu&author=P.-W.+Yuen&title=Tdo2+and+Ido1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DTdo2%2520and%2520Ido1%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overberger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular base-catalyzed imidazole catalysis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">6992</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1021/ja00754a051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00754a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE38XjtlGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1971&pages=6992-6998&author=C.+G.+Overbergerauthor=C.-M.+Shen&title=Intramolecular+base-catalyzed+imidazole+catalysis&doi=10.1021%2Fja00754a051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular base-catalyzed imidazole catalysis</span></div><div class="casAuthors">Overberger, C. G.; Shen, Chah-Moh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6992-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new two-step synthesis of 4(5)-(2'-hydroxyphenyl)imidazole (HPI) was utilized.  Solvolysis of p-nitrophenyl acetate (PNPA) and p-nitrophenyl toluate, (PNPT) catalyzed by HPI and other related imidazole or phenol model compds., such as 1-methyl-4-(2'-hydroxyphenyl)imidazole and 4(5)-(2'-methoxyphenyl)imidazole, indicated that reaction other than simple nucleophilic catalysis by the imidazole group and phenoxide ion function of HPI must operate during the catalyzed solvolysis.  The favored geometry existing between the imidazole and phenoxide groups suggests an intramol. bifunctional catalysis involving the phenoxide and imidazole groups.  The rate const. of this intramol. base-catalyzed imidazole catalysis was 137.4 and 6.39 1./mole min for PNPA and PNPT, resp. 4(5)-[ω-(p-Hydroxyphenyl)nonyl]imidazole (HPNI), which has an imidazole and phenol function joined by 9 methylene units, was synthesized in 7 steps from sebacic acid.  The modest obsd. rate enhancement during the solvolysis of p-nitrophenyl acetate and p-nitrophenyl palmitate catalyzed by HPNI was attributed to a hydrophobic attraction between the substrates and the long chain model compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUTEGP5aCxrVg90H21EOLACvtfcHk0lgihI_u4339DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XjtlGjsw%253D%253D&md5=c86d26fdd8146c2dc460a0fb14d9bc34</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00754a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00754a051%26sid%3Dliteratum%253Aachs%26aulast%3DOverberger%26aufirst%3DC.%2BG.%26aulast%3DShen%26aufirst%3DC.-M.%26atitle%3DIntramolecular%2520base-catalyzed%2520imidazole%2520catalysis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1971%26volume%3D93%26spage%3D6992%26epage%3D6998%26doi%3D10.1021%2Fja00754a051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetter, M. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-substituted imidazoles via palladium-catalyzed cross-coupling reactions</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1055/s-1998-2069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1055%2Fs-1998-2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1cXjslKmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=829-831&author=M.+C.+Jetter&title=Synthesis+of+4-substituted+imidazoles+via+palladium-catalyzed+cross-coupling+reactions&doi=10.1055%2Fs-1998-2069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-substituted imidazoles via palladium-catalyzed cross-coupling reactions</span></div><div class="casAuthors">Jetter, Michele C.; Reitz, Allen B.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Imidazoles bearing vinyl and aryl substitution in the 4-position are prepd. using Pd-catalyzed cross-coupling reactions of 1-tritylimidazol-4-yltin and -zinc reagents in 67-80% yield.  Importantly, these coupling methods appear to be general for aryl and vinyl bromides, iodides, and triflates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJg_UnaPimabVg90H21EOLACvtfcHk0lhEBr9_ofGm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslKmurk%253D&md5=7c212b38801aacced01c0761aaeb1c4b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-2069%26sid%3Dliteratum%253Aachs%26aulast%3DJetter%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%2520of%25204-substituted%2520imidazoles%2520via%2520palladium-catalyzed%2520cross-coupling%2520reactions%26jtitle%3DSynthesis%26date%3D1998%26spage%3D829%26epage%3D831%26doi%3D10.1055%2Fs-1998-2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falling, S. N.</span></span> <span> </span><span class="NLM_article-title">An efficient and selective method for the preparation of iodophenols</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/jo00305a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00305a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK3cXltFCksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=5287-5291&author=K.+J.+Edgarauthor=S.+N.+Falling&title=An+efficient+and+selective+method+for+the+preparation+of+iodophenols&doi=10.1021%2Fjo00305a026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient and selective method for the preparation of iodophenols</span></div><div class="casAuthors">Edgar, Kevin J.; Falling, Stephen N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5287-91</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Direct iodination of a wide range of phenols may be achieved with unprecedented selectivity in aq. alc. solvents by the action of a reagent prepd. in situ from sodium hypochlorite and sodium iodide.  Para-substituted phenols (or ortho-substituted, when the para-position is already occupied) are obtained in fair to excellent yields by simple isolation techniques.  The extent of iodination is easily controlled by stoichiometry.  The technique is also useful with some anilines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGTJmAnTR4arVg90H21EOLACvtfcHk0lhEBr9_ofGm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltFCksbo%253D&md5=4d6d858cdbdfa040056b736fc7c5e7b4</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjo00305a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00305a026%26sid%3Dliteratum%253Aachs%26aulast%3DEdgar%26aufirst%3DK.%2BJ.%26aulast%3DFalling%26aufirst%3DS.%2BN.%26atitle%3DAn%2520efficient%2520and%2520selective%2520method%2520for%2520the%2520preparation%2520of%2520iodophenols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D5287%26epage%3D5291%26doi%3D10.1021%2Fjo00305a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnakenburg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, R. S.</span></span> <span> </span><span class="NLM_article-title">Efficient and reliable iodination and <i>O</i>-methylation of fluorinated phenols</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_fpage">2357</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201000161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1002%2Fejoc.201000161" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=2357-2362&author=R.+Robertauthor=G.+Schnakenburgauthor=R.+S.+Waldvogel&title=Efficient+and+reliable+iodination+and+O-methylation+of+fluorinated+phenols&doi=10.1002%2Fejoc.201000161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000161%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DR.%26aulast%3DSchnakenburg%26aufirst%3DG.%26aulast%3DWaldvogel%26aufirst%3DR.%2BS.%26atitle%3DEfficient%2520and%2520reliable%2520iodination%2520and%2520O-methylation%2520of%2520fluorinated%2520phenols%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26spage%3D2357%26epage%3D2362%26doi%3D10.1002%2Fejoc.201000161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, M. A.</span></span> <span> </span><span class="NLM_article-title">An investigation of imidazole and oxazole syntheses using aryl-substituted TosMIC reagents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1021/jo991782l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo991782l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1516-1524&author=J.+Siskoauthor=A.+J.+Kassickauthor=M.+Mellingerauthor=J.+J.+Filanauthor=A.+Allenauthor=M.+A.+Olsen&title=An+investigation+of+imidazole+and+oxazole+syntheses+using+aryl-substituted+TosMIC+reagents&doi=10.1021%2Fjo991782l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of imidazole and oxazole syntheses using aryl-substituted TosMIC reagents</span></div><div class="casAuthors">Sisko, Joseph; Kassick, Andrew J.; Mellinger, Mark; Filan, John J.; Allen, Andrew; Olsen, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1516-1524</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient and mild protocols are described for prepg. polysubstituted imidazoles in a single pot from aryl-substituted tosylmethyl isocyanide (TosMIC) reagents and imines generated in situ.  Traditional imine-forming reactions employing virtually any aldehyde and an amine followed by addn. of the TosMIC reagent gave 1,4,5-tri-substituted imidazoles with predictable regiochem.  Thus, condensation of pyruvaldehyde with (MeO)2CHCH2NH2 in THF at ambient temp. for 15 min and subsequent reaction with 4-FC6H4CH(Tos)N+≡C- [Tos = 4-MeC6H4SO2] in the presence of piperazine for 18 h gave 71% [(fluorophenyl)imidazolyl]ethanone I.  Employing chiral amines and aldehydes, particularly those derived from α-amino acids, gave imidazoles, e.g. II, with asym. centers appended to N-1 or C-5 with excellent retention of chiral purity.  1,4-Disubstituted imidazoles were also readily prepd. by a simple variant of the above procedure.  Selection of glyoxylic acid as the aldehyde component of the procedure lead to intermediates such as III which readily underwent decarboxylation and elimination of the tosyl moiety to give 1,4-disubstituted imidazoles in high yields.  Alternatively, using NH4OH as the amine component in conjunction with a variety of aldehydes gave 4,5-disubstituted imidazoles in moderate to good yields in a single pot while avoiding the need for protecting groups.  Finally, the facile prepn. of mono- and disubstituted oxazoles, e.g. IV, from these TosMIC reagents and aldehydes was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRTW4a3LyN2rVg90H21EOLACvtfcHk0lhEBr9_ofGm7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCrt7g%253D&md5=96018e9928216132e4e5f36cf89d3c98</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo991782l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991782l%26sid%3Dliteratum%253Aachs%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DFilan%26aufirst%3DJ.%2BJ.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DM.%2BA.%26atitle%3DAn%2520investigation%2520of%2520imidazole%2520and%2520oxazole%2520syntheses%2520using%2520aryl-substituted%2520TosMIC%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1516%26epage%3D1524%26doi%3D10.1021%2Fjo991782l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fürstner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanda, G.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Synthesis of the fully functional macrolide core of salicylihalamide: Remote control of olefin geometry during RCM</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3731</span>– <span class="NLM_lpage">3734</span>, <span class="refDoi"> DOI: 10.1021/ol006646d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006646d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFyktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3731-3734&author=A.+F%C3%BCrstnerauthor=O.+R.+Thielauthor=G.+Blanda&title=Asymmetric+Synthesis+of+the+fully+functional+macrolide+core+of+salicylihalamide%3A+Remote+control+of+olefin+geometry+during+RCM&doi=10.1021%2Fol006646d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of the Fully Functional Macrolide Core of Salicylihalamide: Remote Control of Olefin Geometry during RCM</span></div><div class="casAuthors">Fuerstner, Alois; Thiel, Oliver R.; Blanda, Gaetano</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3731-3734</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A catalysis-based approach to the core region I (R = H, Me, TBS, MOM) of the antitumor agents salicylihalamides A and B is reported.  Key steps are two asym. hydrogenations of β-keto esters catalyzed by [(R)-BINAP·RuCl2]2·NEt3 and an RCM-based macrocyclization effected by an NHC-contg. ruthenium carbene.  The stereochem. outcome of the latter reaction is controlled by remote substituents on the phenolic OH group of the cyclization precursor II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozrrhKOQ5EM7Vg90H21EOLACvtfcHk0lgtnGRfnmzrZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFyktLY%253D&md5=830c4a16d07ebe21c55c3af468408376</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol006646d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006646d%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DThiel%26aufirst%3DO.%2BR.%26aulast%3DBlanda%26aufirst%3DG.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520the%2520fully%2520functional%2520macrolide%2520core%2520of%2520salicylihalamide%253A%2520Remote%2520control%2520of%2520olefin%2520geometry%2520during%2520RCM%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3731%26epage%3D3734%26doi%3D10.1021%2Fol006646d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetina-Rocha, C.</span></span> <span> </span><span class="NLM_article-title">Intramolecular conjugate addition of alkenyl and aryl functions to enones initiated by lithium-iodine exchange</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1021/ol016288u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol016288u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=3245-3247&author=E.+Piersauthor=C.+L.+Harrisonauthor=C.+Zetina-Rocha&title=Intramolecular+conjugate+addition+of+alkenyl+and+aryl+functions+to+enones+initiated+by+lithium-iodine+exchange&doi=10.1021%2Fol016288u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Conjugate Addition of Alkenyl and Aryl Functions to Enones Initiated by Lithium-Iodine Exchange</span></div><div class="casAuthors">Piers, Edward; Harrison, Cristian L.; Zetina-Rocha, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3245-3247</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of 4-[(Z)-3-iodo-2-propenyl] and 4-(2-iodoaryl)cyclohexenones such as I and II with tert-butyllithium and trimethylsilyl chloride in a mixt. of THF and HMPA gives fused bicyclic alkenones such as III and IV stereoselectively and in 72-91% yields.  I was prepd. in 5 steps from 3-(isobutoxy)-6-Me-2-cyclohexenone and Me 4-(benzyloxy)-2-butynoate.  Stereoselective addn. of sodium iodide to PhCH2OCH2C≡CCO2Me in acetic acid, redn. of the ester moiety with diisobutylaluminum hydride, and bromination of the allylic alc. with triphenylphosphine-bromine complex and imidazole gave the allylic bromide (Z)-PhCH2OCH2CI:CHCH2Br.  Treatment of 3-(isobutyloxy)-6-methyl-2-cyclohexenone with LDA in THF followed by alkylation with (Z)-PhCH2OCH2CI:CHCH2Br, redn. of the ketone with diisobutylaluminum hydride and acid-catalyzed hydrolysis and elimination yielded the substituted cyclohexenone I.  Addn. of tert-butyllithium to a soln. of I in THF with trimethylsilyl chloride and HMPA under argon at -78° followed by stirring for 5 min. and warming to room temp. gave III in 83% yield.  3-(Isobutyloxy)-2-cyclohexenone was alkylated with 2-I-5-MeOC6H3CH2Br (prepd. in three steps from 2-iodo-5-methoxybenzyl alc.) followed by redn. and acid-catalyzed elimination to give iodobenzyl cyclohexenone II; treatment of II under similar conditions to I gave the tetrahydrofluorenone IV stereoselectively in 80% yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ol96YEBawbVg90H21EOLACvtfcHk0lgtnGRfnmzrZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtbs%253D&md5=8b49627c3e2fecd030716d72e7f40476</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol016288u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016288u%26sid%3Dliteratum%253Aachs%26aulast%3DPiers%26aufirst%3DE.%26aulast%3DHarrison%26aufirst%3DC.%2BL.%26aulast%3DZetina-Rocha%26aufirst%3DC.%26atitle%3DIntramolecular%2520conjugate%2520addition%2520of%2520alkenyl%2520and%2520aryl%2520functions%2520to%2520enones%2520initiated%2520by%2520lithium-iodine%2520exchange%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D3245%26epage%3D3247%26doi%3D10.1021%2Fol016288u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Nispen, S. P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leusen, A. M.</span></span> <span> </span><span class="NLM_article-title">Use of dilithio-tosylmethyl isocyanide in the synthesis of oxazoles and imidazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3723</span>– <span class="NLM_lpage">3726</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(00)78757-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs0040-4039%2800%2978757-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL3MXhtVent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1980&pages=3723-3726&author=S.+P.+J.+M.+van%0ANispenauthor=C.+Mensinkauthor=A.+M.+van+Leusen&title=Use+of+dilithio-tosylmethyl+isocyanide+in+the+synthesis+of+oxazoles+and+imidazoles&doi=10.1016%2Fs0040-4039%2800%2978757-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of sulfonylmethyl isocyanides.  21.  Use of dilithio(tolylsulfonyl)methyl isocyanide in the synthesis of oxazoles and imidazoles</span></div><div class="casAuthors">Van Nispen, Simon P. J. M.; Mensink, Cees; Van Leusen, Albert M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">3723-6</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The reactions of 4-MeC6H4SO2CLi2NC (I) with a range of substrates were studied.  I reacted with the carbonyl of unsatd. esters to give oxazoles, e.g. reaction with trans-PHCH:CHCO2Me (-70 to 0°, 2 h) gave the oxazole II (53%), whereas the monoanion gave pyrroles by reaction with the conjugated C:C bonds.  With C-N multiple bonds, I gave imidazoles, e.g. with isoquinoline (-70 to 0°, 0.5 h) 44% imidazo[5,1-a]isoquinoline was obtained in a single step.  Reaction of pyridine or pyridazine N-oxides with I gave unsatd. ring opened products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIfKNvIK01zLVg90H21EOLACvtfcHk0lgtnGRfnmzrZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtVent7o%253D&md5=7a83f4b83c99166d9e1a07a78904d463</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4039%2800%2978757-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4039%252800%252978757-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNispen%26aufirst%3DS.%2BP.%2BJ.%2BM.%26aulast%3DMensink%26aufirst%3DC.%26aulast%3Dvan%2BLeusen%26aufirst%3DA.%2BM.%26atitle%3DUse%2520of%2520dilithio-tosylmethyl%2520isocyanide%2520in%2520the%2520synthesis%2520of%2520oxazoles%2520and%2520imidazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1980%26volume%3D21%26spage%3D3723%26epage%3D3726%26doi%3D10.1016%2Fs0040-4039%2800%2978757-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, N.</span>; <span class="NLM_string-name">Friedman, M.</span>; <span class="NLM_string-name">Arnold, L. D.</span>; <span class="NLM_string-name">Yang, B.</span>; <span class="NLM_string-name">Fix-Stenzel, R. S.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Michaelides, M. R.</span>; <span class="NLM_string-name">Qian, X.-D.</span>; <span class="NLM_string-name">Holms, J. H.</span>; <span class="NLM_string-name">Steinman, D. H.</span>; <span class="NLM_string-name">Tian, Z.</span>; <span class="NLM_string-name">Wittenberger, S. J.</span></span> <span> </span><span class="NLM_article-title">Aminobenzoxazoles as Therapeutic Agents</span>. U.S. Patent <span class="NLM_patent">20,060,025,383 A1</span>. Feb 2, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+Wishart&author=M.+Friedman&author=L.+D.+Arnold&author=B.+Yang&author=R.+S.+Fix-Stenzel&author=A.+Ericsson&author=M.+R.+Michaelides&author=X.-D.+Qian&author=J.+H.+Holms&author=D.+H.+Steinman&author=Z.+Tian&author=S.+J.+Wittenberger&title=Aminobenzoxazoles+as+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DAminobenzoxazoles%2520as%2520Therapeutic%2520Agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed intramolecular CH arylation of five-membered <i>N</i>-heterocycles</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3170</span>– <span class="NLM_lpage">3172</span>, <span class="refDoi"> DOI: 10.1055/s-2006-947326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1055%2Fs-2006-947326" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=3170-3172&author=N.+Araiauthor=M.+Takahashiauthor=M.+Mitaniauthor=A.+Mori&title=Palladium-catalyzed+intramolecular+CH+arylation+of+five-membered+N-heterocycles&doi=10.1055%2Fs-2006-947326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-947326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-947326%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DMitani%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520intramolecular%2520CH%2520arylation%2520of%2520five-membered%2520N-heterocycles%26jtitle%3DSynlett%26date%3D2006%26volume%3D18%26spage%3D3170%26epage%3D3172%26doi%3D10.1055%2Fs-2006-947326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span> <span> </span><span class="NLM_article-title">Concise synthesis of pentenyl phenyl acrylic acid</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1080/00397910701473333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1080%2F00397910701473333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=2989-2994&author=D.+Sunauthor=P.+Laiauthor=W.+Xieauthor=J.+Dengauthor=Y.+Jiang&title=Concise+synthesis+of+pentenyl+phenyl+acrylic+acid&doi=10.1080%2F00397910701473333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Concise synthesis of pentenyl phenyl acrylic acid</span></div><div class="casAuthors">Sun, Dequn; Lai, Pengxiang; Xie, Weidong; Deng, Jingen; Jiang, Yaozhong</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2989-2994</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">E-3-[2-Pent-(1Z)-enylphenyl]acrylate (I) is a structural unit of pepticinnamin E, a natural product and a bisubstrate inhibitor of FPTase.  A new synthetic strategy was developed to prep. I with high stereoselectivity and high overall yield of 78.6%.  The method used in producing these effects involved the application of a five-step procedure starting from 2-IC6H4CH2OH through an E-selective Wittig-Horner reaction, followed by Sonogashira reaction to produce E-2-pent-1-ynylcinnamate, which was quant. hydrogenated using Lindlar catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgI-kBCFsGKLVg90H21EOLACvtfcHk0lgJVnaAgJi_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVKqsLc%253D&md5=5de326fef8060f86ff9007adab59d638</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397910701473333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910701473333%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DConcise%2520synthesis%2520of%2520pentenyl%2520phenyl%2520acrylic%2520acid%26jtitle%3DSynth.%2520Commun.%26date%3D2007%26volume%3D37%26spage%3D2989%26epage%3D2994%26doi%3D10.1080%2F00397910701473333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. L.</span></span> <span> </span><span class="NLM_article-title">Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1814</i></span>,  <span class="NLM_fpage">1947</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2011.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.bbapap.2011.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21835273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1814&publication_year=2011&pages=1947-1954&author=D.+Meiningerauthor=L.+Zalamedaauthor=Y.+Liuauthor=L.+P.+Stepanauthor=L.+Borgesauthor=J.+D.+McCarterauthor=C.+L.+Sutherland&title=Purification+and+kinetic+characterization+of+human+indoleamine+2%2C3-dioxygenases+1+and+2+%28IDO1+and+IDO2%29+and+discovery+of+selective+IDO1+inhibitors&doi=10.1016%2Fj.bbapap.2011.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors</span></div><div class="casAuthors">Meininger, David; Zalameda, Leeanne; Liu, Yichin; Stepan, Lara P.; Borges, Luis; McCarter, John D.; Sutherland, Claire L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1814</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1947-1954</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO1) catalyzes the 1st step in tryptophan breakdown along the kynurenine pathway.  Therapeutic inhibition of IDO1 is receiving much attention due to its proposed role in the pathogenesis of several diseases including cancer, hypotension, and neurodegenerative disorders.  A related enzyme, IDO2 has recently been described.  Here. the authors report the 1st purifn. and kinetic characterization of human IDO2 using a facile L-tryptophan consumption assay amenable to high throughput screening.  The authors found that the Km of human IDO2 for L-tryptophan was much higher than that of IDO1.  The authors also described the identification and characterization of a new IDO1 inhibitor compd., Amg-1, by high-throughput screening, and compared the inhibition profiles of IDO1 and IDO2 with Amg-1 and previously described compds.  The data indicated that human IDO1 and IDO2 have different kinetic parameters and different inhibition profiles.  Docking of Amg-1 and related analogs to the known structure of IDO1 and to homol.-modeled IDO2 suggested possible rationales for the different inhibition profiles of IDO1 and IDO2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkjKusST0FNrVg90H21EOLACvtfcHk0lgJVnaAgJi_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSjtbzN&md5=95b88d7de219c1dcc63da1003b73c8f5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DStepan%26aufirst%3DL.%2BP.%26aulast%3DBorges%26aufirst%3DL.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DSutherland%26aufirst%3DC.%2BL.%26atitle%3DPurification%2520and%2520kinetic%2520characterization%2520of%2520human%2520indoleamine%25202%252C3-dioxygenases%25201%2520and%25202%2520%2528IDO1%2520and%2520IDO2%2529%2520and%2520discovery%2520of%2520selective%2520IDO1%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1814%26spage%3D1947%26epage%3D1954%26doi%3D10.1016%2Fj.bbapap.2011.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/s0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2Fs0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lgJVnaAgJi_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2Fs0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljcft7zQAMPsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/s0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2Fs0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljcft7zQAMPsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2Fs0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>Buster</i>, version 2.11.4; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f','cit9g','cit9h','cit9i','cit9j','cit9k','cit9l'],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett Andrew Hopkins, Wensheng Yu, Hongjun Zhang, Sulagna Sanyal, Qinglin Pu, Hua Zhou, Kun Liu, Jongwon Lim, Xavier Fradera, Charles A. Lesburg, Alfred Lammens, Theodore A. Martinot, Ryan D. Cohen, Amy C. Doty, Heidi Ferguson, Elliott B. Nickbarg, Mangeng Cheng, Peter Spacciapoli, Prasanthi Geda, Xuelei Song, Nadya Smotrov, Pravien Abeywickrema, Christine Andrews, Chad Chamberlin, Omar Mabrouk, Patrick Curran, Matthew Richards, Peter Saradjian, J. Richard Miller, Ian Knemeyer, Karin M. Otte, Stella Vincent, Nunzio Sciammetta, Alexander Pasternak, David Jonathan Bennett, <span class="NLM_string-name hlFld-ContribAuthor">Yongxin Han</span>. </span><span class="cited-content_cbyCitation_article-title">Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 389-396. <a href="https://doi.org/10.1021/acsmedchemlett.0c00525" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00525%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarbamate%252Band%252BN-Pyrimidine%252BMitigate%252BAmide%252BHydrolysis%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BTetrahydroquinoline%252BIDO1%252BInhibitors%26aulast%3DLi%26aufirst%3DDerun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D23022021%26date%3D26022021%26volume%3D12%26issue%3D3%26spage%3D389%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ute F. Röhrig, Somi Reddy Majjigapu, Aline Reynaud, Florence Pojer, Nahzli Dilek, Patrick Reichenbach, Kelly Ascencao, Melita Irving, George Coukos, Pierre Vogel, Olivier Michielin, <span class="NLM_string-name hlFld-ContribAuthor">Vincent Zoete</span>. </span><span class="cited-content_cbyCitation_article-title">Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2205-2227. <a href="https://doi.org/10.1021/acs.jmedchem.0c01968" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01968%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAzole-Based%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252B%252528IDO1%252529%252BInhibitors%26aulast%3DR%25C3%25B6hrig%26aufirst%3DUte%2BF.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D09022021%26volume%3D64%26issue%3D4%26spage%3D2205%26epage%3D2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Miyuki Kumazawa, Manabu Tejima, Miwa Fukuda, Shota Takeda, Kenji Suzuki, Yukiko Mizumoto, Kakeru Sato, Minoru Waki, Hiroyuki Miyachi, Akira Asai, Osamu Takikawa, Tomoko Hashimoto, Osamu Ohno, <span class="NLM_string-name hlFld-ContribAuthor">Kenji Matsuno</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Carbono(di)thioates as Indoleamine 2,3-Dioxygenase 1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 211-216. <a href="https://doi.org/10.1021/acsmedchemlett.0c00527" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00527%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BCarbono%252528di%252529thioates%252Bas%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252BInhibitors%26aulast%3DKumazawa%26aufirst%3DMiyuki%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02102020%26date%3D08012021%26date%3D15012021%26volume%3D12%26issue%3D2%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily C. Cherney, Liping Zhang, Susheel Nara, Xiao Zhu, Johnni Gullo-Brown, Derrick Maley, Tai-An Lin, John T. Hunt, Christine Huang, Zheng Yang, Celia Darienzo, Lorell Discenza, Asoka Ranasinghe, Mary Grubb, Theresa Ziemba, Sarah C. Traeger, Xin Li, Kathy Johnston, Lisa Kopcho, Mark Fereshteh, Kimberly Foster, Kevin Stefanski, Joseph Fargnoli, Jesse Swanson, Jennifer Brown, Diane Delpy, Steven P. Seitz, Robert Borzilleri, Gregory Vite, <span class="NLM_string-name hlFld-ContribAuthor">Aaron Balog</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 288-294. <a href="https://doi.org/10.1021/acsmedchemlett.0c00668" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00668%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BPreclinical%252BEvaluation%252Bof%252BBMS-986242%25252C%252Ba%252BPotent%25252C%252BSelective%252BInhibitor%252Bof%252BIndoleamine-2%25252C3-dioxygenase%252B1%26aulast%3DCherney%26aufirst%3DEmily%2BC.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20122020%26date%3D22012021%26date%3D28012021%26volume%3D12%26issue%3D2%26spage%3D288%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Feng, Dongdong Liao, Dongyu Liu, An Ping, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15115-15139. <a href="https://doi.org/10.1021/acs.jmedchem.0c00925" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00925%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252BInhibitors%252Bfor%252BCancer%252BTherapy%252Band%252BBeyond%25253A%252BA%252BRecent%252BPerspective%26aulast%3DFeng%26aufirst%3DXi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31052020%26date%3D20112020%26volume%3D63%26issue%3D24%26spage%3D15115%26epage%3D15139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wolfgang Jahnke, Daniel A. Erlanson, Iwan J. P. de Esch, Christopher N. Johnson, Paul N. Mortenson, Yuji Ochi, <span class="NLM_string-name hlFld-ContribAuthor">Tatsuya Urushima</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2019. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15494-15507. <a href="https://doi.org/10.1021/acs.jmedchem.0c01608" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2019%26aulast%3DJahnke%26aufirst%3DWolfgang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14092020%26date%3D23112020%26volume%3D63%26issue%3D24%26spage%3D15494%26epage%3D15507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xue Tang, Nan Zhang, Gu He, Cheng-Hao Li, Wei Huang, Xiao-Yun Wang, Gu Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Bo Han</span>. </span><span class="cited-content_cbyCitation_article-title">Unconventional [2 + 3] Cyclization Involving [1,4]-Sulfonyl Transfer to Construct Polysubstituted Fluorazones as Inhibitors of Indoleamine 2,3-Dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (20)
                                     , 7909-7914. <a href="https://doi.org/10.1021/acs.orglett.0c02836" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02836</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02836%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DUnconventional%252B%25255B2%252B%25252B%252B3%25255D%252BCyclization%252BInvolving%252B%25255B1%25252C4%25255D-Sulfonyl%252BTransfer%252Bto%252BConstruct%252BPolysubstituted%252BFluorazones%252Bas%252BInhibitors%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%26aulast%3DTang%26aufirst%3DXue%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D29092020%26volume%3D22%26issue%3D20%26spage%3D7909%26epage%3D7914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cristina Crescenzi, Thomas Fuchss, Dimitri Ippoliti, Annunziata Langella, Antonia Di Mola, Antonio Massa, <span class="NLM_string-name hlFld-ContribAuthor">Diego Rozzi</span>. </span><span class="cited-content_cbyCitation_article-title">Reiterative Chiral Resolution/Racemization/Recycle (RRR Synthesis) for an Effective and Scalable Process for the Enantioselective Synthesis of a Dual IDO1/TDO2 Inhibitor Imidazoisoindole Derivative. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (6)
                                     , 1018-1023. <a href="https://doi.org/10.1021/acs.oprd.0c00004" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DReiterative%252BChiral%252BResolution%25252FRacemization%25252FRecycle%252B%252528RRR%252BSynthesis%252529%252Bfor%252Ban%252BEffective%252Band%252BScalable%252BProcess%252Bfor%252Bthe%252BEnantioselective%252BSynthesis%252Bof%252Ba%252BDual%252BIDO1%25252FTDO2%252BInhibitor%252BImidazoisoindole%252BDerivative%26aulast%3DCrescenzi%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08012020%26date%3D14052020%26date%3D30042020%26volume%3D24%26issue%3D6%26spage%3D1018%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brendan T. Parr, Richard Pastor, Benjamin D. Sellers, Zhonghua Pei, Firoz A. Jaipuri, Georgette M. Castanedo, Lewis Gazzard, Sanjeev Kumar, Xiaokai Li, Wen Liu, Rohan Mendonca, Roheeth K. Pavana, Hima Potturi, Cheng Shao, Venkata Velvadapu, Jesse P. Waldo, Guosheng Wu, Po-wai Yuen, Zuhui Zhang, Yamin Zhang, Seth F. Harris, Angela J. Oh, Antonio DiPasquale, Kevin Dement, Hank La, Leanne Goon, Amy Gustafson, Erica C. VanderPorten, Mario R. Mautino, <span class="NLM_string-name hlFld-ContribAuthor">Yichin Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 541-549. <a href="https://doi.org/10.1021/acsmedchemlett.0c00004" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImplementation%252Bof%252Bthe%252BCYP%252BIndex%252Bfor%252Bthe%252BDesign%252Bof%252BSelective%252BTryptophan-2%25252C3-dioxygenase%252BInhibitors%26aulast%3DParr%26aufirst%3DBrendan%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03012020%26date%3D04032020%26date%3D06032020%26date%3D04032020%26volume%3D11%26issue%3D4%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, <span class="NLM_string-name hlFld-ContribAuthor">Silvia Fallarini</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3047-3065. <a href="https://doi.org/10.1021/acs.jmedchem.9b01809" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01809%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%252BBenzimidazole%252BDerivatives%252Bas%252BIndoleamine%252B2%25252C3-Dioxygenase-1%252B%252528IDO1%252529%252BInhibitors%25253A%252BFrom%252BStructure-Based%252BVirtual%252BScreening%252Bto%252Bin%252BVivo%252BPharmacodynamic%252BActivity%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31102019%26date%3D17032020%26date%3D09032020%26volume%3D63%26issue%3D6%26spage%3D3047%26epage%3D3065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christoph Steeneck, Olaf Kinzel, Simon Anderhub, Martin Hornberger, Sheena Pinto, Barbara Morschhaeuser, Floriane Braun, Gerald Kleymann, <span class="NLM_string-name hlFld-ContribAuthor">Thomas Hoffmann</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 179-187. <a href="https://doi.org/10.1021/acsmedchemlett.9b00572" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00572%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BHydroxyamidine%252BBased%252BInhibitors%252Bof%252BIDO1%252Bfor%252BCancer%252BImmunotherapy%252Bwith%252BReduced%252BPotential%252Bfor%252BGlucuronidation%26aulast%3DSteeneck%26aufirst%3DChristoph%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04122019%26date%3D22012020%26date%3D27012020%26volume%3D11%26issue%3D2%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Ya-Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Yihui  Song</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01080-8" title="DOI URL">https://doi.org/10.1186/s13045-021-01080-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01080-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DIndoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%252Bin%252Bclinical%252Btrials%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DTang%26aufirst%3DKai%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junmin  Dong</span>, <span class="hlFld-ContribAuthor ">Xuan  Pan</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhanzhu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113631. <a href="https://doi.org/10.1016/j.ejmech.2021.113631" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113631%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bexiguamine%252BA%252Banalogues%252Bas%252BIDO1%252Binhibitors%26aulast%3DDong%26aufirst%3DJunmin%26date%3D2021%26volume%3D223%26spage%3D113631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaymaa Emam  Kassab</span>, <span class="hlFld-ContribAuthor ">Samar  Mowafy</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>242 </em><a href="https://doi.org/10.1002/cmdc.202100253" title="DOI URL">https://doi.org/10.1002/cmdc.202100253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BBasis%252Bof%252BSelective%252BHuman%252BIndoleamine%2525E2%252580%2525902%25252C3%2525E2%252580%252590dioxygenase%252B1%252B%252528hIDO1%252529%252BInhibition%26aulast%3DKassab%26aufirst%3DShaymaa%2BEmam%26date%3D2021%26date%3D2021%26volume%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Dai</span>, <span class="hlFld-ContribAuthor ">Yuhang  Yan</span>, <span class="hlFld-ContribAuthor ">Xiangli  Ning</span>, <span class="hlFld-ContribAuthor ">Gen  Li</span>, <span class="hlFld-ContribAuthor ">Junlin  Yu</span>, <span class="hlFld-ContribAuthor ">Ji  Deng</span>, <span class="hlFld-ContribAuthor ">Lingling  Yang</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 1931-1946. <a href="https://doi.org/10.1016/j.apsb.2021.01.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DAncPhore%25253A%252BA%252Bversatile%252Btool%252Bfor%252Banchor%252Bpharmacophore%252Bsteered%252Bdrug%252Bdiscovery%252Bwith%252Bapplications%252Bin%252Bdiscovery%252Bof%252Bnew%252Binhibitors%252Btargeting%252Bmetallo-%2525CE%2525B2-lactamases%252Band%252Bindoleamine%25252Ftryptophan%252B2%25252C3-dioxygenases%26aulast%3DDai%26aufirst%3DQingqing%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D1931%26epage%3D1946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Capochiani de Iudicibus</span>, <span class="hlFld-ContribAuthor ">Petr  Tomek</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Sofian M.  Tijono</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Lai-Ming  Ching</span>. </span><span class="cited-content_cbyCitation_article-title">Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116160. <a href="https://doi.org/10.1016/j.bmc.2021.116160" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116160%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DParallel%252Bdiscovery%252Bof%252Bselective%252Band%252Bdual%252Binhibitors%252Bof%252Btryptophan%252Bdioxygenases%252BIDO1%252Band%252BTDO2%252Bwith%252Ba%252Bnewly-modified%252Benzymatic%252Bassay%26aulast%3DCapochiani%2Bde%2BIudicibus%26aufirst%3DRossella%26date%3D2021%26volume%3D39%26spage%3D116160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José T.  Moreira-Filho</span>, <span class="hlFld-ContribAuthor ">Arthur C.  Silva</span>, <span class="hlFld-ContribAuthor ">Rafael F.  Dantas</span>, <span class="hlFld-ContribAuthor ">Barbara F.  Gomes</span>, <span class="hlFld-ContribAuthor ">Lauro R.  Souza Neto</span>, <span class="hlFld-ContribAuthor ">Jose  Brandao-Neto</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Owens</span>, <span class="hlFld-ContribAuthor ">Nicholas  Furnham</span>, <span class="hlFld-ContribAuthor ">Bruno J.  Neves</span>, <span class="hlFld-ContribAuthor ">Floriano P.  Silva-Junior</span>, <span class="hlFld-ContribAuthor ">Carolina H.  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.642383" title="DOI URL">https://doi.org/10.3389/fimmu.2021.642383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.642383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.642383%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DSchistosomiasis%252BDrug%252BDiscovery%252Bin%252Bthe%252BEra%252Bof%252BAutomation%252Band%252BArtificial%252BIntelligence%26aulast%3DMoreira-Filho%26aufirst%3DJos%25C3%25A9%2BT.%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zheng</span>, <span class="hlFld-ContribAuthor ">Paul M.  Stafford</span>, <span class="hlFld-ContribAuthor ">Kurt R.  Stover</span>, <span class="hlFld-ContribAuthor ">Darapaneni Chandra  Mohan</span>, <span class="hlFld-ContribAuthor ">Mayuri  Gupta</span>, <span class="hlFld-ContribAuthor ">Eric C.  Keske</span>, <span class="hlFld-ContribAuthor ">Paolo  Schiavini</span>, <span class="hlFld-ContribAuthor ">Laura  Villar</span>, <span class="hlFld-ContribAuthor ">Fan  Wu</span>, <span class="hlFld-ContribAuthor ">Alexander  Kreft</span>, <span class="hlFld-ContribAuthor ">Kiersten  Thomas</span>, <span class="hlFld-ContribAuthor ">Elana  Raaphorst</span>, <span class="hlFld-ContribAuthor ">Jagadeesh P.  Pasangulapati</span>, <span class="hlFld-ContribAuthor ">Siva R.  Alla</span>, <span class="hlFld-ContribAuthor ">Simmi  Sharma</span>, <span class="hlFld-ContribAuthor ">Ramana R.  Mittapalli</span>, <span class="hlFld-ContribAuthor ">Irina  Sagamanova</span>, <span class="hlFld-ContribAuthor ">Shea L.  Johnson</span>, <span class="hlFld-ContribAuthor ">Mark A.  Reed</span>, <span class="hlFld-ContribAuthor ">Donald F.  Weaver</span>. </span><span class="cited-content_cbyCitation_article-title">A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1002/cmdc.202100107" title="DOI URL">https://doi.org/10.1002/cmdc.202100107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100107%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BSeries%252Bof%252B2%2525E2%252580%252590%252528%2525281%2525E2%252580%252590Phenyl%2525E2%252580%2525901H%2525E2%252580%252590imidazol%2525E2%252580%2525905%2525E2%252580%252590yl%252529methyl%252529%2525E2%252580%2525901H%2525E2%252580%252590indoles%252Bas%252BIndoleamine%252B2%25252C3%2525E2%252580%252590Dioxygenase%252B1%252B%252528IDO1%252529%252BInhibitors%26aulast%3DZheng%26aufirst%3DYong%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Dolšak</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>221 </em>, 107746. <a href="https://doi.org/10.1016/j.pharmthera.2020.107746" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107746%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DIndoleamine%252Band%252Btryptophan%252B2%25252C3-dioxygenases%252Bas%252Bimportant%252Bfuture%252Btherapeutic%252Btargets%26aulast%3DDol%25C5%25A1ak%26aufirst%3DAna%26date%3D2021%26volume%3D221%26spage%3D107746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulun  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Tan</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The ups, downs and new trends of IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104815. <a href="https://doi.org/10.1016/j.bioorg.2021.104815" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104815%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bups%25252C%252Bdowns%252Band%252Bnew%252Btrends%252Bof%252BIDO1%252Binhibitors%26aulast%3DChen%26aufirst%3DShulun%26date%3D2021%26volume%3D110%26spage%3D104815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Singh</span>, <span class="hlFld-ContribAuthor ">Deepak B.  Salunke</span>. </span><span class="cited-content_cbyCitation_article-title">Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113071. <a href="https://doi.org/10.1016/j.ejmech.2020.113071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiverse%252Bchemical%252Bspace%252Bof%252Bindoleamine-2%25252C3-dioxygenase%252B1%252B%252528Ido1%252529%252Binhibitors%26aulast%3DSingh%26aufirst%3DRahul%26date%3D2021%26volume%3D211%26spage%3D113071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Daina</span>, <span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 386-401. <a href="https://doi.org/10.1016/B978-0-12-801238-3.11670-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-801238-3.11670-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801238-3.11670-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801238-3.11670-8%26sid%3Dliteratum%253Aachs%26atitle%3DComputer-Aided%252BDrug%252BDesign%252Bfor%252BCancer%252BTherapy%26aulast%3DDaina%26aufirst%3DAntoine%26date%3D2021%26spage%3D386%26epage%3D401%26pub%3DElsevier%26atitle%3DSystems%252BMedicine%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulei  Pan</span>, <span class="hlFld-ContribAuthor ">Yangli  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yanlin  Wang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Luyi  Huang</span>, <span class="hlFld-ContribAuthor ">Jinshan  Nan</span>, <span class="hlFld-ContribAuthor ">Linli  Li</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112703. <a href="https://doi.org/10.1016/j.ejmech.2020.112703" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112703%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252B1-aryl-1H-naphtho%25255B2%25252C3-d%25255D%25255B1%25252C2%25252C3%25255Dtriazole-4%25252C9-dione%252Bderivatives%252Bas%252Bpotent%252Bdual%252Binhibitors%252Bof%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Band%252Btrytophan%252B2%25252C3-dioxygenase%252B%252528TDO%252529%26aulast%3DPan%26aufirst%3DShulei%26date%3D2020%26volume%3D207%26spage%3D112703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manon  Mirgaux</span>, <span class="hlFld-ContribAuthor ">Laurence  Leherte</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of the presence of the heme cofactor on the JK-loop structure in indoleamine 2,3-dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2020,</strong> <em>76 </em>
                                    (12)
                                     , 1211-1221. <a href="https://doi.org/10.1107/S2059798320013510" title="DOI URL">https://doi.org/10.1107/S2059798320013510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798320013510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798320013510%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DInfluence%252Bof%252Bthe%252Bpresence%252Bof%252Bthe%252Bheme%252Bcofactor%252Bon%252Bthe%252BJK-loop%252Bstructure%252Bin%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%26aulast%3DMirgaux%26aufirst%3DManon%26date%3D2020%26date%3D2020%26volume%3D76%26issue%3D12%26spage%3D1211%26epage%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengnan  Zhang</span>, <span class="hlFld-ContribAuthor ">Leilei  Guo</span>, <span class="hlFld-ContribAuthor ">Dan  Yang</span>, <span class="hlFld-ContribAuthor ">Zikang  Xing</span>, <span class="hlFld-ContribAuthor ">Weirui  Li</span>, <span class="hlFld-ContribAuthor ">Chunxiang  Kuang</span>, <span class="hlFld-ContribAuthor ">Qing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104348. <a href="https://doi.org/10.1016/j.bioorg.2020.104348" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104348%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DEvaluation%252Band%252Bcomparison%252Bof%252Bthe%252Bcommonly%252Bused%252Bbioassays%252Bof%252Bhuman%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Band%252Btryptophan%252B2%25252C3-dioxygenase%252B%252528TDO%252529%26aulast%3DZhang%26aufirst%3DShengnan%26date%3D2020%26volume%3D104%26spage%3D104348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery and development of selective heme-displacing IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 1223-1232. <a href="https://doi.org/10.1080/17460441.2020.1781811" title="DOI URL">https://doi.org/10.1080/17460441.2020.1781811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1781811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1781811%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bselective%252Bheme-displacing%252BIDO1%252Binhibitors%26aulast%3DSun%26aufirst%3DLijun%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D1223%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long-fei  Mao</span>, <span class="hlFld-ContribAuthor ">Yu-wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhao</span>, <span class="hlFld-ContribAuthor ">Gui-qing  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-jun  Yao</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.579024" title="DOI URL">https://doi.org/10.3389/fphar.2020.579024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.579024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.579024%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DDiscovery%252Bof%252BIcotinib-1%25252C2%25252C3-Triazole%252BDerivatives%252Bas%252BIDO1%252BInhibitors%26aulast%3DMao%26aufirst%3DLong-fei%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Zhang</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potential indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors by an FBG-based 3D QSAR pharmacophore model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107628. <a href="https://doi.org/10.1016/j.jmgm.2020.107628" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DIdentification%252Bof%252Bpotential%252Bindoleamine%252B2%25252C%252B3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%252Bby%252Ban%252BFBG-based%252B3D%252BQSAR%252Bpharmacophore%252Bmodel%26aulast%3DZhang%26aufirst%3DLu%26date%3D2020%26volume%3D99%26spage%3D107628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Mammoli</span>, <span class="hlFld-ContribAuthor ">Alice  Coletti</span>, <span class="hlFld-ContribAuthor ">Marco  Ballarotto</span>, <span class="hlFld-ContribAuthor ">Alessandra  Riccio</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Ursula  Grohmann</span>, <span class="hlFld-ContribAuthor ">Emidio  Camaioni</span>, <span class="hlFld-ContribAuthor ">Antonio  Macchiarulo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 891-899. <a href="https://doi.org/10.1002/cmdc.202000116" title="DOI URL">https://doi.org/10.1002/cmdc.202000116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000116%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNew%252BInsights%252Bfrom%252BCrystallographic%252BData%25253A%252BDiversity%252Bof%252BStructural%252BMotifs%252Band%252BMolecular%252BRecognition%252BProperties%252Bbetween%252BGroups%252Bof%252BIDO1%252BStructures%26aulast%3DMammoli%26aufirst%3DAndrea%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D891%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohan  Song</span>, <span class="hlFld-ContribAuthor ">Pu  Sun</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-hua  Meng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112059. <a href="https://doi.org/10.1016/j.ejmech.2020.112059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C2%25252C5-oxadiazole-3-carboximidamide%252Bderivatives%252Bas%252Bnovel%252Bindoleamine-2%25252C3-dioxygenase%252B1%252Binhibitors%26aulast%3DSong%26aufirst%3DXiaohan%26date%3D2020%26volume%3D189%26spage%3D112059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shushan  Ge</span>, <span class="hlFld-ContribAuthor ">Haiqing  Zhong</span>, <span class="hlFld-ContribAuthor ">Xuewei  Ma</span>, <span class="hlFld-ContribAuthor ">Yingbo  Zheng</span>, <span class="hlFld-ContribAuthor ">Yi  Zou</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yue  Hu</span>, <span class="hlFld-ContribAuthor ">Yuezhen  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1240-1257. <a href="https://doi.org/10.1080/14756366.2020.1765165" title="DOI URL">https://doi.org/10.1080/14756366.2020.1765165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1765165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1765165%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bsecondary%252Bsulphonamides%252Bas%252BIDO1%252Binhibitors%252Bwith%252Bpotent%252Bantitumour%252Beffects%252Bin%2525C2%2525A0vivo%26aulast%3DGe%26aufirst%3DShushan%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1240%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0042.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Predicted binding mode for <b>11</b> (magenta) minimized in the IDO1 pocket using the crystal IDO1 structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a> (hydrogen bonding and heme interaction with <b>11</b> shown with the red dotted line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of Combination on IDO1 Inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>37</b> (magenta) minimized in the IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) pocket (receptor surface shown in gray, heme, and ligand interaction shown by red dashes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>S</i>-Isomer of racemate <b>46</b> (magenta) minimized in IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) and cyan dashes show distance (4.2 Å) between the heme propionate side chain and methylene carbon linker.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of C11 substitution to target heme propionate interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Evaluation of <b>52</b> isomers toward IDO1 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>124</b> minimized in the IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a>) pocket; ligand–receptor interactions including hydrogen bond shown by red dashes. The cyan dashes shows the distance between C15 of cyclohexyl and Ser235 oxygen (4.4 Å) and Arg231 nitrogen (4.4 Å).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>NLG-919</b> bound to human IDO1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3I">6O3I</a>). The protein is colored ivory. The heme molecule is displayed in light blue ball-and-stick, highlighting protein/heme interactions at the propionate (yellow dashes) and the iron atom (grey dashes). Hydrogen bonds from <b>NLG-919</b> to the protein are indicated in red dashes, and select residues in the immediate vicinity of the binding site are shown in stick and labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor activity of <b>NLG-919</b> in the Pan02 tumor model. (A) 5 × 10<sup>6</sup> Pan02 cells were implanted s.c. into the flank of C57Bl/6 mice (<i>n</i> = 7/group). <b>NLG-919</b> was dosed at 500 mg/kg/day, from days 7–32. (B) Survival of C57Bl/6 mice bearing Pan02 tumors (<i>n</i> = 12/group), where mice were dosed with <b>NLG-919</b> at 400 mg/kg/day from days 7– 25 post-tumor inoculation, with or without three doses of cyclophosphamide 100 mg/kg i.p. on days 8, 13, and 15.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Substituted 5-(Phenyl)-1<i>H</i>-imidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) CuBr<sub>2</sub>, CHCl<sub>3</sub>, 60 °C; (ii) H<sub>2</sub>NCHO, 170–180 °C, 33–61%.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0023.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) EtMgBr, THF, rt, 1.5 h; (ii) ZnCl<sub>2</sub>, 1.5 h; (b) 4-chloro-2-fluoro-6-iodophenol, 10% Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, 70 °C, 12 h; (c) AcOH, MeOH, 80 °C, 37%.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0025.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>13–20</b> and <b>36</b> by Van Leusen Imidazole Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: conditions A: (a) (i) R<sup>4</sup>NH<sub>2</sub>, MeOH, 15–20 h; (ii) TosMIC, piperidine, 36 h, 46–65%. Conditions B: (a) TosMIC, NaO<i>t</i>-Bu, THF, −40 °C, 50 min, (b) Et<sub>3</sub>N, POCl<sub>3</sub>, −10 °C, 45 min, (c) R<sup>4</sup>NH<sub>2</sub>, MeOH, 25 °C, 12 h, 26–95%.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0026.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-(2-Cyclohexylethoxy)-6-hydroxybenzaldehyde (<b>12c</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-cyclohexylethan-1-ol, DEAD, PPh<sub>3</sub>, THF, overnight, 69%; (b) DIBAL-H, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 1.5 h, 35%.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0027.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>26–35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 1 h; (ii) R–X, 0 °C to rt, 10–15 h; (b) AcOH, MeOH, 80 °C, 2 h, 15–73%.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0028.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) imidazole, DEAD, PPh<sub>3</sub>, THF, 0–60 °C, 14 h, 43%; (b) Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 36 h, 37%; (c) HBr (aq, 48%), 100 °C, 14 h, 68%.</p></p></figure><figure data-id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0029.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-amino-1-ethanol, MeOH, 40 °C, 1 h; (b) TosMIC, DME/MeOH, rt, 72 h, 46%; (c) PPh<sub>3</sub>, DEAD, THF, 0 °C to rt, 16 h, 84%.</p></p></figure><figure data-id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0030.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −40 °C, 1 h; (ii) (2-iodoethyl)cyclohexane, −40 °C to rt, 14 h, 80%.</p></p></figure><figure data-id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0031.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 1 h; (ii) 2-bromo-1-cyclohexylethan-1-one, 0 °C to rt, 14 h; (b) AcOH, MeOH, 80 °C, 2 h, 62%; (c) NaBH<sub>4</sub>, MeOH, 0 °C to rt 1 h, 90%.</p></p></figure><figure data-id="sch10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0013.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Horner–Wadsworth–Emmons Reaction of Dimethyl (2-Oxo)phosphonates with Substituted Aldehydes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, THF, 0 °C, 40 min; (ii) <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0010.eps.gif" alt="" /></img></span> 0 °C to rt, 16 h; (b) AcOH, MeOH, 90 °C, 2 h, 24–96%; (c), NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 43–95%.</p></p></figure><figure data-id="sch11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0014.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Dimethyl (2-Oxo)phosphonates <b>49(a-p)</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>n</i>-BuLi, THF, −78 °C, 0.5 h; (ii) R<sup>1</sup>CO<sub>2</sub>R<sup>2</sup> [<b>49(a-p)-SM]</b>, −78 to 0 °C, 1.5 h. [R<sup>2</sup> = Me for <b>49(a-o)-SM</b>; R<sup>2</sup> = Et for <b>49p-SM</b>].</p></p></figure><figure data-id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0015.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of <b>50(a-f)</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF/H<sub>2</sub>O, 90 °C, 16 h, 46–87%.</p></p></figure><figure data-id="sch13" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0016.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthesis of <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PPh<sub>3</sub>, DEAD, phthalimide, THF, 0 °C to rt, 16 h; (b) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, 6 h, rt, 20%.</p></p></figure><figure data-id="sch14" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0017.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Imidazoisoindoles <b>57</b>, <b>58</b>, and <b>102</b> Synthesis by Negishi Cross-Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) EtMgBr, THF, rt, 1.5 h; (ii) ZnCl<sub>2</sub>, <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0011.eps.gif" alt="" /></img></span>, Pd(PPh<sub>3</sub>)<sub>4</sub>, rt to 70 °C, 12.5 h; (iii) AcOH, MeOH, 80 °C, 3 h, 23–25%; (b) NaBH<sub>4</sub>, LiCl, THF, EtOH, rt, 16 h, 91%; (c) NaBH<sub>4</sub>, MeOH, 0 °C, 1 h, 98%; (d) MeMgBr, THF, 0 °C to rt, 2 h, 52%.</p></p></figure><figure data-id="sch15" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0018.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Aldol Condensation of 2-(1-Trityl-1<i>H</i>-imidazol-4-yl)benzaldehydes with Methyl Ketones Followed by Intramolecular Aza-Michael Cyclization<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaOMe, THF/MeOH, rt, 3 h; (ii) AcOH, MeOH, 80 °C, 3–10 h, 11–61%; (b) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 15–98%.</p></p></figure><figure data-id="sch16" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0019.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Amide Synthesis by HATU Coupling of <b>84</b> with Substituted Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, HCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (b) HATU, <i>i</i>-Pr<sub>2</sub>NEt, DMF, rt, 18 h, 29–76%.</p></p></figure><figure data-id="sch17" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0020.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of <b>94</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhNCO, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 0.5 h, 62%.</p></p></figure><figure data-id="sch18" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0021.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of <b>120</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCl, MeOH, 0–50 °C, 2.5 h, 99%; (b) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1 h, 78%.</p></p></figure><figure data-id="sch19" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0022.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 19. Synthesis and Chiral Separation of <b>127</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 2 h; (ii) 6 N HCl, 50 °C, 45 min; (iii) NaHCO<sub>3</sub>, 92%; (b) chiral SFC.</p></p></figure><figure data-id="sch20" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/medium/jm-2019-00662v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0024.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 20. Synthesis and Chiral SFC Separation of <b>126</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00662/20190719/images/large/jm-2019-00662v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00662&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, HCl, MeOH, 0–50 °C, 2.5 h, 99%; (b) LS-selectride, THF, −78 °C, 3 h, 86%; (c) chiral SFC.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i229">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondarev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span> <span> </span><span class="NLM_article-title">Prevention of allogeneic fetal rejection by tryptophan catabolism</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1126/science.281.5380.1191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1126%2Fscience.281.5380.1191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=9712583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Cqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1191-1193&author=D.+H.+Munnauthor=M.+Zhouauthor=J.+T.+Attwoodauthor=I.+Bondarevauthor=S.+J.+Conwayauthor=B.+Marshallauthor=C.+Brownauthor=A.+L.+Mellor&title=Prevention+of+allogeneic+fetal+rejection+by+tryptophan+catabolism&doi=10.1126%2Fscience.281.5380.1191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of allogeneic fetal rejection by tryptophan catabolism</span></div><div class="casAuthors">Munn, David H.; Zhou, Min; Attwood, John T.; Bondarev, Igor; Conway, Simon J.; Marshall, Brendan; Brown, Corrie; Mellor, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5380</span>),
    <span class="NLM_cas:pages">1191-1193</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In 1953 Medawar pointed out that survival of the genetically disparate (allogeneic) mammalian conceptus contradicts the laws of tissue transplantation.  Rapid T cell-induced rejection of all allogeneic concepti occurred when pregnant mice were treated with a pharmacol. inhibitor of indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing enzyme expressed by trophoblasts and macrophages.  Thus, by catabolizing tryptophan, the mammalian conceptus suppresses T cell activity and defends itself against rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEbmX105sj7Vg90H21EOLACvtfcHk0ljW_jkcD9a7Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Cqu7c%253D&md5=d41cbe1943b4eedf7b5b4a398ad6b81e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5380.1191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5380.1191%26sid%3Dliteratum%253Aachs%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DAttwood%26aufirst%3DJ.%2BT.%26aulast%3DBondarev%26aufirst%3DI.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DMellor%26aufirst%3DA.%2BL.%26atitle%3DPrevention%2520of%2520allogeneic%2520fetal%2520rejection%2520by%2520tryptophan%2520catabolism%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1191%26epage%3D1193%26doi%3D10.1126%2Fscience.281.5380.1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1038/83183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2F83183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11135580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=64-68&author=A.+L.+Mellorauthor=J.+Sivakumarauthor=P.+Chandlerauthor=K.+Smithauthor=H.+Molinaauthor=D.+Maoauthor=D.+H.+Munn&title=Prevention+of+T+cell-driven+complement+activation+and+inflammation+by+tryptophan+catabolism+during+pregnancy&doi=10.1038%2F83183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy</span></div><div class="casAuthors">Mellor, Andrew L.; Sivakumar, Jayabalan; Chandler, Phillip; Smith, Kimberly; Molina, Hector; Mao, Dailing; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-68</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Indoleamine 2,3 dioxygenase (IDO) activity during pregnancy protects developing fetuses from maternal immune responses in CBA mice.  The authors show here that fetal allografts were rejected only in mating combinations where paternally inherited tissue antigens elicited potent maternal T cell responses after exposure to IDO inhibitor.  IDO inhibitor treatment triggered extensive inflammation at the maternal-fetal interface in susceptible mating combinations, which was characterized by complement deposition and hemorrhagic necrosis.  Identical inflammatory responses occurred in B cell-deficient (RAG-I-/-) mothers that carried a monoclonal cohort of CD8+ T cells specific for a single paternally inherited fetal major histocompatibility complex antigen.  Thus, fetal allograft rejection was accompanied by a unique form of inflammation that was characterized by T cell-dependent, antibody-independent activation of complement.  In contrast, no inflammation, complement deposition or T cell infiltration was elicited when mice carrying syngeneic fetuses were exposed to IDO inhibitor.  These data show that IDO activity protects the fetus by suppressing T cell-driven local inflammatory responses to fetal alloantigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokEs6XgjSI4LVg90H21EOLACvtfcHk0lg5Dlah3O_caQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslylsw%253D%253D&md5=88940e78aa4bbb979e327e498c85d5c0</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2F83183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F83183%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DSivakumar%26aufirst%3DJ.%26aulast%3DChandler%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DMolina%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DD.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DPrevention%2520of%2520T%2520cell-driven%2520complement%2520activation%2520and%2520inflammation%2520by%2520tryptophan%2520catabolism%2520during%2520pregnancy%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D64%26epage%3D68%26doi%3D10.1038%2F83183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Extinguishing maternal immune responses during pregnancy: implications for immunosuppression</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1006/smim.2000.0317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1006%2Fsmim.2000.0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11437628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=213-218&author=A.+L.+Mellorauthor=D.+H.+Munn&title=Extinguishing+maternal+immune+responses+during+pregnancy%3A+implications+for+immunosuppression&doi=10.1006%2Fsmim.2000.0317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Extinguishing maternal immune responses during pregnancy: implications for immunosuppression</span></div><div class="casAuthors">Mellor, Andrew L.; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Mammals owe their existence to immunosuppressive processes that prevent fetal rejection in utero.  Blocking tryptophan catabolism during murine pregnancy allows maternal T cells to provoke fetal allograft rejection.  Cells expressing indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan, prevent T cell cycle progression and enhance activation induced T cell death.  Here, we discuss the role of cells expressing IDO in regulating maternal T cell immunity during pregnancy and consider whether this mechanism might contribute to immunol. discrimination by promoting T cell tolerance in other circumstances.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi_mkDEcBEeLVg90H21EOLACvtfcHk0lg5Dlah3O_caQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVOkur0%253D&md5=215cfc2b584ca84b554474e37953f253</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0317%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DExtinguishing%2520maternal%2520immune%2520responses%2520during%2520pregnancy%253A%2520implications%2520for%2520immunosuppression%26jtitle%3DSemin.%2520Immunol.%26date%3D2001%26volume%3D13%26spage%3D213%26epage%3D218%26doi%3D10.1006%2Fsmim.2000.0317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keskin, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munn, D. H.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy</span>. <i>J. Reprod. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/s0165-0378(02)00040-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs0165-0378%2802%2900040-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=12385839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2002&pages=143-150&author=A.+L.+Mellorauthor=P.+Chandlerauthor=G.+K.+Leeauthor=T.+Johnsonauthor=D.+B.+Keskinauthor=J.+Leeauthor=D.+H.+Munn&title=Indoleamine+2%2C3-dioxygenase%2C+immunosuppression+and+pregnancy&doi=10.1016%2Fs0165-0378%2802%2900040-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Indolamine 2,3-dioxygenase, immunosuppression and pregnancy</span></div><div class="casAuthors">Mellor, Andrew L.; Chandler, Phillip; Lee, Geon Kook; Johnson, Theodore; Keskin, Derin B.; Lee, Jeffrey; Munn, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Reproductive Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">143-150</span>CODEN:
                <span class="NLM_cas:coden">JRIMDR</span>;
        ISSN:<span class="NLM_cas:issn">0165-0378</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. inhibition of indolamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses.  Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface.  Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQn3ey-h-Q7Vg90H21EOLACvtfcHk0lg5Dlah3O_caQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOmsrs%253D&md5=b17bf9555775083dc159516b7b2f6c7d</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fs0165-0378%2802%2900040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0165-0378%252802%252900040-2%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DA.%2BL.%26aulast%3DChandler%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKeskin%26aufirst%3DD.%2BB.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%252C%2520immunosuppression%2520and%2520pregnancy%26jtitle%3DJ.%2520Reprod.%2520Immunol.%26date%3D2002%26volume%3D57%26spage%3D143%26epage%3D150%26doi%3D10.1016%2Fs0165-0378%2802%2900040-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wek, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, T. G.</span></span> <span> </span><span class="NLM_article-title">Coping with stress: eIF2 kinases and translational control</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1042/bst0340007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1042%2Fbst0340007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16246168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=7-11&author=R.+C.+Wekauthor=H.-Y.+Jiangauthor=T.+G.+Anthony&title=Coping+with+stress%3A+eIF2+kinases+and+translational+control&doi=10.1042%2Fbst0340007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Coping with stress: eIF2 kinases and translational control</span></div><div class="casAuthors">Wek, R. C.; Jiang, H.-Y.; Anthony, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-11</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  In response to environmental stresses, a family of protein kinases phosphorylate eIF2 (eukaryotic initiation factor 2) to alleviate cellular injury or alternatively induce apoptosis.  Phosphorylation of eIF2 reduces global translation, allowing cells to conserve resources and to initiate a reconfiguration of gene expression to effectively manage stress conditions.  Accompanying this general protein synthesis control, eIF2 phosphorylation induces translation of specific mRNAs, such as that encoding the bZIP (basic leucine zipper) transcriptional regulator ATF4 (activating transcription factor 4).  ATF4 also enhances the expression of addnl. transcription factors, ATF3 and CHOP (CCAAT/enhancer-binding protein homologous protein)/GADD153 (growth arrest and DNA-damage-inducible protein), that assist in the regulation of genes involved in metab., the redox status of the cells and apoptosis.  Reduced translation by eIF2 phosphorylation can also lead to activation of stress-related transcription factors, such as NF-κB (nuclear factor κB), by lowering the steady-state levels of short-lived regulatory proteins such as IκB (inhibitor of NF-κB).  While many of the genes induced by eIF2 phosphorylation are shared between different environmental stresses, eIF2 kinases function in conjunction with other stress-response pathways, such as those regulated by mitogen-activated protein kinases, to elicit gene expression programs that are tailored for the specific stress condition.  Loss of eIF2 kinase pathways can have important health consequences.  Mice devoid of the eIF2 kinase GCN2 [general control non-derepressible-2 or EIF2AK4 (eIF2α kinase 4)] show sensitivity to nutritional deficiencies and aberrant eating behaviors, and deletion of PEK [pancreatic eIF2α kinase or PERK (RNA-dependent protein kinase-like endoplasmic reticulum kinase) or EIF2AK3] leads to neonatal insulin-dependent diabetes, epiphyseal dysplasia and hepatic and renal complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNXgHJoO96crVg90H21EOLACvtfcHk0lgM3RzQkemi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsLbF&md5=3454048d2ad14311acd82f5c06635e54</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2Fbst0340007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0340007%26sid%3Dliteratum%253Aachs%26aulast%3DWek%26aufirst%3DR.%2BC.%26aulast%3DJiang%26aufirst%3DH.-Y.%26aulast%3DAnthony%26aufirst%3DT.%2BG.%26atitle%3DCoping%2520with%2520stress%253A%2520eIF2%2520kinases%2520and%2520translational%2520control%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D7%26epage%3D11%26doi%3D10.1042%2Fbst0340007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinetti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlip, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. R.</span></span> <span> </span><span class="NLM_article-title">Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">118ra11</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3002629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1126%2Fscitranslmed.3002629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22277968" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=118ra11&author=W.+Pengauthor=L.+Robertsonauthor=J.+Gallinettiauthor=P.+Mejiaauthor=S.+Voseauthor=A.+Charlipauthor=T.+Chuauthor=J.+R.+Mitchell&title=Surgical+stress+resistance+induced+by+single+amino+acid+deprivation+requires+Gcn2+in+mice&doi=10.1126%2Fscitranslmed.3002629"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002629%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DRobertson%26aufirst%3DL.%26aulast%3DGallinetti%26aufirst%3DJ.%26aulast%3DMejia%26aufirst%3DP.%26aulast%3DVose%26aufirst%3DS.%26aulast%3DCharlip%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DMitchell%26aufirst%3DJ.%2BR.%26atitle%3DSurgical%2520stress%2520resistance%2520induced%2520by%2520single%2520amino%2520acid%2520deprivation%2520requires%2520Gcn2%2520in%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D118ra11%26doi%3D10.1126%2Fscitranslmed.3002629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mezrich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechner, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingham, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfield, C. A.</span></span> <span> </span><span class="NLM_article-title">An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">3190</span>– <span class="NLM_lpage">3198</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0903670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.4049%2Fjimmunol.0903670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=20720200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSntL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=3190-3198&author=J.+D.+Mezrichauthor=J.+H.+Fechnerauthor=X.+Zhangauthor=B.+P.+Johnsonauthor=W.+J.+Burlinghamauthor=C.+A.+Bradfield&title=An+interaction+between+kynurenine+and+the+aryl+hydrocarbon+receptor+can+generate+regulatory+T+cells&doi=10.4049%2Fjimmunol.0903670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells</span></div><div class="casAuthors">Mezrich, Joshua D.; Fechner, John H.; Zhang, Xiaoji; Johnson, Brian P.; Burlingham, William J.; Bradfield, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3190-3198</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The aryl hydrocarbon receptor (AHR) has been known to cause immunosuppression after binding dioxin.  It has recently been discovered that the receptor may be central to T cell differentiation into FoxP3+ regulatory T cells (Tregs) vs. Th17 cells.  In this paper, we demonstrate that kynurenine, the first breakdown product in the IDO-dependent tryptophan degrdn. pathway, activates the AHR.  We furthermore show that this activation leads to AHR-dependent Treg generation.  We addnl. investigate the dependence of TGF-β on the AHR for optimal Treg generation, which may be secondary to the upregulation of this receptor that is seen in T cells postexposure to TGF-β.  These results shed light on the relationship of IDO to the generation of Tregs, in addn. to highlighting the central importance of the AHR in T cell differentiation.  All tissues and cells were derived from mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnTjsPCkL97Vg90H21EOLACvtfcHk0lgM3RzQkemi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSntL7F&md5=441b434b32547eb126c64a6d995f8081</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0903670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0903670%26sid%3Dliteratum%253Aachs%26aulast%3DMezrich%26aufirst%3DJ.%2BD.%26aulast%3DFechner%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DB.%2BP.%26aulast%3DBurlingham%26aufirst%3DW.%2BJ.%26aulast%3DBradfield%26aufirst%3DC.%2BA.%26atitle%3DAn%2520interaction%2520between%2520kynurenine%2520and%2520the%2520aryl%2520hydrocarbon%2520receptor%2520can%2520generate%2520regulatory%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D3190%26epage%3D3198%26doi%3D10.4049%2Fjimmunol.0903670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, T.</span></span> <span> </span><span class="NLM_article-title">Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">19961</span>– <span class="NLM_lpage">19966</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014465107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.1014465107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21041655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyisLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=19961-19966&author=N.+T.+Nguyenauthor=A.+Kimuraauthor=T.+Nakahamaauthor=I.+Chinenauthor=K.+Masudaauthor=K.+Noharaauthor=Y.+Fujii-Kuriyamaauthor=T.+Kishimoto&title=Aryl+hydrocarbon+receptor+negatively+regulates+dendritic+cell+immunogenicity+via+a+kynurenine-dependent+mechanism&doi=10.1073%2Fpnas.1014465107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism</span></div><div class="casAuthors">Nguyen, Nam Trung; Kimura, Akihiro; Nakahama, Taisuke; Chinen, Ichino; Masuda, Kazuya; Nohara, Keiko; Fujii-Kuriyama, Yoshiaki; Kishimoto, Tadamitsu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">19961-19966, S19961/1-S19961/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although an immunoregulatory role of aryl hydrocarbon receptor (Ahr) has been demonstrated in T cells and macrophages, little is known about its function in dendritic cells (DC).  Here, we show that lipopolysaccharide (LPS) and CpG stimulate Ahr expression in bone marrow-derived dendritic cells (BMDC).  Furthermore, we found that Ahr is required to induce indoleamine 2,3-dioxygenase (IDO) expression, an immunosuppressive enzyme that catabolizes tryptophan into kynurenine (Kyn) and other metabolites in DC.  In the presence of LPS or CpG, Ahr-deficient (Ahr-/-) mature BMDC induced immune responses characterized by reduced Kyn and IL-10 prodn. compared with results obsd. with tolerogenic mature WT BMDC.  In a coculture system with LPS- or CpG-stimulated BMDC and naive T cells, Ahr-/- BMDC inhibited naive T-cell differentiation into regulatory T (Treg) cells, which likely facilitated Th17 cell development and promoted naive T-cell proliferation.  Addn. of synthetic L-Kyn to the coculture system skewed the differentiation of naive T cells to Treg cells rather than Th17 cells.  Taken together, our results demonstrate a previously unknown neg. regulatory role for Ahr in DC-mediated immunogenesis in the presence of LPS or CpG, which, in turn, alters the Kyn-dependent generation of Treg cells and Th17 cells from naive T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXN00-SINf47Vg90H21EOLACvtfcHk0lgLtEz8RmS0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyisLzE&md5=2f3a4ce4b8ae94272340de48a8f653cf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014465107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014465107%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DN.%2BT.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DNakahama%26aufirst%3DT.%26aulast%3DChinen%26aufirst%3DI.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DNohara%26aufirst%3DK.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DAryl%2520hydrocarbon%2520receptor%2520negatively%2520regulates%2520dendritic%2520cell%2520immunogenicity%2520via%2520a%2520kynurenine-dependent%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D19961%26epage%3D19966%26doi%3D10.1073%2Fpnas.1014465107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spits, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mjösberg, J.</span></span> <span> </span><span class="NLM_article-title">The aryl hydrocarbon receptor: a sentinel safeguarding the survival of immune cells in the gut</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.immuni.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22284414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=5-7&author=H.+Spitsauthor=J.+Mj%C3%B6sberg&title=The+aryl+hydrocarbon+receptor%3A+a+sentinel+safeguarding+the+survival+of+immune+cells+in+the+gut&doi=10.1016%2Fj.immuni.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Aryl Hydrocarbon Receptor: A Sentinel Safeguarding the Survival of Immune Cells in the Gut</span></div><div class="casAuthors">Spits, Hergen; Mjoesberg, Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-7</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Innate lymphoid cells (ILCs) regulate the epithelial barrier function and immunity in the gut.  How ILC nos. are maintained is unknown.  In this issue of Immunity, Qiu et al. (2012) report that the transcription factor aryl hydrocarbon receptor controls survival and function of gut-residing ILCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LglJQmUacLVg90H21EOLACvtfcHk0lgLtEz8RmS0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKhs7Y%253D&md5=971e58e1fc05052705f9f2e9638d0807</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSpits%26aufirst%3DH.%26aulast%3DMj%25C3%25B6sberg%26aufirst%3DJ.%26atitle%3DThe%2520aryl%2520hydrocarbon%2520receptor%253A%2520a%2520sentinel%2520safeguarding%2520the%2520survival%2520of%2520immune%2520cells%2520in%2520the%2520gut%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D5%26epage%3D7%26doi%3D10.1016%2Fj.immuni.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uyttenhove, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Théate, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Eynde, B. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1038/nm934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fnm934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=14502282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Clu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1269-1274&author=C.+Uyttenhoveauthor=L.+Pilotteauthor=I.+Th%C3%A9ateauthor=V.+Stroobantauthor=D.+Colauauthor=N.+Parmentierauthor=T.+Boonauthor=B.+J.+Van+den%0AEynde&title=Evidence+for+a+tumoral+immune+resistance+mechanism+based+on+tryptophan+degradation+by+indoleamine+2%2C3-dioxygenase&doi=10.1038%2Fnm934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Uyttenhove, Catherine; Pilotte, Luc; Theate, Ivan; Stroobant, Vincent; Colau, Didier; Parmentier, Nicolas; Boon, Thierry; Van den Eynde, Benoit J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1269-1274</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">T lymphocytes undergo proliferation arrest when exposed to tryptophan shortage, which can be provoked by indoleamine 2,3-dioxygenase (IDO), an enzyme that is expressed in placenta and catalyzes tryptophan degrdn.  Here we show that most human tumors constitutively express IDO.  We also obsd. that expression of IDO by immunogenic mouse tumor cells prevents their rejection by preimmunized mice.  This effect is accompanied by a lack of accumulation of specific T cells at the tumor site and can be partly reverted by systemic treatment of mice with an inhibitor of IDO, in the absence of noticeable toxicity.  These results suggest that the efficacy of therapeutic vaccination of cancer patients might be improved by concomitant administration of an IDO inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2g0Nw1Orz7rVg90H21EOLACvtfcHk0lgLtEz8RmS0NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Clu7c%253D&md5=c2be3620862064fb40da547f976ccf95</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm934%26sid%3Dliteratum%253Aachs%26aulast%3DUyttenhove%26aufirst%3DC.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ate%26aufirst%3DI.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DParmentier%26aufirst%3DN.%26aulast%3DBoon%26aufirst%3DT.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520tumoral%2520immune%2520resistance%2520mechanism%2520based%2520on%2520tryptophan%2520degradation%2520by%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D1269%26epage%3D1274%26doi%3D10.1038%2Fnm934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span> <span> </span><span class="NLM_article-title">Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients</span>. <i>Dermatology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1159/000096906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1159%2F000096906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17191041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A280%3ADC%252BD28jltlWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2007&pages=8-14&author=G.+Weinlichauthor=C.+Murrauthor=L.+Richardsenauthor=C.+Winklerauthor=D.+Fuchs&title=Decreased+serum+tryptophan+concentration+predicts+poor+prognosis+in+malignant+melanoma+patients&doi=10.1159%2F000096906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients</span></div><div class="casAuthors">Weinlich Georg; Murr Christian; Richardsen Laura; Winkler Christiana; Fuchs Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Dermatology (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>
        ISSN:<span class="NLM_cas:issn">1018-8665</span>.
    </div><div class="casAbstract">BACKGROUND:  Indoleamine (2,3)-dioxygenase (IDO) catalyses the initial, rate-limiting step in the degradation of the essential amino acid tryptophan.  Via tryptophan deprivation, IDO activity suppresses T cell proliferation and differentiation and is thought to be a fundamental immune escape mechanism for tumor cells.  OBJECTIVE AND METHODS:  To investigate the potential role of tryptophan degradation as a prognostic marker, serum tryptophan and kynurenine concentrations and the kynurenine-to-tryptophan ratio (kyn/trp) in 87 patients with malignant melanoma were compared to the course of the disease and to concentrations of the immune activation marker neopterin.  RESULTS:  Compared to 49 healthy volunteers, the melanoma patients presented with lower tryptophan levels due to accelerated degradation.  This was especially true for the subgroups of patients with distant metastases (p = 0.01), though not in patients with lymph node metastases or in patients who had not yet progressed.  There existed a positive correlation between kyn/trp and neopterin concentrations (r(s) = 0.587, p <0.001).  In patients who died due to dissemination of the tumor, median tryptophan concentrations were significantly decreased (p = 0.006) and kyn/trp (p = 0.03) and neopterin concentrations (p = 0.002) were higher compared to survivors.  In addition, lower tryptophan concentrations as well as higher kyn/trp and neopterin concentrations predicted a shorter survival.  CONCLUSION:  Decreased serum tryptophan concentrations and elevated serum neopterin levels can be used as predictive markers for the future course in melanoma patients.  Moreover, our data support previous speculations that a higher degree of IDO expression could play a crucial role for tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTojRzUHU0-AIMcDoIzZtNkfW6udTcc2eamxTH0jum7cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jltlWnsQ%253D%253D&md5=0fc93897eb632cd07692e321fd501d6c</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1159%2F000096906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000096906%26sid%3Dliteratum%253Aachs%26aulast%3DWeinlich%26aufirst%3DG.%26aulast%3DMurr%26aufirst%3DC.%26aulast%3DRichardsen%26aufirst%3DL.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DFuchs%26aufirst%3DD.%26atitle%3DDecreased%2520serum%2520tryptophan%2520concentration%2520predicts%2520poor%2520prognosis%2520in%2520malignant%2520melanoma%2520patients%26jtitle%3DDermatology%26date%3D2007%26volume%3D214%26spage%3D8%26epage%3D14%26doi%3D10.1159%2F000096906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Corm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbenotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhermitte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesnel, B.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-gamma</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1016/j.leukres.2008.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.leukres.2008.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=18639339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVCqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=490-494&author=S.+Cormauthor=C.+Berthonauthor=M.+Imbenotteauthor=V.+Biggioauthor=M.+Lhermitteauthor=C.+Dupontauthor=I.+Bricheauthor=B.+Quesnel&title=Indoleamine+2%2C3-dioxygenase+activity+of+acute+myeloid+leukemia+cells+can+be+measured+from+patients%E2%80%99+sera+by+HPLC+and+is+inducible+by+IFN-gamma&doi=10.1016%2Fj.leukres.2008.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-γ</span></div><div class="casAuthors">Corm, Selim; Berthon, Celine; Imbenotte, Michel; Biggio, Valeria; Lhermitte, Michel; Dupont, Caroline; Briche, Isabelle; Quesnel, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">490-494</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The enzyme indoleamine 2,3-dioxygenase (IDO) converts tryptophan to kynurenine, blocking T-cell activation and inducing immunosuppression.  In patients with acute myeloid leukemia (AML), the serum kynurenine/tryptophan ratio (Kyn/Trp) was raised, suggesting a higher IDO activity than in healthy people.  Patients with higher Kyn/Trp ratios showed lower survival.  IDO activity was also detected in AML cells after exposure to IFN-γin vitro, suggesting that the higher Kyn/Trp ratio in serum of AML patients might have resulted from stimulated leukemic blast cells.  Thus, in AML, the activity of IDO can be easily monitored, providing a tool for future clin. testing of IDO-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorMbStcuzqLrVg90H21EOLACvtfcHk0lhripAw1AuElA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVCqsrY%253D&md5=34af1b03d71d94f575ab2e3aa028b26c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DCorm%26aufirst%3DS.%26aulast%3DBerthon%26aufirst%3DC.%26aulast%3DImbenotte%26aufirst%3DM.%26aulast%3DBiggio%26aufirst%3DV.%26aulast%3DLhermitte%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DC.%26aulast%3DBriche%26aufirst%3DI.%26aulast%3DQuesnel%26aufirst%3DB.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520activity%2520of%2520acute%2520myeloid%2520leukemia%2520cells%2520can%2520be%2520measured%2520from%2520patients%25E2%2580%2599%2520sera%2520by%2520HPLC%2520and%2520is%2520inducible%2520by%2520IFN-gamma%26jtitle%3DLeuk.%2520Res.%26date%3D2009%26volume%3D33%26spage%3D490%26epage%3D494%26doi%3D10.1016%2Fj.leukres.2008.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span> <span> </span><span class="NLM_article-title">Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.3892/or.17.6.1333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.3892%2For.17.6.1333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17487387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvF2isLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1333-1339&author=M.+Takaoauthor=A.+Okamotoauthor=T.+Nikaidoauthor=M.+Urashimaauthor=S.+Takakuraauthor=M.+Saitoauthor=S.+Okamotoauthor=O.+Takikawaauthor=H.+Sasakiauthor=M.+Yasudaauthor=K.+Ochiaiauthor=T.+Tanaka&title=Increased+synthesis+of+indoleamine-2%2C3-dioxygenase+protein+is+positively+associated+with+impaired+survival+in+patients+with+serous-type%2C+but+not+with+other+types+of%2C+ovarian+cancer&doi=10.3892%2For.17.6.1333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer</span></div><div class="casAuthors">Takao, Miho; Okamoto, Aikou; Nikaido, Takashi; Urashima, Mitsuyoshi; Takakura, Satoshi; Saito, Misato; Saito, Motoaki; Okamoto, Sanshiro; Takikawa, Osamu; Sasaki, Hiroshi; Yasuda, Makoto; Ochiai, Kazunori; Tanaka, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1333-1339</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">We previously reported that indoleamine-2,3-dioxygenase (IDO) is assocd. with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA).  In this study, to explore the role of IDO in the development of various histol. types of ovarian cancer, we further examd. IDO expression not only in SA but also in other types of ovarian cancers.  Expression of IDO protein was analyzed by immunohistochem. for a total of 122 ovarian cancers including 40 SA, 67 clear cell adenocarcinomas (CCA), and 15 endometrioid adenocarcinomas (EA) with informed consent.  Among these cases, there were 11 CCA accompanied with endometriosis and 60 cases with lymph node metastasis.  We classified the samples into four categories by IDO staining pattern.  IDO staining was pos. in 57.5% of SA, 49.2% of CCA, and 73.3% of EA, resp.  The Kaplan-Meier survival curve showed a clear relationship between staining score and overall survival for patients with advanced (stages III and IV) SA (n = 33) who underwent optimal surgery and paclitaxel-carboplatin (TC) chemotherapy as a first-line regimen.  There was no assocn. between IDO staining score and overall survival in the CCA cases.  Eight of 11 cases (72.7%) of CCA accompanied by endometriosis presented identical staining patterns of IDO between CCA and endometriosis.  In 43 of 60 cases (71.6%) with lymph node metastasis, the staining patterns of IDO showed a correspondence between the primary lesion and metastatic site.  These results suggested that the increased synthesis of IDO protein was pos. assocd. with impaired survival only in the serous type of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRDgeRRyeADrVg90H21EOLACvtfcHk0lhripAw1AuElA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvF2isLs%253D&md5=1b32496ba3260be755569d051b8985c9</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.3892%2For.17.6.1333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.17.6.1333%26sid%3Dliteratum%253Aachs%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DYasuda%26aufirst%3DM.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26atitle%3DIncreased%2520synthesis%2520of%2520indoleamine-2%252C3-dioxygenase%2520protein%2520is%2520positively%2520associated%2520with%2520impaired%2520survival%2520in%2520patients%2520with%2520serous-type%252C%2520but%2520not%2520with%2520other%2520types%2520of%252C%2520ovarian%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2007%26volume%3D17%26spage%3D1333%26epage%3D1339%26doi%3D10.3892%2For.17.6.1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanaihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isonishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6030</span>– <span class="NLM_lpage">6039</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-04-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.ccr-04-2671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16115948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6030-6039&author=A.+Okamotoauthor=T.+Nikaidoauthor=K.+Ochiaiauthor=S.+Takakuraauthor=M.+Saitoauthor=Y.+Aokiauthor=N.+Ishiiauthor=N.+Yanaiharaauthor=K.+Yamadaauthor=O.+Takikawaauthor=R.+Kawaguchiauthor=S.+Isonishiauthor=T.+Tanakaauthor=M.+Urashima&title=Indoleamine+2%2C3-dioxygenase+serves+as+a+marker+of+poor+prognosis+in+gene+expression+profiles+of+serous+ovarian+cancer+cells&doi=10.1158%2F1078-0432.ccr-04-2671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells</span></div><div class="casAuthors">Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu; Yamada, Kyosuke; Takikawa, Osamu; Kawaguchi, Rie; Isonishi, Seiji; Tanaka, Tadao; Urashima, Mitsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6030-6039</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We aimed to find key mols. assocd. with chemoresistance in ovarian cancer using gene expression profiling as a screening tool.  Exptl. Design: Using two newly established paclitaxel-resistant ovarian cancer cell lines from an original paclitaxel-sensitive cell line and four supersensitive and four refractory surgical ovarian cancer specimens from paclitaxel-based chemotherapy, mols. assocd. with chemoresistance were screened with gene expression profiling arrays contg. 39,000 genes.  We further analyzed 44 genes that showed significantly different expressions between paclitaxel-sensitive samples and paclitaxel-resistant samples with permutation tests, which were common in cell lines and patients' tumors.  Results: Eight of these genes showed reproducible results with real-time reverse transcription-PCR, of which indoleamine 2,3-dioxygenase gene expression was the most prominent and consistent.  Moreover, by immunohistochem. anal. using a total of 24 serous-type ovarian cancer surgical specimens (stage III, n = 21; stage IV, n = 7), excluding samples used for GeneChip anal., the Kaplan-Meier survival curve showed a clear relationship between indoleamine 2,3-dioxygenase staining patterns and overall survival (log-rank test, P = 0.0001).  All patients classified as neg. survived without relapse.  The 50% survival of patients classified as sporadic, focal, and diffuse was 41, 17, and 11 mo, resp.  Conclusion: The indoleamine 2,3-dioxygenase screened with the GeneChip was pos. assocd. with paclitaxel resistance and with impaired survival in patients with serous-type ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKy6bi9608B7Vg90H21EOLACvtfcHk0liUiF6UMSLoCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D&md5=b8b8784e723cd5c337cec2c4e159d865</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-04-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-04-2671%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DYanaihara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKawaguchi%26aufirst%3DR.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520serves%2520as%2520a%2520marker%2520of%2520poor%2520prognosis%2520in%2520gene%2520expression%2520profiles%2520of%2520serous%2520ovarian%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6030%26epage%3D6039%26doi%3D10.1158%2F1078-0432.ccr-04-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brandacher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perathoner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladurner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obrist, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner-Felmayer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margreiter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Königsrainer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amberger, A.</span></span> <span> </span><span class="NLM_article-title">Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-05-1966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.ccr-05-1966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16489067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1144-1151&author=G.+Brandacherauthor=A.+Perathonerauthor=R.+Ladurnerauthor=S.+Schneebergerauthor=P.+Obristauthor=C.+Winklerauthor=E.+R.+Wernerauthor=G.+Werner-Felmayerauthor=H.+G.+Weissauthor=G.+G%C3%B6belauthor=R.+Margreiterauthor=A.+K%C3%B6nigsrainerauthor=D.+Fuchsauthor=A.+Amberger&title=Prognostic+value+of+indoleamine+2%2C3-dioxygenase+expression+in+colorectal+cancer%3A+effect+on+tumor-infiltrating+T+cells&doi=10.1158%2F1078-0432.ccr-05-1966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span></div><div class="casAuthors">Brandacher, Gerald; Perathoner, Alexander; Ladurner, Ruth; Schneeberger, Stefan; Obrist, Peter; Winkler, Christiana; Werner, Ernst R.; Werner-Felmayer, Gabriele; Weiss, Helmut G.; Goebel, Georg; Margreiter, Raimund; Koenigsrainer, Alfred; Fuchs, Dietmar; Amberger, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1144-1151</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pathol. interactions between tumor and host immune cells within the tumor microenvironment create an immunosuppressive network that promotes tumor growth and protects the tumor from immune attack.  In this study, we examd. the contribution of the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) on this phenomenon.  Exptl. Design: Expression of IDO was analyzed in colorectal cancer cell lines by reverse transcription-PCR and functional enzyme activity was assessed by high-pressure liq. chromatog.  Semiquant. immunohistochem. was used to evaluate IDO expression in the tissue samples of 143 patients with colorectal carcinoma, and was then correlated with the no. of tumor-infiltrating T cells and clin. variables.  RESULTS: In vitro IDO expression and functional enzyme activity in colorectal cancer cells was found to be strictly dependent on IFN-γ stimulation.  Immunohistochem. scores revealed IDO-high expression in 56 of 143 (39.2%) tumor specimens, whereas 87 of 143 (60.8%) cases showed low IDO expression levels.  IDO-high expression was assocd. with a significant redn. of CD3+ infiltrating T cells (46.02 ± 7.25) as compared with tissue samples expressing low IDO (19.42 ± 2.50; P = 0.0003).  Furthermore, IDO-high immunoreactivity significantly correlated with the frequency of liver metastases (P = 0.003).  Kaplan-Meier anal. showed the crossing of survival curves at 45 mo.  By multivariate Cox's anal., IDO-high expression emerged as an independent prognostic variable (<45 mo, P = 0.006; >45 mo, P = 0.04).  CONCLUSION: IDO-high expression by colorectal tumor cells enables certain cancer subsets to initially avoid immune attack and defeat the invasion of T cells via local tryptophan depletion and the prodn. of proapoptotic tryptophan catabolites.  Thus, IDO significantly contributes to disease progression and overall survival in patients with colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuBdys9PLf7Vg90H21EOLACvtfcHk0liUiF6UMSLoCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D&md5=623837bb245e71dd4fe137e790ddbfe9</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-05-1966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-05-1966%26sid%3Dliteratum%253Aachs%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DPerathoner%26aufirst%3DA.%26aulast%3DLadurner%26aufirst%3DR.%26aulast%3DSchneeberger%26aufirst%3DS.%26aulast%3DObrist%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DWerner%26aufirst%3DE.%2BR.%26aulast%3DWerner-Felmayer%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DH.%2BG.%26aulast%3DG%25C3%25B6bel%26aufirst%3DG.%26aulast%3DMargreiter%26aufirst%3DR.%26aulast%3DK%25C3%25B6nigsrainer%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DAmberger%26aufirst%3DA.%26atitle%3DPrognostic%2520value%2520of%2520indoleamine%25202%252C3-dioxygenase%2520expression%2520in%2520colorectal%2520cancer%253A%2520effect%2520on%2520tumor-infiltrating%2520T%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1144%26epage%3D1151%26doi%3D10.1158%2F1078-0432.ccr-05-1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen-Mersh, T. G.</span></span> <span> </span><span class="NLM_article-title">Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1696</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6600336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fsj.bjc.6600336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=12087451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=1691-1696&author=A.+Huangauthor=D.+Fuchsauthor=B.+Widnerauthor=C.+Gloverauthor=D.+C.+Hendersonauthor=T.+G.+Allen-Mersh&title=Serum+tryptophan+decrease+correlates+with+immune+activation+and+impaired+quality+of+life+in+colorectal+cancer&doi=10.1038%2Fsj.bjc.6600336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer</span></div><div class="casAuthors">Huang, A.; Fuchs, D.; Widner, B.; Glover, C.; Henderson, D. C.; Allen-Mersh, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1696</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer-related indoleamine (2,3)-dioxygenase up-regulation by interferon-γ might influence quality of life by depleting serum tryptophan.  The authors correlated serum tryptophan levels with immune activation and quality of life in patients with colorectal liver metastases.  Venous blood was sampled from patients with primary colorectal cancer and from patients with metachronous colorectal liver metastases who completed quality of life and psychol. questionnaires.  Serum tryptophan, kynurenine, neopterin, interleukin 2 sol. receptor α (IL-2 sRα), sol. tumor necrosis factor receptor I (sTNF RI), interleukin 6, and C-reactive protein were measured.  Liver metastasis vol. was estd. by computerized tomog., and survival from blood sampling was noted.  Sixty-six patients with colorectal cancer were studied (39 males; median age 66 yr) of whom 25 had colorectal liver metastases only (17 males; median age 62 yr; median liver metastasis vol. 208 mL; median survival 234 days).  Reduced serum tryptophan was significantly assocd. with Rotterdam Symptom Checklist phys. symptom (r=-0.51) and Sickness Impact Profile (r=-0.42) scores, and correlated with increased serum neopterin (r=-0.36), IL-2 sRα (r=-0.51) and sTNF RI (r=-0.45) levels.  Stepwise regression analyses suggested that serum tryptophan was an independent predictor of Rotterdam Symptom Checklist phys. symptom (regression coeff. -20.78) and Sickness Impact Profile (regression coeff. -109.09) scores.  The results supported a role for interferon-γ-mediated serum tryptophan decrease in cancer-induced quality of life deterioration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPqTqopr5DbVg90H21EOLACvtfcHk0ligOZdddcGEAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVait7c%253D&md5=08fb2ac4be5b357d658dfdaeb7802f22</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6600336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6600336%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DWidner%26aufirst%3DB.%26aulast%3DGlover%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DD.%2BC.%26aulast%3DAllen-Mersh%26aufirst%3DT.%2BG.%26atitle%3DSerum%2520tryptophan%2520decrease%2520correlates%2520with%2520immune%2520activation%2520and%2520impaired%2520quality%2520of%2520life%2520in%2520colorectal%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2002%26volume%3D86%26spage%3D1691%26epage%3D1696%26doi%3D10.1038%2Fsj.bjc.6600336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, F.</span></span> <span> </span><span class="NLM_article-title">Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2317</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-4144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F1078-0432.CCR-07-4144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=18413819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=2310-2317&author=K.+Inoauthor=E.+Yamamotoauthor=K.+Shibataauthor=H.+Kajiyamaauthor=N.+Yoshidaauthor=M.+Terauchiauthor=A.+Nawaauthor=T.+Nagasakaauthor=O.+Takikawaauthor=F.+Kikkawa&title=Inverse+correlation+between+tumoral+indoleamine+2%2C3-dioxygenase+expression+and+tumor-infiltrating+lymphocytes+in+endometrial+cancer%3A+its+association+with+disease+progression+and+survival&doi=10.1158%2F1078-0432.ccr-07-4144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival</span></div><div class="casAuthors">Ino, Kazuhiko; Yamamoto, Eiko; Shibata, Kiyosumi; Kajiyama, Hiroaki; Yoshida, Norio; Terauchi, Mikio; Nawa, Akihiro; Nagasaka, Tetsuro; Takikawa, Osamu; Kikkawa, Fumitaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2310-2317</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Tumor escape from host immune systems is a crucial mechanism for disease progression.  We recently showed that the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO) is a prognostic indicator for endometrial cancer.  The purpose of the present study was to investigate the relationship between IDO expression and tumor-infiltrating lymphocytes (TIL) or natural killer (NK) cells and to clarify their prognostic effect in endometrial cancer.  Exptl. Design: Immunohistochem. staining for IDO expression in endometrial cancer tissues (n = 65) was done.  Tumor-infiltrating CD3+ and CD8+ lymphocytes, as well as CD57+ NK cells, were counted in serial tissue sections.  RESULTS: High IDO expression in tumor cells was found in 32 of 65 cases and was pos. correlated with myometrial invasion, nodal metastasis, and lymph-vascular space involvement.  We also found a significant correlation between high IDO expression and reduced nos. of CD3+, CD8+, and CD57+ cells infiltrating into both the tumor epithelium and stroma.  Patients with high IDO expression, a low no. of stromal CD3 (<60), low intraepithelial CD8 (<25), or low stromal CD8 (<40) had significantly impaired progression-free survival.  On multivariate anal., IDO expression and the no. of stromal CD3+ TILs were independent prognostic factors for impaired progression-free survival.  CONCLUSIONS: Tumoral IDO expression correlated with a reduced no. of TILs and NK cells in endometrial cancer, possibly contributing to disease progression and impaired clin. outcome.  These findings suggest that targeting IDO to restore host antitumor immunity may be a therapeutic strategy for endometrial cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZtHpmlR407Vg90H21EOLACvtfcHk0ligOZdddcGEAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFGmtL0%253D&md5=6baa8848c1ba82c24fd749f907c4acef</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4144%26sid%3Dliteratum%253Aachs%26aulast%3DIno%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DM.%26aulast%3DNawa%26aufirst%3DA.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKikkawa%26aufirst%3DF.%26atitle%3DInverse%2520correlation%2520between%2520tumoral%2520indoleamine%25202%252C3-dioxygenase%2520expression%2520and%2520tumor-infiltrating%2520lymphocytes%2520in%2520endometrial%2520cancer%253A%2520its%2520association%2520with%2520disease%2520progression%2520and%2520survival%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D2310%26epage%3D2317%26doi%3D10.1158%2F1078-0432.ccr-07-4144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidokoro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, F.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6603477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1038%2Fsj.bjc.6603477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=17117179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cntr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1555-1561&author=K.+Inoauthor=N.+Yoshidaauthor=H.+Kajiyamaauthor=K.+Shibataauthor=E.+Yamamotoauthor=K.+Kidokoroauthor=N.+Takahashiauthor=M.+Terauchiauthor=A.+Nawaauthor=S.+Nomuraauthor=T.+Nagasakaauthor=O.+Takikawaauthor=F.+Kikkawa&title=Indoleamine+2%2C3-dioxygenase+is+a+novel+prognostic+indicator+for+endometrial+cancer&doi=10.1038%2Fsj.bjc.6603477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer</span></div><div class="casAuthors">Ino, K.; Yoshida, N.; Kajiyama, H.; Shibata, K.; Yamamoto, E.; Kidokoro, K.; Takahashi, N.; Terauchi, M.; Nawa, A.; Nomura, S.; Nagasaka, T.; Takikawa, O.; Kikkawa, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-1561</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolizing enzyme inducing immune tolerance.  The present study aimed to investigate IDO expression and its prognostic significance in endometrial cancer.  Indoleamine 2,3-dioxygenase expression in endometrial cancer tissues (n=80) was immunohistochem. scored as four groups (IDO-, 1+, 2+, and 3+).  The high IDO expression (IDO2+ or 3+) in tumor cells was found in 37 (46.3%) of the 80 cases, and was pos. correlated with surgical stage, myometrial invasion, lymph-vascular space involvement, and lymph node metastasis, but not with the histol. grade.  Patients with high IDO expression had significantly impaired overall survival and progression-free survival (PFS) (P=0.002 and P=0.001, resp.) compared to patients with no or weak expression of IDO (IDO- or 1+).  The 5-yr PFS for IDO-/1+, 2+, and 3+ were 97.7, 72.9, and 36.4%, resp.  Even in patients with early-stage disease (International Federation of Gynecol. and Obstetrics I/II, n=64), the PFS for IDO2+/3+ was significantly poor (P=0.001) compared to that for IDO-/1+.  On multivariate anal., IDO expression was an independent prognostic factor for PFS (P=0.020).  These results indicated that the high IDO expression was involved in the progression of endometrial cancer and correlated with the impaired clin. outcome, suggesting that IDO is a novel and reliable prognostic indicator for endometrial cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUeJItF1I2LVg90H21EOLACvtfcHk0ligOZdddcGEAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cntr3F&md5=eb86788d5aad3ff319d03439b617022c</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603477%26sid%3Dliteratum%253Aachs%26aulast%3DIno%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DE.%26aulast%3DKidokoro%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DM.%26aulast%3DNawa%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKikkawa%26aufirst%3DF.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520a%2520novel%2520prognostic%2520indicator%2520for%2520endometrial%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D95%26spage%3D1555%26epage%3D1561%26doi%3D10.1038%2Fsj.bjc.6603477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brant, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin-Tindall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohnig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span> <span> </span><span class="NLM_article-title">Identification of potent indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors based on a phenylimidazole scaffold</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00488</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00488" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=131-136&author=M.+G.+Brantauthor=J.+Goodwin-Tindallauthor=K.+R.+Stoverauthor=P.+M.+Staffordauthor=F.+Wuauthor=A.+R.+Meekauthor=P.+Schiaviniauthor=S.+Wohnigauthor=D.+F.+Weaver&title=Identification+of+potent+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitors+based+on+a+phenylimidazole+scaffold&doi=10.1021%2Facsmedchemlett.7b00488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold</span></div><div class="casAuthors">Brant, Michael G.; Goodwin-Tindall, Jake; Stover, Kurt R.; Stafford, Paul M.; Wu, Fan; Meek, Autumn R.; Schiavini, Paolo; Wohnig, Stephanie; Weaver, Donald F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-136</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of indoleamine 2,3-dioxygenase (IDO1) is an attractive immunotherapeutic approach for the treatment of a variety of cancers.  Dysregulation of this enzyme has also been implicated in other disorders including Alzheimer's disease and arthritis.  Herein, the authors report the structure-based design of two related series of mols.: N1-substituted 5-indoleimidazoles and N1-substituted 5-phenylimidazoles.  The latter (and more potent) series was accessed through an unexpected rearrangement of an imine intermediate during a Van Leusen imidazole synthesis reaction.  Evidence for the binding modes for both inhibitor series is supported by computational and structure-activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjv6cCPCyqrVg90H21EOLACvtfcHk0lgy_ai7sPA19A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gsg%253D%253D&md5=f83e9d7dce45932e5f94818cebd2b3c8</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00488%26sid%3Dliteratum%253Aachs%26aulast%3DBrant%26aufirst%3DM.%2BG.%26aulast%3DGoodwin-Tindall%26aufirst%3DJ.%26aulast%3DStover%26aufirst%3DK.%2BR.%26aulast%3DStafford%26aufirst%3DP.%2BM.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DMeek%26aufirst%3DA.%2BR.%26aulast%3DSchiavini%26aufirst%3DP.%26aulast%3DWohnig%26aufirst%3DS.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26atitle%3DIdentification%2520of%2520potent%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitors%2520based%2520on%2520a%2520phenylimidazole%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D131%26epage%3D136%26doi%3D10.1021%2Facsmedchemlett.7b00488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crosignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannelle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwenberghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordonnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Négrerie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eynde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel and selective indoleamine 2,3-dioxygenase (IDO-1) inhibitor 3-(5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and its characterization as a potential clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9617</span>– <span class="NLM_lpage">9629</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9617-9629&author=S.+Crosignaniauthor=P.+Binghamauthor=P.+Bottemanneauthor=H.+Cannelleauthor=S.+Cauwenberghsauthor=M.+Cordonnierauthor=D.+Dalvieauthor=F.+Derooseauthor=J.+L.+Fengauthor=B.+Gomesauthor=S.+Greasleyauthor=S.+E.+Kaiserauthor=M.+Krausauthor=M.+N%C3%A9grerieauthor=K.+Maegleyauthor=N.+Millerauthor=B.+W.+Murrayauthor=M.+Schneiderauthor=J.+Soloweijauthor=A.+E.+Stewartauthor=J.+Tumangauthor=V.+R.+Tortiauthor=B.+Van+Den+Eyndeauthor=M.+Wythes&title=Discovery+of+a+novel+and+selective+indoleamine+2%2C3-dioxygenase+%28IDO-1%29+inhibitor+3-%285-fluoro-1H-indol-3-yl%29pyrrolidine-2%2C5-dione+%28EOS200271%2FPF-06840003%29+and+its+characterization+as+a+potential+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate</span></div><div class="casAuthors">Crosignani, Stefano; Bingham, Patrick; Bottemanne, Pauline; Cannelle, Helene; Cauwenberghs, Sandra; Cordonnier, Marie; Dalvie, Deepak; Deroose, Frederik; Feng, Jun Li; Gomes, Bruno; Greasley, Samantha; Kaiser, Stephen E.; Kraus, Manfred; Negrerie, Michel; Maegley, Karen; Miller, Nichol; Murray, Brion W.; Schneider, Manfred; Soloweij, James; Stewart, Albert E.; Tumang, Joseph; Torti, Vince R.; Van Den Eynde, Benoit; Wythes, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9617-9629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment.  IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function.  As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncol.  Starting from HTS hit I, IDO-1 inhibitor II has been developed.  The structure-activity relationship around II is described and rationalized using the x-ray crystal structure of II bound to human IDO-1, which shows that II, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode.  Clin. candidate II shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16-19 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfHmZRAC-dLVg90H21EOLACvtfcHk0lgy_ai7sPA19A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK&md5=dc2e45c243aa22c100ccc39db9b5918a</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00974%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DCannelle%26aufirst%3DH.%26aulast%3DCauwenberghs%26aufirst%3DS.%26aulast%3DCordonnier%26aufirst%3DM.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeroose%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DS.%2BE.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DN%25C3%25A9grerie%26aufirst%3DM.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSoloweij%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTumang%26aufirst%3DJ.%26aulast%3DTorti%26aufirst%3DV.%2BR.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%26aulast%3DWythes%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO-1%2529%2520inhibitor%25203-%25285-fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2520%2528EOS200271%252FPF-06840003%2529%2520and%2520its%2520characterization%2520as%2520a%2520potential%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9617%26epage%3D9629%26doi%3D10.1021%2Facs.jmedchem.7b00974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takvorian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bower, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansbury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span></span> <span> </span><span class="NLM_article-title">INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immuno-oncology</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00391</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00391" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Gqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=486-491&author=E.%0AW.+Yueauthor=R.+Sparksauthor=P.+Polamauthor=D.+Modiauthor=B.+Doutyauthor=B.+Waylandauthor=B.+Glassauthor=A.+Takvorianauthor=J.+Glennauthor=W.+Zhuauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=T.+Emmauthor=P.+A.+Scherleauthor=B.+Metcalfauthor=A.+P.+Combs&title=INCB24360+%28Epacadostat%29%2C+a+highly+potent+and+selective+indoleamine-2%2C3-dioxygenase+1+%28IDO1%29+inhibitor+for+immuno-oncology&doi=10.1021%2Facsmedchemlett.6b00391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology</span></div><div class="casAuthors">Yue, Eddy W.; Sparks, Richard; Polam, Padmaja; Modi, Dilip; Douty, Brent; Wayland, Brian; Glass, Brian; Takvorian, Amy; Glenn, Joseph; Zhu, Wenyu; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Emm, Tom; Scherle, Peggy A.; Metcalf, Brian; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">486-491</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A data-centric medicinal chem. approach led to the invention of a potent and selective IDO1 inhibitor 4f, INCB24360 (epacadostat).  The mol. structure of INCB24360 contains several previously unknown or underutilized functional groups in drug substances, including a hydroxyamidine, furazan, bromide and sulfamide.  These moieties taken together in a single structure afford a compd. which falls outside of "drug-like" space.  Nevertheless, the in vitro ADME data is consistent with the good cell permeability and oral bioavailability obsd. in all species (rat, dog, monkey) tested.  The extensive intramol. hydrogen bonding obsd. in the small mol. crystal structure of 4f is believed to significantly contribute to the obsd. permeability and PK.  Epacadostat in combination with anti-PD1 mAb pembrolizumab is currently being studied in a phase 3 clin. trial in patients with unresectable or metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpm79ArpY1yLVg90H21EOLACvtfcHk0linKn_D7VkSUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Gqsb0%253D&md5=92bebde519334e9e2a776250bb0258ac</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00391%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DSparks%26aufirst%3DR.%26aulast%3DPolam%26aufirst%3DP.%26aulast%3DModi%26aufirst%3DD.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DGlass%26aufirst%3DB.%26aulast%3DTakvorian%26aufirst%3DA.%26aulast%3DGlenn%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DEmm%26aufirst%3DT.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DINCB24360%2520%2528Epacadostat%2529%252C%2520a%2520highly%2520potent%2520and%2520selective%2520indoleamine-2%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitor%2520for%2520immuno-oncology%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D486%26epage%3D491%26doi%3D10.1021%2Facsmedchemlett.6b00391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passacantilli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famiglini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patsilinakos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoccoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisinni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regina, G.</span></span> <span> </span><span class="NLM_article-title">New inhibitors of indoleamine 2,3-dioxygenase 1: molecular modeling studies, synthesis, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9760</span>– <span class="NLM_lpage">9773</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9760-9773&author=A.+Colucciaauthor=S.+Passacantilliauthor=V.+Famigliniauthor=M.+Sabatinoauthor=A.+Patsilinakosauthor=R.+Ragnoauthor=C.+Mazzoccoliauthor=L.+Sisinniauthor=A.+Okunoauthor=O.+Takikawaauthor=R.+Silvestriauthor=G.+Regina&title=New+inhibitors+of+indoleamine+2%2C3-dioxygenase+1%3A+molecular+modeling+studies%2C+synthesis%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.6b00718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation</span></div><div class="casAuthors">Coluccia, Antonio; Passacantilli, Sara; Famiglini, Valeria; Sabatino, Manuela; Patsilinakos, Alexandros; Ragno, Rino; Mazzoccoli, Carmela; Sisinni, Lorenza; Okuno, Alato; Takikawa, Osamu; Silvestri, Romano; La Regina, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9760-9773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1) is an attractive target for anticancer therapy.  Herein, we report a virtual screening study which led to the identification of compd. I as a new IDO1 inhibitor.  In order to improve the biol. activity of the identified hit, arylthioindoles were synthesized and tested.  Among these, deriv. II exhibited an IC50 value of 7 μM, being the most active compd. of the series.  Furthermore, compds. I and II induced a dose-dependent growth inhibition in IDO1 expressing cancer cell lines HTC116 and HT29.  3-D QSAR studies were carried out in order to rationalize obtained results and suggest new chem. modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfHwAbMNZXrVg90H21EOLACvtfcHk0linKn_D7VkSUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtL7I&md5=9a1267db6fdeadfbbb693464ba4dddd6</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00718%26sid%3Dliteratum%253Aachs%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DPassacantilli%26aufirst%3DS.%26aulast%3DFamiglini%26aufirst%3DV.%26aulast%3DSabatino%26aufirst%3DM.%26aulast%3DPatsilinakos%26aufirst%3DA.%26aulast%3DRagno%26aufirst%3DR.%26aulast%3DMazzoccoli%26aufirst%3DC.%26aulast%3DSisinni%26aufirst%3DL.%26aulast%3DOkuno%26aufirst%3DA.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DRegina%26aufirst%3DG.%26atitle%3DNew%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%25201%253A%2520molecular%2520modeling%2520studies%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9760%26epage%3D9773%26doi%3D10.1021%2Facs.jmedchem.6b00718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La Regina, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S.-H.</span></span> <span> </span><span class="NLM_article-title">Phenyl benzenesulfonylhydrazides exhibit selective indoleamine 2,3-dioxygenase inhibition with potent <i>in vivo</i> pharmacodynamic activity and antitumor efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01640</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01640" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=419-430&author=S.-Y.+La+Reginaauthor=T.-K.+Yehauthor=C.-C.+Kuoauthor=J.-S.+Songauthor=M.-F.+Chengauthor=F.-Y.+Liaoauthor=M.-W.+Chaoauthor=H.-L.+Huangauthor=Y.-L.+Chenauthor=C.-Y.+Yangauthor=M.-H.+Wuauthor=C.-L.+Hsiehauthor=W.+Hsiaoauthor=Y.-H.+Pengauthor=J.-S.+Wuauthor=L.-M.+Linauthor=M.+Sunauthor=Y.-S.+Chaoauthor=C.+Shihauthor=S.-Y.+Wuauthor=S.-L.+Panauthor=M.-S.+Hungauthor=S.-H.+Ueng&title=Phenyl+benzenesulfonylhydrazides+exhibit+selective+indoleamine+2%2C3-dioxygenase+inhibition+with+potent+in+vivo+pharmacodynamic+activity+and+antitumor+efficacy&doi=10.1021%2Facs.jmedchem.5b01640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01640%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BRegina%26aufirst%3DS.-Y.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DKuo%26aufirst%3DC.-C.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DCheng%26aufirst%3DM.-F.%26aulast%3DLiao%26aufirst%3DF.-Y.%26aulast%3DChao%26aufirst%3DM.-W.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DWu%26aufirst%3DM.-H.%26aulast%3DHsieh%26aufirst%3DC.-L.%26aulast%3DHsiao%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DY.-H.%26aulast%3DWu%26aufirst%3DJ.-S.%26aulast%3DLin%26aufirst%3DL.-M.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DChao%26aufirst%3DY.-S.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DS.-Y.%26aulast%3DPan%26aufirst%3DS.-L.%26aulast%3DHung%26aufirst%3DM.-S.%26aulast%3DUeng%26aufirst%3DS.-H.%26atitle%3DPhenyl%2520benzenesulfonylhydrazides%2520exhibit%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520inhibition%2520with%2520potent%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520antitumor%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D419%26epage%3D430%26doi%3D10.1021%2Facs.jmedchem.5b01640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dounay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8762</span>– <span class="NLM_lpage">8782</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00461</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8762-8782&author=A.+B.+Dounayauthor=J.+B.+Tuttleauthor=P.+R.+Verhoest&title=Challenges+and+opportunities+in+the+discovery+of+new+therapeutics+targeting+the+kynurenine+pathway&doi=10.1021%2Facs.jmedchem.5b00461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway</span></div><div class="casAuthors">Dounay, Amy B.; Tuttle, Jamison B.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8762-8782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The kynurenine pathway is responsible for the metab. of more than 95% of dietary tryptophan (TRP) and produces numerous bioactive metabolites.  Recent studies have focused on three enzymes in this pathway: indoleamine dioxygenase (IDO1), kynurenine monooxygenase (KMO), and kynurenine aminotransferase II (KAT II).  IDO1 inhibitors are currently in clin. trials for the treatment of cancer, and these agents may also have therapeutic utility in neurol. disorders, including multiple sclerosis.  KMO inhibitors are being investigated as potential treatments for neurodegenerative diseases, such as Huntington's and Alzheimer's diseases.  KAT II inhibitors have been proposed in new therapeutic approaches toward psychiatric and cognitive disorders, including cognitive impairment assocd. with schizophrenia.  Numerous medicinal chem. studies are currently aimed at the design of novel, potent, and selective inhibitors for each of these enzymes.  The emerging opportunities and significant challenges assocd. with pharmacol. modulation of these enzymes will be explored in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNTjn9vtU54bVg90H21EOLACvtfcHk0lin2UafKm4DGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1alur%252FJ&md5=8d2bcd65935fc25ae013559e583c144e</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00461%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DChallenges%2520and%2520opportunities%2520in%2520the%2520discovery%2520of%2520new%2520therapeutics%2520targeting%2520the%2520kynurenine%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8762%26epage%3D8782%26doi%3D10.1021%2Facs.jmedchem.5b00461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in lewis lung cancer (LLC) tumor-bearing mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8321</span>– <span class="NLM_lpage">8331</span>, <span class="refDoi"> DOI: 10.1021/jm401195n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401195n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8321-8331&author=S.+Yangauthor=X.+Liauthor=F.+Huauthor=Y.+Liauthor=Y.+Yangauthor=J.+Yanauthor=C.+Kuangauthor=Q.+Yang&title=Discovery+of+tryptanthrin+derivatives+as+potent+inhibitors+of+indoleamine+2%2C3-dioxygenase+with+therapeutic+activity+in+lewis+lung+cancer+%28LLC%29+tumor-bearing+mice&doi=10.1021%2Fjm401195n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tryptanthrin Derivatives as Potent Inhibitors of Indoleamine 2,3-Dioxygenase with Therapeutic Activity in Lewis Lung Cancer (LLC) Tumor-Bearing Mice</span></div><div class="casAuthors">Yang, Shuangshuang; Li, Xishuai; Hu, Fangfang; Li, Yinlong; Yang, Yunyun; Yan, Junkai; Kuang, Chunxiang; Yang, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8321-8331</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO-1) is emerging as an important new therapeutic target for the treatment of cancer, neurol. disorders, and other diseases that are characterized by pathol. tryptophan metab.  However, only a few structural classes are known to be IDO-1 inhibitors.  In this study, a natural compd. tryptanthrin was discovered to be a novel potent IDO-1 inhibitor by screening of indole-based structures.  Three series of 13 tryptanthrin derivs. were synthesized, and the structure-activity anal. was undertaken.  The optimization led to the identification of 5c, which exhibited the inhibitory activity at a nanomolar level.  In vitro 5c dramatically augmented the proliferation of T cells.  When administered to Lewis lung cancer (LLC) tumor-bearing mice, 5c significantly inhibited IDO-1 activity and suppressed tumor growth.  In addn., 5c reduced the nos. of Foxp3+ regulatory T cells (Tregs), which are known to prevent the development of efficient antitumor immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ioPL3rWy1bVg90H21EOLACvtfcHk0lin2UafKm4DGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynsrjL&md5=ac744f81ce97b0435f2bfd240e1393a1</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Fjm401195n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401195n%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520tryptanthrin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520with%2520therapeutic%2520activity%2520in%2520lewis%2520lung%2520cancer%2520%2528LLC%2529%2520tumor-bearing%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8321%26epage%3D8331%26doi%3D10.1021%2Fjm401195n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasceri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Aminophenoxazinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis of exfoliazone and chandrananimycin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3310</span>– <span class="NLM_lpage">3317</span>, <span class="refDoi"> DOI: 10.1021/jm400049z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400049z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFSru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3310-3317&author=R.+Pasceriauthor=D.+Siegelauthor=D.+Rossauthor=C.+J.+Moody&title=Aminophenoxazinones+as+inhibitors+of+indoleamine+2%2C3-dioxygenase+%28IDO%29.+Synthesis+of+exfoliazone+and+chandrananimycin+A&doi=10.1021%2Fjm400049z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">Aminophenoxazinones as Inhibitors of Indoleamine 2,3-Dioxygenase (IDO). Synthesis of Exfoliazone and Chandrananimycin A</span></div><div class="casAuthors">Pasceri, Raffaele; Siegel, David; Ross, David; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3310-3317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of 2-aminophenoxazin-3-ones has been prepd. by oxidative cyclocondensation of 2-aminophenols, including the natural products exfoliazone (I) and chandrananimycin A (II), both synthesized for the first time.  The compds. were evaluated for their ability to inhibit indoleamine 2,3-dioxygenase.  Compds. contg. addnl. electron-withdrawing carboxylate groups, such as cinnabarinic acid, showed modest inhibitory activity with a dose response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE1AFH8y_k1LVg90H21EOLACvtfcHk0lhKemJjjIBGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFSru7s%253D&md5=6498cacf5e76b962baa7222677bcf407</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Fjm400049z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400049z%26sid%3Dliteratum%253Aachs%26aulast%3DPasceri%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DAminophenoxazinones%2520as%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529.%2520Synthesis%2520of%2520exfoliazone%2520and%2520chandrananimycin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3310%26epage%3D3317%26doi%3D10.1021%2Fjm400049z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Röhrig, U. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majjigapu, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den
Eynde, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5270</span>– <span class="NLM_lpage">5290</span>, <span class="refDoi"> DOI: 10.1021/jm300260v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300260v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5270-5290&author=U.+F.+R%C3%B6hrigauthor=S.+R.+Majjigapuauthor=A.+Grosdidierauthor=S.+Bronauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=P.+Vogelauthor=B.+J.+Van+den%0AEyndeauthor=V.+Zoeteauthor=O.+Michielin&title=Rational+design+of+4-aryl-1%2C2%2C3-triazoles+for+indoleamine+2%2C3-dioxygenase+1+inhibition&doi=10.1021%2Fjm300260v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition</span></div><div class="casAuthors">Rohrig, Ute F.; Majjigapu, Somi Reddy; Grosdidier, Aurelien; Bron, Sylvian; Stroobant, Vincent; Pilotte, Luc; Colau, Didier; Vogel, Pierre; Van den Eynde, Benoit J.; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5270-5290</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target for the treatment of diseases such as cancer that involve pathol. immune escape.  Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands.  This approach yielded highly efficient low mol. wt. inhibitors, the most active being of nanomolar potency both in an enzymic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO).  A quant. structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chem. derived charges of the triazole ring demonstrated a good explanatory power for the obsd. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CFYZnWiLSLVg90H21EOLACvtfcHk0lhKemJjjIBGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yiu7c%253D&md5=6ba6c0b628165673cd49c7a950ed885e</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1021%2Fjm300260v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300260v%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DBron%26aufirst%3DS.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DRational%2520design%2520of%25204-aryl-1%252C2%252C3-triazoles%2520for%2520indoleamine%25202%252C3-dioxygenase%25201%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5270%26epage%3D5290%26doi%3D10.1021%2Fjm300260v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Röhrig, U. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosdidier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobant, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerundolo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, A. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eynde, B. J. V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michielin, O.</span></span> <span> </span><span class="NLM_article-title">Rational design of indoleamine 2,3-dioxygenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1172</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1021/jm9014718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9014718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1172-1189&author=U.+F.+R%C3%B6hrigauthor=L.+Awadauthor=A.+Grosdidierauthor=P.+Larrieuauthor=V.+Stroobantauthor=D.+Colauauthor=V.+Cerundoloauthor=A.+J.+G.+Simpsonauthor=P.+Vogelauthor=B.+J.+V.+D.+Eyndeauthor=V.+Zoeteauthor=O.+Michielin&title=Rational+design+of+indoleamine+2%2C3-dioxygenase+inhibitors&doi=10.1021%2Fjm9014718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9jR"><div class="casContent"><span class="casTitleNuber">9j</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors</span></div><div class="casAuthors">Rohrig, Ute F.; Awad, Loay; Grosdidier, Aurelien; Larrieu, Pierre; Stroobant, Vincent; Colau, Didier; Cerundolo, Vincenzo; Simpson, Andrew J. G.; Vogel, Pierre; Van den Eynde, Benoit J.; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1172-1189</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is an important therapeutic target for the treatment of diseases such as cancer that involve pathol. immune escape.  We have used the evolutionary docking algorithm EADock to design new inhibitors of this enzyme.  First, we investigated the modes of binding of all known IDO inhibitors.  On the basis of the obsd. docked conformations, we developed a pharmacophore model, which was then used to devise new compds. to be tested for IDO inhibition.  We also used a fragment-based approach to design and to optimize small org. mol. inhibitors.  Both approaches yielded several new low-mol. wt. inhibitor scaffolds, the most active being of nanomolar potency in an enzymic assay.  Cellular assays confirmed the potential biol. relevance of four different scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9k4hgz-V8J7Vg90H21EOLACvtfcHk0lhKemJjjIBGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1emsA%253D%253D&md5=be50f3dff0bcee6ae59f19d2fc4e5552</span></div><a href="/servlet/linkout?suffix=cit9j&amp;dbid=16384&amp;doi=10.1021%2Fjm9014718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014718%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DAwad%26aufirst%3DL.%26aulast%3DGrosdidier%26aufirst%3DA.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DCerundolo%26aufirst%3DV.%26aulast%3DSimpson%26aufirst%3DA.%2BJ.%2BG.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DEynde%26aufirst%3DB.%2BJ.%2BV.%2BD.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DRational%2520design%2520of%2520indoleamine%25202%252C3-dioxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1172%26epage%3D1189%26doi%3D10.1021%2Fjm9014718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bower, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansbury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7364</span>– <span class="NLM_lpage">7367</span>, <span class="refDoi"> DOI: 10.1021/jm900518f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900518f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7364-7367&author=E.+W.+Yueauthor=B.+Doutyauthor=B.+Waylandauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=C.+Liuauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=B.+Metcalfauthor=P.+A.+Scherleauthor=A.+P.+Combs&title=Discovery+of+potent+competitive+inhibitors+of+indoleamine+2%2C3-dioxygenase+with+in+vivo+pharmacodynamic+activity+and+efficacy+in+a+mouse+melanoma+model&doi=10.1021%2Fjm900518f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9kR"><div class="casContent"><span class="casTitleNuber">9k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model</span></div><div class="casAuthors">Yue, Eddy W.; Douty, Brent; Wayland, Brian; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Liu, Changnian; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Metcalf, Brian; Scherle, Peggy A.; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7364-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydroxyamidine chemotype has been discovered as a key pharmacophore in novel inhibitors of indoleamine 2,3-dioxygenase (IDO).  Optimization led to the identification of (I), which is a potent (HeLa IC50 = 19 nM) competitive inhibitor of IDO.  Testing of I in mice demonstrated pharmacodynamic inhibition of IDO, as measured by decreased kynurenine levels (>50%) in plasma and dose dependent efficacy in mice bearing GM-CSF-secreting B16 melanoma tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsq88hx0J77Vg90H21EOLACvtfcHk0liPuIwFpW0gnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D&md5=328d92bffb88a86da030c31eff707dc6</span></div><a href="/servlet/linkout?suffix=cit9k&amp;dbid=16384&amp;doi=10.1021%2Fjm900518f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900518f%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520competitive%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%2520with%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520efficacy%2520in%2520a%2520mouse%2520melanoma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7364%26epage%3D7367%26doi%3D10.1021%2Fjm900518f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malachowski, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1021/jm7014155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1706-1718&author=S.+Kumarauthor=W.+P.+Malachowskiauthor=J.+B.+DuHadawayauthor=J.+M.+LaLondeauthor=P.+J.+Carrollauthor=D.+Jallerauthor=R.+Metzauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Indoleamine+2%2C3-dioxygenase+is+the+anticancer+target+for+a+novel+series+of+potent+naphthoquinone-based+inhibitors&doi=10.1021%2Fjm7014155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9lR"><div class="casContent"><span class="casTitleNuber">9l</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Is the Anticancer Target for a Novel Series of Potent Naphthoquinone-Based Inhibitors</span></div><div class="casAuthors">Kumar, Sanjeev; Malachowski, William P.; DuHadaway, James B.; LaLonde, Judith M.; Carroll, Patrick J.; Jaller, Daniel; Metz, Richard; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1706-1718</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  While small mol. inhibitors of IDO exist, there remains a dearth of high-potency compds. offering in vivo efficacy and clin. translational potential.  In this study, the authors address this gap by defining a new class of naphthoquinone-based IDO inhibitors exemplified by the natural product menadione, which is shown in mouse tumor models to have similar antitumor activity to previously characterized IDO inhibitors.  Genetic validation that IDO is the crit. in vivo target is demonstrated using IDO-null mice.  Elaboration of menadione to a pyranonaphthoquinone has yielded low nanomolar potency inhibitors, including new compds. which are the most potent reported to date (Ki = 61-70 nM).  Synthetic accessibility of this class will facilitate preclin. chem.-genetic studies as well as further optimization of pharmacol. parameters for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ZM1JKuRtPbVg90H21EOLACvtfcHk0liPuIwFpW0gnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKqtL4%253D&md5=9d3c1bc16796927ab88fc5d6b6ef065a</span></div><a href="/servlet/linkout?suffix=cit9l&amp;dbid=16384&amp;doi=10.1021%2Fjm7014155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014155%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DCarroll%26aufirst%3DP.%2BJ.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DR.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520the%2520anticancer%2520target%2520for%2520a%2520novel%2520series%2520of%2520potent%2520naphthoquinone-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1706%26epage%3D1718%26doi%3D10.1021%2Fjm7014155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, S.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiro, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O<sub>2</sub> incorporation by a heme-containing dioxygenase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2611</span>– <span class="NLM_lpage">2616</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508996103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.0508996103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=16477023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2rsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2611-2616&author=H.+Sugimotoauthor=S.-i.+Odaauthor=T.+Otsukiauthor=T.+Hinoauthor=T.+Yoshidaauthor=Y.+Shiro&title=Crystal+structure+of+human+indoleamine+2%2C3-dioxygenase%3A+catalytic+mechanism+of+O2+incorporation+by+a+heme-containing+dioxygenase&doi=10.1073%2Fpnas.0508996103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase</span></div><div class="casAuthors">Sugimoto, Hiroshi; Oda, Shun-ichiro; Otsuki, Takashi; Hino, Tomoya; Yoshida, Tadashi; Shiro, Yoshitsugu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2611-2616</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human indoleamine 2,3-dioxygenase (IDO) catalyzes the cleavage of the pyrrole ring of L-tryptophan and incorporates both atoms of an O2 mol.  Here, the authors report on the x-ray crystal structure of human IDO, complexed with the inhibitors, 4-phenylimidazole and cyanide.  The overall structure of IDO showed 2 α-helical domains with the heme between them.  Residue Ala-264 of the flexible loop on the heme distal side was in close proximity to the Fe.  A mutant anal. showed that none of the polar amino acid residues in the distal heme pocket were essential for activity, suggesting that, unlike the heme-contg. monooxygenases (e.g., peroxidase and cytochrome P 450), no protein group of IDO is essential in O2 activation or proton abstraction.  These characteristics of the IDO structure provided support for a reaction mechanism involving the abstraction of a proton from the substrate by Fe-bound O2.  The inactive mutants (F226A, F227A, and R231A) retained substrate-binding affinity, and an electron d. map revealed that 2-(N-cyclohexylamino)ethanesulfonic acid (CHES), a component of the crystn. buffer, was bound to these residues, mimicking the substrate.  These findings suggest that strict shape complementarities between the indole ring of the substrate and the protein side-chains are required, not for binding, but, rather, to permit the interaction between the substrate and Fe-bound O2 in the 1st step of the reaction.  This study provides the structural basis for a heme-contg. dioxygenase mechanism, a missing piece in the understanding of heme chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdrCQcNUKrrVg90H21EOLACvtfcHk0li82M5OVtysDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2rsb4%253D&md5=aaf94d532920b2b855bf6fe1a58dfa92</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508996103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508996103%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DS.-i.%26aulast%3DOtsuki%26aufirst%3DT.%26aulast%3DHino%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DShiro%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520human%2520indoleamine%25202%252C3-dioxygenase%253A%2520catalytic%2520mechanism%2520of%2520O2%2520incorporation%2520by%2520a%2520heme-containing%2520dioxygenase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2611%26epage%3D2616%26doi%3D10.1073%2Fpnas.0508996103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malachowski, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-Dioxygenase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4977</span>, <span class="refDoi"> DOI: 10.1021/jm800512z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800512z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4968-4977&author=S.+Kumarauthor=D.+Jallerauthor=B.+Patelauthor=J.+M.+LaLondeauthor=J.+B.+DuHadawayauthor=W.+P.+Malachowskiauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Structure+based+development+of+phenylimidazole-derived+inhibitors+of+indoleamine+2%2C3-Dioxygenase&doi=10.1021%2Fjm800512z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase</span></div><div class="casAuthors">Kumar, Sanjeev; Jaller, Daniel; Patel, Bhumika; LaLonde, Judith M.; DuHadaway, James B.; Malachowski, William P.; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4968-4977</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  With the goal of developing more potent IDO inhibitors, a systematic study of 4-phenylimidazole (4-PI) derivs. was undertaken.  Computational docking expts. guided design and synthesis efforts with analogs of 4-PI.  In particular, three interactions of 4-PI analogs with IDO were studied: the active site entrance, the interior of the active site, and the heme iron binding.  The three most potent inhibitors I (R = 4-HOC6H4, 3-HSC6H4, 4-HSC6H4) appear to exploit interactions with C129 and S167 in the interior of the active site.  All three inhibitors are approx. 10-fold more potent than 4-PI.  The study represents the first example of enzyme inhibitor development with the recently reported crystal structure of IDO and offers important lessons in the search for more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTIIEf7DjmLVg90H21EOLACvtfcHk0li82M5OVtysDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D&md5=6e232cb983d0ba2396bea16060a5b7a1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800512z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800512z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DStructure%2520based%2520development%2520of%2520phenylimidazole-derived%2520inhibitors%2520of%2520indoleamine%25202%252C3-Dioxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4968%26epage%3D4977%26doi%3D10.1021%2Fjm800512z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0li82M5OVtysDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Magdalou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel-Gigleux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouzzine, M.</span></span> <span> </span><span class="NLM_article-title">Insights on membrane topology and structure/function of UDP-glucuronosyltransferases</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.3109/03602530903209270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.3109%2F03602530903209270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=19807219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=159-166&author=J.+Magdalouauthor=S.+Fournel-Gigleuxauthor=M.+Ouzzine&title=Insights+on+membrane+topology+and+structure%2Ffunction+of+UDP-glucuronosyltransferases&doi=10.3109%2F03602530903209270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on membrane topology and structure/function of UDP-glucuronosyltransferases</span></div><div class="casAuthors">Magdalou, Jacques; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-166</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The main characteristic of uridine diphosphate (UDP)-glucuronosyltransferases is their potency to glucuronidate a large array of structurally unrelated substances with various nucleophilic groups.  The activity of these enzymes strongly depends on their tight assocn. to the membrane of the endoplasmic reticulum.  In light of recent data, this review is focused on the membrane-assembly process, which is a prerequisite for activity, and on the amino acids that govern substrate recognition and catalysis at the active site.  The major implication of the highly variable N-terminal domain of UDP-glucuronosyltransferases in the substrate specificity of these enzymes is highlighted.  In the absence of crystal data of the N-terminal domain, multidisciplinary approaches of genetic-/protein-engineering techniques, homol. modeling with glycosyltransferases, and quant. structure-activity relationships allowed us to point out crucial amino acids.  On the basis of these results, possible reaction mechanisms for the glucuronidation of xenobiotics, involving histidine and aspartic acid residues, have been built and are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ1jNLDZdQPrVg90H21EOLACvtfcHk0lic4-OTFlVtZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFantw%253D%253D&md5=28cae4aa50f41e218d4dd85940389c2a</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.3109%2F03602530903209270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903209270%26sid%3Dliteratum%253Aachs%26aulast%3DMagdalou%26aufirst%3DJ.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26aulast%3DOuzzine%26aufirst%3DM.%26atitle%3DInsights%2520on%2520membrane%2520topology%2520and%2520structure%252Ffunction%2520of%2520UDP-glucuronosyltransferases%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26spage%3D159%26epage%3D166%26doi%3D10.3109%2F03602530903209270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>– <span class="NLM_lpage">6652</span>, <span class="refDoi"> DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup</span></div><div class="casAuthors">Glossop, Paul A.; Lane, Charlotte A. L.; Price, David A.; Bunnage, Mark E.; Lewthwaite, Russell A.; James, Kim; Brown, Alan D.; Yeadon, Michael; Perros-Huguet, Christelle; Trevethick, Michael A.; Clarke, Nicholas P.; Webster, Robert; Jones, Rhys M.; Burrows, Jane L.; Feeder, Neil; Taylor, Stefan C. J.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6640-6652</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of potent and selective sulfonamide derived β2-adrenoreceptor agonists are described that exhibit potential as inhaled ultra-long-acting bronchodilators for the treatment of asthma and chronic obstructive pulmonary disease.  Analogs from this series mediate very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  The sulfonamide agonist headgroup confers high levels of intrinsic crystallinity that could relate to the acidic sulfonamide motif supporting a zwitterionic form in the solid state.  Optimization of pharmacokinetic properties was achieved through targeted introduction of a phenolic moiety to support rapid phase II clearance, thereby minimizing systemic exposure following inhalation and reducing systemically mediated adverse events.  Compd. 38 (PF-610355) is identified as a clin. candidate from this series, with in vivo duration of action studies confirming its potential for once-daily use in humans.  Compd. 38 is currently in advanced phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGaBcfoYeu7Vg90H21EOLACvtfcHk0lic4-OTFlVtZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2ktLjJ&md5=34cf266aa0f796ee5ec370369c726f6e</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entwistle, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel tertiary amine muscarinic M3 receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6888</span>– <span class="NLM_lpage">6904</span>, <span class="refDoi"> DOI: 10.1021/jm200884j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200884j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SltbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6888-6904&author=P.%0AA.+Glossopauthor=C.+A.+L.+Watsonauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=D.+S.+Middletonauthor=A.+Woodauthor=K.+Jamesauthor=D.+Robertsauthor=R.+S.+Strangauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=N.+P.+Clarkeauthor=M.+A.+Trevethickauthor=I.+Machinauthor=E.+F.+Stuartauthor=S.+M.+Evansauthor=A.+C.+Harrisonauthor=D.+A.+Fairmanauthor=B.+Agoramauthor=J.+L.+Burrowsauthor=N.+Feederauthor=C.+K.+Fultonauthor=B.+R.+Dillonauthor=D.+A.+Entwistleauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+tertiary+amine+muscarinic+M3+receptor+antagonists+with+slow+off-rate+binding+kinetics+for+inhaled+once-daily+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200884j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Glossop, Paul A.; Watson, Christine A. L.; Price, David A.; Bunnage, Mark E.; Middleton, Donald S.; Wood, Anthony; James, Kim; Roberts, Dannielle; Strang, Ross S.; Yeadon, Michael; Perros-Huguet, Christelle; Clarke, Nicholas P.; Trevethick, Michael A.; Machin, Ian; Stuart, Emilio F.; Evans, Steven M.; Harrison, Anthony C.; Fairman, David A.; Agoram, Balaji; Burrows, Jane L.; Feeder, Neil; Fulton, Craig K.; Dillon, Barry R.; Entwistle, David A.; Spence, Fiona J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6888-6904</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel tertiary amine series of potent muscarinic M3 receptor antagonists are described that exhibit potential as inhaled long-acting bronchodilators for the treatment of chronic obstructive pulmonary disease.  Geminal di-Me functionality present in this series of compds. confers very long dissociative half-life (slow off-rate) from the M3 receptor that mediates very long-lasting smooth muscle relaxation in guinea pig tracheal strips.  Optimization of pharmacokinetic properties was achieved by combining rapid oxidative clearance with targeted introduction of a phenolic moiety to secure rapid glucuronidation.  Together, these attributes minimize systemic exposure following inhalation, mitigate potential drug-drug interactions, and reduce systemically mediated adverse events.  Compd. 47 (PF-3635659) is identified as a Phase II clin. candidate from this series with in vivo duration of action studies confirming its potential for once-daily use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8Q4T5oR53bVg90H21EOLACvtfcHk0ljw_C8Qf-3N7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SltbzM&md5=ca9b632b4c7982fb44c0d5dd17a056bf</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm200884j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200884j%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DMachin%26aufirst%3DI.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DEvans%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DAgoram%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DDillon%26aufirst%3DB.%2BR.%26aulast%3DEntwistle%26aufirst%3DD.%2BA.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520tertiary%2520amine%2520muscarinic%2520M3%2520receptor%2520antagonists%2520with%2520slow%2520off-rate%2520binding%2520kinetics%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6888%26epage%3D6904%26doi%3D10.1021%2Fjm200884j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaitre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahnke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7797</span>– <span class="NLM_lpage">7814</span>, <span class="refDoi"> DOI: 10.1021/jm200677b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200677b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7797-7814&author=D.+S.+Millanauthor=M.+E.+Bunnageauthor=J.+L.+Burrowsauthor=K.+J.+Butcherauthor=P.+G.+Doddauthor=T.+J.+Evansauthor=D.+A.+Fairmanauthor=S.+J.+Hughesauthor=I.+C.+Kiltyauthor=A.+Lemaitreauthor=R.+A.+Lewthwaiteauthor=A.+Mahnkeauthor=J.+P.+Mathiasauthor=J.+Philipauthor=R.+T.+Smithauthor=M.+H.+Stefaniakauthor=M.+Yeadonauthor=C.+Phillips&title=Design+and+synthesis+of+inhaled+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200677b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Millan, David S.; Bunnage, Mark E.; Burrows, Jane L.; Butcher, Kenneth J.; Dodd, Peter G.; Evans, Timothy J.; Fairman, David A.; Hughes, Samantha J.; Kilty, Iain C.; Lemaitre, Arnaud; Lewthwaite, Russell A.; Mahnke, Axel; Mathias, John P.; Philip, James; Smith, Robert T.; Stefaniak, Mark H.; Yeadon, Michael; Phillips, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7797-7814</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease.  Structure based drug design and "inhalation by design" principles have been applied to the optimization of the lead series exemplified by compd. I.  Analogs have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissocn. kinetics to deliver prolonged lung p38 inhibition.  Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events.  High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug-drug interactions.  Furthermore, pharmaceutical properties such as stability, crystallinity, and soly. were considered to ensure compatibility with a dry powder inhaler.  P38 Inhibitor II (PF-03715455) was subsequently identified as a clin. candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzy5ivwDBL6rVg90H21EOLACvtfcHk0ljw_C8Qf-3N7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E&md5=9bc6cccf04a78831f50fb402bf7cb4b1</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200677b%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DEvans%26aufirst%3DT.%2BJ.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMahnke%26aufirst%3DA.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DPhilip%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520inhaled%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7797%26epage%3D7814%26doi%3D10.1021%2Fjm200677b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.</span></span> <i>Drug-like Properties: Concepts, Structure Design and Methods 1st Edition from ADME to Toxicity Optimization</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Di&author=E.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+1st+Edition+from+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%25201st%2520Edition%2520from%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DAcademic%2520Press%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span> <span> </span><span class="NLM_article-title">Recognizing molecules with drug-like properties</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/s1367-5931(99)80058-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs1367-5931%2899%2980058-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10419858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1ejtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=384-387&author=W.+P.+Waltersauthor=A.+A.+Murckoauthor=M.+A.+Murcko&title=Recognizing+molecules+with+drug-like+properties&doi=10.1016%2Fs1367-5931%2899%2980058-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Recognizing molecules with drug-like properties</span></div><div class="casAuthors">Walters, W. Patrick; Ajay; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-387</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 36 refs.  A variety of successful approaches to the problem of recognizing "drug-like" mols. have been employed.  These range from simple counting schemes such as the Lipinski "rule of five" to the anal. of the multidimensional "chem. space" occupied by drugs, to neural network learning systems.  With this variety of tools, it now appears possible to design libraries that are enriched in compds. which have desirable or "drug-like" properties.  Verifying the robustness of these methods, and extending them, will form the basis of research in this field during the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAWoMBJtUuE7Vg90H21EOLACvtfcHk0liIe8BJAkZWkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1ejtb0%253D&md5=d3ccb8e38e1e0a3981fad87d10ed66e2</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fs1367-5931%2899%2980058-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1367-5931%252899%252980058-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DMurcko%26aufirst%3DA.%2BA.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DRecognizing%2520molecules%2520with%2520drug-like%2520properties%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D1999%26volume%3D3%26spage%3D384%26epage%3D387%26doi%3D10.1016%2Fs1367-5931%2899%2980058-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/s1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2Fs1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eb1_YclbtQSH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2Fs1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boose, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, D. J.</span></span> <span> </span><span class="NLM_article-title">Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/0006-291x(74)90948-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2F0006-291x%2874%2990948-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=4151402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE2cXksleiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1974&pages=426-433&author=H.+E.+Mayauthor=R.+Booseauthor=D.+J.+Reed&title=Hydroxylation+of+the+carcinostatic+1-%282-chloroethyl%29-3-cyclohexyl-1-nitrosourea+%28CCNU%29+by+rat+liver+microsomes&doi=10.1016%2F0006-291x%2874%2990948-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes</span></div><div class="casAuthors">May, Hubert E.; Boose, Richard; Reed, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">426-33</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Ring hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (I) [13010-47-4] occurred in the presence of liver microsomes prepd. from both normal and phenobarbital [50-06-6]-treated rats.  The metabolite was identified by mass spectrometry after selective, extn. and purifn.  The microsomal catalyzed reaction was O2- and NADPH-dependent, inhibited by CO, and induced 4-5 fold by in vivo phenobarbital pretreatment.  Microsomes isolated from the liver of phenobarbital-treated animals hydroxylated the substrate at 17.6 nmoles/min/mg protein at 37.deg..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-F-T_qxlgI7Vg90H21EOLACvtfcHk0liIe8BJAkZWkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXksleiu78%253D&md5=d5054fa144b863a57a885dd114aa6aee</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2F0006-291x%2874%2990948-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291x%252874%252990948-6%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BE.%26aulast%3DBoose%26aufirst%3DR.%26aulast%3DReed%26aufirst%3DD.%2BJ.%26atitle%3DHydroxylation%2520of%2520the%2520carcinostatic%25201-%25282-chloroethyl%2529-3-cyclohexyl-1-nitrosourea%2520%2528CCNU%2529%2520by%2520rat%2520liver%2520microsomes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D57%26spage%3D426%26epage%3D433%26doi%3D10.1016%2F0006-291x%2874%2990948-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Montogomery, J. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry and structure-activity studies of the nitrosoureas</span>. <i>Cancer Treat. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=954007" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1976&pages=651-664&author=J.+A.+Montogomery&title=Chemistry+and+structure-activity+studies+of+the+nitrosoureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMontogomery%26aufirst%3DJ.%2BA.%26atitle%3DChemistry%2520and%2520structure-activity%2520studies%2520of%2520the%2520nitrosoureas%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1976%26volume%3D60%26spage%3D651%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boose, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, D. J.</span></span> <span> </span><span class="NLM_article-title">Microsomal monooxygenation of the rcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Synthesis and identification of <i>cis</i> and <i>trans</i> monohydroxylated products</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4723</span>– <span class="NLM_lpage">4730</span>, <span class="refDoi"> DOI: 10.1021/bi00692a025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00692a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE28XpsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=4723-4730&author=H.+E.+Mayauthor=R.+Booseauthor=D.+J.+Reed&title=Microsomal+monooxygenation+of+the+rcinostatic+1-%282-chloroethyl%29-3-cyclohexyl-1-nitrosourea.+Synthesis+and+identification+of+cis+and+trans+monohydroxylated+products&doi=10.1021%2Fbi00692a025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Microsomal monooxygenation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.  Synthesis and identification of cis and trans monohydroxylated products</span></div><div class="casAuthors">May, Hubert E.; Boose, Richard; Reed, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4723-30</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Liver microsomal hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (I)t [13010-47-4] occurred on the cyclohexyl ring at positions 3 and 4.  Four metabolites were isolated and synthesized:the cis-4 [52049-26-0], trans-4- [56239-24-8], cis-3- [56323-45-6], and trans-3-OH [56323-44-5] derivs. of I.  Microsomes from rats pretreated with phenobarbital showed a sixfold increase in hydroxylation rate (19.8 vs. 3.3 nomole/mg/min).  The induction was selective for cis-4 hydroxylation (19-fold); however, induction of trans-4 (threefold), cis-3 (threefold), and trans-3 (twofold) hydroxylation did occur.  The cis-4-hydroxy metabolite was 67% of the total product by phenobarbital-induced microsomes and 21% for normal microsomes.  Microsomes from animals pretreated with 3-methylcholanthrene gave about the same rate and product distribution that normal microsomes gave.  A mixt. of 80% CO-20% O inhibited formation of all 4 hydroxy metabolites with the inhibition ranging from 55 to 78%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpINOijcdGQtLVg90H21EOLACvtfcHk0li8zXUwgCZ-oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XpsA%253D%253D&md5=d2aed2d8a2238aed184227fd2f41c480</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fbi00692a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00692a025%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BE.%26aulast%3DBoose%26aufirst%3DR.%26aulast%3DReed%26aufirst%3DD.%2BJ.%26atitle%3DMicrosomal%2520monooxygenation%2520of%2520the%2520rcinostatic%25201-%25282-chloroethyl%2529-3-cyclohexyl-1-nitrosourea.%2520Synthesis%2520and%2520identification%2520of%2520cis%2520and%2520trans%2520monohydroxylated%2520products%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D4723%26epage%3D4730%26doi%3D10.1021%2Fbi00692a025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roychowdhury, A.</span></span> <span> </span><span class="NLM_article-title">Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3621</span>, <span class="refDoi"> DOI: 10.2174/092986712801323180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.2174%2F092986712801323180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=22680629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2itbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3605-3621&author=S.+Kumarauthor=R.+Sharmaauthor=A.+Roychowdhury&title=Modulation+of+cytochrome-P450+inhibition+%28CYP%29+in+drug+discovery%3A+a+medicinal+chemistry+perspective&doi=10.2174%2F092986712801323180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective</span></div><div class="casAuthors">Kumar, Sanjay; Sharma, Rajiv; Roychowdhury, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3605-3621</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP450) has widely been implicated for drug-drug interactions (DDI) in the pharmaceutical industry.  Inhibition or induction of this enzyme family has led to withdrawal of multiple drugs from the market leading to major time and financial losses for the pharmaceutical industry.  CYP450 plays a prevailing role in the biotransformation of a large no. of structurally diverse drugs.  Few isoenzymes of the CYP enzyme family (CYP3A4, 2D6 and 2C9 family) are mainly involved in metab. of most of the drugs.  To avoid such interactions and potentially minimize DDI, major pharmaceutical organizations prefer to incorporate CYP enzyme screening at an early stage of their discovery program.  While this has been a prevalent practice in the pharmaceutical industry lately, there is very limited literature available reviewing the relationship between chemotypes and CYP isoforms.  This review will collate literature pertaining to CYP-inhibition modulation through physicochem. parameters and chem. modification and thus bring to focus commonly used trends by medicinal chemists world-wide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVIogYUZJywLVg90H21EOLACvtfcHk0li8zXUwgCZ-oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2itbrF&md5=1f675ef0f7cd31a254b82d8b2eaac44b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986712801323180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712801323180%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DRoychowdhury%26aufirst%3DA.%26atitle%3DModulation%2520of%2520cytochrome-P450%2520inhibition%2520%2528CYP%2529%2520in%2520drug%2520discovery%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3605%26epage%3D3621%26doi%3D10.2174%2F092986712801323180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patick, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borer, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayyar, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovalsantos, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohajeri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosa, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batugo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J.-P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meador, J. W.,  3rd.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4572</span>– <span class="NLM_lpage">4585</span>, <span class="refDoi"> DOI: 10.1021/jm030166l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030166l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Ojs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4572-4585&author=P.+S.+Dragovichauthor=T.+J.+Prinsauthor=R.+Zhouauthor=T.+O.+Johnsonauthor=Y.+Huaauthor=H.+T.+Luuauthor=S.+K.+Sakataauthor=E.+L.+Brownauthor=F.+C.+Maldonadoauthor=T.+Tuntlandauthor=C.+A.+Leeauthor=S.+A.+Fuhrmanauthor=L.+S.+Zalmanauthor=A.+K.+Patickauthor=D.+A.+Matthewsauthor=E.+Y.+Wuauthor=M.+Guoauthor=B.+C.+Borerauthor=N.+K.+Nayyarauthor=T.+Moranauthor=L.+Chenauthor=P.+A.+Rejtoauthor=P.+W.+Roseauthor=M.+C.+Guzmanauthor=E.+Z.+Dovalsantosauthor=S.+Leeauthor=K.+McGeeauthor=M.+Mohajeriauthor=A.+Lieseauthor=J.+Taoauthor=M.+B.+Kosaauthor=B.+Liuauthor=M.+R.+Batugoauthor=J.-P.+R.+Gleesonauthor=Z.+P.+Wuauthor=J.+Liuauthor=J.+W.+Meadorauthor=R.+A.+Ferre&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+irreversible+human+rhinovirus+3C+protease+inhibitors.+8.+Pharmacological+optimization+of+orally+bioavailable+2-pyridone-containing+peptidomimetics&doi=10.1021%2Fjm030166l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics</span></div><div class="casAuthors">Dragovich, Peter S.; Prins, Thomas J.; Zhou, Ru; Johnson, Theodore O.; Hua, Ye; Luu, Hiep T.; Sakata, Sylvie K.; Brown, Edward L.; Maldonado, Fausto C.; Tuntland, Tove; Lee, Caroline A.; Fuhrman, Shella A.; Zalman, Leora S.; Patick, Amy K.; Matthews, David A.; Wu, Ellen Y.; Guo, Ming; Borer, Bennett C.; Nayyar, Naresh K.; Moran, Terence; Chen, Lijian; Rejto, Paul A.; Rose, Peter W.; Guzman, Mark C.; Dovalsantos, Elena Z.; Lee, Steven; McGee, Kevin; Mohajeri, Michael; Liese, Andreas; Tao, Junhua; Kosa, Maha B.; Liu, Bo; Batugo, Minerva R.; Gleeson, Jean-Paul R.; Wu, Zhen Ping; Liu, Jia; Meador, James W., III; Ferre, Rose Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4572-4585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of the pharmacokinetic performance of various 2-pyridone-contg. human rhinovirus (HRV) 3C protease (3CP) inhibitors following oral administration to either beagle dogs or CM-monkeys is described.  The mols. described in this work are composed of a 2-pyridone-contg. peptidomimetic binding determinant and an α,β-unsatd. ester Michael acceptor moiety which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme.  Modification of the ester contained within these compds. is detailed along with alteration of the P2 substituent present in the peptidomimetic portion of the inhibitors.  The pharmacokinetics of several inhibitors in both dogs and monkeys are described (7 h plasma concns. after oral administration) along with their human plasma stabilities, stabilities in incubations with human, dog, and monkey microsomes and hepatocytes, Caco-2 permeabilities, and aq. solubilities.  Compds. contg. an α,β-unsatd. Et ester fragment and either an Et or propargyl P2 moiety displayed the most promising combination of 3C enzyme inhibition (kobs/[I] 170 000-223 000 M-1 s-1), antiviral activity (EC50 = 0.047-0.058 μM, mean vs. seven HRV serotypes), and pharmacokinetics following oral administration (7 h dog plasma levels = 0.248-0.682 μM; 7 h CM-monkey plasma levels = 0.057-0.896 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom7ef81WRYlrVg90H21EOLACvtfcHk0li8zXUwgCZ-oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Ojs78%253D&md5=c4b964698cce3c97c107076f24692056</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm030166l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030166l%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DPrins%26aufirst%3DT.%2BJ.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DH.%2BT.%26aulast%3DSakata%26aufirst%3DS.%2BK.%26aulast%3DBrown%26aufirst%3DE.%2BL.%26aulast%3DMaldonado%26aufirst%3DF.%2BC.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DFuhrman%26aufirst%3DS.%2BA.%26aulast%3DZalman%26aufirst%3DL.%2BS.%26aulast%3DPatick%26aufirst%3DA.%2BK.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DE.%2BY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DBorer%26aufirst%3DB.%2BC.%26aulast%3DNayyar%26aufirst%3DN.%2BK.%26aulast%3DMoran%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26aulast%3DGuzman%26aufirst%3DM.%2BC.%26aulast%3DDovalsantos%26aufirst%3DE.%2BZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DMcGee%26aufirst%3DK.%26aulast%3DMohajeri%26aufirst%3DM.%26aulast%3DLiese%26aufirst%3DA.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DKosa%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DBatugo%26aufirst%3DM.%2BR.%26aulast%3DGleeson%26aufirst%3DJ.-P.%2BR.%26aulast%3DWu%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMeador%26aufirst%3DJ.%2BW.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520irreversible%2520human%2520rhinovirus%25203C%2520protease%2520inhibitors.%25208.%2520Pharmacological%2520optimization%2520of%2520orally%2520bioavailable%25202-pyridone-containing%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4572%26epage%3D4585%26doi%3D10.1021%2Fjm030166l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tagat, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCombie, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazareno, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neustadt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vantuno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strizki, J. M.</span></span> <span> </span><span class="NLM_article-title">Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3343</span>– <span class="NLM_lpage">3346</span>, <span class="refDoi"> DOI: 10.1021/jm0155401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0155401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3343-3346&author=J.+R.+Tagatauthor=R.+W.+Steensmaauthor=S.+W.+McCombieauthor=D.+V.+Nazarenoauthor=S.-I.+Linauthor=B.+R.+Neustadtauthor=K.+Coxauthor=S.+Xuauthor=L.+Wojcikauthor=M.+G.+Murrayauthor=N.+Vantunoauthor=B.+M.+Baroudyauthor=J.+M.+Strizki&title=Piperazine-based+CCR5+antagonists+as+HIV-1+inhibitors.+II.+Discovery+of+1-%5B%282%2C4-dimethyl-3-pyridinyl%29carbonyl%5D-4-+methyl-4-%5B3%28S%29-methyl-4-%5B1%28S%29-%5B4-%28trifluoromethyl%29phenyl%5Dethyl%5D-1-piperazinyl%5D-piperidine+N1-oxide+%28Sch-350634%29%2C+an+orally+bioavailable%2C+potent+CCR5+antagonist&doi=10.1021%2Fjm0155401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist</span></div><div class="casAuthors">Tagat, Jayaram R.; Steensma, Ruo W.; McCombie, Stuart W.; Nazareno, Dennis V.; Lin, Sue-Ing; Neustadt, Bernard R.; Cox, Kathleen; Xu, Serena; Wojcik, Lisa; Murray, Michael G.; Vantuno, Nicole; Baroudy, Bahige M.; Strizki, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3343-3346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Truncation of the original piperidino-2(S)-Me piperazine lead structure, from a family of muscarinic antagonists, gave a compd. which has improved selectivity for the HIV-1 co-receptor CCR5 over muscarinic receptors.  Further optimization for pharmacokinetic properties afforded Sch-350634, a prototypical piperazine-based CCR5 antagonist, which is a potent inhibitor of HIV-1 entry and replication in PBMCs.  The title compd. Sch-350634 has excellent oral bioavailability in rat, dog, and monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFljx4tHdwt7Vg90H21EOLACvtfcHk0ljkoTbzOdTW7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFejtLc%253D&md5=03c6ca2481017857a9b737ce24d0eb66</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm0155401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0155401%26sid%3Dliteratum%253Aachs%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DSteensma%26aufirst%3DR.%2BW.%26aulast%3DMcCombie%26aufirst%3DS.%2BW.%26aulast%3DNazareno%26aufirst%3DD.%2BV.%26aulast%3DLin%26aufirst%3DS.-I.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWojcik%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DM.%2BG.%26aulast%3DVantuno%26aufirst%3DN.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DStrizki%26aufirst%3DJ.%2BM.%26atitle%3DPiperazine-based%2520CCR5%2520antagonists%2520as%2520HIV-1%2520inhibitors.%2520II.%2520Discovery%2520of%25201-%255B%25282%252C4-dimethyl-3-pyridinyl%2529carbonyl%255D-4-%2520methyl-4-%255B3%2528S%2529-methyl-4-%255B1%2528S%2529-%255B4-%2528trifluoromethyl%2529phenyl%255Dethyl%255D-1-piperazinyl%255D-piperidine%2520N1-oxide%2520%2528Sch-350634%2529%252C%2520an%2520orally%2520bioavailable%252C%2520potent%2520CCR5%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3343%26epage%3D3346%26doi%3D10.1021%2Fjm0155401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-Y.</span></span> <span> </span><span class="NLM_article-title">Important hydrogen bond networks in indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=282-293&author=Y.-H.+Pengauthor=S.-H.+Uengauthor=C.-T.+Tsengauthor=M.-S.+Hungauthor=J.-S.+Songauthor=J.-S.+Wuauthor=F.-Y.+Liaoauthor=Y.-S.+Fanauthor=M.-H.+Wuauthor=W.-C.+Hsiaoauthor=C.-C.+Hsuehauthor=S.-Y.+Linauthor=C.-Y.+Chengauthor=C.-H.+Tuauthor=L.-C.+Leeauthor=M.-F.+Chengauthor=K.-S.+Shiaauthor=C.+Shihauthor=S.-Y.+Wu&title=Important+hydrogen+bond+networks+in+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitor+design+revealed+by+crystal+structures+of+imidazoleisoindole+derivatives+with+IDO&doi=10.1021%2Facs.jmedchem.5b01390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1</span></div><div class="casAuthors">Peng, Yi-Hui; Ueng, Shau-Hua; Tseng, Chen-Tso; Hung, Ming-Shiu; Song, Jen-Shin; Wu, Jian-Sung; Liao, Fang-Yu; Fan, Yu-Shiou; Wu, Mine-Hsine; Hsiao, Wen-Chi; Hsueh, Ching-Cheng; Lin, Shu-Yu; Cheng, Chia-Yi; Tu, Chih-Hsiang; Lee, Lung-Chun; Cheng, Ming-Fu; Shia, Kak-Shan; Shih, Chuan; Wu, Su-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-293</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase 1 (IDO1), promoting immune escape of tumors, is a therapeutic target for the cancer immunotherapy.  A no. of IDO1 inhibitors have been identified, but only limited structural biol. studies of IDO1 inhibitors are available to provide insights on the binding mechanism of IDO1.  In this study, we present the structure of IDO1 in complex with 24, a NLG919 analog with potent activity.  The complex structure revealed the imidazole nitrogen atom of 24 to coordinate with the heme iron, and the imidazoleisoindole core situated in pocket A with the 1-cyclohexylethanol moiety extended to pocket B to interact with the surrounding residues.  Most interestingly, 24 formed an extensive hydrogen bond network with IDO1, which is a distinct feature of IDO1/24 complex structure and is not obsd. in the other IDO1 complex structures.  Further structure-activity relationship, UV spectra, and structural biol. studies of several analogs of 24 demonstrated that extensive hydrophobic interactions and the unique hydrogen bonding network contribute to the great potency of imidazoleisoindole derivs.  These results are expected to facilitate the structure-based drug design of new IDO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJqtuECqcsrVg90H21EOLACvtfcHk0ljkoTbzOdTW7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtLnJ&md5=2258be36595a3fa8e6c9064b2f15e1de</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01390%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.-H.%26aulast%3DUeng%26aufirst%3DS.-H.%26aulast%3DTseng%26aufirst%3DC.-T.%26aulast%3DHung%26aufirst%3DM.-S.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DWu%26aufirst%3DJ.-S.%26aulast%3DLiao%26aufirst%3DF.-Y.%26aulast%3DFan%26aufirst%3DY.-S.%26aulast%3DWu%26aufirst%3DM.-H.%26aulast%3DHsiao%26aufirst%3DW.-C.%26aulast%3DHsueh%26aufirst%3DC.-C.%26aulast%3DLin%26aufirst%3DS.-Y.%26aulast%3DCheng%26aufirst%3DC.-Y.%26aulast%3DTu%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DL.-C.%26aulast%3DCheng%26aufirst%3DM.-F.%26aulast%3DShia%26aufirst%3DK.-S.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DS.-Y.%26atitle%3DImportant%2520hydrogen%2520bond%2520networks%2520in%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitor%2520design%2520revealed%2520by%2520crystal%2520structures%2520of%2520imidazoleisoindole%2520derivatives%2520with%2520IDO%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D282%26epage%3D293%26doi%3D10.1021%2Facs.jmedchem.5b01390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Enzyme Inhibitors in Drug Discovery</span>.  <i>A Guide for Medicinal Chemists and Pharmacologists</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26btitle%3DA%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayaishi, O.</span></span> <span> </span><span class="NLM_article-title">Induction of pulmonary indoleamine 2,3-dioxygenase by interferon</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1073/pnas.78.1.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.78.1.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=6165986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL3MXhtF2gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1981&pages=129-132&author=R.+Yoshidaauthor=J.+Imanishiauthor=T.+Okuauthor=T.+Kishidaauthor=O.+Hayaishi&title=Induction+of+pulmonary+indoleamine+2%2C3-dioxygenase+by+interferon&doi=10.1073%2Fpnas.78.1.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pulmonary indoleamine 2,3-dioxygenase by interferon</span></div><div class="casAuthors">Yoshida, Ryotaro; Imanishi, Jiro; Oku, Tohru; Kishida, Tsunataro; Hayaishi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">An in vitro system with mouse lung slices was developed in which bacterial endotoxin (5 μg/mL) produced an induction (approx. 10-fold) of indoleamine 2,3-dioxygenase.  The endotoxin was substituted by interferon from mouse L cells or mouse brain.  The pulmonary enzyme activity increased almost linearly for 48 h after addn. of mouse interferon (104 units/mL) to lung slices.  Interferon from mouse L cells or mouse brain produced a 10- to 15-fold increase in the enzyme activity, whereas that from human leukocytes was all but ineffective.  The effect also was obsd. using highly purified L-cell interferon, prepd. by poly(U) affinity column chromatog.  When interferon was treated either by heat, α-chymotrypsin, or anti-interferon serum, such increase in the enzyme activity was diminished essentially to the same extent as seen in the antiviral activity.  The increase in the enzyme activity was blocked when actinomycin D or cycloheximide was added to the slices before interferon treatment.  Thus, the enzyme induction was produced by interferon and not by possible contaminants in the interferon prepns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqscIenhGY1bbVg90H21EOLACvtfcHk0li_HF1V1Yxikg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtF2gs7w%253D&md5=b5b00406098a81610504cab35e1fff67</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.78.1.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.78.1.129%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DImanishi%26aufirst%3DJ.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DKishida%26aufirst%3DT.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DInduction%2520of%2520pulmonary%2520indoleamine%25202%252C3-dioxygenase%2520by%2520interferon%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1981%26volume%3D78%26spage%3D129%26epage%3D132%26doi%3D10.1073%2Fpnas.78.1.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayaishi, O.</span></span> <span> </span><span class="NLM_article-title">Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase</span>. <i>J. Bio. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">3648</span>– <span class="NLM_lpage">3653</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=2419335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL28XitVCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=3648-3653&author=O.+Takikawaauthor=R.+Yoshidaauthor=R.+Kidoauthor=O.+Hayaishi&title=Tryptophan+degradation+in+mice+initiated+by+indoleamine+2%2C3-dioxygenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Takikawa, Osamu; Yoshida, Ryotaro; Kido, Ryo; Hayaishi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3648-53</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Tryptophan (I) degrdn. in mice initiated by indoleamine 2,3-dioxygenase (II) was characterized, taking advantage of its induction by bacterial lipopolysaccharide.  In various tissues, N-formylkynurenine produced by II from I was rapidly hydrolyzed into kynurenine (III) by a kynurenine formamidase, but it was not further metabolized.  The localization in the liver and kidney of the III-metabolizing enzymes suggested that III thus formed was transported by the bloodstream of these 2 organs to be metabolized.  In fact, the plasma III level increased in parallel with the induction of II by lipopolysaccharide, and kinetic anal. indicated that at the maximal induction of the enzyme there was a 3-fold increase in III prodn.  The major metabolic route of III was excretion in urine as xanthurenic acid.  This increase in III prodn. was not explained by L-tryptophan 2,3-dioxygenase in the liver, because during the induction of II, the hepatic enzyme level was substantially suppressed.  Thus, II actively oxidized I in mice, and its induction resulted in an increase in I degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTdpt5zY14brVg90H21EOLACvtfcHk0li_HF1V1Yxikg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVCnsrs%253D&md5=dddaa22122b6da9105a779497252c22b</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DKido%26aufirst%3DR.%26aulast%3DHayaishi%26aufirst%3DO.%26atitle%3DTryptophan%2520degradation%2520in%2520mice%2520initiated%2520by%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DJ.%2520Bio.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D3648%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span> <span> </span><span class="NLM_article-title">Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1845</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-09-3613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1158%2F0008-5472.can-09-3613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=20160032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1845-1853&author=A.+J.+Mullerauthor=J.+B.+DuHadawayauthor=D.+Jallerauthor=P.+Curtisauthor=R.+Metzauthor=G.+C.+Prendergast&title=Immunotherapeutic+suppression+of+indoleamine+2%2C3-dioxygenase+and+tumor+growth+with+ethyl+pyruvate&doi=10.1158%2F0008-5472.can-09-3613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate</span></div><div class="casAuthors">Muller, Alexander J.; DuHadaway, James B.; Jaller, Daniel; Curtis, Peter; Metz, Richard; Prendergast, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1845-1853</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Efforts to improve cancer care in the developing world will benefit from the identification of simple, inexpensive, and broadly applicable medical modalities based on emergent innovations in treatment, such as targeting mechanisms of tumoral immune tolerance.  In this report, we offer preclin. evidence that the low-cost, anti-inflammatory agent Et pyruvate elicits a potent immune-based antitumor response through inhibition of indoleamine 2,3-dioxygenase (IDO), a key tolerogenic enzyme for many human tumors.  Consistent with its reported ability to interfere with NF-κB function, Et pyruvate blocks IDO induction both in vitro and in vivo.  Antitumor activity was achieved in mice with a noncytotoxic dosing regimen of Et pyruvate shown previously to protect against lethality from sepsis.  Similar outcomes were obtained with the functional Et pyruvate analog 2-acetamidoacrylate.  Et pyruvate was ineffective at suppressing tumor outgrowth in both athymic and Ido1-deficient mice, providing in vivo corroboration of the importance of T-cell-dependent immunity and IDO targeting for Et pyruvate to achieve antitumor efficacy.  Although Et pyruvate has undergone early-phase clin. testing, this was done without consideration of its possible applicability to cancer.  Our findings that IDO is effectively blocked by Et pyruvate treatment deepen emerging links between IDO and inflammatory processes.  Further, these findings rationalize oncol. applications for this agent by providing a compelling basis to reposition Et pyruvate as a low-cost immunochemotherapy for clin. evaluation in cancer patients.  Cancer Res; 70(5); 1845-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohkSC_ZW9ndLVg90H21EOLACvtfcHk0li_HF1V1Yxikg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWju78%253D&md5=3d6e683754a5f97ef5215319ad454e2c</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-09-3613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-09-3613%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DCurtis%26aufirst%3DP.%26aulast%3DMetz%26aufirst%3DR.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26atitle%3DImmunotherapeutic%2520suppression%2520of%2520indoleamine%25202%252C3-dioxygenase%2520and%2520tumor%2520growth%2520with%2520ethyl%2520pyruvate%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1845%26epage%3D1853%26doi%3D10.1158%2F0008-5472.can-09-3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astola, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span> <span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">13033</span>– <span class="NLM_lpage">13038</span>, <span class="refDoi"> DOI: 10.1073/pnas.1517820112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1073%2Fpnas.1517820112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=26438837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=13033-13038&author=J.+E.+Coleauthor=N.+Astolaauthor=A.+P.+Cribbsauthor=M.+E.+Goddardauthor=I.+Parkauthor=P.+Greenauthor=A.+H.+Daviesauthor=R.+O.+Williamsauthor=M.+Feldmannauthor=C.+Monaco&title=Indoleamine+2%2C3-dioxygenase-1+is+protective+in+atherosclerosis+and+its+metabolites+provide+new+opportunities+for+drug+development&doi=10.1073%2Fpnas.1517820112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development</span></div><div class="casAuthors">Cole, Jennifer E.; Astola, Nagore; Cribbs, Adam P.; Goddard, Michael E.; Park, Inhye; Green, Patricia; Davies, Alun H.; Williams, Richard O.; Feldmann, Marc; Monaco, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">13033-13038</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide.  Despite much focus on lipid abnormalities in atherosclerosis, it is clear that the immune system also has important pro- and antiatherogenic functions.  The enzyme indoleamine-2,3-dioxygenase (IDO) catalyzes degrdn. of the essential amino acid tryptophan into immunomodulatory metabolites.  How IDO deficiency affects immune responses during atherogenesis is unknown and we explored potential mechanisms in models of murine and human atherosclerosis.  IDO deficiency in hypercholesterolemic ApoE-/- mice caused a significant increase in lesion size and surrogate markers of plaque vulnerability.  No significant changes in cholesterol levels were obsd. but decreases in IL-10 prodn. were found in the peripheral blood, spleen and lymph node B cells of IDO-deficient compared with IDO-competent ApoE-/- mice.  3,4,-Dimethoxycinnamoyl anthranilic acid (3,4-DAA), an orally active synthetic deriv. of the tryptophan metabolite anthranilic acid, but not l-kynurenine, enhanced prodn. of IL-10 in cultured splenic B cells.  Finally, 3,4-DAA treatment reduced lesion formation and inflammation after collar-induced arterial injury in ApoE-/- mice, and reduced cytokine and chemokine prodn. in ex vivo human atheroma cell cultures.  Our data demonstrate that endogenous prodn. of tryptophan metabolites via IDO is an essential feedback loop that controls atherogenesis and athero-inflammation.  We show that the IDO pathway induces prodn. of IL-10 in B cells in vivo and in vitro, suggesting that IDO may induce immunoregulatory functions of B cells in atherosclerosis.  The favorable effects of anthranilic acid derivs. in atherosclerosis indicate a novel approach toward therapy of CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWCuNzxk2Po7Vg90H21EOLACvtfcHk0lj0_syfIWiLDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7nE&md5=3108cf2a1db341a946359ba644c43be8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1517820112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1517820112%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DJ.%2BE.%26aulast%3DAstola%26aufirst%3DN.%26aulast%3DCribbs%26aufirst%3DA.%2BP.%26aulast%3DGoddard%26aufirst%3DM.%2BE.%26aulast%3DPark%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DA.%2BH.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMonaco%26aufirst%3DC.%26atitle%3DIndoleamine%25202%252C3-dioxygenase-1%2520is%2520protective%2520in%2520atherosclerosis%2520and%2520its%2520metabolites%2520provide%2520new%2520opportunities%2520for%2520drug%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D13033%26epage%3D13038%26doi%3D10.1073%2Fpnas.1517820112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Jaipuri, F.</span>; <span class="NLM_string-name">Kumar, S.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Pavana, R.</span>; <span class="NLM_string-name">Potturi, H.</span>; <span class="NLM_string-name">Velvadapu, V.</span>; <span class="NLM_string-name">Waldo, J.</span>; <span class="NLM_string-name">Zhang, Z.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 Inhibitors</span>. PCT <span class="NLM_patent">WO2017107979A1</span>, June 29, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+Mendonca&author=B.+Parr&author=R.+Pastor&author=Z.+Pei&author=L.+Gazzard&author=F.+Jaipuri&author=S.+Kumar&author=X.+Li&author=R.+Pavana&author=H.+Potturi&author=V.+Velvadapu&author=J.+Waldo&author=Z.+Zhang&author=G.+Wu&author=X.+Lin&author=P.-W.+Yuen&title=Tdo2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMendonca%26aufirst%3DR.%26atitle%3DTdo2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Mendonca, R.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 and Ido1 Inhibitors</span>. PCT <span class="NLM_patent">WO2019005559</span>, March 1, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Z.+Pei&author=R.+Pastor&author=L.+Gazzard&author=B.+Parr&author=W.+Liu&author=R.+Mendonca&author=G.+Wu&author=P.-W.+Yuen&title=Tdo2+and+Ido1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DTdo2%2520and%2520Ido1%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span>; <span class="NLM_string-name">Parr, B.</span>; <span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Pastor, R.</span>; <span class="NLM_string-name">Gazzard, L.</span>; <span class="NLM_string-name">Jaipuri, F.</span>; <span class="NLM_string-name">Kumar, S.</span>; <span class="NLM_string-name">Potturi, H.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Chu, Y.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Tdo2 and Ido1 Inhibitors</span>. PCT <span class="NLM_patent">WO2019006047</span>. March 1, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Z.+Pei&author=B.+Parr&author=W.+Liu&author=R.+Pastor&author=L.+Gazzard&author=F.+Jaipuri&author=S.+Kumar&author=H.+Potturi&author=G.+Wu&author=X.+Lin&author=Y.+Chu&author=P.-W.+Yuen&title=Tdo2+and+Ido1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DTdo2%2520and%2520Ido1%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overberger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular base-catalyzed imidazole catalysis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">6992</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1021/ja00754a051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00754a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaE38XjtlGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1971&pages=6992-6998&author=C.+G.+Overbergerauthor=C.-M.+Shen&title=Intramolecular+base-catalyzed+imidazole+catalysis&doi=10.1021%2Fja00754a051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular base-catalyzed imidazole catalysis</span></div><div class="casAuthors">Overberger, C. G.; Shen, Chah-Moh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6992-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new two-step synthesis of 4(5)-(2'-hydroxyphenyl)imidazole (HPI) was utilized.  Solvolysis of p-nitrophenyl acetate (PNPA) and p-nitrophenyl toluate, (PNPT) catalyzed by HPI and other related imidazole or phenol model compds., such as 1-methyl-4-(2'-hydroxyphenyl)imidazole and 4(5)-(2'-methoxyphenyl)imidazole, indicated that reaction other than simple nucleophilic catalysis by the imidazole group and phenoxide ion function of HPI must operate during the catalyzed solvolysis.  The favored geometry existing between the imidazole and phenoxide groups suggests an intramol. bifunctional catalysis involving the phenoxide and imidazole groups.  The rate const. of this intramol. base-catalyzed imidazole catalysis was 137.4 and 6.39 1./mole min for PNPA and PNPT, resp. 4(5)-[ω-(p-Hydroxyphenyl)nonyl]imidazole (HPNI), which has an imidazole and phenol function joined by 9 methylene units, was synthesized in 7 steps from sebacic acid.  The modest obsd. rate enhancement during the solvolysis of p-nitrophenyl acetate and p-nitrophenyl palmitate catalyzed by HPNI was attributed to a hydrophobic attraction between the substrates and the long chain model compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUTEGP5aCxrVg90H21EOLACvtfcHk0lj0_syfIWiLDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XjtlGjsw%253D%253D&md5=c86d26fdd8146c2dc460a0fb14d9bc34</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00754a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00754a051%26sid%3Dliteratum%253Aachs%26aulast%3DOverberger%26aufirst%3DC.%2BG.%26aulast%3DShen%26aufirst%3DC.-M.%26atitle%3DIntramolecular%2520base-catalyzed%2520imidazole%2520catalysis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1971%26volume%3D93%26spage%3D6992%26epage%3D6998%26doi%3D10.1021%2Fja00754a051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetter, M. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-substituted imidazoles via palladium-catalyzed cross-coupling reactions</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1055/s-1998-2069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1055%2Fs-1998-2069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK1cXjslKmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=829-831&author=M.+C.+Jetter&title=Synthesis+of+4-substituted+imidazoles+via+palladium-catalyzed+cross-coupling+reactions&doi=10.1055%2Fs-1998-2069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-substituted imidazoles via palladium-catalyzed cross-coupling reactions</span></div><div class="casAuthors">Jetter, Michele C.; Reitz, Allen B.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Imidazoles bearing vinyl and aryl substitution in the 4-position are prepd. using Pd-catalyzed cross-coupling reactions of 1-tritylimidazol-4-yltin and -zinc reagents in 67-80% yield.  Importantly, these coupling methods appear to be general for aryl and vinyl bromides, iodides, and triflates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJg_UnaPimabVg90H21EOLACvtfcHk0lhLpXJvBlNuYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslKmurk%253D&md5=7c212b38801aacced01c0761aaeb1c4b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-2069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-2069%26sid%3Dliteratum%253Aachs%26aulast%3DJetter%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%2520of%25204-substituted%2520imidazoles%2520via%2520palladium-catalyzed%2520cross-coupling%2520reactions%26jtitle%3DSynthesis%26date%3D1998%26spage%3D829%26epage%3D831%26doi%3D10.1055%2Fs-1998-2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falling, S. N.</span></span> <span> </span><span class="NLM_article-title">An efficient and selective method for the preparation of iodophenols</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5291</span>, <span class="refDoi"> DOI: 10.1021/jo00305a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00305a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaK3cXltFCksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=5287-5291&author=K.+J.+Edgarauthor=S.+N.+Falling&title=An+efficient+and+selective+method+for+the+preparation+of+iodophenols&doi=10.1021%2Fjo00305a026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient and selective method for the preparation of iodophenols</span></div><div class="casAuthors">Edgar, Kevin J.; Falling, Stephen N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5287-91</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Direct iodination of a wide range of phenols may be achieved with unprecedented selectivity in aq. alc. solvents by the action of a reagent prepd. in situ from sodium hypochlorite and sodium iodide.  Para-substituted phenols (or ortho-substituted, when the para-position is already occupied) are obtained in fair to excellent yields by simple isolation techniques.  The extent of iodination is easily controlled by stoichiometry.  The technique is also useful with some anilines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGTJmAnTR4arVg90H21EOLACvtfcHk0lhLpXJvBlNuYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltFCksbo%253D&md5=4d6d858cdbdfa040056b736fc7c5e7b4</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjo00305a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00305a026%26sid%3Dliteratum%253Aachs%26aulast%3DEdgar%26aufirst%3DK.%2BJ.%26aulast%3DFalling%26aufirst%3DS.%2BN.%26atitle%3DAn%2520efficient%2520and%2520selective%2520method%2520for%2520the%2520preparation%2520of%2520iodophenols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D5287%26epage%3D5291%26doi%3D10.1021%2Fjo00305a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnakenburg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, R. S.</span></span> <span> </span><span class="NLM_article-title">Efficient and reliable iodination and <i>O</i>-methylation of fluorinated phenols</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_fpage">2357</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201000161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1002%2Fejoc.201000161" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=2357-2362&author=R.+Robertauthor=G.+Schnakenburgauthor=R.+S.+Waldvogel&title=Efficient+and+reliable+iodination+and+O-methylation+of+fluorinated+phenols&doi=10.1002%2Fejoc.201000161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000161%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DR.%26aulast%3DSchnakenburg%26aufirst%3DG.%26aulast%3DWaldvogel%26aufirst%3DR.%2BS.%26atitle%3DEfficient%2520and%2520reliable%2520iodination%2520and%2520O-methylation%2520of%2520fluorinated%2520phenols%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26spage%3D2357%26epage%3D2362%26doi%3D10.1002%2Fejoc.201000161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, M. A.</span></span> <span> </span><span class="NLM_article-title">An investigation of imidazole and oxazole syntheses using aryl-substituted TosMIC reagents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1021/jo991782l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo991782l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1516-1524&author=J.+Siskoauthor=A.+J.+Kassickauthor=M.+Mellingerauthor=J.+J.+Filanauthor=A.+Allenauthor=M.+A.+Olsen&title=An+investigation+of+imidazole+and+oxazole+syntheses+using+aryl-substituted+TosMIC+reagents&doi=10.1021%2Fjo991782l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of imidazole and oxazole syntheses using aryl-substituted TosMIC reagents</span></div><div class="casAuthors">Sisko, Joseph; Kassick, Andrew J.; Mellinger, Mark; Filan, John J.; Allen, Andrew; Olsen, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1516-1524</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient and mild protocols are described for prepg. polysubstituted imidazoles in a single pot from aryl-substituted tosylmethyl isocyanide (TosMIC) reagents and imines generated in situ.  Traditional imine-forming reactions employing virtually any aldehyde and an amine followed by addn. of the TosMIC reagent gave 1,4,5-tri-substituted imidazoles with predictable regiochem.  Thus, condensation of pyruvaldehyde with (MeO)2CHCH2NH2 in THF at ambient temp. for 15 min and subsequent reaction with 4-FC6H4CH(Tos)N+≡C- [Tos = 4-MeC6H4SO2] in the presence of piperazine for 18 h gave 71% [(fluorophenyl)imidazolyl]ethanone I.  Employing chiral amines and aldehydes, particularly those derived from α-amino acids, gave imidazoles, e.g. II, with asym. centers appended to N-1 or C-5 with excellent retention of chiral purity.  1,4-Disubstituted imidazoles were also readily prepd. by a simple variant of the above procedure.  Selection of glyoxylic acid as the aldehyde component of the procedure lead to intermediates such as III which readily underwent decarboxylation and elimination of the tosyl moiety to give 1,4-disubstituted imidazoles in high yields.  Alternatively, using NH4OH as the amine component in conjunction with a variety of aldehydes gave 4,5-disubstituted imidazoles in moderate to good yields in a single pot while avoiding the need for protecting groups.  Finally, the facile prepn. of mono- and disubstituted oxazoles, e.g. IV, from these TosMIC reagents and aldehydes was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRTW4a3LyN2rVg90H21EOLACvtfcHk0lhLpXJvBlNuYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCrt7g%253D&md5=96018e9928216132e4e5f36cf89d3c98</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo991782l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991782l%26sid%3Dliteratum%253Aachs%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DFilan%26aufirst%3DJ.%2BJ.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DM.%2BA.%26atitle%3DAn%2520investigation%2520of%2520imidazole%2520and%2520oxazole%2520syntheses%2520using%2520aryl-substituted%2520TosMIC%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1516%26epage%3D1524%26doi%3D10.1021%2Fjo991782l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fürstner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanda, G.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Synthesis of the fully functional macrolide core of salicylihalamide: Remote control of olefin geometry during RCM</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3731</span>– <span class="NLM_lpage">3734</span>, <span class="refDoi"> DOI: 10.1021/ol006646d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006646d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFyktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3731-3734&author=A.+F%C3%BCrstnerauthor=O.+R.+Thielauthor=G.+Blanda&title=Asymmetric+Synthesis+of+the+fully+functional+macrolide+core+of+salicylihalamide%3A+Remote+control+of+olefin+geometry+during+RCM&doi=10.1021%2Fol006646d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of the Fully Functional Macrolide Core of Salicylihalamide: Remote Control of Olefin Geometry during RCM</span></div><div class="casAuthors">Fuerstner, Alois; Thiel, Oliver R.; Blanda, Gaetano</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3731-3734</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A catalysis-based approach to the core region I (R = H, Me, TBS, MOM) of the antitumor agents salicylihalamides A and B is reported.  Key steps are two asym. hydrogenations of β-keto esters catalyzed by [(R)-BINAP·RuCl2]2·NEt3 and an RCM-based macrocyclization effected by an NHC-contg. ruthenium carbene.  The stereochem. outcome of the latter reaction is controlled by remote substituents on the phenolic OH group of the cyclization precursor II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozrrhKOQ5EM7Vg90H21EOLACvtfcHk0lhn8AM_4k8oQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFyktLY%253D&md5=830c4a16d07ebe21c55c3af468408376</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol006646d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006646d%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DThiel%26aufirst%3DO.%2BR.%26aulast%3DBlanda%26aufirst%3DG.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520the%2520fully%2520functional%2520macrolide%2520core%2520of%2520salicylihalamide%253A%2520Remote%2520control%2520of%2520olefin%2520geometry%2520during%2520RCM%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3731%26epage%3D3734%26doi%3D10.1021%2Fol006646d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetina-Rocha, C.</span></span> <span> </span><span class="NLM_article-title">Intramolecular conjugate addition of alkenyl and aryl functions to enones initiated by lithium-iodine exchange</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3245</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1021/ol016288u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol016288u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=3245-3247&author=E.+Piersauthor=C.+L.+Harrisonauthor=C.+Zetina-Rocha&title=Intramolecular+conjugate+addition+of+alkenyl+and+aryl+functions+to+enones+initiated+by+lithium-iodine+exchange&doi=10.1021%2Fol016288u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Conjugate Addition of Alkenyl and Aryl Functions to Enones Initiated by Lithium-Iodine Exchange</span></div><div class="casAuthors">Piers, Edward; Harrison, Cristian L.; Zetina-Rocha, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3245-3247</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of 4-[(Z)-3-iodo-2-propenyl] and 4-(2-iodoaryl)cyclohexenones such as I and II with tert-butyllithium and trimethylsilyl chloride in a mixt. of THF and HMPA gives fused bicyclic alkenones such as III and IV stereoselectively and in 72-91% yields.  I was prepd. in 5 steps from 3-(isobutoxy)-6-Me-2-cyclohexenone and Me 4-(benzyloxy)-2-butynoate.  Stereoselective addn. of sodium iodide to PhCH2OCH2C≡CCO2Me in acetic acid, redn. of the ester moiety with diisobutylaluminum hydride, and bromination of the allylic alc. with triphenylphosphine-bromine complex and imidazole gave the allylic bromide (Z)-PhCH2OCH2CI:CHCH2Br.  Treatment of 3-(isobutyloxy)-6-methyl-2-cyclohexenone with LDA in THF followed by alkylation with (Z)-PhCH2OCH2CI:CHCH2Br, redn. of the ketone with diisobutylaluminum hydride and acid-catalyzed hydrolysis and elimination yielded the substituted cyclohexenone I.  Addn. of tert-butyllithium to a soln. of I in THF with trimethylsilyl chloride and HMPA under argon at -78° followed by stirring for 5 min. and warming to room temp. gave III in 83% yield.  3-(Isobutyloxy)-2-cyclohexenone was alkylated with 2-I-5-MeOC6H3CH2Br (prepd. in three steps from 2-iodo-5-methoxybenzyl alc.) followed by redn. and acid-catalyzed elimination to give iodobenzyl cyclohexenone II; treatment of II under similar conditions to I gave the tetrahydrofluorenone IV stereoselectively in 80% yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ol96YEBawbVg90H21EOLACvtfcHk0ljl-E5u5ukFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtbs%253D&md5=8b49627c3e2fecd030716d72e7f40476</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol016288u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016288u%26sid%3Dliteratum%253Aachs%26aulast%3DPiers%26aufirst%3DE.%26aulast%3DHarrison%26aufirst%3DC.%2BL.%26aulast%3DZetina-Rocha%26aufirst%3DC.%26atitle%3DIntramolecular%2520conjugate%2520addition%2520of%2520alkenyl%2520and%2520aryl%2520functions%2520to%2520enones%2520initiated%2520by%2520lithium-iodine%2520exchange%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D3245%26epage%3D3247%26doi%3D10.1021%2Fol016288u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Nispen, S. P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leusen, A. M.</span></span> <span> </span><span class="NLM_article-title">Use of dilithio-tosylmethyl isocyanide in the synthesis of oxazoles and imidazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3723</span>– <span class="NLM_lpage">3726</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(00)78757-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fs0040-4039%2800%2978757-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADyaL3MXhtVent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1980&pages=3723-3726&author=S.+P.+J.+M.+van%0ANispenauthor=C.+Mensinkauthor=A.+M.+van+Leusen&title=Use+of+dilithio-tosylmethyl+isocyanide+in+the+synthesis+of+oxazoles+and+imidazoles&doi=10.1016%2Fs0040-4039%2800%2978757-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of sulfonylmethyl isocyanides.  21.  Use of dilithio(tolylsulfonyl)methyl isocyanide in the synthesis of oxazoles and imidazoles</span></div><div class="casAuthors">Van Nispen, Simon P. J. M.; Mensink, Cees; Van Leusen, Albert M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">3723-6</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The reactions of 4-MeC6H4SO2CLi2NC (I) with a range of substrates were studied.  I reacted with the carbonyl of unsatd. esters to give oxazoles, e.g. reaction with trans-PHCH:CHCO2Me (-70 to 0°, 2 h) gave the oxazole II (53%), whereas the monoanion gave pyrroles by reaction with the conjugated C:C bonds.  With C-N multiple bonds, I gave imidazoles, e.g. with isoquinoline (-70 to 0°, 0.5 h) 44% imidazo[5,1-a]isoquinoline was obtained in a single step.  Reaction of pyridine or pyridazine N-oxides with I gave unsatd. ring opened products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIfKNvIK01zLVg90H21EOLACvtfcHk0ljl-E5u5ukFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtVent7o%253D&md5=7a83f4b83c99166d9e1a07a78904d463</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4039%2800%2978757-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4039%252800%252978757-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNispen%26aufirst%3DS.%2BP.%2BJ.%2BM.%26aulast%3DMensink%26aufirst%3DC.%26aulast%3Dvan%2BLeusen%26aufirst%3DA.%2BM.%26atitle%3DUse%2520of%2520dilithio-tosylmethyl%2520isocyanide%2520in%2520the%2520synthesis%2520of%2520oxazoles%2520and%2520imidazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1980%26volume%3D21%26spage%3D3723%26epage%3D3726%26doi%3D10.1016%2Fs0040-4039%2800%2978757-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, N.</span>; <span class="NLM_string-name">Friedman, M.</span>; <span class="NLM_string-name">Arnold, L. D.</span>; <span class="NLM_string-name">Yang, B.</span>; <span class="NLM_string-name">Fix-Stenzel, R. S.</span>; <span class="NLM_string-name">Ericsson, A.</span>; <span class="NLM_string-name">Michaelides, M. R.</span>; <span class="NLM_string-name">Qian, X.-D.</span>; <span class="NLM_string-name">Holms, J. H.</span>; <span class="NLM_string-name">Steinman, D. H.</span>; <span class="NLM_string-name">Tian, Z.</span>; <span class="NLM_string-name">Wittenberger, S. J.</span></span> <span> </span><span class="NLM_article-title">Aminobenzoxazoles as Therapeutic Agents</span>. U.S. Patent <span class="NLM_patent">20,060,025,383 A1</span>. Feb 2, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+Wishart&author=M.+Friedman&author=L.+D.+Arnold&author=B.+Yang&author=R.+S.+Fix-Stenzel&author=A.+Ericsson&author=M.+R.+Michaelides&author=X.-D.+Qian&author=J.+H.+Holms&author=D.+H.+Steinman&author=Z.+Tian&author=S.+J.+Wittenberger&title=Aminobenzoxazoles+as+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DAminobenzoxazoles%2520as%2520Therapeutic%2520Agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed intramolecular CH arylation of five-membered <i>N</i>-heterocycles</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3170</span>– <span class="NLM_lpage">3172</span>, <span class="refDoi"> DOI: 10.1055/s-2006-947326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1055%2Fs-2006-947326" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=3170-3172&author=N.+Araiauthor=M.+Takahashiauthor=M.+Mitaniauthor=A.+Mori&title=Palladium-catalyzed+intramolecular+CH+arylation+of+five-membered+N-heterocycles&doi=10.1055%2Fs-2006-947326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-947326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-947326%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DMitani%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520intramolecular%2520CH%2520arylation%2520of%2520five-membered%2520N-heterocycles%26jtitle%3DSynlett%26date%3D2006%26volume%3D18%26spage%3D3170%26epage%3D3172%26doi%3D10.1055%2Fs-2006-947326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span> <span> </span><span class="NLM_article-title">Concise synthesis of pentenyl phenyl acrylic acid</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1080/00397910701473333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1080%2F00397910701473333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=2989-2994&author=D.+Sunauthor=P.+Laiauthor=W.+Xieauthor=J.+Dengauthor=Y.+Jiang&title=Concise+synthesis+of+pentenyl+phenyl+acrylic+acid&doi=10.1080%2F00397910701473333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Concise synthesis of pentenyl phenyl acrylic acid</span></div><div class="casAuthors">Sun, Dequn; Lai, Pengxiang; Xie, Weidong; Deng, Jingen; Jiang, Yaozhong</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2989-2994</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">E-3-[2-Pent-(1Z)-enylphenyl]acrylate (I) is a structural unit of pepticinnamin E, a natural product and a bisubstrate inhibitor of FPTase.  A new synthetic strategy was developed to prep. I with high stereoselectivity and high overall yield of 78.6%.  The method used in producing these effects involved the application of a five-step procedure starting from 2-IC6H4CH2OH through an E-selective Wittig-Horner reaction, followed by Sonogashira reaction to produce E-2-pent-1-ynylcinnamate, which was quant. hydrogenated using Lindlar catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgI-kBCFsGKLVg90H21EOLACvtfcHk0lj_4wADhJNTSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVKqsLc%253D&md5=5de326fef8060f86ff9007adab59d638</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397910701473333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910701473333%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DConcise%2520synthesis%2520of%2520pentenyl%2520phenyl%2520acrylic%2520acid%26jtitle%3DSynth.%2520Commun.%26date%3D2007%26volume%3D37%26spage%3D2989%26epage%3D2994%26doi%3D10.1080%2F00397910701473333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. L.</span></span> <span> </span><span class="NLM_article-title">Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1814</i></span>,  <span class="NLM_fpage">1947</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2011.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1016%2Fj.bbapap.2011.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21835273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1814&publication_year=2011&pages=1947-1954&author=D.+Meiningerauthor=L.+Zalamedaauthor=Y.+Liuauthor=L.+P.+Stepanauthor=L.+Borgesauthor=J.+D.+McCarterauthor=C.+L.+Sutherland&title=Purification+and+kinetic+characterization+of+human+indoleamine+2%2C3-dioxygenases+1+and+2+%28IDO1+and+IDO2%29+and+discovery+of+selective+IDO1+inhibitors&doi=10.1016%2Fj.bbapap.2011.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors</span></div><div class="casAuthors">Meininger, David; Zalameda, Leeanne; Liu, Yichin; Stepan, Lara P.; Borges, Luis; McCarter, John D.; Sutherland, Claire L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1814</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1947-1954</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO1) catalyzes the 1st step in tryptophan breakdown along the kynurenine pathway.  Therapeutic inhibition of IDO1 is receiving much attention due to its proposed role in the pathogenesis of several diseases including cancer, hypotension, and neurodegenerative disorders.  A related enzyme, IDO2 has recently been described.  Here. the authors report the 1st purifn. and kinetic characterization of human IDO2 using a facile L-tryptophan consumption assay amenable to high throughput screening.  The authors found that the Km of human IDO2 for L-tryptophan was much higher than that of IDO1.  The authors also described the identification and characterization of a new IDO1 inhibitor compd., Amg-1, by high-throughput screening, and compared the inhibition profiles of IDO1 and IDO2 with Amg-1 and previously described compds.  The data indicated that human IDO1 and IDO2 have different kinetic parameters and different inhibition profiles.  Docking of Amg-1 and related analogs to the known structure of IDO1 and to homol.-modeled IDO2 suggested possible rationales for the different inhibition profiles of IDO1 and IDO2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkjKusST0FNrVg90H21EOLACvtfcHk0lj_4wADhJNTSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSjtbzN&md5=95b88d7de219c1dcc63da1003b73c8f5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DStepan%26aufirst%3DL.%2BP.%26aulast%3DBorges%26aufirst%3DL.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DSutherland%26aufirst%3DC.%2BL.%26atitle%3DPurification%2520and%2520kinetic%2520characterization%2520of%2520human%2520indoleamine%25202%252C3-dioxygenases%25201%2520and%25202%2520%2528IDO1%2520and%2520IDO2%2529%2520and%2520discovery%2520of%2520selective%2520IDO1%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1814%26spage%3D1947%26epage%3D1954%26doi%3D10.1016%2Fj.bbapap.2011.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/s0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2Fs0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lh8zG6zyCN_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2Fs0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh8zG6zyCN_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/s0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2Fs0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lh8zG6zyCN_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2Fs0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Sharff, A.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>Buster</i>, version 2.11.4; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T','PDB','2D0T'); return false;">PDB: 2D0T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3I','PDB','6O3I'); return false;">PDB: 6O3I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i221"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_63438"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00662">10.1021/acs.jmedchem.9b00662</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Calculation of <i>K</i><sub><i>i</i></sub>, mode of inhibition of <b>NLG-919</b>, in vivo pharmacodynamics, single crystal X-ray data for <b>122–124</b>, <b>132</b> and <b>NLG-919</b>, co-crystal data for <b>NLG-919</b> bound in hIDO, chiral and achiral HPLC of selected final compounds, <sup>1</sup>H NMR spectra of <b>121–124</b>, <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>NLG-919</b>, and <b>123</b> minimized in 2D0T (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_002.csv">CSV</a>)</p></li><li><p class="inline">Compound <b>11</b> minimized in 2D0T (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Compound <b>37</b> minimized in 2D0T (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Compound <b>46</b> minimized in 2D0T (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_005.pdb">PDB</a>)</p></li><li><p class="inline">Compound <b>124</b> minimized in 2D0T (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_006.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_001.pdf">jm9b00662_si_001.pdf (3.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_002.csv">jm9b00662_si_002.csv (5.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_003.pdb">jm9b00662_si_003.pdb (479.03 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_004.pdb">jm9b00662_si_004.pdb (648.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_005.pdb">jm9b00662_si_005.pdb (650.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00662/suppl_file/jm9b00662_si_006.pdb">jm9b00662_si_006.pdb (650.95 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">CCDC accession code: <b>NLG-919</b>, 1905358; <b>132</b>, 1905087; <b>124·HCl</b>, 1905094; <b>123·HBr</b>, 1905089; <b>122·HBr</b>, 1905093.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00662&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00662%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-14%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00662" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799cc7a8e5d24f5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
